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v/v  Volume/volume ratio 
w/v  Weight/volume ratio XXI 
ABSTRACT 
This work has involved the characterisation of a number of avian isolates of S. 
aureus from Scotland, England, N. Ireland, America and Sri Lanka. Other avian, 
human and animal coagulase-positive and coagulase-negative species served as 
control organisms in the various test procedures. The isolates were mainly from 
clinically-diseased birds. More than half of the avian isolates of S.  aureus were 
from  N.  Ireland.  The  identity  of the  strains  was  confirmed  by  conventional 
cultural and biochemical tests (including Rapidec Staph and API Staph) and by 
rapid molecular methods.  The strains were also characterised in terms of their 
plasmid profiles  and  antibiotic  resistance.  A high proportion  (95%)  of the  S. 
aureus isolates contained one or more plasmids ranging in size from 1.6 to  16 
kb.  The sensitivity of these strains to a number of antibiotics  was  determined 
and 96% of the avian  S.  aureus isolates  were resistant to  one or more  of the 
antibiotics  tested.  A  high  proportion  (71 %  )  of  isolates  were  resistant  to 
tetracycline,  kanamycin,  tobramycin  and  gentamicin.  A  close  correlation 
between  tetracycline  resistance  and  the  presence  of a  4.4  kb  plasmid  was 
demonstration by e1etrotransformation of the plasmid into tetracycline sensitive 
strains. 
The main part of the work was to develop PCR techniques for identification and 
typing of avian S.  aureus. Different primer sets were applied in order to generate 
reproducible profiles of the PCR amplimers. Of the 86 avian S.  aureus studied, 
12, 7, 4 and 5 groups were recognised by the use of ribosomal, REP, coagulase 
gene  and  protein  A  gene  primers  respectively.  PCR-ribotyping  (method  1) 
produced a relatively simple pattern which was useful for rapid identification of 
these isolates  and for  differentiation  of these  isolates  from  each other.  These 
PCR  fingerprinting  methods  were  simple  to  perform  and  reproducible.  The 
majority  (80%)  of the  strains  even from  different geographical  locations  had 
similar "typical avian" profiles whereas 20% had atypical avian profiles. 
Results showed that many of the virulence factors characterised in this study in 
avian S.  aureus were likely to be regulated by the agr and sal' loci. Sequencing 
of the  agrD  region  in  selected  strains  suggested  that  80%  of avian  (typical XXII 
avian) isolates belonged to agr specificity group II and the other (20%) (atypical 
avian) strains belonged to agr specificity groups I or III. 
An investigation by multiplex peR for eight toxin genes (encoding enterotoxins 
A-E,  exfoliative toxins  A-B  and  toxic  shock syndrome toxin-I) revealed that 
only 5% of the avian isolates produced one or more of these toxin genes and all 
were  atypical  by  other  criteria.  A  multiplex  peR  developed  to  detect 
haemolysin (ct,  Y and 8)  genes showed that all the  86  avian S.  aureus isolates 
had the ct  and 8-haemolysin genes and a majority (86%) of the strains also had 
the y-haemolysin gene.  Many of those that lacked the y-haemolysin gene were 
atypical by other criteria. Only 5% of the avian S.  aureus strains possessed the 
~-haemolysin gene and, again, these isolates were atypical by other criteria. 
One of the most striking findings in the present study was that a single dominant 
protein band of 22 kDa was present in the culture supernates of 89.5% of avian 
S.  aureus strains.  N-terminal sequence analysis  of the 22 kDa protein gave a 
sequence  that  was  almost  identical  to  that  previously  reported  for  a  thiol 
(cysteine) protease in an  avian S.  aureus strain and the presence of a cysteine 
protease gene in the avian strains was confirmed by peR and sequence analysis 
of the  amplimer.  Other  tests  with  different  inhibitors  and  an  activator  of 
protease activity supported the conclusion that the 22  kDa band represented a 
cysteine protease. 1. INTRODUCTION 1.1 STAPHYLOCOCCI 
1.1.1 History and bacteriological characteristics 
Ogston  (1882,  cited  by  Baird-Parker,  1972)  introduced  the  name 
"Staphylococcus" (from staphyle, a bunch of grapes) for the group of  micrococci 
causing inflammation and suppuration. Rosenbach (1884, cited by Baird-Parker, 
1972) used the term in a taxonomic sense and provided the first description of 
the  genus  Staphylococcus.  Members  of the  genus  Staphylococcus  are  Gram-
positive cocci (0.5-1.5  J,!m)  that occur singly, in pairs, tetrads, short chain, and 
irregular  "grape-like"  clusters.  They  are  non-motile  and  non-spore  forming. 
Most species demonstrate catalase activity. Most grow in the presence of lO% 
sodium  chloride  and  at  18-40  dc.  They  are  usually  unencapsulated  or  have 
limited capsule formation. Most species are facultative anaerobes and except for 
S.  saccharolyticus and S.  aureus subsp. anaerobius, their growth is more rapid 
and abundant under aerobic conditions. The G+C content of staphylococci was 
found to be 30-40 mol% (Kocur et al.,  1971).  The cell walls of staphylococci 
contain  both peptidoglycan and  teichoic  acid  and  the  peptidoglycan  contains 
large amount of  glycine (Schleifer and Kandler, 1972). 
Species: There are 32 species currently recognized in the genus Staphylococcus 
(Kloos,  1998).  Coagulase-positive species of Staphylococcus include S.  aureus 
subsp.  aureus,  S.  aureus  subsp.  anaerobius,  S.  hyicus,  S.  intermedius,  S. 
delphini, and S.  schleiferi subsp. coagulase (Pantuceck et al.,  1996). 
Staphylococcus  species  can be  identified  on the  basis  of colony morphology, 
coagulase production, oxygen requirements,  haemolysins,  resistance to  certain 
antibiotics,  various  enzyme  activities  and  acid  production  from  certain 
carbohydrates under aerobic  conditions.  Most clinically significant coagulase-
positive species are compared in Table 1.1. 2 
Table 1.1 Differentiation of coagulase-positive Staphylococclls species (Data from Kloos and 
Lambe 1991, Kloos, 1998). 
Property" 
Colony size (large)b 
Colony pigment" 
Anaerobic growth
d 
Aerobic growth 
Staphylocoagulase
C 
Clumping factor
f 
Heat-stable nuclease 
Haemolysins 
Catalase 
Oxidase 
Alkaline phosphatase 
Arginine arylamidase 
Pyrrolidonyl arylamidase 
Ornithine decarboxylase 
Urease 
p-glucosidase 
p-glucuronidase 
p-galactosidase 
Arginine utilization 
Acetoin production 
Nitrate reduction 
Esculin hydrolysis 
Novobiocin resistance 
Polymyxin B resistance 
D-trehalose 
D-mannitol 
D-mannose 
D-turanose 
D-xylose 
D-cellobiose 
L-arabinose 
Maltose 
a-lactose 
Sucrose 
N-acetylglucosamine 
Raffinose 
S.  aureus S.  schleiferi 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
d 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
± 
+ 
(+) 
+ 
+ 
+ 
(+) 
+ 
+ 
+ 
d 
+ 
(+) 
S.  intermedius 
+ 
(+) 
+ 
+ 
d 
+ 
d 
+ 
+ 
+ 
+ 
d 
+ 
d 
+ 
+ 
(d) 
+ 
d 
(±) 
d 
+ 
+ 
S.  delphini 
+ 
(+) 
+ 
+ 
+ 
+ 
+ 
ND 
ND 
ND 
+ 
ND 
ND 
ND 
+ 
+ 
ND 
ND 
(+) 
+ 
ND 
ND 
+ 
+ 
+ 
ND 
ND 
S.  hyicus 
+ 
+ 
+ 
d 
+ 
+ 
+ 
d 
d 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
a  Symbols  (unless  otherwise  indicated):  +,  90%  or  more  strains  positive;  ±,  90%  or more  strains  weakly 
positive;  -,  90% or more  strains negative;  d,  II to  89%  of strains positive;  ND,  not determined;  (  ),  delayed 
reaction. 
b Positive is defined as a colony diameter of  ~6 mm after incubation on P agar at 34 to 35°C for 3 days and at 
room temperature (ca. 25°C) for an additional 2 days (Kloos and Schleifer, 1975a). 
C  Positive is  defined as  the  visual  detection of carotenoid pigments (e.g.,  yellow,  yellow-orange,  or orange) 
during  colony  development  at  normal  incubation  or room  temperatures.  Pigments  may  be  enhanced  by  the 
addition of milk, fat, glycerol monoacetate, or soaps to P agar. 
d Anaerobic growth in a semisolid thioglycolate medium (Kloos and Schleifer, 1975a). Symbols: +, moderate or 
heavy growth down tube within 18 to 24; ±, heavier growth in the upper portion and weaker growth in the lower, 
anaerobic portion of tube; -,  no visible growth within 48 h,  but by 72 to 96 h very weak diffuse growth or a few 
scattered, small colonies may be observed in the lower portion of tube; ( ), delayed growth appearing within 24 to 
72 h, sometimes noted as large discrete colonies in the lower portion of tube. 
C  ±, staphylocoagulase test for S.  schUeferi subsp. schleiferi was negative, but for S.  schUeferi subsp. coagulase 
was positive. 
f±, clumping factor test for S.  schUeferi subsp. schleiferi was positive, but for S.  schUeferi subsp. coagulase was 
negative 3 
Avian species: Staphylococci isolated frequently from poultry include S.  aureus 
and S.  epidermidis (Lukas  ova et al.,  1986; Jose et al.,  1994). Another species, S. 
gallinarum, has been isolated from processed poultry (Deveriese et al.,  1983). S. 
hyicus has been associated with fibrinoheterophi1ic  blepharitis in chickens and 
turkeys (Cheville et al.,  1988), and was isolated in profuse and often pure culture 
from  skin lesions, and from  internal organs of chickens and turkeys suffering 
from pox (Devriese et al.,  1992). It was also isolated from five of  nine tibiotarsal 
growth plates of turkeys  with  stifle joint osteoarthritis  (Tate  et al.,  1993).  S. 
intermedius  is  found  frequently  on  carnivora  (Devriese  et al.,  1984)  and has 
been  isolated  also  from  certain  other  mammals  and  birds  (Kloos,  1998).  S. 
arlettae has been isolated from poultry and goats (Schleifer et al.,  1984). 
Cutaneous habitats:  Staphylococci are widespread in nature,  though they are 
mainly  found  living  on  the  skin,  skin  glands,  and  mucous  membranes  of 
mammals and birds (Noble and Somerville 1974; Devriese et al.,  1978; Devriese 
et al.,  1983; Akatov et al.,  1985; Devriese et al.,  1986; Kloos et al.,  1991). 
Cutaneous  habitats  in  birds:  Staphylococcus  spp.  are  ubiquitous,  normal 
inhabitants  of skin  and  mucous  membranes,  and  are  common  organisms  in 
environments  where  poultry  are  hatched,  reared  or  processed.  Most 
staphylococcal species are considered to  be normal flora,  which help suppress 
other possible pathogens by their presence through interference or competitive 
exclusion.  Some have  the  potential  to  be  pathogenic  and  produce  disease  if 
allowed entry through the skin or mucous membranes (Skeeles, 1997). 
Staphylococci and S.  aureus in particular were found to be present on the body 
surfaces of live poultry (Devriese et al.,  1975). S.  aureus has also been isolated 
from  the  skin  and  nasopharynx  of poultry  and  of wild  birds  (Cooper  and 
Needham, 1976). 4 
Other habitats:  Staphylococci have been detected in the pharynx,  conjuctiva, 
mouth,  blood,  mammary  glands,  faeces,  bodily  discharges,  excretions  and 
intestinal, genitourinary and respiratory tracts of their hosts (Elek, 1959). Small 
numbers of staphylococci have been found  in air,  dust, soil and water, and on 
inanimate surfaces or fomites,  molluscs, insects and plants in areas frequented 
by mammals and birds (Elek, 1959; Kloos and Schleifer, 1981). 
1.1.2 Culture and isolation 
1.1.2.1 Colonial appearance 
Staphylococci produce distinctive colonies on a variety of commercial, selective 
and  non-selective  agar  media.  The  commonly  used  selective  media  include 
mannitol-salt agar, lipase-salt-mannitol agar, phenylethylalcohol agar; Columbia 
colistin-nalidixic  acid  (CAN)  agar,  and Baird-Parker  agar  base  supplemented 
with egg  yolk tellurite  enrichment.  These media inhibit the  growth of Gram-
negative bacteria, but allow the growth of staphylococci and certain other Gram-
positive bacteria.  Baird-Parker agar base supplemented with egg yolk tellurite 
enrichment  is  widely  recommended  for  the  detection  and  enumeration  of S. 
aureus  in  foods  (Schwab  et al.,  1984).  This  medium  and  the  other selective 
media were designed to distinguish S.  aureus from other species on the basis of 
colonial and biochemical properties; however, with the discovery of additional 
staphylococcal  species  that  share  some  properties  with  S.  aureus,  it  is  now 
recognised that such a distinction can not be made accurately. Schleifer-Kramer 
agar (Schleifer and Kramer, 1980) is used by some laboratories for the selective 
isolation  and  enumeration  of staphylococci  from  foods  and  other  heavily 
contaminated sources. Incubation of cultures on selective media should be for at 
least 48-72 h at 35-37 °C for colony development. 
Staphylococci  from  a  variety  of clinical  specImens  are  usually  isolated  in 
primary culture on blood agar (e.g. tryptic soy agar supplemented with 5% sheep 
blood), following an incubation period of 18-24 h at 35-37 0c, In this short time, 5 
most  staphylococcal  species  will  produce  abundant  growth  and  well  isolated 
colonies  will  be  1-3  mm  in  diameter,  circular,  smooth  and  raised,  with  a 
butyrous  consistency;  unfortunately,  however colonies  of most  of the  species 
and  subspecies  can  not  be  distinguished  from  one  another.  Considering  the 
necessity for  the  rapid  identification of S.  aureus  in  clinical  specimens,  it  is 
fortunate  that  colonies  of pigmented  haemolytic  strains  of S.  aureus  can  be 
tentatively identified within 24 h. Suggestions to extend the incubation period, to 
allow for  the  development of species,  subspecies,  and  strain-specific  colonial 
features, have been largely ignored, until recently. Now there is an appreciation 
that certain coagulase-negative staphylococcal species (CNS)  are opportunistic 
pathogens and that individual species, subspecies and strains should be identified 
in multiple specimens taken from the site(s) of infection when determining the 
aetiological agent. 
The  identification  of staphylococci  should  start  with  the  characterisation  of 
colony morphology (Kloos,  1998).  P-agar (Kloos et al' J  1974) and tryptic soy 
agar have been widely used for  isolation from the primary cutaneous  habitats 
(Kloos et al' J  1991). Colonies of each of the recognised species and subspecies 
can  be  distinguished  from  one  another  on  these  media  with  considerable 
accuracy,  provided  reference  strains  of each  of the  taxa  are  included  for 
comparison. Detailed descriptions of colonies have been reported in the original 
taxonomic descriptions of  the species and subspecies. Pigmentation and pigment 
sectoring patterns  are  usually more  pronounced in  colonies  growing on these 
media  than  on  blood  agar.  When  pigment  is  present,  colonies  are  usually 
different shades of cream-yellow, yellow, yellow-orange, or orange, depending 
on  the  particular  species  and  strain.  Some  strains  of  S.  epidermidis,  S. 
intermedius  and  S.  lentus  demonstrate  a  subtle  violet,  pinkish,  or  brownish 
pigment. All staphylococcal species grow well on tryptic soy agar, but S.  vUulus, 
S.  lentus,  S.  caseolyticus and  some strains of S.  sciuri grow poorly on P-agar. 
These  species  should  be  cultured  on  tryptic  soy  agar  or  tryptic  soy  agar 
supplemented  with  blood.  The  anaerobic  species  S.  saccharolyticus  and  S. 6 
aureus  subsp.  anaerobius  grow well on the  above non-selective media under 
anaerobic conditions, but grow very poorly under aerobic conditions. Brain-heart 
infusion agar and nutrient agar support good growth of staphylococci, although 
not many species comparisons have been made of colonies growing on these 
media. 
1.1.2.2 Growth in broth and semi-solid media 
Staphylococci  grow  well  in  a  variety  of commercial  broth media,  including 
tryptic  soy  broth,  brain-heart  infusion  broth,  nutrient  broth  and  tryptose 
phosphate broth, with or without the addition of blood. Most of the species are 
butyrous and easy to  emulsify, but the S.  sciuri species group,  S.  caseolyticus 
and  the  strong  slime-producing  strains  of S.  epidermidis  are  glutinous  and 
difficult to emulsify. Many of the staphylococcal species can produce abundant 
anaerobic growth in a semi-solid Brewer's thioglycollate medium within 24-72 h 
at 35-37 °C (Kloos and Schleifer, 1975b; Kloos and Bannerman, 1995). Species 
such as  S.  aureus,  S.  epidermidis,  S.  lugdunensis  and S.  schleiferi,  which are 
among the most pathogenic species, produce abundant anaerobic growth with 
overnight incubation. Some species such as S.  hominis, S.  auricularis, S.  kloosii, 
S.  equorum, S.  arlettae, S.  caseolyticus, S.  vitulus and S.  lentus fail to grow or 
grow only very slowly in the anaerobic portion of  this medium (Kloos, 1998). 
1.1.3 Identification of species with commercial biochemical test systems 
To expedite the process of identifying staphylococcal species and subspecies in 
the clinical laboratory, several manufacturers have developed rapid identification 
kits and automated systems requiring only a few hours to one day for completing 
tests.  With these products, identification of most species and subspecies can be 
made with an accuracy of 70->90% (Kloos and Wolfshohl,  1982; Crouh et al., 
1987; Kloos and George, 1991; Bannerman et aI.,  1993). Currently, S.  aureus, S. 
epidermidis, S.  haemolyticus, S.  capitis subsp. capitis, S.  saprophyticus, S.  cohnii 
subsp. cohn ii, S.  simulans, S.  intermedius and S.  sciuri can be identified reliably 
by most of the commercial systems available.  Some additional testing may be 7 
required  to  increase  the  accuracy  of identification  above  90%.  The  rapid 
identification  systems  now  available  include  the  following:  API-STAPH-
IDENT,  STAPH  Trac  System,  API  STAPH,  RAPIDEC  STAPH  and  ID  32 
STAPH kits and the fully automated Vitek and Vitek, Jr systems, which utilize a 
Gram Positive Identification (GPI)  Card (bioMerieux Vitek Inc.,  Hazelwood, 
MO, USA); MicroScan pos ID panel, MicroScan Rapid Pos ID  panel, and the 
Pos Combo and Rapid Pos Combo panels, which combine species identification 
and antimicrobial susceptibility tests  (Dade MicroScan Inc.,  West Sacramento 
Microbiology  Systems);  Sceptor  Staphylococcus  MIC/ID  panel  and  Sceptor 
Gram  Positive  BreakpointiID  Panel  (Becton  Dickinson  Instrument  Systems, 
Towson, MD, USA); GP MicroPlate test panel (Biology, Haywood, CA, USA); 
and the Microbial Identification System (MIS) that automates identification by 
combining  cellular  fatty  acid  analysis  with  computerised  high-resolution  gas 
chromatography (MIDI, Newark, DE, USA). 
Rapid identification of the species S.  aureus can be made using the AccuProbe 
culture identification test for S.  aureus (Gen-Probe Inc., San Diego, CA, USA). 
The test is  a DNA probe assay directed against rRNA and it is  very accurate. 
This species can also be identified by a new immunoenzymatic assay based on a 
monoclonal  antibody  prepared  against  the  S.  aureus  endo-p-N-
acetylglucosaminidase (Guardati et al.,  1993).  These species tests are specially 
useful  in identifying coagulase-negative, protein A-negative,  and/or  clumping 
factor-negative mutants of S.  aureus, that would otherwise be misidentified by 
coagulase and latex agglutination tests. 
1.1.4 Antimicrobial sensitivity 
Staphylococci have a record of  developing resistance quickly and successfully to 
antibiotics. Penicillin-resistant S.  aureus strains began emerging shortly after the 
introduction of penicillin in medicine in the early 1940s. Today the percentage 
of penicillin-resistant strains has risen to  75-95% with the highest percentages 
found  among  hospital  strains  (Kloos,  1998).  The  methicillin-resistant  strains 8 
isolated  in  Britain came  from  hospitalized patients,  were  multiply  antibiotic-
resistant,  belong  to  phage  group  III,  and  their  resistance  to  methicillin  was 
heterogenous,  affecting only a minority of the  cell population.  After the  mid-
1970s,  large outbreaks of infection by methicillin-resistant S.  aureus  (MRS A) 
were  recorded  in  many  hospitals  in  some  countries  (Schaefler  et  al.,  1981; 
Pavillard et al.,  1982). Many of  these outbreaks appear to have been caused by a 
single epidemic strain that was transferred between hospitals by the movement 
of patients  (Duckworth  et al.,  1988).  Genetic  analyses  and  molecular typing 
methods have indicated that various isolates of MRSA may have had a clonal 
origin, and suggest that the methicillin-resistance determinant was acquired by S. 
aureus at some point in time  before or around the time of the introduction of 
methicillin (Kreiswirth et at.,  1993).  Although the mechanism of this  type  of 
resistance  is  not  fully  understood,  it  at  least  partly  involves  the  presence  of 
modified penicillin-binding proteins with decreased p-lactam affinity (Brakstad 
and Maeland, 1997). 
Erythromycin-resistant staphylococci often have cross-resistance to macrolides 
(erythromycin,  oleandomycin,  spiramycin,  clarithromycin,  azithromycin), 
lincosamides  (lincomycin,  clindamycin)  and  streptogramin type  B  antibiotics. 
These  antibiotics,  collectively  designated  Macrolids,  Lincosamide,  and 
Streptogramins  B  (MLS),  bind  to  the  50S  ribosomal  subunit  at  overlapping 
binding  sites,  and  binding  interferes  with  transpeptidation  and  translocation 
reactions needed for peptide chain elongation. In resistant strains these sites are 
protected by the N
6
, N
6 -dimethylation of an adenine-2058 residue at the peptidyl 
transferase centre of 23S  rRNA,  a reaction performed by a rRNA methylase. 
Three  distinct  rRNA  methylase  genes  have  been  detected  in  staphylococci: 
ermA, ermB and ermC (Weisblum, 1985a). 
Tetracycline resistance is  widespread among staphylococcal species and ranks 
along with p-lactam and MLS  resistance as  one of the most frequent types of 
antibiotic resistance found  in  natural populations of staphylococci (Schwarz et 9 
at.,  1994).  There are two mechanisms of tetracycline resistance recognised in 
staphylococci.  The most common one  involves  an  energy-dependent pumping 
(efflux)  of tetracycline and doxycycline  from  the  cell,  so  that  levels of these 
antibiotics are reduced below that required to  inhibit the ribosome. The efflux 
protein is  most often encoded by the inducible gene tetK which is  located on 
class I plasmids of  the PT181 family (see section 1.3.2). The second mechanism, 
one that is controlled by the gene tetM,  involves ribosome protection such that 
protein synthesis is  unaffected by the presence of tetracycline, doxycycline, or 
minocycline (Schaefler et at.,  1976). 
Trimethoprim resistance is either mediated by alterations in the expression of  the 
intrinsic chromosomal dfr gene (e.g. dfrB of  S.  aureus or dfre of  S.  epiderm idis) , 
possibly  resulting  in  overproduction  of the  native  dihydrofolate  reductase 
(DHFR) or a reduced affinity of the native DHFR for trimethoprim, or by the 
acquisition of  a second chromosomal or plasmid dfr gene (e.g. dfr  A in S.  aureus, 
S.  epidermidis  and  S.  hominis)  that  encodes  a  trimethoprim-resistant  DHFR 
capable of  rescuing the reduction step leading to tetrahydrofolate in the presence 
oftrimethoprim (Galetto et at.,  1987; Rouch et at.,  1989; Dale et at.,  1995). 
1.1.4.1 Resistance to antimicrobial agents in avian strains 
In  a  study  of the  putative  transfer  of antibiotic  resistance  from  poultry  to 
humans, hens and eggs were examined for the presence of various pathogens. 
Sensitivity tests showed the presence of strains of S.  aureus resistant to one or 
more of penicillin-G, tetracycline,  erythromycin,  clindamycin,  cephalosporins, 
oxacillin,  gentamicin,  chloramphenicol,  tobramycin,  ciporofloxacin, 
sulphamethoxazole and novobiocin (Papadopoulou et at.,  1997;  Nawaz et at., 
1999;  Aarestrup  et  at.,  2000).  Methicillin-resistant  coagUlase-negative 
staphylococci were isolated from the nares and skin of 1 to 8 week old healthy 
chickens (Kawano et at.,  1996). There is no report about avian MRS A strains. 10 
1.2 CELLULAR COMPONENTS 
1.2.1 Cell surface components 
The principal structures of the cell envelope or surface of staphylococci are the 
cell membrane, cell wall and exocellular material. Many of the components of 
these structures have biological activities and playa vital role in the interaction 
of staphylococci with their habitat or environment. The cell surface is  a mosaic 
in which the cell wall components and certain membrane components may be 
exposed sufficiently to interact with external factors.  Some of these components 
may  be  submerged  beneath  the  surface  in  staphylococci  that  produce  large 
amounts of  exocellular material. 
1.2.1.1 Cell membrane 
The cell membrane appears to be a typical lipid-protein bilayer, being composed 
mainly of  phospholipids and proteins. It represents a selective barrier and fulfils 
many  functions,  including  electron transport,  active  transport,  participation in 
septum  formation,  and  segregation  of  DNA.  The  cytochromes  and 
menaquinones  bound  to  cell  membranes  are  important  components  of the 
electron  transport  system.  Phospholipids,  glycolipids,  menaquinones  and 
carotenoids make up the major lipid components of the membrane.  The major 
polar lipids are phospholipids and glycolipids (Shaw, 1975; Nahaie et ai.,  1984). 
The  major  phospholipids  are  phosphatidylglycerol,  diphosphatidylglycerol 
(cardiolipin)  and phosphatidic  acid.  Lysylphosphatidylglucose  is  also  a  major 
component  of the  cell  membrane  of  S.  aureus  and  S.  intermedius.  The 
glycolipids  are  monoglucosyl  and  ~-diglucosyl diglycerides  and  phosphatidyl 
glucose.  The  (1 ~6)-~-linked  diglucosyl  (gentiobiosyl)  diacyglycerol  of 
staphylococci is  also  found  in the membrane of Bacillus species.  There  is  no 
information specifically about the cell membrane composition of avian isolates 
of  staphylococci. 11 
1.2.1.2 Cell wall 
Peptidoglycan and teichoic acid are the major components of the staphylococcal 
cell  wall.  The  peptidoglycan  amounts  to  about  50-60%  of the  dry  weight 
(Schleifer  and  Kandler,  1972;  Schleifer,  1983).  The  cell  wall  teichoic  acid 
amounts  to  about  30-50%  of the  dry  weight,  and  it  is  covalently  linked  to 
peptidoglycan. The peptidoglycan is the main structural polymer in the wall and 
it plays an impOliant role in maintaining the spherical shape of the cell. It is  a 
heteropolymer  consisting  of  glycan  chains  that  are  cross-linked  by  short 
peptides. The glycan moiety is  made up  of alternating  ~-I,4-linked units of N-
acetylglucosamine and N-acetylmuramic acid.  Some of the C-6 hydroxl groups 
of the  muramyl-6-phosphate  residue  represent the  attachment points  between 
peptidoglycan and teichoic acid (Kojima et al.,  1985).  There is  no  information 
specifically about the cell wall composition of  avian isolates of staphylococci. 
1.2.1.3 Protein A 
Protein A is  a cell wall-associated protein of S.  aureus, and it has the ability to 
bind to the Fc portion ofIgG antibodies (Forsgren and Sjoquist, 1966; Forsgren, 
et aI.,  1983).  Protein A  (SpA)  of S.  aureus  has  been  detected  in 90-99% of 
biotype A strains isolated from man (Hajek and Marsalek, 1976; Forsgren et aI., 
1983).  It is  detected  less  frequently  in  S.  aureus  biotype  B  strains  (2-5%), 
isolated from pigs and poultry and in biotype C strains (6-40%), isolated from 
cattle, pigs, sheep and goats.  S.  hyicus produces a type of SpA that is different 
from that S.  aureus (Muller et aI.,  1981).  About 85% of S.  intermedius strains 
produce an extracellular type  of SpA,  whereas  4%  of strains  produce a  cell-
bound form (Cox et aI.,  1986). The absence of  protein A differentiates S.  aureus 
of the poultry biotype from S.  aureus of the slaughterhouse biotype as described 
by Isigidi et al.  (1990). 
1.2.1.4 Cell slllface adltesins 
Staphylococci  have  a  group  of  cell  surface  proteins  that  act  as  adhesins 
(microbial  surface  components  recogmsmg  adhesive  matrix  molecules, 12 
MSCRAMMs)  and  bind  to  extracellular  matrix  proteins  such  as  fibronectin, 
vitronectin, fibrinogen, laminin, bone sialoprotein, thrombospondin, elastin and 
collagen types I, II and IV, of their host (Wadstrom and Rozgonyi, 1986; Ryden 
et al.,  1983; 1989; 1990; Switalski et al.,  1989; Wadstrom, 1991). 
The matrix proteins play important roles in the systematic organisation of host 
tissues  (e.g.  connective tissue,  bone tissue)  and maintenance of homoeostasis. 
The two fibronectin-binding adhesins (FnBPs) of S.  aureus are encoded by two 
distinct,  but  highly  homologous,  genes fnbA  andfnbB  (JOnsson et al.,  1991). 
S.  aureus produces a collagen-binding adhesin that is encoded by the gene ena 
(Patti et al.,  1992). 
The  cell surface  fibrinogen-binding  adhesin  (clumping factor)  of S.  aureus  is 
encoded by gene elf  A (McDevitt et al.,  1995).  Staphylocoagulase (coagulase) is 
mainly an extracellular protein of  S.  aureus and certain other species that binds 
prothrombin  and  activates  the  coagulation  pathway  (Hemker  et  al.,  1975). 
However, a small fraction of the coagulase molecules remains bound to the cell 
wall and this fraction can bind fibrinogen as  well as  prothrombin (Boden and 
Flock,  1989).  There  is  no  information  about  cell-surface  adhesins  in  avian 
isolates of  S.  aureus. 
1.2.1.5 Exocellular material 
Staphylococcal  capsules  are  located  external  to  the  cell  wall  and  they  are 
composed primarily of antigenic (capsular) polysaccharides (Sutherland,  1977). 
The capsular polysaccharides of  S.  aureus are made up of different combinations 
of either  amino  uronic  acids  (N-acetyl-D-aminoglucuronic  acid,  N-acetyl-D-
aminogalacturonic acid or N-acetyl-D-aminomannuronic acid) or non-amidated 
uronic acids (glucuronic acid or galacturonic acid)  and N-acetyl-D-fucosamine 
or galactose, depending upon the particular strain (Wilkinson, 1983). 13 
Slime  is  a  complex  extracellular  substance  produced  in  varying  amounts  by 
many, if  not most, staphylococci. The amounts of slime produced by a particular 
strain  may  vary  widely  according  to  genetic  factors  and  growth  conditions. 
Many strains of  S.  epidermidis and some strains of S.  capitis subsp. ureotyticus 
produce  copious  amounts  of this  substance (Peters  et at.,  1987;  Kloos  et at., 
1992).  There is  no  information  about  exocellular material  produced by  avian 
isolates of  S.  aureus. 
1.2.2 Extracellular proteins 
S.  aureus produces a wide variety of exoproteins that contribute to its ability to 
colonize and cause disease in mammalian hosts. Nearly all strains are reported to 
secrete  a  group  of enzymes  and  cytotoxins  which  includes  four  haemolysins 
(alpha, beta, gamma, and delta), nuclease, proteases, lipases, hyaluronidase, and 
collagenase.  The main function of these proteins may be  to  convert local host 
tissues into nutrients required for bacterial growth. Some strains produce one or 
more  additional  exoproteins,  which  include  toxic  shock  syndrome  toxin-l 
(TSST-l),  the  staphylococcal  enterotoxins  (SEA,  SEB,  SECI-3,  SED,  SEE, 
SEG,  SEH,  and SEI), the  exfoliative  toxins  (ETA  and ETB),  and  leukocidin. 
Each of these toxins is known to have potent effects on cells of  the host immune 
system, but many of them have other biological effects as  well.  Their primary 
function in vivo may be to inhibit host immune responses to S.  aureus. TSST-l 
and  the  staphylococcal  enterotoxins  are  also  known  as  pyrogenic  toxin 
superantigens  (PTSAgs).  Two  former  names  for  TSST-l  were  staphylococcal 
pyrogenic exotoxin C and  staphylococcal enterotoxin F (Dinges  et at.,  2000). 
The  PTSAgs  are  a  group  of  exotoxins  secreted  by  either  S.  aureus  or 
Streptococcus pyogenes  that  have  been  grouped  together  because  they  share 
several  important biological  characteristics  (Bohach  et at.,  1990;  1997).  The 
family  of PTSAgs  presently  includes  TSST  -1,  most  of the  staphylococcal 
enterotoxins  (SEA,  SEB,  SECn,  SED,  SEE,  and  SEH),  and  the  streptococcal 
pyrogenic  exotoxins  (SPE  A,  B,  C,  F,  G,  Hand  J  and  streptococcal 
superantigen) (Bergdoll et ai.,  1973; Bergdoll, 1983; Bohach et aI.,  1990; 1997). 14 
Each  of  these  exotoxins  exhibits  at  least  three  biological  properties: 
pyrogenicity; superantigenicity, which refers to  the ability of these exotoxins to 
stimulate  proliferation  of  T  -lymphocytes  without  regard  for  the  antigen 
specificity of these cells; and the capacity to  enhance the lethality of endotoxin 
in rabbits up to 100,000-fold (Bohach et al.,  1990; 1997). 
1.2.2.1 Staphylococcal enterotoxins 
Eight major toxins have been identified, two very recently (SEG and SEI), and 
various  degrees of investigation into  their  structures  and  functions  have  been 
undertaken.  The  SEs,  SEA  to  SEI  except  SEF,  are  produced  by  various 
coagulase-positive staphylococci. All toxins thus far identified share a number of 
important properties (Bergdoll et al.,  1973; Bergdoll, 1983; Bohach et al.,  1990; 
1997), including (i)  an ability to  cause emesis and gastroenteritis in  a primate 
model,  (ii)  superantigenicity,  (iii)  intermediate  resistance  to  heat  and  pepsin 
digestion,  and  (iv)  tertiary  structural  similarity  (where  known)  including  an 
intramolecular disulphide  bond.  SEC  can  be  further  divided  into  three  major 
antigenic subtypes, SEC 1, SEC2 and SEC3. 
Genigeorgis and Sadler (1966) have emphasized the public health significance 
of  S.  aureus (ca. 40% of which were found to be enterotoxigenic) strains which 
could  be  isolated  from  the  livers  of poultry  slaughtered  commercially.  The 
presence of enterotoxigenic  strains of S.  aureus  in  foods  was  suggested  as  a 
potential public health hazard because of the ability of these strains to produce 
intoxication or food poisoning. 
In a study of enterotoxin production in poultry strains by Harvey et al.  (1982), S. 
aureus strains were isolated from end-of-Iay poultry carcasses obtained from  a 
plant at two  different stages of processing before and after storage at different 
temperatures.  These  strains  were  supplemented with S.  aureus strains isolated 
from poultry from a wide range of sources and biotyped, phage-typed, and tested 
for production of enterotoxins A-E. The isolates were found to consist of poultry 15 
and human specific strains  and  each of these groups  contained strains  able  to 
produce  enterotoxins.  Poultry  strains  produced  only  enterotoxin  D  whereas 
human strains  produced enerotoxins  A,  C  and  D.  The  hen  carcasses  used  in 
storage experiments were found  to  be naturally contaminated with enterotoxin 
D-producing staphylococci.  However enterotoxin D  could not be  detected  on 
any  of  the  carcasses  even  after  storage  at  temperatures  which  allowed 
multiplication of the organisms to occur. Other investigators have suggested that 
enterotoxin-producing  S.  aureus  strains,  which  can  be  isolated  from  poultry 
carcasses at processing, have their origin from either contaminated equipment or 
people in the processing plant (Notermans et al.,  1982; Adams and Meat,  1983; 
Thompson and Patterson, 1983). 
1.2.2.2 Toxic shock syndrome toxin-1 (TSST-1) 
Toxic shock syndrome  is  an  acute  and  potentially fatal  human illness  that  is 
characterised by a high fever,  diffuse  erythematous rash,  desquamation of the 
skin  1 to  2 weeks after onset (if not fatal  before this time),  hypotension,  and 
involvement of three or more organ systems (Todd et al.,  1978;  Shands et al., 
1980;  Davis  et al.,  1980;  Reingold et al.,  1982;  Chesney,  1989;  Deresiewicz, 
1990).  The  illness  was  initially  brought  to  the  attention  of  the  medical 
community in 1978 by Todd et al.  (1978), who recognised it as a major systemic 
illness associated with non-invasive S.  aureus infections in children. The illness 
was designated TSS by these investigators. In the early  1980s, an epidemic of 
TSS  occurred among young women in  the  United States.  Nearly all  of these 
cases of  TSS were associated with menstruation, the use of  tampons (particularly 
those of higher absorbency), and the presence of S.  aureus localised to cervical 
or vaginal colonization (Davis et al.,  1980; Shands et al.,  1980). The absence of 
detectable  bacteremia  in  these  patients  suggested  that  TSS  resulted  from 
intoxication with products elaborated by S.  aureus. TSST-l was the first marker 
toxin identified for TSS (Bergdoll et al.,  1981;  Bergdoll and Schlievert 1984), 
and  this  toxin  is  currently  accepted  as  the  cause  of 100%  of menstruation-
associated TSS  cases.  TSST-l  is  the  only PTSAg known to  cause  TSS  from 16 
intravaginal  sources;  this  is  presumably  due  to  its  umque  capacity  to  cross 
mucosal surfaces. Of the S.  aureus strains isolated in TSS  cases not associated 
with tampon usage,  approximately  50% produce TSST  -1,  47%  produce  SEB, 
and  3%  produce  SEC  (Schlievert,  1986;  Bohach  et  at.,  1990).  Coagulase-
negative  staphylococci  have  not  been  shown  to  cause  TSS.  There  is  no 
information about TSST  -1  produced by avian isolates. 
1.2.2.3 Exfoliative toxins 
Like  the  enterotoxins,  the  exfoliative  toxins  have  been  purified  to  relative 
homogeneity and,  in pure  form,  have  been shown to  cause effects  in  animals 
similar to what is  observed in infected patients. The purified exfoliative toxins, 
also  called  epidermolytic  toxins,  have  produced  skin  symptoms  of 
staphylococcal scalded skin syndrome (SSSS),  a disease most often associated 
with neonates (Gemmell, 1995). This disease starts with a localised skin lesion, 
followed  by widespread  erythema  and  exfoliation.  The  name  of the  disease 
comes  from  the  fact  that  the  skin  looks  as  though  it  has  been  burned. 
Epidemiologically,  exfoliative  toxin-producing  strains  are  correlated  with 
staphylococcal bullous  impetigo  (Piemont et at.,  1984;  Murono  et at.,  1988). 
The genes for exfoliative toxin A (eta)  and exfoliative toxin B (etb) have been 
cloned and sequenced (Lee et at.,  1987), showing 45% similarity at the amino 
acid  level  and  have  highly  similar  hydrophobicitylhydrophilicity  profiles. 
Despite  this  similarity,  the  two  proteins  are  antigenically  distinct,  with  little 
cross-reactivity. 
Exfoliative toxin produced by S.  hyicus bound to GM4-like glycolipid extracted 
from  the skin of I-day-old chickens but did not bind to  glycolipid from  adult 
chickens or suckling mice. Exfoliative toxin produced by S.  aureus bound to the 
GM4-like  glycolipid  extracted  from  the  skin  of suckling  mice  but  not  to 
glycolipid from  I-day-old or adult chickens. S.  hyicus and S.  aureus exfoliative 
toxins lost their toxicity by preincubation with GM4-like glycolipid from  I-day-
old chickens and suckling mice, respectively (Tanabe et at.,  1995). 17 
1.2.2.4 Alpha-haemolysin (alpha-toxin) 
Alpha-haemolysin  is  by  far  the  most  intensively  studied  of the  S.  aureus 
cytotoxins. A high percentage of strains is reported to make this toxin, and it is 
toxic to a wide range of mammalian cells (Dinges et al.,  2000). It is particularly 
active against rabbit erythrocytes, and it is  also dermonecrotic and neurotoxic. 
Levels  of alpha-toxin  as  low  as  1  III  are  lethal  when  injected  into  rabbits 
intravenously. Extensive reviews of alpha-toxin have been published (Freer and 
Arbuthnott, 1982; Bhakdi and Tranum-Jensen, 1991). 
The  gene that  encodes  alpha-haemolysin,  hla,  was  cloned from  the  S.  aureus 
chromosome and sequenced (Gray and Kehoe,  1984).  The first  26  residues of 
the translated polypeptide comprise a signal sequence, which is cleaved during 
secretion. The mature protein contains 293  residues and has a molecular weight 
of 33  kDa and a pI of about 8.5.  There are no cysteines in the mature protein, 
which  is  composed  primarily  of p-sheets  (65%),  with  a-helical  structures 
making up  a much smaller percentage (10%)  of the secondary structure.  This 
toxin is under control of  the accessory gene regulator (agr) and is therefore made 
during the late exponential phase of growth in a batch culture (see section 1.4). It 
was observed by O'Reilly et al.  (1990) that some strains contain the hla gene but 
do not produce detectable alpha-toxin. 
Alpha-haemolysin was expressed phenotypically in 37% of the bovine isolates 
of S.  aureus, in 59% of the human carrier isolates, and in 67% of the  isolates 
from  human septicaemia (Aaresstrup  et al.,  1999).  Gibbs  et al.  (1978b)  have 
reported that some S.  aureus poultry strains of  phage types A (100%), Bl (36%), 
B2 (100%) and C (100%) were alpha-haemolysin producers. 
1.2.2.5 Beta-haemolysin (beta-toxin, sphingomyelinase C) 
S.  aureus beta-haemolysin, first identified in  1935 by Glenny and Stevens, was 
also  shown  by  them  to  be  highly  haemolytic  for  sheep  but  not  rabbit 
erythrocytes. It is  not dermonecrotic in guinea pigs, and it is not lethal in mice. 18 
Glenny and Stevens (1935) also noted that the haemolytic activity of this toxin 
was enhanced by incubation below 10°C after treatment at 37°C, leading to the 
appellation 'hot-cold' haemolysin. 
Beta-haemolysin is  secreted into the  culture medium as  an exotoxin and has  a 
molecular weight of 35 kDa. The gene was cloned by Coleman et al.  (1986) and 
Projan et al.  (1989), and the nucleotide sequence was published by Projan et al. 
(1989).  The  gene named hlb,  is  chromosomally-located on a 4-kb  Cia! DNA 
fragment and encodes a 330-amino-acid polypeptide with a predicted molecular 
weight of 39 kDa. A 200-residue region of  homology has been found to Bacillus 
cereus sphingomyelinase (55. 7% similarity). 
According to some reports,  ~-toxin is produced by 75-100% of  S.  aureus bovine 
strains  and  by  10-15%  of human  strains  (Elek  and  Levy,  1950;  Poutre  I and 
Ducelliz, 1979). Aarestrup et al.  (1999) reported that  ~-toxin was expressed by 
S.  aureus in 72% of bovine,  11% of human carrier isolates and 13% of human 
septicemia  isolates.  Gibbs  et  al.  (1978b)  have  reported  that  some  S.  aureus 
poultry phage type Bl (93%) and B2 (Variable) strains were ~-toxin producers. 
1.2.2.6 Gamma-haemolysin and PV-leukocidin (two-component toxins) 
Two types ofbicomponent toxins are made by S.  aureus, gamma-haemolysin (y-
toxin) and Panton-Valenine (PV) leukocidin. Each of  these toxins is made as two 
non-associated secreted proteins, referred to  as  Sand F components (for slow-
and  fast-eluting  proteins  in  an  ion-exchange  column)  (Woodin,  1959;  1960). 
Gamma-haemolysin is reported to be made by virtually every human strain of  S. 
aureus, while PV leukocidin is made by 2 to 3% of strains (Prevost et al.,  1995). 
The  toxins  affect  neutrophils  and  macrophages,  and  garnrna-haemolysin  is 
additionally able  to  lyse  many varieties of mammalian erythrocytes.  Garnrna-
haemolysin  is  not  identifiable  on  blood  agar  plates,  however,  due  to  the 
inhibitory effect of agar on toxin activity (Prevost et al.,  1995). 19 
The genes for gamma-haemolysin are transcribed from a single locus, located on 
a 4.5-kb Seal-digested chromosomal fragment.  Extracts from a clone containing 
this  fragment  were  haemolytic  and  leukotoxic.  The  open  reading  frames,  in 
order,  are  named  htgA,  hlgC,  and  htgB,  and  they  correspond  to  previously 
identified gamma-hemolysin gene (Couch et at.,  1988; Kamio et al.,  1993; Colin 
et al.,  1994).  hlgC and hlgB are transcribed on a single mRNA, while hlgB is 
separately  expressed.  There  is  no  information  about  gamma-haemolysin 
production in avian isolates of  S.  aureus isolates. 
1.2.2.7 Delta-haemolysin (delta-lysin, delta-toxin) 
Delta-haemolysin,  a  26-amino-acid peptide,  is  capable  of causing  membrane 
damage in a variety of  mammalian cells. Toxin from human isolates of  S.  aureus 
contain  nine  amino  acid  differences  from  the  canine  strain-derived  delta-
haemolysin although both are 26 residues long and have molecular weights of 
approximately  3  kDa.  These  different  haemolysins  have  conserved  charge 
properties,  and  both  are  haemolytic  ally  active,  but  only  partial  serological 
identity is observed.  This protein is  made by 97% of human S.  aureus strains, 
and an immunologically related protein is made by S.  haemolytieus strains. It is 
also hypothesized that 50-70% of coagulase-negative staphylococci produce this 
toxin  (Bohach  et  at.,  1997).  Although  delta-toxin  causes  a  wide  range  of 
cytotoxic  effects,  its  importance  in  disease  aetiology remains  unclear.  Delta-
haemolysin is  itself controlled by the  accessory gene regulator (agr) , and the 
highest  expression  in  broth  culture  is  found  in  the  late-logarithmic  (post-
exponential) phase (Arvidson et at.,  1990). 
Delta-toxin is capable of lysing erythocytes and other mammalian cells, as well 
as  subcellular  structures  such  as  membrane-bound  organelles,  and  also 
spheroplasts, and protoplasts (Freer and Birkbeck, 1982). Also, a dermonecrotic 
activity has  been observed,  as  well as  lethality in experimental animals when 
used in high concentrations. It remains possible, however, that these activities 
result from contamination with very small amounts of alpha-toxin. The presence 20 
of phospholipids inhibits delta-toxin activity. Gibbs et al.  (1978b) have reported 
that some S.  aureus poultry strains  of phage types  A  (100%),  B1  (93%),  B2 
(60%) (40% of B2 isolates had variable results) and C (100%) were delta-toxin 
producers. 
1.2.2.8 Lipase,jatty acid-metabolizing enzyme (FAME) 
In response to  an infection, the host can produce a variety of fatty  acids and 
other lipid molecules that act as  surfactants to  disrupt the bacterial membrane, 
especially when an abscess is  formed.  Virtually all  strains of staphylococci of 
human  origin  are  lipolytic  (Elek,  1959).  Genes  encoding  lipases  have  been 
cloned from S.  aureus (Lee and Landolo, 1986) and the non-pathogenic S.  hyicus 
(G5tz et al.,  1985), and it has been proposed that lipases have a negative effect 
on immune function.  However, the definitive genetic  inactivation experiments 
remain  to  be  done.  Lipases,  like  proteases,  may  well  represent  scavenging 
enzymes, one of whose roles  is  to  harvest nutrients from the environment. An 
enzyme known as  fatty acid-metabolizing enzyme (FAME)  has been described 
(G5tz et al.,  1985), that has been proposed to  function to  detoxify bactericidal 
fatty acids at the site of an infection. Consistent with a role in abscess formation, 
both lipase and FAME have been reported to be expressed extracellularly during 
the post-exponential phase.  There  is  no  information about the above genes  in 
avian isolates of  S.  aureus. 
1.2.2.9 Staphylocoagulase (coagulase) 
Coagulase is  a protein that clots  plasma in the  absence of Ca
2
+ but requires  a 
plasma constituent known as  coagulase-reacting factor (CRF).  CRF, perhaps a 
derivative of prothrombin, reacts  with coagulase,  and  the  resulting coagulase-
CFR complex (staphylothrombin) converts fibrinogen to fibrin (Drummond and 
Tager,  1963).  A  very  high percentage  (98-99%)  of S.  aureus  strains  exhibit 
coagulase  activity  (Kloos,  1998).  Coagulase  activity  is  also  exhibited  by the 
species S.  intermedius,  S.  hyicus,  S.  delphini and S.  schleiferi subsp.  coagulase. 
The role of coagulase in virulence remains unclear. However, given the fact that 21 
a large majority of strains of  S.  aureus produced this protein and that it binds to 
and activates prothrombin and causes coagulation of serum, it is likely to playa 
role in staphylococcal disease (Projan et al.,  1997). All poultry S.  aureus strains 
examined, with one exception, rapidly coagulate rabbit and human plasmas, the 
remaining  strain  taking  24  h  to  coagulate  human  plasma.  None  coagulated 
bovine plasma as rapidly as the bovine control strains though a collapsed sac or 
flaky precipitate was often present after 24 h incubation. The lack of ability to 
coagulase bovine plasma appears to be a characteristic of  poultry isolates (Harry 
1967a, b;  Hajek and Marsalek  1971;  Bajljosov and  Georgiev  1974),  although 
Harry (1967a;  b)  also  reported  a  flaky  precipitate  after  incubating  his  avian 
isolates with bovine plasma for  18  h.  On the other hand, Rodgers et al.  (1999) 
reported that all  S.  aureus strains of the poultry biotype were negative  for the 
ability to coagulate bovine plasma. 
1.2.2.10 Staphylokinase 
Staphylokinase, a protein that exhibits fibrinolytic activity indirectly by binding 
to plasminogen, is produced by a relatively high percentage (60-98%) of human 
S.  aureus strains of  biotype A, but by only a small percentage (5-10%) of  bovine 
S.  aureus strains of biotype C (Hajek and Marsalek,  1969). No substrate other 
than plasminogen has been found for staphylokinase. Activation of plasminogen 
to plasmin is  specific and proceeds primarily through the cleavage of a single 
arginine-valine bond.  Plasmin formed  through activation of plasminogen with 
staphylokinase  is  indistinguishable  from  the  plasmin  formed  with  other 
activators  streptokinase,  urokinase  or  tissue-activators  (Arvidson,  1983). 
Rodgers et al.  (1999) reported that no  S.  aureus strains of the poultry biotype 
according to  the schemes of Devriese (1984) and Isigidi et al.  (1990), produced 
staphy10kinase. 22 
1.2.2.11 Bacteriolytic enzymes 
The  bacteriolytic  enzymes  endo-~-N-acetylglucosaminidase  and  N-
acetylmuramyl-l-alanine amidase (Wadstrom and Hisatsune, 1970) are produced 
by  S.  aureus  and  many  other  staphylococcal  species.  The  former  enzyme  is 
especially  active  against  the  cells  of Bacillus  and  Micrococcus  spp.,  which 
compete  for  some  of the  same  cutaneous  habitats  as  staphylococci.  The 
bacteriolytic enzyme known as  lysostaphin (or lysostaphin endopeptidase) is  a 
zinc metalloenzyme that has as its main target the polyglycyl bridge of the cell 
wall peptidoglycan of staphylococci (Schindler and Schuhardt 1964; Trayer and 
Buckley,  1970) and salinicocci (Ventosa et al.,  1990). Lysostaphin is produced 
by  S.  simulans  biovar  staphylolyticus  (Sloan,  et  al.,  1982).  The  plasmid 
containing  the  endopeptidase  gene  end  also  contains  the  lysostaphin 
endopeptidase resistance gene epr that specifies modification of the interpeptide 
bridge of the peptidoglycan, making the host S.  simulans strain resistant to the 
lysostaphin  endopeptidase  that  it  produces  (DeHart  et  al.,  1995).  The 
modification of the interpeptide bridge involves a replacement of many of the 
glycine  residues  by  serine  residues.  Most  strains  of  S.  sciuri  produce  a 
staphylolytic  enzyme  that  is  immunologically related  to  lysostaphin,  but it  is 
determined by  a  gene  sharing  little  nucleotide  sequence  homology  with  end 
(Kloos et al.,  1997b).  There  is  no  information about bacteriolytic enzymes  in 
avian isolates of  S.  aureus. 
1.2.2.12 Staphylococcal nuclease (thermonuclease) 
Both  heat-stable  and  heat-labile  nucleases  are  produced  by  staphylococci.  A 
large percentage (95-100%) of the strains of  S.  aureus,  S.  hyicus, S.  intermedius 
and  S.  schleiferi  produce  detectable  levels  of the  heat-stable  nuclease  (or 
thermonuclease)  (Devriese  et al.,  1978;  Freney  et al.,  1988).  Staphylococcal 
nuclease  hydrolyses  both  DNA  and  RNA  yielding  predominantly  3'  and 
dinucleotide  products.  The  enzymatic  attack  is  both  exonucleolytic  and 
endonucleolytic (Arvidson, 1983). Gibbs and Patterson (1978 a, b) have reported 23 
that  all  poultry  S.  aureus  strains  of phage  types  Band C  were  nuclease 
producers. 
1.2.2.13 Urease 
Urease activity is  exhibited by many staphylococcal species,  and it apparently 
plays  a  role  in  the  invasiveness  of S.  saprophyticus  in  the  urinary  tract 
(Gatermann et ai.,  1989). Mead et ai.  (1989) reported urease activity in avian S. 
aureus isolates in a comparison of strains from freshly slaughtered poultry and 
strains "endemic" to processing plants. 
1.2.2.14 Hyaluronate lyase (hyaluronidase) 
Hyaluronate lyase (hyaluronidase) is a glycoprotein produced by S.  aureus and 
S.  hyicus  that  hydrolyses  the  mucopolysaccharide  hyaluronate  (Rautela  and 
Abramson,  1973).  Pathogenic staphylococci that produce this enzyme have the 
capacity to break down hyaluronate-rich tissue barriers, thereby increasing their 
invasiveness. The S.  aureus 8325-4 hyaluronate lyase gene (hysA) was identified 
after detecting hyaluronate lyase activity expressed by phages from a genomic 
library.  The hysA  open reading frame,  capable of encoding a protein of 91980 
Da, was identified by Tn5 mutagenesis and nucleotide sequencing. HysA shares 
35  and  36%  amino  acid  sequence  identity  with  group  B  streptococcal 
hyaluronate lyase and pneumococcal hyaluronidase, respectively (Farrell et ai., 
1995).  There  is  no  information  about  hyaluronidase  in  avian  isolates  of S. 
aureus. 
1.2.2.15 Proteases 
Most strains of  S.  aureus are proteolytic. This property is generally demonstrated 
by the use of gelatin or casein as  substrates (Baired-Parker,  1965). Four major 
extracellular proteases are  produced by  strains  of S.  aureus (Arvidson  2000): 
staphylococcal serine protease (V8  protease) (SspA),  a metalloprotease named 
aureolysin (Aur) , a cysteine protease (Scp) named staphopain (Hofmann et ai., 
1993), and a second cysteine protease (SspB) encoded within the same operon as 24 
SspA (McGavin et ai.,  1997; Chan and Foster,  1998). All four proteases appear 
to  be  synthesized  as  preproenzymes,  which  are  proteolytic  ally  cleaved  to 
generate the mature enzymes. In the case of the serine protease, the proform is 
enzymatically inactive and needs to  be cleaved by aureolysin to  become active 
(Drapeau, 1978). The proform of SspB that appeared to possess enzyme activity 
seems to be processed by SspA (Rice et ai.,  2001). Which enzymes are involved 
in the processing of aureolysin and staphopain remains to  be determined.  The 
synthesis of extracellular proteases is positively regulated by agr and negatively 
regulated by sarA (Janzon et ai.,  1986; Chan and Foster, 1998) (see section 1.4). 
Karlsson et ai.  (2001) have found that in sarA mutant cells, which produce high 
amounts  of the  four  major  extracellular  proteases,  the  level  of cell-bound 
fibronectin-binding proteins (FnBPs) and protein A were very low compared to 
those of wild-type cells,  in spite of unaltered or increased transcription of the 
corresponding genes. 
The serine protease has  a serine residue  in  the  active site and  is  inhibited by 
diisopropyl fluorophosphate. There is  a single report of a protease produced by 
an avian strain of  S.  aureus, from a chicken suffering from dermatitis. Its activity 
was  inhibited  by  thiol  protease  inhibitors,  but  was  not  inhibited  by 
metalloprotease or serine protease inhibitors (Takeuchi et ai.,  1999).  The thiol 
protease  produced  by  S.  aureus  strain  V8  is  active  only  in  the  presence  of 
reducing  agents  and  is  inactivated  by  heavy  metals.  The  metalloprotease 
produced by S.  aureus strain V8  is  completely inactivated by metal chelators, 
such as EDTA and 1,  10-phenanthroline (Drapeau et ai.,  1972; Arvidson,  1973; 
Arvidson et ai.,  1973).  A  second serine protease was  noted by Kuroda et ai. 
(2001) in the genome of two MRSA strains, which may have a function similar 
to serine protease (V8 protease) (SspA). 
Genes encoding metalloproteases have been cloned from  S.  hyicus (Ayora and 
G6tz,  1994; Takeuchi et ai.,  2000) and S.  epidermidis (Teufel and G6tz,  1993), 
with the metalloprotease from  S.  epidermidis  exhibiting elastase  activity.  The 25 
serine protease known as V8 protease (from S.  aureus strain V8) has the ability 
to  cleave  and  inactivate  antibodies  and  has  been  proposed  to  function  in 
blocking  the  action  of antibodies.  A  second  role  for  proteases  may  involve 
protection  against  antimicrobial  peptides  such  as  the  neutrophil  defensins 
(Selsted et ai.,  1993) or the platelet microbicidal proteins  (PMPs) (Yeaman et 
ai.,  1994). It has also been proposed that these proteases may not only function 
to  inactivate key proteins and peptides involved in  host defence but may also 
contribute  to  the  destruction  of tissue  proteins  and  enhance  invasiveness 
(Goguen et aI.,  1995). Another logical role for these proteases is that they serve 
as  molecular scavengers to  obtain usable nutrients from  the environment. The 
fact that many non-pathogenic bacteria found in the environment also elaborate 
similar proteases (e.g., Bacillus subtilis) suggests that this may be the case. 
1.3 THE CHROMOSOME 
Before the recent whole genome sequencing of a number of S.  aureus strains 
(see  section  1.3.4),  one  strain,  NCTC  8325  (PS47),  was  most  extensively 
studied. The NCTC 8325 strain belongs to phage group III and was obtained as a 
clinical  isolate  more  than  40  years  ago.  The  chromosome  of this  strain  was 
mapped mainly by Pattee and coworkers (Pattee,  1990;  1993a;  1993b) by using 
genetic and physical methods. Genetic methods involved mutagenesis (formerly 
by chemicals and at present by transposons),  transduction,  transformation and 
cloning.  Physical  methods  are  based  on  the  digestion  of a  genome  with 
restriction enzymes that have a low number of recognized sites, e.g.  Sma! and 
estimation of fragment  length.  These  studies  by  physical  mapping  showed  a 
great deal of similarity among the genomes of different S.  aureus strain and the 
sizes were estimated as:  NCTC 8325, 2.8 mbp;  PS55  strain, 2.771  mbp; strain 
112  (phage  group  I)  2.768  mbp;  strain  42D  (phage  group  IV)  2.652  mbp 
(Bannantine and Pattee, 1996; Iandolo et al.,  1997). 26 
1.3.1 Mobile elements of the genome 
Mobile  elements  of the  bacterial  genome  include  insertion  sequences  (ISs), 
transposons  (Tns),  gene  cassettes  and  integrons.  The  first  two  possess  genes 
responsible  for  their  own transposition  and  most  of them were  classified  by 
Sakaguchi  (1990)  as  genetic  elements  named  invertrons  on the  basis  of the 
presence of  short inverted repeats (IRs) at the ends. Gene cassettes and integrons 
were  described  originally  in  Gram-negative  bacteria  and,  although  strongly 
supposed  to  exist,  they  had  not  been  found  in  staphylococci.  Very  recently 
however, some of these were found by Kuroda et al.  (2001) in S.  aureus strains 
N315  and Mu50 (see  section  1.3.4).  For mobilization and integration of gene 
cassettes, specific genetic systems, i.e.  integrons, are needed (Recchia and Hall 
1995).  Cassettes can exist either free  in a circular form  or integrated with an 
integron  at  the  attI  site.  An  integron  encodes  a  site-specific  recombinase 
(integrase)  that  is  responsible  for  the  insertion  of cassettes  at  att!,  and  also 
provides  the  promoter  for  expression  of  the  cassette-encoded  antibiotic 
resistance genes. Integrons have been found in several independent locations in 
different plasmids and transposons (Brown et al.,  1996). 
A  variety of mobile  genetic  elements  has  been described to  be  present in  S. 
aureus:  insertion  sequence  (ISs),  transposons  (Tns)  and  transposon-like 
elements. ISs are transposable elements that do not carry any genetic information 
except that required  for  transposition.  They  are  present in many sites  on  the 
chromosome and on plasmids belonging to classes II or III. Although ISs do not 
code  for  any  resistance,  they  are  responsible  for  a  recombination  and 
stabilization of some resistance genes and their presence is very important in the 
evolution of the  bacterial genome.  Staphylococcal transposons possess one  or 
two resistance markers beside genes responsible for transposition. Some of  these 
transposons, e.g. Tn551  or Tn552, are closely-related to the Tn3  family of the II 
class of transposons. They have inverted terminal repeats (ITR) and transpose to 
more  or less  random sites  creating  duplicates  of 5  or  6  nucleotides  in  target 
DNA. An interesting situation was observed in the case of the plasmid pIP 1  066 27 
from  S.  aureus,  where  two  closely  located  transposons  Tn552  and  Tn5404 
possessed a common invertible fragment (3.5  kb).  Orientation of this fragment 
alternatively determined if the  Tn552 on the right end, or Tn5404 on the left is 
present  (Derbise  et  ai.,  1995).  Within  Tn5404,  a  third  smaller  transposon, 
Tn5405 (related element to  Tn3854) (Udo and Grubb,  1991) is located. Tn5405 
is flanked by IS1182 (Derbise et ai.,  1996). Other transposons like  Tn400l are 
representatives  of class  I of transposons  and are  organized similarly to  TnlO. 
Transposons of class I are flanked by identical ISs on both ends.  One of the S. 
aureus  transposons,  Tn554,  lacked  the  terminal  inverted  repeats  and  target 
duplications characteristic of  other transposons. 
1.3.2 Plasmids 
Plasmids  are  common  in  natural  populations  of most  staphylococcal  species 
(Lacey, 1975; Kloos et ai.,  1981; Weinstein et al.,  1982). They are rare «2% of 
strains)  in the  species  S.  auricularis  (Kloos,  1990)  and relatively uncommon 
«20% of strains) in S.  schleiferi (Etienne et al.,  1990a) and members of the S. 
sciuri species  group  (Kloos  et al.,  1981).  The  characteristics  of many of the 
plasmids from S.  aureus have been reviewed by Lyon and Skurray (1987) and 
Novick (1989).  S.  aureus plasmids have been classified into three classes, I,  II 
and  III.  Class  I plasmids  are  of small  size  (1-5  kbp)  and have  a  high  copy 
number (10-55 copies per cell), and usually encode a single antibiotic resistance 
or are cryptic. They have been subdivided into four subgroups or families on the 
basis  of their  nucleotide  sequence  and  functional  organisation  (Rubby  and 
Novick, 1975; Iordanescu and Surdeanu, 1980; Novick, 1989). Class II plasmids 
have been subdivided into  two  major families  on the basis of incompatibility. 
These plasmids, commonly referred to as penicillinase or  ~-lactamase plasmids, 
are relativly large (15-33 kbp), have a low copy number (4-6 per cell), they carry 
various combinations of antibiotic  and heavy metal resistance genes, many of 
which  are  located on  transposons  (Novick  and  Richmond,  1965;  Sheehy  and 
Novick,  1975;  Shalita et al.,  1980).  Class II  plasmids, unlike class  I plasmids, 
are very uncommon in the species S.  hyicus, S.  intermedius,  S.  simuians and S. 28 
lugdunensis (Kloos et al.,  1981; Gotz et al.,  1983; Etienne et al.,  1990a; 1990b). 
Most of the conjugative plasmids are class III plasmids that encode resistance to 
gentamicin  and  certain  other  aminoglycosides,  such  as  tobramycin  and 
kanamycin.  These plasmids are relatively large (30-60 kbp).  Class III plasmids 
have been identified also in S.  epidermidis (Thomas and Archer, 1989). 
Dodd et at.  (1987;  1988) showed that plasmids were detected in 72% of strains 
of  S.  aureus isolates from different poultry processing plants but the proportion 
of plasmidless strains isolated varied amongst plants. Also plasmids were more 
common in strains of S.  aureus  characteristically associated with live  poultry 
than  with  strains  endemic  in  poultry  plants  and  strains  of human  origin 
(Thompson and Holding, 1986). 
1.3.3 Bacteriophages 
Viruses infecting bacteria belong to  13  families (Murphy et al.,  1995). Known 
staphylococcal bacteriophages  are  members  of two  families  of tailed  phages: 
Myoviridae  and  Siphoviridae.  Most  naturally  occurring  S.  aureus  strains  are 
multiply  lysogenic.  The  temperate  phages  are  usually  inducible  by UV  and 
mitomicin  C  and  typically  integrate  at  unique  chromosomal  sites  by  the 
Campbell mechanism (Novick, 1990). All known temperate phages of  S.  aureus 
have a morphology typical of Siphoviridae (head and noncontractile tail).  The 
bacteriophages of  S.  aureus were divided into 7 serological groups designated as 
A,  B,  C,  D,  F,  G,  L.  Temperate bacteriophages, being most important for the 
variability of  the bacterial genome, fall into three main serological groups, A,  B 
and  F.  The  majority  of  genetic  investigations  were  performed  using 
bacteriophage <l> 11  (prophage ofNCTC 8325 strain). Physical typing and genetic 
maps of this phage have been constructed (Krestschmer and Egan, 1975; Bachi, 
1980). 
The presence of a phage genome (prophage) can influence the bacterial cell and 
mediate  lysogenic  conversion  (Smeltzer  et  al.,  1994).  The  first  type  of 
conversion  leads  to  the  inactivation  of  the  bacterial  gene  caused  by  an 29 
integration of the prophage in the gene (negative conversion). The best known 
examples of negative conversion in  S.  aureus take place when the  integration 
site (attB) is localized within gene htb (p-haemolysin) or gene geh (lipase). The 
attB  sites  of several  prophages  were  mapped  in different  localizations  of the 
NCTC 8325 strain chromosome: <DM and <D12  (SmaI-A fragment), <D53  and <D85 
(SmaI-B fragment);  <DL54a,  <D77,  <DJ84  SmaI-E);  <D11,  <D13  and  <D42  (SmaI-F) 
(Berger-Bachi, et at.,  1989).  The  second type of conversion is  positive and  is 
mediated by an expression of prophage genes within the host cell.  Some phages 
carry the genes of  enterotoxin A (sea) or staphylokinase (sak) production or both 
(Mlynarczyk  et  al.,  1993;  1995a;  1995b).  Additionally,  expression  of the 
structural  genes  of tails  of some  prophages  can  mediate  competence  for 
transformation  and  transfection  (Lyon  and  Skurray,  1987).  Moreover,  some 
lysogenic  bacteria  acquire  the  ability  of intracellular  exchange  of genetic 
material in mixed cultures (bacteriophage-mediated conjugation, a phenomenon 
quite different from  transduction)  (Lacey,  1972;  Witte,  1981).  Additionally,  it 
has  been  shown  that  the  presence  of  phage  confers  the  loss  of  the 
chloramphenicol-resistance  plasmid  in  S.  aureus  strains  (Mlynarczyk  et  at., 
1981).  Lysogenic  conversion  changes  the  susceptibility  of  S.  aureus  to 
phagocytosis  (Mlynarczyk  et at.,  1991)  and  is  thought  to  cause  tolerance  to 
vancomycin (Mlynarczyk et at.,  1997). 
1.3.4 Whole genome sequencing of  S. aureus 
The  whole  genome  sequencing  of two  strains  N315  and  Mu50  of S.  aureus 
(methicillin-resistant S.  aureus and vancomycin-resistant S.  aureus, MRS A and 
VRSA,  respectively)  has  been  reported  recently  by  Kuroda  et  at.  (2001). 
According  to  their  web  sites  the  Institute  for  Genomic  Research  (TIGR) 
(http://www.tigr.org/tdb/mdb/mdbinprogress.html) is sequencing S.  aureus strain 
COL  and the  University of Oklahoma (http://www.genome.ou.edu/staph.html) 
has completed the sequence (unpublished data) of  S.  aureus strain 8325. Another 
S.  aureus  strain  EMRSA-16  is  being  sequenced  by  the  Sanger  Centre 30 
(http://www.sanger.ac.uklProjects/S_aureus)  and S.  epidermidis  strains  RP62A 
and  ATCC12228  are  being sequenced of TIGR and  by the  Chinese National 
Human Genome Centre at Shanghai (http://www.chgc.sh.cn/). respectively. 
General features  of S.  allrellS N315  and Mu50  genomes. N315  is  a MRS A 
strain isolated in 1982, and Mu50 is an MRS A strain with vancomycin resistance 
isolated in 1997. The length of the genome of strain N315 is 2,813,641  bp and 
for strain Mu50 is 2,878,084 bp. The G+C content of strain N315 was 32.8% for 
the whole genome, 33.6% for  the protein coding regions,  49.5% for the RNA 
coding regions and 27.7% for the non-coding regions. Corresponding values for 
strain Mu50 were very similar and there was 96% nucleotide sequence identity 
between  the  two  strains.  Mu50-specific  mobile  genetic  elements  represented 
most of the differences between the strains. Approximately 2,600 open reading 
frames  for protein coding  were  identified.  Other features  of interest that were 
identified include different insertion sequences, transposons, bacteriophage and 
pathogenicity islands. Almost all of  the known S.  aureus pathogenic factors were 
identified within the genomes, as well as 70 new candidates. The latter included 
new genes  for  a possible  staphylocoagulase,  serine  protease,  thermonuclease, 
various possible toxins, haemolysins and superantigens. 
Plasmid pN315 found in strain N315 is  24,653 bp and plasmid pMu50 in strain 
Mu50 is  25,107 bp.  The antibiotic resistance genes  identified in the N315 and 
Mu50 genomes are located on plasmids or mobile genetic elements. 
1.4 VIRULENCE GENE REGULATORS OF S.  allrellS 
In S.  aureus, the expression of  many virulence factors is co-ordinately regulated. 
The genetics of this regulation is largely understood in terms of the function of 
agr  (accessory  gene  regulator)  and  sar  (staphylococcal  accessory  regulator) 
genes (Novick, 1995). Together, the components encoded by these loci form part 
of a  complex  pathway  that  leads  to  decreased  transcription  of selected  cell-31 
surface  virulence  factor  genes  and  increased  transcription  of  regulated 
extracellular toxins and enzymes (see Figure 1.1) (Janzon and Arvidson,  1990; 
Kornblum et ai.,  1990; Novick et ai.,  1990; Cheung and Projan, 1994; Heinrichs 
et ai.,  1996). Translational control of alpha-toxin by the agr-sar system has also 
been demonstrated (Novick et aI.,  1993;  Morfeldt et ai.,  1995).  In agr or sar 
mutant  strains,  regulated  cell-surface  proteins  (e.g.,  coagulase,  fibronectin-
binding protein,  and  protein A)  are  produced throughout the  exponential  and 
post-exponential phases of growth.  This  is  in contrast to  wild-type strains that 
only produce these proteins during exponential growth. Furthermore, in agr and 
sar mutant  strains,  many  extracellular  toxins  and  enzymes  that  are  normally 
present in post-exponential  phase  cultures  (e.g.,  alpha-toxin,  metalloprotease, 
cysteine  protease  and  serine  protease)  are  reduced  to  as  low  as  5%  of their 
normal levels (Janzon et ai.,  1986;  Janzon and Arvidson,  1990; Novick et ai., 
1993; Chan and Foster, 1998; Karlsson et ai.,  2001). 
The agr locus encodes a self-inducing, pheromone-sensing, signal transduction 
circuit (Figure 1.1).  One of two  divergent agr messages  is  transcribed from  a 
promotor designated P2  (Novick et ai.,  1995). This message, RNA II, encodes 
four proteins, AgrA, AgrB, AgrC and AgrD. Two of  these agr-encoded proteins: 
AgrC  and AgrA,  function  as  sensor and regulator proteins,  respectively.  The 
activating  signal  of the  agr  system  is  a  pheromone  encoded  within  the 
prepeptide protein AgrD. AgrB is believed to be the enzyme responsible for the 
maturation and/or secretion of AgrD pheromone (Ji et ai.,  1995;  1997).  AgrD 
serves  as  a  peptide  pheromone  and  is  specifically  recognised  by  the  AgrC 
membrane-bound receptor. Once the extracellular concentration of  AgrD reaches 
a particular level, AgrC initiates a signal transduction pathway that is believed to 
include  AgrA.  AgrA  is  thought to  activate  the  expression  of the  agr operon 
(RNA  II)  and  the  divergently  expressed  RNA  III.  AgrA  mutants  have 
dramatically  reduced  virulence  in  animal  models  of staphylococcal  arthritis, 
osteomyelitis, endocarditis and endophthalmitis (Abdelnour et al.,  1993; Cheung 
et ai.,  1994a; Booth et ai.,  1995; Gillaspy et aI.,  1995).  Mutations  in  any of the 32 
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Figure 1.1 Model of the function of the agr-sar system. 
Chromosomal DNA is depicted as a thick black line. 
Promoters (P) are numbered and genes are shown as 
boxes. Phosphorylated proteins are associated with a 
circled letter P. The straight arrows and squiggly lines 
represent mRNA. The curved arrows show the 
relationships among the components of the system. 
Positive effect is marked with (+). hid: Delta-haemolysin 
gene (McNamara et ai.,  2000). 33 
agr open reading frames  (ORFs A,  B,  C and D)  eliminate the upregulation of 
RNA II and RNA III expression. The agr system up-regulates its function when 
AgrC binds the AgrD-derived signal (Novick, 1995). Like other bacterial sensor 
proteins,  the  binding of the  signal results  in the  autophosphorylation of AgrC 
and,  presumably, a concomitant activating conformational change (Lina et at., 
1998).  The phosphate group  on AgrC is  then thought to  be transferred to the 
regulator protein AgrA, resulting in the activation of  AgrA. 
Unlike  other  bacterial  signal  transduction  systems  in  which  the  activated 
regulator protein directly  initiates  the  transcription of target promoters,  AgrA 
functions with the translation product of an unlinked locus named sar (Cheung 
et at.,  1995). The sar product, SarA, binds a region of  DNA between the two agr 
promoters, and in conjunction with activated AgrA it up-regulates transcription 
of the agr messages (Cheung and Proj an,  1994; Heinrichs et at.,  1996; Morfeldt 
et at.,  1996). The result of the increased transcription is  an amplification of the 
circuit encoded by RNA II  and  high-level production of a 51 a-ribonucleotide 
message known as RNA III  (Janzon and Arvidson,  1990; Novick et at.,  1993; 
Morfeldt et at.,  1996). 
RNA  III  is  the  effector  molecule  of  the  agr  response  that  upregulates 
transcription of many staphylococcal exoproteins and represses transcription of 
certain surface protein genes (Novick et at.,  1993; Novick et at.,  1995).  In the 
case of alpha-toxin, a direct interaction between RNA  III  and the  alpha-toxin 
message  is  required  for  full  translation  (Morfeldt  et at.,  1995;  1996).  When 
synthesised  from  a  heterologous  promoter  in  an  agr-null  mutant,  RNA  III 
returns a wild-type pattern of virulence factor messages and translation products 
(Vandenesch et at.,  1991; Morfeldt et at.,  1995). 
Thus,  the  staphylococcal  virulence  gene  system  is  activated  by  the  density-
sensing  agr  system,  which  is  autoinduced  by  a  short  peptide  (autoinducing 
peptide [AlP]) processed from  a propeptide encoded by agrD.  Four groups  of 34 
these ALPs,  I, II, III and IV, have been described (Ji et ai.,  1997, Jarraud et aI., 
2000). A central segment of the N-terminal half of AgrC (the receptor),  shows 
striking interstrain variation.  This  finding  has led to  the  division of S.  aureus 
isolates  into  three different agr specificity groups  and to  the  division of non-
aureus staphylococci into  a number of other ALPs  groups.  The  different ALPs 
cross-inhibit the agr responses between groups  (Ji  et ai.,  1997,  Jarraud et ai., 
2000). 
An additional layer of complexity in this model is added by the observation that 
SarA is transcribed on three different overlapping messages known from largest 
to  smallest as  A,  C,  and B (Bayer et aI.,  1996).  These messages are  initiated 
from  distinct upstream promoters named PI, P3,  and P2, respectively (Figure 
1.1). Each message ends at a common terminator downstream of the SarA open 
reading  frame.  The  PI  and  P2  promoters  are  dependent  on  a
SA
,  the  primary 
sigma factor in S.  aureus, while the P3 promoter is dependent on aSB, a multiple-
stress-responsive sigma factor  (Vandenesch  et ai.,  1991;  Kullik et  ai.,  1998). 
These data can be linked to  the observation that virulence factor production is 
regulated by environmental conditions. For example, SarA message and levels 
of  alpha-toxin are both elevated when the bacteria are exposed to oxidative stress 
(Cheung and Projan, 1994). 
Despite  the  progress  made  in  understanding  the  agr-sar  system,  the  best 
available  evidence  suggests  that additional regulatory  factors  are  required  for 
virulence factor production (Compagnone-Post et ai.,  1991;  Vandenesch et ai., 
1991; Dassy et at.,  1993; Balaban and Novick, 1995; Bayer et al.,  1996; Wesson 
et ai.,  1998; Rechtin et at.,  1999;  Bischoff et ai.,  2001).  Very recent study has 
identified more  loci  directly or indirectly (by modulating agr expression) that 
regulate the expression of virulence genes. They are sarR (Manna and Cheung, 
2001),  sarHl  (Tegmark  et  at.,  2000),  rot  (McNamara  et  at.,  2000),  seaSR 
(Giraudo  et  al.,  1999)  and  srrAB  (Yarwood  et  al.,  2001).  Sigma  B  also 
modulates this multifactorial regulatory network by regulating the transcription 35 
of SarA and sarH  1.  Kuroda et at.  (2001) identified all  of these regulators and 
two novel sarA homologues, sarH2 and sarH3, in the S.  aureus genomes. There 
is  no  information about the presence or the role of these regulatory virulence 
factors in avian isolates of  S.  aureus. 
1.5 DISEASES CAUSED BY STAPHYLOCOCCUS 
1.5.1 Pathogenicity of  S. aureus 
Certain  of the  cell  surface  adhesins,  exocellular  material  and  extracellular 
proteins  produced  by  S.  aureus  are  believed  to  play  important  roles  in  the 
pathogenicity of this  organism.  The  species  is  well  supported with  accessory 
DNA elements carrying a variety of virulence and resistance factors, which act 
together  with  other  mechanisms  to  make  this  organism  one  of the  most 
successful opportunistic pathogens in man and animals. Infections caused by this 
species  are  often  acute  and  pyogenic  and,  if  untreated,  may  spread  to 
surrounding tissue or to internal sites involving other organs. Some of the more 
common infections of the skin include furuncles or boils, cellulitis and impetigo. 
1.5.2 Staphylococcosis in man 
S.  aureus  is  a  common aetiological agent of post-operative wound infections, 
bacteraemia, pneumonia, osteomyelitis, acute endocarditis, mastitis, toxic shock 
syndrome and abscesses of the muscle, urogenital tract, central nervous system 
and various intra-abdominal organs.  Food poisoning is  frequently  attributed to 
staphylococcal  enterotoxins.  Comprehensive  reviews  on the  nature  of human 
and animal model infections have been reported by Elek (1959), Cohen (1972), 
Jeljaszewicz (1973; 1976; 1981; 1985), Easmon and Adlam (1983), Wadstrom et 
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1.5.3 Staphylococcosis in animals 
Many of the infections produced in animals are rather similar to those produced 
in humans.  Staphylococcal mastitis in either a clinical or subclinical form may 
have considerable economic consequences in the dairy industry. S.  aureus subsp. 
anaerobius  is  the  aetiological  agent  of  an  abscess  disease  (caseous 
lymphadenitis) in sheep.  S.  intermedius is  a common opportunistic pathogen of 
dogs  and  may  cause  otitis  media,  pyoderma,  abscesses  in  various  organs, 
mastitis,  reproductive tract infections and purulent wound infections  (Devriese 
and Hajek,  1980; Phillips and Kloos,  1981; Raus and Love,  1983; Szynkiewicz 
et  at.,  1985).  This  species  can  also  produce  wound  infections  in  humans 
following  dog  bites.  S.  hyicus is  the  aetio10gical  agent of infectious  exudative 
epidermitis (greasy pig disease) (Devrise and Hajek,  1980; Phillips and Kloos, 
1981) and can also cause septic polyarthritis in pigs (Phillips et at.,  1980), skin 
lesions in cattle and horses (Devriese and Derycke, 1979; Devriese et at.,  1983), 
osteomyelitis in cattle and poultry (Carnaghan, 1966; Wise,  1971; De Kesel and 
Devriese,  1982),  and  may  on  occasion  be  associated  with  mastitis  in  cattle 
(Devriese and De Keyser, 1980). S.  delphini has been implicated in purulent skin 
lesions of dolphins, external otitis, cystitis and abscesses and wound infections 
in the cat (lgimi et at.,  1989). S.  schteiferi subsp. coagutans can produce external 
otitis in dogs (lgimi et at.,  1990). 
1.5.4 Pathogenesis of staphylococcal infections in birds 
All  avian  species  are  susceptible  to  staphylococcal  infections.  Coagulase-
positive isolates of  S.  aureus are considered to be pathogenic for poultry, while 
coagulase-negative strains are thought to be non-pathogenic. 
1.5.4.1 Transmission 
For infection to  occur,  a breakdown in  the  natural defence mechanism of the 
host must occur (Anderson, 1986). In most cases, this would involve damage to 
an environmental barrier, such as a skin wound or inflamed mucous membranes. 
S.  aureus enters through the  breached barrier and travels to  internal  locations 37 
where  a  locus  of infection  (e.g.,  osteomyelitis)  is  established,  usually  in  the 
metaphyseal area of a nearby joint (Nairn,  1973; Daum et al.,  1990). In newly 
hatched chicks, the open navel provides a portal of entry leading to  omphalitis 
and other types of infections. Minor surgical procedures (e.g., trimming of toes, 
beak,  or  comb;  removal of the  snood)  and  parenteral  vaccinations  may  offer 
additional means of entry for staphylococci. 
Another  type  of host  defence  impairment  occurs  following  infectious  bursal 
disease (Santivatr et al.,  1981), chicken infectious anaemia, or possibly Marek's 
disease, a virus infection where the bursa of  Fabricius or thymus is damaged and 
the  immune  system  is  compromised.  Under  these  conditions,  septicaemic 
staphylococcal  infections  can  occur  and  cause  death.  Gangrenous  dermatitis 
caused by S.  aureus,  along with Clostridium septicum,  can be  seen following 
early infectious bursal disease virus infection (Frazier et at.,  1964; Rosenberger 
et al.,  1975). 
Escherichia  coli was  discovered to  be the  predominant bacterial organism  in 
livers  of turkeys  immediately following  challenge with virulent haemorrhagic 
enteritis virus (HEV). However, when livers of survivors were cultured 2 weeks 
post-exposure, Staphylococcus spp.  were the predominant bacteria (Newberry et 
al.,  1994).  This  suggests  that HEV,  and possibly other similar viral intestinal 
infections  may  create  portals  of entry  and  provide  the  underlying  basis  for 
subsequent staphylococcal problems associated with older, commercial turkeys. 
Susceptibility to  staphylococcal infections  also  may be influenced genetically. 
Two  related  lines  of New  Hampshire  chickens  had  significant  differences  III 
mortality following experimental infection (Cotter and Taylor, 1991). 
1.5.4.2 Incubation period 
The  incubation period  is  short.  In  experimental  chickens,  clinical  signs  were 
evident 48-72 h following intravenous inoculation. Experimentally, chickens can 38 
be  readily  infected  by  the  intravenous  route,  but  not by  the  intratracheal  or 
aerosol  routes.  The  number  of  bacteria  affects  the  ability  to  produce 
experimental  disease  consistently;  at  least  10
5  organismslkg body weight  are 
necessary (Mutalib et ai.,  1983a; 1983b). 
1. 5.4.3 Signs 
Early clinical signs include ruffled feathers, limping on one leg, drooping of one 
or both wings,  reluctance  to  walk,  and  fever  (Mutalib  et ai.,  1983a).  Severe 
depression and death can follow. Birds surviving the acute disease have swollen 
joints, sit  on their hocks  and keel  bone,  and  are  reluctant or unable to  stand 
(Emslie  et  at.,  1983;  Mutalib  et  at.,  1983a).  Clinical  signs  of septicaemic 
staphylococcal  infection  and  gangrenous  dennatitis  occur  in  birds  in  good 
condition, and may only be evident because of increased mortality in the flock 
(Frazier et at.,  1964; Bickford and Rosenwald, 1975; Rosenberger et at.,  1975). 
1.5.4.4 Morbility and mortality 
Morbidity and mortality due to staphylococcosis is usually low, unless there has 
been massive contamination of chicks because of exposure to  unusually high 
numbers  of bacteria  in  the  hatchery  through  environmental  contamination, 
vaccination, or servicing procedures. Leg disorders are one of  the most prevalent 
problems observed in broilers and turkeys. With the advent of further processing 
and  need  for  birds  with  more  breast  meat,  leg  problems  have  become  more 
prevalent.  Several reports  from  diagnostic  laboratories  have  indicated  that  S. 
aureus is the most common bacterial agent isolated from affected legs and joints 
(Kibenge et at.,  1982b). 
Morbidity and  mortality from  septicaemic  staphylococal  infection  are  usually 
low.  The number of chickens  that develop  gangrenous  dennatitis  is  low,  but 
usually all that develop  lesions  succumb to  the  infection (Frazier et al.,  1964; 
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1.5.5 Diseases caused by avian S. aureus 
Staphylococcosis in poultry and other avian species has been recognised for over 
100  years;  most  early  reports  describe  arthritis  and  synovitis.  S.  aureus 
infections are common in poultry;  the most frequent sites being bones, tendon 
sheaths,  and joints of the leg (Table 1.2).  Staphylococcal infections occur less 
frequently  in  other  locations  including  skin,  sternal  bursa,  yolk  sac,  heart, 
vertebrae,  eyelid,  and  as  granulomas  in  the  liver  and  lungs.  Staphylococcal 
septicaemia, causing deaths in laying birds, seems to be prevalent in hot weather 
and resembles fowl cholera (Skeeles, 1997). 
Subdermal abscesses: These conditions are seen most commonly affecting the 
feet (bumblefoot) and sternal bursa and occur most frequently in mature birds, 
particularly those of the heavy breeds. There is abscess formation with swelling, 
heat and usually some pain. In bumb1efoot, the under-surface of the foot is  first 
affected and  the  lesion  may  then  spread  to  involve  the  whole  foot.  There  is 
caseation and necrotic tissue and some haemorrhage. The sternal bursa may be 
similarly  affected but  less  frequently  and  less  severely  (Jordan  and  Pattison, 
1996). 
Gangrenous  dermatitis:  This  may  be  seen  in  birds  of all  ages  but  most 
commonly in broiler chickens. The wing tips and the dorsal pelvic region are the 
sites most frequently affected and the lesions are dark, moist and gangrenous in 
appearance  with  crepitation.  Staphylococci  are  often  associated  with  ct. 
perJringens type A,  which may be  the primary pathogen.  Immunosuppression 
resulting from damage to the bursa of Fabricius predisposes to  the condition in 
growing chickens (Jordan and Pattison, 1996). 
Arthritis and tenosynovitis: These conditions may be seen in birds only a few 
weeks old but more commonly occur at about 7-12 weeks in chickens and 9-12 
weeks in turkeys. In broiler breeders, stress caused by uneven feed distribution 
or coccidiosis  may  well  predispose  to an  increase  in  cases  of staphylococcal 40 
Table 1.2 Staphylococcal infections in poultry 
Location  Age  Lesion  Usual outcome 
Bone  Any, usually older  Osteomyelitis  Lameness 
Joint  Any, usually older  Arthritis/Synovitis  Lameness 
Yolk sac  Chick, poults  Omphalitis  Death 
Blood  Any  Generalized necrosis  Death 
(septicaemia) 
Skin  Young  Gangrenous dermatitis  Death 
Feet  Mature  "Bumblefoot"  Lameness 
From Skeeles (1997) 41 
infection. The affected joints, usually the hocks (tibiotarso-tarsometatarsal), are 
hot  swollen  and  painful  and  affected  birds  are  usually  depressed,  lame  and 
reluctant  to  walk.  When  the  phalangeal  joints  are  affected,  subdermal 
staphylococcal abscesses ("bumblefoot") may occur.  The synovial membranes 
of joints and tendon  sheaths  (commonly  in  the region of the  hock and  feet) 
become thickened and oedematous and exudate with fibrin deposits is produced 
within  and  around  the joints  and  around  the  tendon  sheaths.  There  is  some 
necrosis  and  exudate  may  later  become  caseous.  Petechiae  and  larger 
haemorrhages  may  be  present  in  the  early  stages.  If the  bird  survives,  the 
condition  becomes  chronic  with  the  formation  of fibrous  tissue  (Jordan  and 
Pattison, 1996). 
Yolk sac infection:  S.  aureus was isolated from chicks below ten days of age 
showing yolk sac infection. The yolk sacs were found distended and contained 
foul smelling yolk material and curdled material and the colour also varied from 
greenish yellow to dark brown (Lakshmamna-Char et at.,  1987). 
Staphylococcal  septicaemia,  endocarditis  and  granuloma:  Septicaemia  is 
perhaps most commonly a sequel to a primary local staphylococcal focus. It is 
relatively rare and may result in sudden death with marked congestion of the 
carcass or initial depression and the appearance of haemorrhages and necrotic 
foci  in the  liver,  lungs,  spleen and myocardium.  In chronic  cases  these  may 
develop into granulomas with loss of weight. Endocarditis may also be a sequel 
and vegetations, particularly affecting the left atrioventricular valves, are seen at 
necropsy.  Following  experimental  intravenous  infection  with  this  organism 
emaciation may occur without any specific gross  lesions (Jordan and Pattison, 
1996). 
Spondylitis and osteomyelitis:  S.  aureus can cause abscesses in the bodies of 
the  fifth  to  seventh  thoracic  vertebrae  with  periostitis  and  osteomyelitis  and 
consequent pressure on the  spinal cord resulting in  paralysis. The head of the 42 
femur,  tibiotarsus  and  occasionally  other  bones  may  also  be  affected  with 
osteomyelitis (Jordan and Pattison, 1996). 
1.5.6 Diseases caused by avian S. hyicus 
S.  hyicus has been associated with fibrinoheterophilic blepharitis in chickens and 
turkeys  (Cheville  et at.,  1988)  and was  isolated  from  five  of nine  tibiotarsal 
growth plates of  turkeys with stifle joint osteoarthritis (Tate et ai.,  1993). 
1.5.7 Prevention and control 
1.5.7.1 Management procedures 
Any management procedure reducing damage to host defence mechanisms will 
help  prevent  staphylococcosis.  Because  wounds  are  a  portal  of entry  for  S. 
aureus into the body, anything reducing the chance of injury will help prevent 
infection. Sharp objects such as  splinters, jagged rocks, or metal edges that cut 
or  puncture  feet  should  be  eliminated  from  areas  where  poultry  are  reared. 
Maintenance of good litter quality  will reduce  foot  pad ulceration.  Particular 
attention should be given to  hatchery management and sanitation.  S.  aureus is 
found  everywhere,  and  conditions  in  incubators  and  hatchers  are  ideal  for 
bacterial growth. Recently hatched and hatching chicks with open navels and an 
immature  immune  system  can  easily  be  infected,  leading  to  mortality  and 
chronic  infections  shortly  after  hatching.  Prevention  of early  infections  with 
infectious  bursal  disease  virus  and chicken infectious  anaemia virus  will also 
help prevent staphylococcosis (Santivatr et ai.,  1981). 
1.6 MOLECULAR APPROACHES TO MICROBIAL IDENTIFICATION 
AND TYPING 
1.6.1 Introduction 
It has  been  observed  that  random  isolates  of the same species often differ in 43 
mUltiple  characteristics,  whereas  the  progeny  of any  particular  isolate  are 
typically indistinguishable  or highly similar.  The  central  hypothesis of typing 
studies is that a set of isolates obtained from an epidemiological cluster or during 
the course of an infection in a single patient are, in fact, directly descended from 
a common precursor and, as such, will share characteristics by which they can be 
differentiated from unrelated isolates. 
1. 6.1.1 Biotyping 
Biotyping refers to the pattern of  metabolic activities expressed by an isolate and 
may  include  specific  biochemical  reactions,  colonial  morphology,  and 
environmental  tolerances  (e.g.,  the  ability  to  grow  on  certain  media  or  at 
extremes of pH or temperature). Such characteristics have classically been used 
for  taxonomy.  In  many  clinical  microbiology  laboratories,  biotyping  is  now 
routinely and reliably performed using automated or modular systems designed 
for  species  identification.  Attempts  to  use  biochemical  reactions  for  strain 
differentiation of  S.  aureus and of  coagulase-negative staphylococci have proved 
largely unsatisfactory both because of poor reproducibility among independent 
isolates representing the same strain and relatively weak discriminatory power 
(Mickelsen et at.,  1985; Tenover et at.,  1994). 
When strains of S.  aureus isolates from poultry were biotyped according to the 
scheme of  Hajek and Marsalek (1973), they were found in three groups: biotype 
B, similar to other strains of pig or poultry origin; biotype A, similar to strains of 
human origin; and intermediate strains which could not be assigned to either of 
the  other  biotypes.  The  biotyping  scheme  of Hajek  and  Marsalek  (1973)  is 
shown in Table 1.3.  A more recent biotyping scheme, that has been applied to 
isolates from N.  Ireland that were used in the present study, is  shown in Table 
2.7. Table 1.3 The classification of S. aureus strains from poultry according to Hajek 
and Marsalek (1973) 
Biotype  Fibrino- Pigment b 
lysin a 
A  +  + 
B  + 
Coagulation 
of plasma 
human bovine 
+ 
+ 
Haemolysin 
a  13 
+  ± 
+  ± 
CV-agar 
test C 
+ 
Inter- ±  +  +  ±  +  ±  ± 
Mediate 
Fibrinolysin a: This enzyme, also call staphylokinase. Pigment b:  Colonies cream, 
cream-yellow or yellow, positive. CV  -agar test c: Crystal violet 
agar test. 
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1.6.1.2 Phage typing 
Bacteriophage typing proved to be a useful method in studying the ecology of  S. 
aureus and the epidemiology of the disease due to  this organism.  The finding 
that  the  international  sets  of phages  for  typing  human and  bovine S.  aureus 
strains  had  limited  application  to  poultry  strains  of S.  aureus  led  to  the 
establishment of separate phage sets specific for S.  aureus from poultry sources 
(Shimizu,  1976;  1977b;  1978;  Gibbs  et ai.,  1978a).  Gibbs  et ai.  (1978b)  in 
Northern Ireland developed a diverse phage typing set for poultry strains of S. 
aureus  consisting  of  22  phages  (Gibbs'  set).  In  Japan,  Shimizu  (1977a) 
developed an avian phage typing set consisting of 25  phages (Shimizu's set). 
The  set  has  been  successfully  used  on  chicken  strains  isolated  from 
Czechoslovakia,  England,  Bulgaria,  Belgium,  Italy,  Argentina,  Australia  and 
Japan  (Hajek  and Horak,  1978;  Terzolo  and  Shimizu,  1979;  Shimizu,  1979; 
Kibenge  et ai.,  1982a).  Thompson  et  al.  (1980a)  used  another phage  typing 
method in their laboratory. They showed that their basic poultry phage set was 
able  to  type  80%  of S.  aureus  strains  isolated  from  diseased  and  healthy 
chickens  or  from  the  poultry  environment  in  several  countries  (Germany, 
France,  England,  Belgium,  Bulgaria,  Argentina  and  Japan).  Also,  the 
Thompson's set has  been successfully used  on  chicken  strains  isolated  from 
Germany (Hentschel and Kusch, 1980) and Bulgaria (Grigorova et al.,  1982). 
Shimizu et al.  (1986) used  Shimizu and Gibbs'  phage sets  for  typing 295  S. 
aureus strains isolated from diseased and healthy chickens, a turkey, pigeons and 
birds of  prey in Japan and 5 other countries. Typability with Shimizu's set of 25 
phages and with Gibbs'  set of 22  phages was  compared.  Of 295  strains,  230 
(78%) strains were typable with the former and 238 (80.7%) strains were typable 
with  the  latter,  respectively.  The  majority of the  poultry strains  were  highly 
susceptible at routine test dilution to the phages in the two sets. When the two 
typing sets were combined, the increase oftypability was ca.  10%. 46 
One  obvious  problem  in  applying  a  phage  typing  system  on  a  national  or 
international basis is its effectiveness in lysing strains from different geographic 
regions (Shimizu, 1978). Bacteriophage typing is not a static system, as  it must 
respond to the emergence of new strains of staphylococci that are nontypable by 
the latest set of phages (Kloos and Lambe, 1991). In some studies, phage typing 
is only performed at 100 X RTD (routine test dilutions) and is reported to show 
"increased  sensitivity"  because  "more  distinct  types  are  resolved".  The 
significance of defining more "distinct types" among unrelated isolates can be 
difficult to interpret unless the reproducibility of  the methodology has been fully 
assessed  (Hunter,  1990).  Simply  generating  more  types  does  not  mean  the 
discriminatory power has improved. In fact,  in some instances, the observation 
that phage typing systems produce illogical or inconsistent results may indicate 
problems in methodology or interpretation (Kristjansson et a/. J  1994).  Studies 
using phage typing also  document the  extent to  which ongoing variation may 
complicate attempts to track epidemic strains. With the emergence of MRSA as 
both  a  major  epidemiological  problem  and  a  relatively  common  class  of 
nontypable isolates,  phage  typing  became  increasingly unsatisfactory (Parker, 
1983). 
1.6.2 Molecular techniques 
Macromolecules like nucleic acids, proteins, and lipopolysaccharides (in Gram-
negative bacteria) carry important information about a particular organism. The 
sequence and organisation of these macromolecules should provide a universal 
molecular  approach  to  microbial  identification  and  typing  of any  organism. 
Recently developed techniques used to isolate and characterise macromolecules 
in molecular biology have become increasingly rapid and simple, to  the extent 
that they are now readily available for any laboratory. Although the examination 
of protein and  lipopolysaccharide profiles  has  been used to  type  a variety  of 
different bacteria, there is a limitation to these techniques in that they analyse the 
phenotype rather than the genotype of a particular organism. The analysis of the 
genotype  of an  organism  does  not  depend  on  phenotypic  variation.  Thus, 47 
genotypic characterisation of bacteria is  superior to  phenotypic characterisation 
(Kerr,  1994).  Some  of the  molecular  techniques  that  have  been  used  for 
identification and typing of  S.  aureus strains are outlined below. 
1.6.2.1 Protein analysis 
Proteins play a role of structural and metabolic function in any organism. The 
diversity of  these proteins among organisms provides potential identification and 
typing systems.  Several techniques have been applied to detect protein profiles. 
Electrophoretic  protein  typing  is  performed  by  isolating  materials,  including 
proteins  and  glycoprotein  conjugates  from  whole  cell  or  cell  surface 
preparations, separating the materials by sodium dodecyl sulfate-polyacrylamide 
gel  electrophoresis  (SDS-P AGE),  and  staining  the  proteins  in  the  gel  to 
determine  the  resulting  pattern.  These  techniques  have  been  used  in 
epidemiological investigations of  S.  aureus (Gaston et al.,  1988; Mulligan et al., 
1988).  For example in the  study by Gaston et al.  (1988) three electrophoretic 
methods  of typing  methicillin-resistant  S.  aureus  (MRS A)  strains,  namely 
plasmid profiles (PP), whole-cell protein profiles (WCPP) and immunoblotting 
profiles  (IP),  were  evaluated  and  compared  with  phage  typing.  The  results 
obtained  with  isolates  from  12  outbreaks  were  compared  both  within  the 
outbreaks, to determine the consistency of results, and between outbreaks. There 
was  generally  good  agreement  between  the  typing  methods  but  in  only  six 
outbreaks did all four methods indicate the same relationship between isolates. It 
was concluded that both WCPP and IP  could provide valuable epidemiological 
data on MRSA and that IP was the easiest of  the three methods to interpret. 
However,  it  is  important to  remember that the  electrophoretic patterns of cell 
proteins  are  usually  highly  complex  and  the  profiles  generated  may  vary 
according to growth conditions and the method of  sample preparation. 48 
1.6.3 Nucleic acid analysis 
With the advent of molecular biology, strain typing has become more focused on 
DNA-based methods. Initial techniques compared restriction endonuclease patterns 
of chromosomal or plasmid DNA. The next generation of genotyping methods has 
included  Southern  blot  hybridisation  using  gene-specific  probes,  ribotyping, 
polymerase  chain  reaction  (PCR)-based  approaches,  pulsed-field  gel 
electrophoresis (PFGE) for typing of S.  aureus isolates (Bannerman et at.,  1995; 
McCullagh et at.,  1998), and multilocus sequence typing (MLST) (Enright et aI., 
2000).  These  methods  require  interpretation  and  comparison  of patterns  and 
fingerprint images. The ability to digitise and store images and to compare patterns 
by using matching software programmes has enhanced these methods. 
1.6.3.1 Analysis ofplasmid DNA 
Bacterial  plasmids  are  autonomously  replicating  extrachromosomal  genetic 
elements that are normally quite distinct from  the  chromosomal genotype that 
defines the host strain.  Plasmids can be acquired by a variety of mechanisms 
and,  although often stably inherited as  the host strain proliferates, they can be 
lost spontaneously, as they are not generally essential for the survival of the host 
cell (Archer et at.,  1985; John and Twitty, 1986; Woodford et al.,  1993). 
Plasmid profile analysis is technically simple and represents the first DNA-based 
typing method applied  to  S.  aureus  (McGowan  et al.,  1979;  Locksley  et at., 
1982). The number and size of  the plasmids carried by an isolate are determined 
by  preparing  a  plasmid  extract  and  subjecting  it  to  routine  agarose  gel 
electrophoresis (Mayer, 1988). The technical reproducibility of plasmid profiles 
is confounded by the fact that a plasmid can exist in different molecular forms, 
that is, supercoiled (closed circle), nicked (open circle), linear, and oligomeric, 
each of which migrates differently during agarose gel electrophoresis. Thus, in 
different preparations,  there  can be variation in both the  number and relative 
intensity of bands representing each individual plasmid (Zuccarelli et al.,  1990). 
Both the discriminatory power and technical reproducibility of plasmid analyses 49 
can  be  improved  by  digesting  the  plasmids  with  restriction  enzymes  and 
analysing  the  number and  size  of the  resulting  restriction  fragments  (Mayer, 
1988). 
For further information on plasmids in staphylococci, see Section 1.3.2. 
1.6.4 Analysis of chromosomal DNA 
Restriction  endonuclase  analysis  (REA).  In  conventional  restriction  enzyme 
analysis  (REA),  bacterial  DNA  is  digested  with  endonucleases  that  have 
relatively  frequent  restriction  sites,  generating hundreds of fragments  ranging 
from approximately 0.5 to 50 kb in length. Different strains have different REA 
profiles because of variations in their DNA sequences that alter the number and 
distribution of restriction sites.  All isolates are  typable by REA;  however, the 
profiles consist of hundreds of bands that may be unresolved and overlapping, 
and therefore difficult to compare e.g. for Pseudomonas aeruginosa (Ogle et al., 
1987) and for coagulase-negative staphylococci (Bialkowska-Hobizanska et al., 
1990).  In addition,  the  patterns  may be  confounded by  restriction  fragments 
derived  from  plasmids,  which  can  readily  contaminate  genomic  DNA 
preparations.  Thus,  isolates  that  differ  only  in their plasmid content may be 
designated as different strains. The analysis of  independent plasmid preparations 
coupled with computer-assisted subtraction techniques can compensate for this 
effect  (Bialkowska-Hobizanska  et  al.,  1990);  however,  such  laborious 
procedures  are  rarely implemented.  In general,  REA has  been  supplanted by 
other genotyping methods. 
1.6.4.1 Hybridisation procedures 
Nucleic acid hybridisation is done using a labelled nucleic acid probe. There are 
two steps involved in the hybridisation technique. First, the target nucleic acid 
molecule is  denatured by treatment with alkali  or heating  and then a labelled 
nucleic  acid  probe  is  annealed  by subsequent  neutralisation  or  cooling.  The 
specificity  (stringency)  and  speed  of such  a  hybridisation  reaction  can  be 50 
controlled  by  manipulating  the  temperature,  salt  concentration,  pH,  probe 
concentration  and  probe  size.  The  greater  the  stringency,  the  greater  the 
specificity.  The probe can be a  specific cloned DNA fragment  or a synthetic 
oligonucleotide. The method of labelling of the probe depends on whether the 
detecting system is  either direct or indirect. The direct labels are radioisotopes 
such  as  32p  and  35S,  and  indirect  labels  include  enzymes  such  as  alkaline 
phosphatase and horseradish peroxidase or dyes  like  ethidium,  fluorescein  or 
DIG  labelling  system.  In  indirect  labelling,  the  probe  is  labelled  with  a 
modifying  group  which  subsequently  binds  with  a  reporter  molecule.  The 
radioactive labels have restrictions to use i.e. they may have short half-lives and 
possible  health  and  safety  hazards.  The  hybridisation  can  be  applied  after 
purification of  target DNA by agarose gel electrophoresis and transferring DNA 
to a solid (nitrocellulose or nylon membranes) matrix by Southern blotting or in 
liquid phase.  In general, probe assays which are  based on labels  that provide 
signal amplification (i.e.  enzymes) can be expected to  be more sensitive than 
assays based on labels that provide only a single signal per label e.g. fluorescein. 
The main drawback is  that each individual species to  be identified requires its 
own specific  probe and this  is  an  identification method rather than  a  typing 
system. However, it can be developed into a typing method by combining with 
restriction endonuclease analysis (Towner and Cockayne, 1993). 
Many different Southern blot analyses  have  been applied to  typing  S.  aureus 
isolates  (Ten  over et at.,  1994).  However,  few systems,  other than ribotyping, 
have been used widely, and none has been established as particularly effective. 
1.6.5 PeR-based techniques 
Nucleic  acid  amplification  by  PCR  has  been  applied  to  the  detection  and 
identification  of microbes  and  is  becoming  widely  used  for  detection  for 
diagnostic purposes in clinical research and diagnostic laboratories (Whelen and 
Persing,  1996;  Vaneechoutte and VanEldere,  1997).  PCR allows identification 
of low amounts of DNA and is  highly specific since the amplification depends 51 
on  the  use  of primers  with  sequences  which  are  complementary to  the  DNA 
molecule to  be  amplified.  The  PCR is  not hindered by the presence of DNA 
from other sources and therefore allows the selective amplification of one DNA 
molecule with a predefined sequence in the presence of large amounts of other 
nucleic  acids.  The  ability  to  specifically  amplifY  DNA  by  PCR  from  low 
numbers of bacteria, as well as its simplicity, rapidity and reproducibility offers 
advantages  over  the  conventional  cultural  and  phenotypic  methods  for 
identification and differentiation of  strains. 
1.6.5.1 PCR-rihotyping 
The  16S-23S rRNA intergenic spacer of the ribosomal RNA operon (rrn) has 
proved useful for identification of strains and species (Barry et at.,  1991; Jensen 
et at.,  1993; Giirtle and Stanisich,  1996).  The spacer region is  considered non-
functional and is  consequently argued to  be under minimal  selective pressure 
(Barry et at.,  1991).  Its  evolutionary rate  is  10  times greater than that of 16S 
rDNA (Leblond-Bourget et at.,  1996), the sequence of which is  routinely used 
for  phylogenetic studies  of bacteria (Ludwing  and  Schleifer,  1994).  The  high 
evolutionary  rate  makes  it  possible  to  distinguish  closely-related  bacterial 
species and strains. 
PCR amplification of  the intergenic spacer region, using primers complementary 
to  conserved regions of the  16S  and 23S  genes, i.e.  PCR ribotyping, generally 
produces multiple fragments  for  each isolate, with appreciable diversity in the 
pattern of fragments among a few epidemiologically-unrelated isolates (Dolzani 
et at.,  1994; Kostman et at.,  1995). However, there is  considerable variation in 
the  amount of each  of the  different  fragments  produced  for  a  given  isolate. 
Consequently,  the  patterns  comprise  mixtures  of intense  and  faint  staining 
bands, which may complicate comparisons of different isolates (Dolzani et at., 
1994). Appuhamy et at.  (1998a, b) characterised the spacer region between 16S 
and  23S  rRNA  genes  of two  ribosomal  operons,  termed  rrnA and  rrnB  of 52 
Actinobacillus  seminis  isolates  and used  PCR-ribotyping  to  differentiate  this 
organism from related species. 
Jensen et al.  (1993) have developed a unified set of primers and PCR conditions 
to  amplify spacer regions  between the  16S  and 23S  genes in the prokaryotes 
including S.  aureus isolates. On the basis of the results obtained with their test 
group of 300 bacterial strains,  amplification of the  16S-23S ribosomal spacer 
region is  a suitable process for generating a data base for use in a PCR-based 
identification method,  which  can be  comprehensively  applied to  the  bacterial 
kingdom. A high level of intraspecies variation of 16S-23S spacer regions has 
been  reported  in  S.  aureus  (Jensen  et  at.,  1993;  Saruta  et  al.,  1997).  Also, 
Forsman et al.  (1997) detennined the sequences of the 16S-23S spacer regions 
for bovine mastitis S.  aureus  and the eight Staphylococcus  and Streptococcus 
species with specific primers pairs for these species and genera. 
1.6.5.2 Randomly amplified polymorphic DNA (RAPD)-PCR 
Welsh  and  McClelland  (1990)  and  Williams  et  al.  (1990)  reported  that 
organisms could be typed using PCR fingerprints with primers having random 
sequences. The application of  this method in microbiology has been reviewed by 
Power (1996). It has been tenned arbitrarily-primed PCR (AP-PCR) or random 
amplified polymorphic DNA assay (RAPD). For conventional PCR, knowledge 
of target sequence is  a prerequisite and that drawback has been eliminated with 
RAPD-PCR. The basis of the method is that a single primer combined with two 
cycles of PCR at low stringency and many cycles at high stringency generate a 
discrete  and  reproducible  set  of  amplification  products  characteristic  of 
particular genomes.  The  theory  for  this  method is  that  at  a  sufficiently  low 
temperature  a  primer  can  anneal  to  many  sequences  with  a  variety  of 
mismatches. Some of these sequences will be within a few hundred base pairs of 
each other and on opposite strands, such that the intervening sequences will be 
amplified by PCR (Welsh and McClelland,  1990). The primers used for RAPD 53 
have varied in the number ofnucleotides: 20 (Welsh and McClelland, 1990); 10-
12 (Williams et at.,  1990): and as short as five (Caetano-Annolles et at.}  1991). 
Meunier and  Grimont  (1993)  have  investigated  the  reproducibility  of RAPD 
fingerprinting.  They found that different brands of Taq  DNA polymerase have 
drastic effects on the reproducibility of banding patterns of RAPD and that the 
cause of  this variation was the buffer recommended by the manufacturer, not the 
Taq DNA polymerase. They also found that make of thermal cycler affected the 
reproducibility of the RAPD pattern. van Belkum and Meis (1994) reported that 
RAPD was a good PCR fingerprinting method that gave excellent resolution,  a 
high degree of reproducibility, exquisite sensitivity and extreme versatility when 
compared to  other typing techniques  and that large  numbers of strains  can be 
analysed within a short period of time. Arbeit et at.  (1994) however has pointed 
out  that  RAPD  produces  some  bands  by  inefficient  reactions,  resulting  in 
variation in amplification and generation of  bands of  different sizes and intensity 
that  cause  difficulties  in  comparing profiles.  They  reported that there  are  no 
standards  for  the  reproducibility  of RAPD  and  the  discriminatory  power  of 
pulsed field gel electrophoresis is  higher than RAPD.  On the other hand, it has 
been reported that RAPD typing  is  far  more sensitive than multilocus enzyme 
electrophoresis  typing  for  discriminating  between  related  strains  of a  species 
(Wang et al.,  1993). A comparative study of ribotyping, PFGE and RAPD with 
Clostridium  difficile  has  shown  that the  discriminatory power and analysis  of 
patterns is  higher but time-consuming  in PFGE than RAPD  (Chachaty et at., 
1994). 
van Belkum et al.  (1995) have been leading contributors in evaluating AP-PCR 
for  S.  aureus. They concluded that AP-PCR is well suited for genetic analysis 
and  monitoring  of  nosocomial  spreading  of  staphylococci.  However  the 
interlaboratory  reproducibility  and  standardisation  of DNA-banding  patterns 
remains a problem. Benito et al.  (2000) used AP-PCR for rapid identification of 
S.  aureus from other staphylococcal species. 54 
1.6.5.3 Repeat element peR 
REP-PCR.  Versalovic  et  al.  (1991)  described  a  method  for  fingerprinting 
bacterial  genomes  by  examining  strain-specific  patterns  obtained  from  PCR 
amplification of repetitive DNA elements present within bacterial genomes. The 
repetitive  extragenic  palindromic  (REP)  elements  are  38-bp  sequences 
consisting of six degenerate positions  and  a 5-bp variable loop  between each 
side  of a  conserved palindromic  stem  (Stem et al.,  1984).  DelVecchio  et al. 
(1995)  described a REP-PCR for  the  molecular genotyping of 170  MRSA  S. 
aureus isolates. They concluded that REP-PCR of MRS A can easily determine 
an  outbreak  source,  and  it  can  have· important  clinical  and  epidemiological 
ramifications.  It can  be  used  in  routine  surveillance  and  can  enhance  the 
potential for infection control. This high-stringency PCR fingerprinting method 
is  based on a repetitive  sequence found  in Mycoplasma pneumoniae (Wenzel 
and Hermann,  1988), but it also generates strain-specific DNA fragments when 
S.  aureus DNA is used as an amplification template. Very recently Kuroda et al. 
(2001) has shown the presence of unique repetitive sequences in two human S. 
aureus genome sequences. 
ERIC-PCR.  The  enterobacterial  repetitive  intergenic  consensus  (ERIC) 
sequences have also been targeted for bacterial typing. ERIC sequences are 126-
bp elements which contain a highly conserved central inverted repeat and  are 
located in intergenic regions of  the bacterial genome (Sharples and Lloyd, 1990; 
Hulton  et  al.,  1991).  They  have  been  defined  primarily  on  sequence  data 
obtained from E.  coli and Salmonella typhimurium (Sharples and Lloyd,  1990; 
Hulton et al.,  1991). Appuhamy et at.  (1997) used both REP- and ERIC-PCR to 
distinguish bovine Haemophilus somnus isolates. In another study by Appuhamy 
et al.  (1998a)  REP- and ERIC-PCR were  used for  strain differentiation in an 
epidemiological  study  of Actinobacillus  seminis  isolates.  van  Belkum  et  al. 
(1993) reported that ERIC sequences have not been demonstrated to be present 
in S.  aureus or other Gram-positive bacteria. However, Wieser and Busse (2000) 
used an ERIC-PCR method for rapid identification of  S.  epidermidis strains. 55 
While the REP  and ERIC  sequences are  the most commonly used targets  for 
DNA  typing,  other  repeat  sequences  have  been  used  as  the  basis  of DNA 
fingerprinting methods. 
BOX repeat element peR. The BOX sequence has been used to  differentiate 
strains of Streptococcus pneumoniae (Martin et al.,  1992; Koeuth et al.,  1995; 
van Belkum et al.,  1996b). Box elements are located within intergenic regions 
and can also  form  stem-loop  structures due  to  their dyad symmetry.  They are 
mosaic repetitive sequences referred to as  boxA, boxB, and boxC (Martin et al., 
1992).  The three  subunit sequences  have  molecular  lengths  of 59,  45  and  50 
nucleotides long, respectively. There are no relationship between these elements 
and the REP and ERIC units (Martin et al.,  1992). While initially thought to be 
unique to S.  pneumoniae, BOX elements have now been found in Helicobacter 
pylori (Kwon et al.,  1998) and Wieser and Busse (2000) used REP-, ERIC- and 
BOX-PCR for  further  genotypic  characterisation  of some  human  coagulase-
negative staphylococci and S.  aureus. ERIC- and BOX-PCR yielded a species-
specific banding pattern for all Staphylococcus epidermidis strains. Furthermore, 
all  staphylococcal  reference  strains  investigated  exhibited  distinct  banding 
patterns, clearly distinguishable from that of  S.  epidermidis. No species-specific 
banding patterns could be observed after REP-PCR. As species identification of 
coagulase-negative staphylococci by fatty acid analysis and biochemical tests is 
known to be difficult, ERIC- and BOX-PCR seem to be excellent tools for the 
identification of  S.  epidermidis strains. 
1.6.5.4 Restriction fragment  length  polymorphism  (RFLP)  analysis of peR 
products 
PCR  of specific  chromosomal  regIOns  has  been  combined  with  restriction 
endonuclease digestion of the PCR products which are then resolved on agarose 
or polyacrylamide gels to  produce RFLPs.  This system has  been successfully 
applied to differentiate strains of rickettsiae by amplifying the citrate synthetase 
gene  (Regnery  et  al.,  1991).  The  advantages  of this  system  are  that  small 56 
quantities of chromosomal DNA are sufficient and the procedure takes only a 
short  time.  The  coagulase  gene  of S.  aureus  shows  a  high  level  of allelic 
variation associated with a series of 81-bp tandem repeats,  varying in number 
among  different  strains;  the  sequences  of  individual  repeats  are  highly 
homologous but differ in the presence or absence of an Alul restriction site. Alul 
digests  of this  locus  have  proved  highly  reproducible  but  only  moderately 
discriminatory  for  S.  aureus  strain typing  (Goh  et  al.}  1992;  Tenover  et al.} 
1994).  The  polymorphic X-region  of the  protein A  gene  (spa)  consists  of a 
variable number of 24-bp repeats  and  is  located immediately upstream of the 
region  encoding  the  C-terminal  cell  wall  attachment  sequence.  PCR 
amplification of the  X-region followed  by restriction  analysis  was  equally  as 
reproducible and easy to implement in the laboratory as  was RAPD and RNA 
spacer region amplification. It also allowed further subtyping of bovine mastitis 
isolates with identical PFGE patterns (Lange et al.}  1999). Frenay et al.  (1996) 
demonstrated the discrimination of MRSA isolates by amplification of the X-
region. Also, van Belkum et al.  (1996a)  showed that a Danish collection of S. 
aureus strains varied within the X-region of  the protein A gene. They concluded 
that the X-region is hyper-variable and that the spa region has probably evolved 
independently from the remaining S.  aureus genome. 
1.6.6 Multilocus enzyme electrophoresis (MLEE) 
In  multilocus  enzyme  electrophoresis  (MLEE),  isolates  are  analysed  for 
differences  in  the  electrophoretic  mobilities  of a  set  of metabolic  enzymes 
(Selander et al.}  1986).  Cell extracts containing the soluble metabolic enzymes 
are electrophoresed in non-denaturing starch gels.  For each enzyme analysed, a 
replicated gel, or slice of a gel, is stained with a specific colorimetric substrate, 
such that the position of the enzyme is  detected by the appearance of a visible 
reaction product (Selander et al.}  1986). Such analysis of variation on the basis 
of differences  at a  limited number of proteins has  been useful for  estimating 
population structure and evolution (Enright et al.}  2000). MLEE is powerful tool 
for  such population studies,  because as  each individual  enzyme represents  an 57 
independent  characteristic,  the  data  are  suitable  for  rigorous  mathematical 
analysis  (Selander  et  al.,  1986).  However,  MLEE  method  is  generally 
considered tedious and time-consuming, since population genetic studies require 
the analysis of sizeable numbers of loci in large number of isolates (Combe et 
al.,  2000). Also, the techniques and equipment are somewhat specialized and are 
available  in  relatively  few  laboratories.  Consequently,  the  method  has  had 
relatively limited application to  epidemiological studies (Tenover et al.,  1994; 
Maslow et al.,  1995). 
MLEE has proved to be only moderately discriminatory for the epidemiological 
analysis of clinical isolates of  S.  aureus and other species. Sixty-three S.  aureus 
isolates recovered from bovine sources in the USA and the Republic of Ireland 
were  characterised by  MLEE,  ribotyping  and  random  amplified  polymorphic 
DNA PCR (RAPD-PCR)  typing  at  two  separate  laboratories.  The  S.  aureus 
isolates  were  assigned by MLEE  to  10  electrophoretic  types  (ETs)  (index  of 
discrimination, D  =  0.779).  In contrast, the  same isolates were assigned to  13 
ribotypes  (D  =  0.888)  and to  12  RAPD  types  (D  = 0.898).  S.  aureus clones 
recovered from cows in Ireland were also associated with mastitis in dairy cows 
in the USA. These finding were consistent with the hypothesis that only a few 
specialised  clones  of S.  aureus  are  responsible  for  the  majority  of cases  of 
bovine  mastitis,  and  that  these  clones  had  a  broad  geographic  distribution 
(Fitzgerald et al.,  1997). 
1.6.7 Pulsed-field gel electrophoresis (PFGE) 
This  method,  developed  by  Schwmiz  and  Cantor  (1984),  is  a  variation  of 
agarose gel  electrophoresis in which the  orientation of the electric field  across 
the gel is changed periodically ("pulsed"), rather than being kept constant as  in 
conventional  agarose  gel  electrophoresis used for  the  REA  and  Southern blot 
studies. This critical modification enables DNA fragments as large as mega  bases 
to  be separated effectively by size (Birren and  Lai,  1993).  Suitable unsheared 
DNA is  obtained by embedding intact organisms  in  agarose plugs  ("inserts"), 58 
and enzymatically lysing the  cell wall  and digesting the  cellular proteins.  The 
isolated genomes are then digested in situ with restriction enzymes that have few 
recognition sites (Arbeit et ai.,  1990; Maslow et ai.,  1993). 
When a staphylococcal chromosome of about 2,800 kb,  with a G+C content of 
approximately  34%  is  digested  with  Sma! (recognition  sequence  CCCGGG), 
PFGE analysis provides a chromosomal restriction profile composed of 15 to 20 
distinct,  well-resolved  fragments  ranging  from  approximately  10  to  800  kb. 
PFGE  was  more  efficient  at  differentiating  strains  of methicillin-resistant  S. 
aureus than other methods tested such as  random amplified polymorphic DNA 
(RAPD) (Saulnier et ai.,  1993). 
Many of the strains used in the present work were provided by Dr. McCullagh 
and had been typed by PFGE. McCullagh et ai.  (1998) used the PFGE method to 
investigate the  epidemiology of S.  aureus  infection  in N.  Ireland commercial 
broiler flocks  and to  show that the majority of the strains originated from  the 
hatcheries. The resultant banding patterns were visually compared to  a control 
included on each gel.  The control selected, strain 24, was obtained from a case 
of proximal femoral degeneration (PFD) in broilers. The bacterial grouping was 
based  on  the  number  of similar  bands  present  between  restriction  fragment 
patterns. The groups consisted of strains (a) identical to strain 24 type, showing 
no  band  differences,  (b)  closely  related,  showing  1-3  band  differences,  (c) 
possibly related, showing 4-6 band differences and (d) unrelated, showing more 
than 6 band differences. The results of the clinical studies of S.  aureus isolates 
from broiler farms showed that the majority of  these strains (60%) were from leg 
infections i.e. bone, joint or hock, 34% were from  liver and the remainder were 
from  wattles  (6%).  PFGE  typing  for  strains  isolated  from  clinical  disease  of 
broiler chickens,  compared with  strain 24,  showed that 57% were  identical,  a 
further 28% showed relatedness to strain 24 and only 15% were unrelated. Also 
the results of isolates from hatcheries showed 48% strains were identical, 22% 
showed relatedness and 29% were totally unrelated to strain 24. 59 
PFGE  has  two  notable  limitations.  First,  because  of the  need  to  diffuse  all 
buffers  and enzymes into  the  agarose  insert,  the  preparation of suitable DNA 
involves  several  extended  incubations  and  takes  2 to  4  days  (Maslow et al., 
1993).  This  can reduce  the  laboratory's  ability  to  analyse  large  numbers  of 
samples.  Second,  PFGE  requires  relatively  expensive  specialised  equipment 
(Birren and Lai, 1993). 
1.6.8 Multilocus sequence typing (MLST) 
MLST is a recent and highly discriminatory method of characterising bacterial 
isolates, on the basis of  the sequences of  ~450 bp internal fragments of, usually, 
seven housekeeping genes  (Maiden et al.,  1998).  For each gene, the different 
sequences are  assigned as  alleles  and  the  alleles  at  the  seven loci provide an 
allelic  profile,  which unambiguously  defines  the  sequence  type  (ST)  of each 
isolate. MLST has been used for the identification of the hypervirulent lineages 
of Neisseria meningitidis (Maiden et al.,  1998) and for assigning Streptococcus 
pneumoniae  strains  to  the  major  hypervirulent  clones  (Enright  et  al.,  1998; 
Enright et al.,  1999). MLST has also been applied to S.  aureus. The sequences of 
internal fragments of seven housekeeping genes were obtained for 155 S.  aureus 
isolates from patients with community-acquired and hospital-acquired invasive 
disease in the Oxford area, United Kingdom. Fifty-three different allelic profiles 
were  identified,  and  17  of these  were  represented  by  at  least  two  isolates 
(Enright et al.,  2000). 
1.6.9 DNA micro  arrays 
It is  now possible to  index  diversity in  overall  chromosomal  gene content in 
isolates  of a  bacterial  species.  For example,  whole-genome  DNA microarray 
analysis has been used to compare the genomes of 13 variants of  the tuberculosis 
vaccine  strain,  bacillus  Calmette-Guerin,  and  Mycobacterium  tuberculosis 
H37Rv (Behr et al.,  1999). Fitzgerald et al.  (2001) reported a DNA microarray 
representing >90% of the S.  aureus genome to  characterise genomic diversity, 
evolutionary  relationships,  and  virulence  gene  distribution  among  36  human, 60 
bovine  and ovine  isolates  of divergent  clonal  lineages,  including  methicillin-
resistant isolates and organisms causing toxic shock syndrome. Genetic variation 
in  S.  aureus  is  very  extensive,  with  ~22% of the  genome  comprised  of 
dispensable  genetic  material.  Eighteen  large  regions  of  difference  were 
identified,  and  10  of these  regions  have  genes  that encode putative  virulence 
factors  or proteins mediating antibiotic resistance.  Also they found  that lateral 
gene transfer has played a fundamental role in the  evolution of S.  aureus.  The 
mec gene has been horizontally transferred into distinct S.  aureus chromosomal 
backgrounds at least five  times,  demonstrating that methicillin-resistant strains 
have evolved at multiple, independent times, rather than from a single ancestral 
strain. This finding resolves a long-standing controversy in S.  aureus research. 
DNA micro  array  analysis  of large  samples  of clinically  characterised isolates 
provides broad insights into evolution, pathogenesis, and disease emergence. 
1.6.10 Comparative studies on different typing methods 
A number of DNA-based methods have therefore been developed for typing S. 
aureus strains.  Pulsed-field gel electrophoresis (PFGE) analysis is  an accurate, 
reliable,  and  discriminatory  method  used  by  many  hospitals  and  reference 
laboratories (Bannerman et al.,  1995; Shimizu et al.,  1997a;  1997b; McCullagh 
et al.,  1998;  Shimizu et al.,  2000;  Zadoks  et al.,  2000),  but  it  is  technically 
demanding  and  time-consuming.  Compared  to  PFGE  analysis,  PCR-based 
typing  methods  offer  the  advantages  of rapidity  and  simplicity.  Repetitive-
element  PCR  (REP-PCR)  analysis  based  on  multicopy  elements  of  the 
staphylococcal  genome  has  shown  good  reproducibility  and  discriminatory 
power in single-centre studies (Del Vecchio et al.,  1995; Cuny and Witte, 1996; 
Deplano et al.,  1997; Kumari et al.,  1997; van der Zee et al.,  1999; Deplano et 
al.,  2000). The MLST method was highly discriminatory and was validated by 
showing that pairs  of human  S.  aureus  isolates  with the  same  allelic  profile 
produced very similar Sma! restriction fragment  patterns  by PFGE.  However, 
the  major  use  of the  MLST  scheme  for  S.  aureus  will  probably  be  to 61 
unambiguously identify MRSA isolates and to probe the origins and evolution of 
these isolates (Enright et at.,  2000). 
1.6.11 Identification and detection of  S. aureus by peR 
Although S.  aureus is easy to cultivate and is not difficult to identify, some peR 
methods have been developed for rapid identification of S.  aureus. Brakstad et 
at.  (1992) developed a peR assay specific for  S.  aureus  by targeting the nuc 
gene  coding  for  staphylococcal thermonuclease.  This  assay was shown to  be 
suitable  for  diagnostic  purposes.  Martineau  et  at.  (1998)  described  the 
development of another species-specific DNA-based assay for the identification 
of S.  aureus.  In  ordered  to  select  a  genetic  target  suitable  for  diagnostic 
purposes, a S.  aureus genomic library was screened by hybridization of DNAs 
from an array of both Gram-positive and Gram-negative bacterial species. Using 
this strategy, they were able to identify a clone carrying a chromosomal DNA 
insert suitable as a probe for the identification of  S.  aureus. The genomic DNA 
fragment  inserted into  this  clone  was  species-specific  and ubiquitous  (i.e.,  it 
hybridized to DNA from any S.  aureus strain) for the identification of  S.  aureus. 
This  genomic  DNA  fragment  was  sequenced  and  was  used to  design  peR 
amplification primers for S.  aureus-specific peR assays.  The simple and rapid 
peR assay  that they  developed provided  a  new tool  for  the  diagnosis  of S. 
aureus infections, and the assay may be applied for the direct detection of S. 
aureus from blood culture or clinical specimens. 62 
1.7 AIMS OF RESEARCH 
Staphylococci are a common cause of infection in birds and most infection are 
caused by coagulase-positive staphylococci, especially Staphylococcus aureus. 
However  much  still  remains  to  be  done  to  complete  our  knowledge  of 
Staphylococcus aureus from birds.  There is  very little information available on 
the molecular characterisation of avian Staphylococcus aureus strains and their 
virulence genes. The approach in this study was to obtain a number of  isolates of 
avian S.  aureus, which were mainly from  diseased birds in commercial flocks 
from different geographic areas, and to characterise these strains by a variety of 
conventional  and  molecular  methods.  The  aims  were  two-fold:  to  develop 
discriminating and reproducible identification and typing systems to investigate 
disease outbreaks, and to understand the disease potential of  S.  aureus in poultry. 
Any information gained would be of  benefit to the poultry industry. 2. MATERIALS AND METHODS 63 
2.1 BACTERIAL STRAINS 
A total of 130 bacterial isolates were used. They belonged to different species of 
staphylococci and a description of each isolate is  given in Tables 2.1, 2.2, 2.3, 
2.4, 2.5 and 2.6. Identification of  isolates at species level was clear, with isolates 
showing properties similar to  those  described by Kloos  and Schleifer (1975), 
Kloos and Lambe (1991), Kloos (1998). 
2.1.1 Avian coagulase-positive strains 
The  87  isolates were obtained during the  study (Table 2.1).  The strains were 
field isolates and were from diseased birds. There was no type strain available in 
any of  the major culture collections, but the strain selected as a control, strain 24, 
was obtained from a case of proximal femoral  degeneration, in a broiler from 
Northern Ireland. 
2.1.2 Avian coagulase-negative strains 
The  six  isolates  of three  different  coagUlase-negative  staphylococcal  species 
were included as  controls in the  study (Table 2.2).  There was no type strain 
available for these species in any of the culture collections. These bacteria were 
isolated from diseased flocks. 
2.1.3 Human coagulase-positive strains 
Twenty one human isolates were obtained for the study (Table 2.3) including 
the type strain of  S.  aureus. 
2.1.4 Human coagulase-negative strains 
Three isolates were used. They belonged to two species of bacteria, namely S. 
epidermidis and S.  saprophyticus (Table 2.4). 
2.1.5 Animal coagulase-positive strains 
Eight isolates were obtained during the study (Table 2.5). They belonged to two 64 
Table 2.1 Description of avian coagulase-positive isolates 
Isolate#  Source  Site of  Disease  Geographic  Origin+ 
isolate  status  origin 
2A  Chicken  Joint  SYN
a  Scotland  DJT 
2B  Chicken  Joint  SYN  Scotland  DJT 
3A  Chicken  Joint  FHN
b
, TIDe,  Scotland  DJT 
SYN 
4  Chicken  Joint  FHN,SYN  Scotland  DJT 
RTId 
5  Chicken  Gut  No record  Scotland  DJT 
6  Chicken  Joint  FHN,SYN,  Scotland  DJT 
TID, RTI 
7A  Chicken  Joint  SYN  Scotland  DJT 
7B  Chicken  Joint  SYN  Scotland  DJT 
8  Chicken  Joint  SYN  Scotland  DJT 
31174  Chicken  Heart  MSH
e  Scotland  DJT 
31175  Chicken  Yolk sac  YSI
f  Scotland  DJT 
31176  Chicken  Heart  YSI  Scotland  DJT 
31177  Chicken  Heart  MSH  Scotland  DJT 
31178  Chicken  Heart  YSI  Scotland  DJT 
31179  Chicken  Heart  YSI  Scotland  DJT 
31180  Chicken  Heart  YSI  Scotland  DJT 
31181  Chicken  Heart  YSI  Scotland  DJT 
31182  Chicken  Heart  MSH/YSI  Scotland  DJT 
31183  Chicken  Heart  MSHlYSI  Scotland  DJT 
31036  Chicken  Skin  Skin scalp lesion  Scotland  DJT 
31039  Chicken  Skin  Skin scalp lesion  Scotland  DJT 
32528  Cockatoo  No record  No record  Scotland  DJT 
E  Goshawk  Foot  Bumblefoot  England  NAF 
K  Saker falcon  Foot  Bumblefoot  England  NAF 
SV6  Steppes falcon  Foot  Bumblefoot  England  NAF 
SV132  Harris Hawk  Foot  Bumblefoot  England  NAF 
SV289  Lanner falcon  Foot  Bumblefoot  England  NAF 
NFR  Gyr falcon  Foot  Bumblefoot  England  NAF 
PD486  Chicken  Joint  SYN  Sri Lanka  SA 
PD458  Chicken  Joint  SYN  Sri Lanka  SA 
PD380  Chicken  Liver  Pericarditis  Sri Lanka  SA 
PD27  Chicken  Liver  YSI  Sri Lanka  SA 
199  Duck  No record  No record  USA  RJM 
214  Duck  No record  No record  USA  RJM 
217  Duck  No record  No record  USA  RJM 
235  Duck  No record  No record  USA  RJM 
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Isolate  Source  Site of  Disease  Geographic  Origin 
isolate  status  origin 
24*  Chicken  No record  Clinical In.
g  N. Ireland  JJM 
34  Chicken  No record  Clinical In.  N. Ireland  JJM 
35  Chicken  No record  Clinical In.  N. Ireland  JJM 
36  Chicken  No record  Clinical In.  N. Ireland  JJM 
38  Chicken  No record  Clinical In.  N. Ireland  JJM 
77  Chicken  No record  Clinical In.  N. Ireland  JJM 
82  Chicken  No record  Clinical In.  N. Ireland  JJM 
83  Chicken  No record  Clinical In.  N. Ireland  JJM 
85  Chicken  No record  Clinical In.  N. Ireland  JJM 
86  Chicken  No record  Clinical In.  N. Ireland  JJM 
98  Chicken  No record  Clinical In.  N. Ireland  JJM 
99  Chicken  No record  Clinical In.  N. Ireland  JJM 
100  Chicken  No record  Clinical In.  N. Ireland  JJM 
104  Chicken  No record  Clinical In.  N. Ireland  JJM 
105  Chicken  No record  Clinical In.  N. Ireland  JJM 
122  Chicken  No record  Clinical In.  N. Ireland  JJM 
123  Chicken  No record  Clinical In.  N. Ireland  JJM 
496  Chicken  No record  Clinical In.  N. Ireland  JJM 
562  Chicken  No record  Clinical In.  N. Ireland  JJM 
564  Chicken  No record  Clinical In.  N. Ireland  JJM 
572  Chicken  No record  Clinical In.  N. Ireland  JJM 
580  Chicken  No record  Clinical In.  N. Ireland  JJM 
582  Chicken  No record  Clinical In.  N. Ireland  JJM 
595  Chicken  No record  Clinical In.  N. Ireland  JJM 
596  Chicken  No record  Clinical In.  N. Ireland  JJM 
597  Chicken  No record  Clinical In.  N. Ireland  JJM 
598  Chicken  No record  Clinical In.  N. Ireland  JJM 
3  Chicken  No record  Clinical In.  N. Ireland  JJM 
11  Chicken  No record  Clinical In.  N. Ireland  JJM 
20  Chicken  No record  Clinical In.  N. Ireland  JJM 
25  Chicken  No record  Clinical In.  N. Ireland  JJM 
30  Chicken  No record  Clinical In.  N. Ireland  JJM 
48  Chicken  No record  Clinical In.  N. Ireland  JJM 
51  Chicken  No record  Clinical In.  N. Ireland  JJM 
52  Chicken  No record  Clinical In.  N. Ireland  JJM 
53  Chicken  No record  Clinical In.  N. Ireland  JJM 
88  Chicken  No record  Clinical In.  N. Ireland  JJM 
170  Chicken  No record  Clinical In.  N. Ireland  JJM 
172  Chicken  No record  Clinical In.  N. Ireland  JJM 
259  Chicken  No record  Clinical In.  N. Ireland  JJM 
329  Chicken  No record  Clinical In.  N. Ireland  JJM 
330  Chicken  No record  Clinical In.  N. Ireland  JJM 
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Isolate  Source  Site of  Disease  Geographic  Origin 
isolate  status  origin 
352  Chicken  No record  Clinical In.  N. Ireland  JJM 
373  Chicken  No record  Clinical In.  N. Ireland  JJM 
390  Chicken  No record  Clinical In.  N. Ireland  JJM 
410  Chicken  No record  Clinical In.  N. Ireland  JJM 
451  Chicken  No record  Clinical In.  N. Ireland  JJM 
31  Chicken  No record  Clinical In.  N. Ireland  JJM 
33  Chicken  No record  Clinical In.  N. Ireland  JJM 
47  Chicken  No record  Clinical In.  N. Ireland  JJM 
525  Chicken  No record  Clinical In.  N. Ireland  JJM 
# All isolates are S.  aureus except for isolate SV132 which is S.  intennedius. 
tOrigin, DJT: Prof. D.  J.  Taylor, Department of Veterinary Pathology, University of 
Glasgow; NAF: Dr. N.  A.  Forbes, Lansdown Veterinary Surgeons, The Clockhouse 
Veterinary  Hospital,  Wallbridge,  Stroud,  Gloucestershire;  SA:  Dr.  S.  Appuhamy, 
Veterinary  Research  Institute,  Peradeniya,  Sri  Lanka;  RJM:  Dr.  R.  1.  Montali, 
Department of Pathology, National Zoological Park, Washington DC, USA; JJM: Dr. 
J. J. McCullagh, Veterinary Science Division of Agriculture for Northern Ireland. 
SYN
a
: Synovitis, FHN
b
: Femoral head necrosis; TIDe: Tibial dischondroplasia; 
RTld:  Rotated tibia; MSH
e
:  Mushy chick disease; yst Yolk sac infection; Clinical 
In.
g
: Clinical infection. 
24  *:  Strain  24,  was  obtained from  a  case of proximal femoral  degeneration,  in  a 
broiler from Northern Ireland. 67 
Table 2.2 Description of avian coagulase-negative isolates 
Isolate  Source  Site of  Disease  Geographic  Origint 
isolate  status  origin 
31037"  Chicken  Skin  Skin lesion  Scotland  DJT 
31038
b  Chicken  Skin  Skin lesion  Scotland  DJT 
31040
b  Chicken  Skin  Skin lesion  Scotland  DJT 
31041 b  Chicken  Skin  Skin lesion  Scotland  DJT 
31051
c  Chicken  Skin  Skin lesion  Scotland  DJT 
3B
a  Chicken  Joint  FHN
d
, TIDe,  Scotland  DJT 
SYNf 
fDJT: Professor D. J. Taylor, Department of Veterinary Pathology, University of Glasgow, 
as.  cohnii, bS. sciuri, cs.  cap rae, 
FHN
d
: Femoral Head Necrosis, TIDe: Tibial dischondroplasia and SYNf: Synovitis. 
Table 2.3 Description of human S. alireliS  isolates 
Isolate  Site of  Disease  Geographic  Origint 
isolate  status  origin 
HUM-2  No record  No record  Scotland  DP 
HUM-3  No record  No record  Scotland  DP 
CN4575  No record  No record  No record  THB 
HUM-II  No record  No record  Scotland  DP 
8530*  No record  No record  No record  NCTC 
RN4220  No record  No record  No record  JM 
HUM-108  Foot  No record  Scotland  DP 
HUM-I09  Foot  No record  Scotland  DP 
HUM-Gl  No record  No record  Scotland  CG 
HUM-G2  No record  No record  Scotland  CG 
HUM-G3  No record  No record  Scotland  CG 
HUM-G4  No record  No record  Scotland  CG 
HUM-G5  No record  No record  Scotland  CG 
HUM-G6  No record  No record  Scotland  CG 
HUM-271  No record  No record  N. Ireland  JJM 
HUM-275  No record  No record  N. Ireland  JJM 
HUM-282  No record  No record  N. Ireland  JJM 
HUM-284  No record  No record  N. Ireland  JJM 
HUM-294  No record  No record  N. Ireland  JJM 
HUM-298  No record  No record  N. Ireland  JJM 
HUM-BB  No record  No record  No record  THB 
fDP:  Dr. D. Platt, Department of Bacteriology, Glasgow Royal Infirmary; THB: Dr. T. H. 
Birkbeck, Division of Infection and  Immunity, University of Glasgow;  NCTe: National 
Collection of Type Culture, PHLS  Central Public Health Laboratory, Colindale, London; 
JM:  Dr.  J.  Murray,  University  of Sheffield;  CG:  Prof.  C.  Gemmell,  Department  of 
Bacteriology, Glasgow Royal Infirmary and JJM: Dr.  J.  J.  McCullagh, Veterinary Science 
Division of Agriculture for Northern Ireland. 
8530*: NCTC type strain. 68 
species namely S.  aureus and S.  intermedius and were field isolates. There was 
no type strain available in any of the major culture collections. 
2.1.6 Animal coagulase-negative strains 
Five isolates of four species, namely S.  epidermidis, S.  warneri, S.  hominis and 
S.  chromogenes were included in the study (Table 2.6). 
2.2 GENERAL BACTERIOLOGICAL PROCEDURES 
2.2.1 Growth media 
Tryptone soya agar (TSA) (Oxoid) 4% (w/v), Mannitol salt agar (MSA) (Oxoid) 
11.1 %  (w/v) ,  Blood  agar  base  no.  2  (Oxoid)  4%  (w/v)  supplemented  with 
defibrinated sheep blood (E and 0  Laboratories Ltd., Bonnybridge, UK) of, 5% 
(v/v)  (SBA), Nutrient agar (NA)  (Oxoid)  2.8% (w/v)  and Luria Bertani broth 
(LB)  (Appendix I) were  used  as  solid  media for  routine  growth of bacteria. 
Brain  heart  infusion  broth  (BHIB)  (Oxoid)  3.7%  (w/v)  was  used  as  liquid 
medium. 
2.2.2 Sterilisation of culture media 
All the culture media were sterilised by autoclaving at  15  lbs p.s.i (121  DC)  for 
15 min unless otherwise stated. 
2.2.3 Storage of isolates 
The isolates were received on swabs,  agar slopes or in freeze-dried ampoules. 
They  were  subcultured  onto  TSA,  MSA,  SBA  and  NA  and  incubated  as 
described in section 2.2.5.  After assessing their purity (see below)  they were 
harvested from MSA plates, suspended in BHIB plus sterile glycerol 10% (v/v) 
and stored as aliquots in sterile plastic vials at -70°C. Subsequent cultures were 
made from these frozen stocks and used for all experiments. 69 
Table 2.4 Description of human coagulase-negative isolates 
Isolate  Site of  Disease  Geographic  Origin  t 
isolate  status  origin 
134a  No record  No record  No record  CG 
I-TLa  No record  No record  No record  Teaching lab 
132
b  No record  No record  No record  CG 
tCG: Prof. C. Gemmell, Department of Bacteriology, Glasgow Royal Infirmary; 
Teaching lab: The Teaching Laboratory, Division of Infection and Immunity, 
University of Glasgow. 
as.  epidermidis 
bS.  saprophyticus 
Table 2.5 Description of animal coagulase-positive isolates 
Isolate  Source  Site of  Disease  Geographic  Origint 
isolate  status  origin 
Horse  Skin  No record  Scotland  HOR-31912
a  DJT 
Dog  Skin  No record  Scotland  DOG-32236
b  DJT 
Bovine  Milk  Mastitis  Scotland  BOV  -32276
a  DJT 
Rabbit  Skin  No record  Scotland  RAB-32253
b  DJT 
Zoo Mouse  No record  No record  No record  ZM-7
a  THB 
Bovine  No record  No record  N. Ireland  BOV-65
a  JJM 
Bovine  No record  No record  N. Ireland  BOV-66
a  JJM 
BOV-67
a  Bovine  No record  No record  N. Ireland  JJM 
tDJT:  Professor  D.  J.  Taylor,  Department  of Veterinary  Pathology,  University  of 
Glasgow, THB: Dr. T. H.  Birkbeck; Division of Infection and Immunity, University of 
Glasgow,  JJM:  Dr.  J.  J.  McCullagh,  Veterinary  Science Division  of Agriculture for 
Northern Ireland. 
as.  aureus 
bS. intermedius 
Table 2.6 Description of animal coagulase-negative isolates 
Isolate  Source  Site of 
isolate 
Disease 
status 
Geographic  Origint 
origin 
No record  Scotland  DUK-3191Sa  Duck  Feathers  DJT 
Mastitis  Scotland  BOV-3226Sb  Bovine  Milk  DJT 
Mastitis  Scotland  BOV-32268c  Bovine  Milk  DJT 
Mastitis  Scotland  BOV-32298d  Bovine  Milk  DJT 
BOV  -32304d  Bovine  Milk  Mastitis  Scotland  DJT 
t DJT: Professor D. 1. Taylor, Department of Veterinary Pathology, University of Glasgow. 
also late was S.  hominis 
bIsolate was S.  warneri 
cIsolate was S.  chromogenes 
dIsolate were S.  epidermidis 70 
2.2.4 Culture purity checks 
All  routine  agar plates  and  broth cultures  were  subjected  to  thorough purity 
checks by Gram staining and by culture. The broth cultures were inoculated (100 
Ill) onto TSA plates and, after incubation, checked for purity of  colony growth. 
2.2.5 Incubation conditions 
All cultures of staphylococci on MSA were incubated at 37°C for 48 h and for 
other media at 37°C for 24 h. 
2.3 IDENTITY OF TEST ISOLATES 
Isolates were received after identification in the source laboratories. To confirm 
their identity for this study, some of the isolates were subjected to cultural and 
biochemical tests. In addition, the identity of all isolates was determined by the 
API Staph and Rapidec Staph systems (bioMerieux, Marcy-t' Etoile, France). 
2.3.1 Cultural and biochemical tests 
Identity of the isolates was assessed according to the results of a panel of basic 
tests. These were Gram staining; colony morphology; production of coagulase; 
nuclease production;  catalase  and haemolysins;  various  enzyme activities  and 
carbohydrate fermentation. These tests were performed according to the methods 
of Kloos  and Lambe (1991)  or were included in the API Staph and Rapidec 
Staph multi-test kits described below. 
2.3.2 Biotyping 
The  40  strains  from  N.  Ireland  were  examined  usmg  a  biotyping  scheme 
described by Devriese (1984) and Isigidi et al.  (1990) (Table 2.7)  and results 
were  provided  by  Dr.  J.  J.  McCullagh,  Veterinary  Science  Division  of 
Agriculture for Northern Ireland, Belfast. Table 2.7 Staphylococcus aureus biotypes (Devriese, 1984; Isigidi et al., 1990) 
Biotype 
Human p-ve 
Human p+ve 
Slaughterhouse 
Poultry 
Bovine 
Ovine 
Staphylokinase 
+ 
+ 
aTest result not required. 
p-haemolysin 
+ 
+ 
+ 
Bovine plasma  Crystal 
coagulation within 6 h violet ty~e 
C 
C 
A 
A 
+  A 
+  C 
Protein A 
*a 
*a 
+ 
*a 
*a 
-...l 
>-' 72 
2.3.3 Rapidec Staph 
Tests  were  carried  out  according  to  the  manufacturer's  instructions.  Sterile 
distilled water 250 JlI  was added to cupules C and S. The level of the water was 
1 mm below the top  edge of the cupule. The contents of cupule C were gently 
homogenised with an applicator stick and  then,  with the  end of a new  stick, 
several colonies of the same morphology were picked from a culture plate and 
homogenised  in  cupule  S  until  a  turbidity  equivalent  to  that  in  cupule  C 
(McFarland  4)  was  obtained.  50  JlI  of the  bacterial  suspension  (S)  was 
transferred into each of cupules 0,  1, 2 and 3 by using a Pasteur pipette and then 
a lid was placed on the strip and the strip incubated for 2 hours at 37°C. At the 
end  of the  incubation  period,  all  cupules  were  examined  for  the  fluorescent 
reaction, spontaneous coloured reaction, and the ~-galatosidase and catalase tests 
were carried out according Table 2.8. 
2.3.4 API Staph 
Again, tests were carried out according to  the manufacturer's instructions. An 
incubation box (tray and lid) was prepared by distributing about 5 ml of distilled 
water into the trays. The test organisms were culture on blood agar for 18-24 h at 
37°C and  checked  that  they  belonged  to  the  Micrococcaceae  family  (by 
morphology,  Gram stain,  catalase etc.)  and also  that the  culture was pure.  An 
ampoule  of  API  Staph  Medium  was  opened  and  homogeneous  bacterial 
suspension with a turbidity equal to  0.5  McFarland standard was prepared. The 
microtubes  were  then  filled  with  the  inoculated  API  Staph  Medium. 
Anaerobiosis in the ADH and URE tests was ensured by filling the cupules with 
sterile mineral oil to form a convex meniscus. The trays were incubated at 37°C 
for 18-24 h. Reactions were developed by adding 1 drop of each of the reagents, 
VP, NIT and ZYM to appropriate cupules and then the colour reactions obtained 
after 10 min were noted. The different tests and the colour grades obtained in the 
API Staph are detailed in Table 2.9. 73 
Table 2.8 Reading table of Rapidec Staph for different species of staphylococci 
Fluorescence  Fluorescent  Spontaneous  Reaction  Results 
control  reaction  reaction  to reveal 
Cupule 0  Cupule 1  Cupule 2  Cupule 3 
aAUR (UV)  bpAL  Cp  GAL (FVB) 
Fluorescent  Yellow or colourless colourless  S.  aureus 
colourless  yellow  pink/red  S.  intermedius 
colourless  yellow  pink/red  S. xylosus 
colourless  yellow  colourless/yellow S.  epidermidis 
colourless  colourless  pink/red  S.  saprophytic  us 
colourless  colourless  colourless/yellow Staphylococcus spp. 
a AUR (UV) : "aurease" (AUR) enzyme specific for S.  aureus 
bp AL : alkaline phosphatase 
c~ GAL (FVB) : ~-galactosidase 74 
Table 2.9 API Staph reading table 
Test  Substrate  ReactionlEnzyme  Reading the stri~ 
Negative  Positive 
0  No substrate  Negative control  red 
GLU  D-Glucose  (Positive control) 
FRU  D-Fructrose 
MNE  D-Mannose 
MAL  Maltose  Acidification due to 
LAC  Lactose  carbohydrate utilisation  red  yellow 
TRE  D-Trehalose 
MAN  D-Mannitol 
XLT  Xylitol 
MEL  D-Melibiose 
NIT  Potassium nitrate  Reduction of nitrate  NIT 1  +NIT 211 0 min 
to nitrite  colourless-light Qink  Yellow 
PAL  p-naphthyl-acid phosphate  Alkaline phosphatase  ZYM A+ZYM B/l0 min 
Yellow  Violet 
VP  Sodium pyruvate  Acetyl-methyl-carbinol  VP  l+VP 2/10 min 
Qroduction  colourless  violet-Qink 
RAF  Raffinose 
XYL  Xylose 
SAC  Sucrose  Acidification due to  red  yellow 
MDG  a-methyl-D-glucoside  carbohydrate utilisation 
NAG  N-acetyl-glucosamine 
ADH  Arginine  Arginine dihydrolase  yellow  orange-red 
URE  Urea  Urease  yellow  red-violet 75 
2.4  CHARACTERISATION  OF ISOLATES  BY  PLASMID  PROFILES 
AND ANTIBIOTIC SENSITIVITY 
2.4.1 Plasmid DNA extraction 
Isolates were grown in BHIB as above, then 1.5 ml of culture was centrifuged at 
4,000 x g for 3 min, the pellet washed with 1 ml SET buffer (sucrose 20%, 50 
mM EDTA,  50  mM  Tris,  pH  8.0)  and then centrifuged at  13,000 x g.  Pellets 
were resuspended in  150  III  of SET buffer,S III  of RNase (10 mg/ml) (Sigma) 
the mixture vortexed before  15  III  oflysostaphin (5  mg/ml) (Sigma) was added 
and the mixture incubated at  37°C for  30 min.  The plasmid preparation was 
done  with  a  QIA Prep  Spin  Plasmid  Kit  (QIAGEN  Ltd,  Sussex,  UK).  This 
method is  normally used  for  Gram-negative  organisms  but  in this  study was 
modified for staphylococci by including a lysostaphin lysis step (as above). The 
method  was  then  continued  according  to  the  manufacturer's  protocol  that 
included resuspending pelleted bacterial cells in 250 Jll of Buffer PI, transfer to 
a microfuge tube, and lysis using 250  III of Buffer P2 (alkali-detergent solution) 
for  5  min  at  room  temperature.  The  macromolecules  were  then  precipitated 
using 350 III of  Buffer N3  (chaotropic solution) and then centrifuged at 15,000 x 
g  for  10  min  (Biofuge,  Rotor:  HFA  14.2).  The  supernate  was  added  to  a 
QIAprep® column and centrifuged at  10,000 x g for  I min.  The flow-through 
was discarded and the column was then washed with 500  III  of Buffer PB (trace 
nuclease removal) and  centrifuged at  10,000 x g for  1 min.  The flow-through 
was again discarded and the final wash was performed with 750 III of Buffer PE 
(containing ethanol) with a further centrifugation, as  described previously.  An 
additional  centrifugation  was  performed  following  flow-through  removal  to 
ensure  thorough  removal  of  ethanol.  Finally,  the  DNA  was  eluted  by 
centrifugation after  addition of 50  III  of sterile  distilled  water.  Ten to  fifteen 
microliter of  plasmid DNA was analysed after electrophorosis in agarose type II-
A (Sigma) 0.7% (w/v) in Tris-borate-EDTA buffer (PH 8.0) containing ethidium 
bromide 0.5 mg/ml (see section 2.6.6). 76 
2.4.2 Determination of antibiotic sensitivity profiles 
Antibiotic sensitivity profiles of plasmid-containing and plasmidless isolates were 
detennined by the ATB ANTIBIOGRAM (bioMerieux). The ATB strips contain 18 
antibiotics at one or two concentrations (c and C). The antibiotics were penicillin G 
(0.25  mg/I),oxacillin  (2  mg/l) ,  kanamycin  (8-16  mg/l)  ,  tobramycin  (4-8  mg/l) , 
gentamicin (4-8 mg/l), tetracycline (4 mg/l), minocyclin (4 mg/l), erythromycin (1-
4  mg/l)  ,  lincomycin  (2-8  mg/I),  pristinamycin  (2  mg/l)  ,  fosfomycin  (32  mg/l)  , 
nitrofurantoin  (25-100  mg/l),  pefloxacin  (1-4  mg/l),  rifampicin  (0.25-16  mg/l)  , 
fusidic  acid  (2-16  mg/l)  ,  vancomycin  (4  mg/l),  teicoplanin  (4  mg/l)  and 
cotrimoxazole  (2/38-8/152  mg/l).  Bacterial  suspensions  were  prepared  with  a 
turbidity equivalent to  0.5  McFarland standard and added to  each cupule.  Strips 
were incubated for  18-24 h at 37°C and observed for turbidity (+) in each cupule 
by visual reading. 
2.4.3 Electrotransformation 
2.4.3.1 Bacterial strains 
S.  aureus RN4220 (originally from R. P. Novick, New York University Medical 
Centre, kindly supplied by Dr. 1.  Murray, University of Sheffield) is a mutant of 
strain NCTC 8325 that lacks restriction barriers. This strain and avian S.  aureus 
isolate 6 were used as recipients in electroporation experiments. 
2.4.3.2 Plasmid purification 
Plasmid DNA was  isolated by the  QIA Prep Spin Plasmid Kit (QIAGEN)  as 
described above and then a 4.4 kb  plasmid was purified from avian isolate S. 
aureus 7  A by the QIAquick Gel Extraction Kit Protocol (QIAGEN). First, the 
plasmid band of 4.4 kb was excised from  an agarose gel with a clean scalpel. 
The gel slice was weighed and 3 volumes of  Buffer QG were added to 1 volume 
of gel.  This  was  incubated  at  50°C for  10  min (or  until  the  gel  slice  had 
completely dissolved). To help dissolve the gel, the tube was mixed by vortexing 
every  2-3  min  during  the  incubation.  After  the  gel  slice  had  dissolved 77 
completely, the colour of the mixture was yellow (similar to Buffer QG without 
the  dissolved agarose).  One  volume of isopropanol was  then added to  the gel 
sample  and  mixed.  The  mixture  was  then placed in  a QIAquick spin column 
provided with a 2 ml collection tube. This was centrifuged for  I min, the flow-
through discarded and 0.5  ml  of Buffer QG was  then added to  the  QIAquick 
column and centrifuged for 1 min. To wash, 0.75 ml of  Buffer PE was added and 
again the  column was  centrifuged for  1 min.  The flow-through was discarded 
and the column centrifuged for an additional 1 min at ~10,000 xg (~13,000 rpm). 
The column was then placed into a clean  1.5  ml microfuge tube.  To elute the 
DNA,  50  ).11  of H20 was  added  onto  the  centre of the  QIAquick membrane, 
allowed to stand for 5 min (not 1 min.  as  in the protocol) and then the column 
was centrifuged for 1 min at maximum speed. 
2.4.3.3 Solutions and reagents for electroporation 
1. B2 broth: casein hydrolysate 109, yeast extract 25 g, glucose 5 g, NaCI 25  g, 
K2HP04 1 g, dissolved in 1 litre of water. The pH was adjusted to 7.5 and then 
the medium was autoclaved. 
2.  0.2  M  sodium  hydrogen  maleate:  maleic  anhydride  11.6  g,  NaOH  4  g 
dissolved in 500 ml water and then autoclaved. 
3.  4  X  Penassay  broth:  penassay  medium  (antibiotic  medium  3;  Difco 
Laboratories Limited, Surrey, UK)  17.5  g dissolved in 250 ml  water and then 
autoclaved. 
4. 2 X SMM: 25 ml of 0.2 M sodium hydrogen maleate, 40 ml of 0.1  M NaOH. 
pH adjusted to  6.5.  5 ml  of 1 M MgCh and 42.7 g sucrose were added to  the 
mixture,  dissolved  and  the  final  volume  adjusted to  125  ml  with water.  This 
solution was filter-sterilised. 
5.  SMMP:  55  ml of 2 X SMM,  pH 6.8,  40  ml  of 4 X penassay broth, bovine 
serum albumin (Sigma) 10% (w/v). pH adjusted to 7.0 and filter-sterilised. 
6. Glycerol 10% (v/v) in water and then filter-sterilised. 78 
2.4.3.4 Preparation of  electro  competent cells 
A single colony of a selected strain was inoculated into 3 ml of  B2 broth and the 
culture  incubated  overnight  at  37°C with  constant  aeration.  1.5  ml  of the 
overnight culture was added to  150 ml of fresh B2 broth in a 1 litre flask and 
incubated with constant aeration  (~250 rpm) at 37°C until the  OD at 650 nrn 
reached 0.5. The culture was then chilled on ice for  15 min to stop growth. The 
cells were harvested by centrifugation at 12,000 x g for  15 min at 4°C, washed 
three times in an equal volume of sterile water and washed once with 30 ml  of 
glycerol 10% (v/v). After centrifugation, the bacterial pellet was resuspended in 
15  ml  of glycerol  10%  (v/v) ,  and  incubated  at  20°C for  15  min.  The  cell 
suspension  was  then  centrifuged  again  as  described  above,  and  the  cells 
suspended in 5 ml of glycerol 10% (v/v). The final cell concentration should be 
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10  colony-forming  units  (cfu)/ml.  Aliquots  (250  Ill)  of  the 
electro  competent cells were prepared in sterile 1.5 ml tubes. The cells were used 
fresh or stored after flash-freezing in dry ice. Electrocompetent staphylococci are 
stable for several months at -70°C. 
2.4.3.5 Electroporation procedure 
Prior to electroporation, a 0.2 cm electroporation cuvette (Flowgen, UK) and the 
safety chamber were  chilled at -20°C. To  the  cold  cuvette,  1-5  III  of DNA 
(ligation mix or plasmid preparation) and 40  III  of competent cells were added. 
The mixture was shaken to the bottom of the cuvette and a Bio-Rad Gene Pulser 
(model  1652078,  Bio-Rad  laboratories,  UK)  set  at  2.5  KV,  25  IlFD  was 
connected to  a Bio-Rad pulse  controller (model  1652098) set to  100  Q.  The 
cells  were  pulsed  once  to  give  a  time  constant  of 4-5  msec.  Immediately 
following electroporation, the cells were resuspended in 950  III  of SMMP. The 
mixture was transferred to a sterile culture tube and incubated at 37°C without 
shaking for 1 h. Aliquots of  the electroporation mixture (50-100 Ill) were spread 
on LB agar medium containing tetracycline (5  Ilg/ml) and plates incubated up to 
48 h at 37°C. 79 
2.5 CHARACTERISATION OF EXOPROTEINS 
2.5.1 Expression of exoproteins 
A single colony of an isolate was inoculated into 5 ml of BHI broth and shaken 
at 37  DC  overnight. The culture was then centrifuged at 5,000 x g for 5 min and 
then supernates were filter-sterilised with a 0.22 Jlm pore size filter.  Supernates 
were then concentrated 30x at  14,000 xg for 30 min in a Microcon Centrifugal 
Filter Device model YM-30 (pore size 30 kDa) (Millipore, USA). 
2.5.2 Sample preparation for electrophoresis 
The samples were made up to a total volume of 50  JlI  with 8 JlI  of 6x protein 
loading  dye  (Appendix  I)  was  added.  Samples  were  stored  at  -20  DC  until 
loading.  Immediately before use,  samples  were boiled in a water bath for  10 
min.  A 10 kDa protein ladder (Gibco BRL) or Unstained Protein Ladder (Bio-
Rad) were used according to the manufacturer's instructions. 
2.5.3 SDS-P  AGE 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed  according  to  the  method  of  Laemmli  (1970)  in  a  vertical 
electrophoresis  gel  tank  (model  SE600,  Hoefer  Scientific  Instruments, 
California, USA). The composition of all solutions can be found in Appendix I. 
Glass  plates  were  assembled  according  to  the  manufacturer's  instructions. 
Resolving  gels,  containing  acrylamide  12%  (w/v) , were  poured  between  the 
assembled plates until the gel was 4 cm below the top of the plates and ethanol 
100%  (v/v)  was  used  as  an  overlay.  The  gel  was  left  undisturbed  for 
approximately 1 h at room temperature until set. The ethanol was poured off and 
the  gel  surface  washed  with  distilled  water.  A  stacking  gel  containing 
acrylamide  6%  (w/v)  was  poured  onto  the  polymerised  separating  gel  and  a 
comb was placed into the gel solution. Again the gel was left for approximately 
1 h at room temperature and  the  comb  removed.  The wells  were immediately 
filled with  Ix electrode buffer and assembled into the electrophoresis gel tank. 80 
Samples were added to the wells. The lower buffer reservoir was stirred with a 
magnetic stirrer during vertical gel electrophoresis. The gel was run at 20 rnA 
until the dye entered the separating (lower) gel when the current was increased 
to 30 rnA. The gel was removed when the tracker dye reached the bottom of the 
separating gel (approximately 3 h). The gel was stained or blotted as appropriate. 
For staining, Coomassie blue stain (Appendix I) was utilised for a minimum of 
2 h on a rotating platform.  The  stain was  then replaced with de stain solution 
until the background was decolourised. 
2.5.4 Skim milk agar plates 
Skim milk agar plates were used in order to examine the protease activity of  the 
isolates. Briefly, the isolates to be tested were inoculated into Tryptone soy agar 
(Oxoid) containing skim milk 2% (w/v). After incubation for 24 h at 37°C, the 
presence of a clear zone around a colony was judged as  a positive reaction for 
protease. 
2.5.5 Effect of different reagents on protease activity 
The  effect  of different  reagents  on  protease  activity  was  measured  usmg 
azocasein  (Sigma)  as  a  substrate.  Briefly,  100  III  of cultural  supernate  was 
activated or inhibited by individual incubation with 50 mM L-cysteine (cysteine 
protease  activator)  (Sigma),  1.3  mM  EDTA-Na2  (metalloprotease  inhibitor) 
(Fisher  Scientific,  UK),  1  IlM  pepstatin  (aspartic  acid  protease  inhibitor) 
(Sigma), 20 IlM APMSF [(4-amidino-phenyl) methane-sulfonyl fluoride] (serine 
protease inhibitor) (Sigma),  130 IlM bestatin (amino peptidase inhibitor) and 28 
IlM  E64  (N-(N-(L-3-trans-carboxirane-2-carbonyl)-L-Ieucyl)-agmatine) 
(cysteine  protease  inhibitor)  (Sigma)  at  37°C for  30  min.  Then,  400  III  of 
azocasein  (2  mglml)  in  50  mM  Tris-HCI  buffer,  pH  7.2  was  added  to  the 
activated or inhibited protease solutions and they were incubated at 37°C for 2 
h.  The reaction was stopped by the addition of 1 ml of 10% trichloroacetic acid 
(TCA)  (BDH  Laboratory  Supplies,  UK).  After  centrifugation,  1  ml  of the 81 
supernatant was mixed with the same volume of 0.5  M NaOH and the optical 
density was determined at 440 nm. 
2.5.6 Protease analysis on SDS-P  AGE gelatin gels 
Proteases were analysed by non-reducing SDS-PAGE (12% (w/v) acrylamide) 
by using Coomassie blue stain to detect the hydrolysis of gelatin co-polymerised 
in  the  gel  as  previously  described  (Lockwood,  et  al.,  1987).  After 
electrophoresis, the gel was removed from the plates and then was washed free 
of SDS  in  2.5%  (v/v)  Triton  X-IOO  solution  at  37°C for  30  min.  Gelatin 
hydrolysis  was  performed  at  37  °C  in  0.1  M  sodium  acetate  buffer  pH  9.0 
containing 1 mM DTT for 2 h. For staining, Coomassie blue stain (Appendix I) 
was utilised for  a minimum of 2 h on a rotating platform.  The  stain was then 
replaced with destain solution until the background was decolourised. 
2.5.7 Determination of N  -terminal amino acid sequence of 22 kDa protein 
Concentrated culture  supemates  were  subjected  to  SDS-PAGE  as  above  (see 
section  2.5.3)  and  bands  were  transferred  electrophoretic  ally  onto  a  PVDF 
membrane (Bio-Rad) by the method of Matsudaira (1987).  After staining with 
Coomassie brilliant blue R-250,  a major protein band of interest (22 kDa) was 
cut  out  and  sent  to  the  Protein  and  Nucleic  Acid  Chemistry  Laboratory 
(PNACL)  at  the  University  of Leicester for  N-terminal  amino  acid  sequence 
determination. 
2.5.8 Amplification of N-terminal sequence of 22 kDa protein 
Template DNA used for  this  amplification was prepared according to  Section 
2.6.1. After sequencing of the N-terminus of the 22 kDa protein, primers PRS-1 
and  PRS-2  were  designed  according  to  this  sequence  (Table  2.11).  PCR 
amplification  of the  N-terminal  sequence  was  carried  out  in  25  fll  reaction 
volumes with Ready-To-Go Beads (Amersham Pharmacia biotech, UK).  Each 
reaction mixture contained 1.5 unit of Taq  DNA polymerase,  10 mM Tris-HCI, 
(pH 9.0 at room temperature), 50 mM KCI,  2.5  mM MgCb, 200 mm of each 82 
dNTP,  100 pM of primer, 1 III of 1 in 20 dilution of template DNA preparation 
and  16  III of distilled  water  (double-processed tissue  culture  water)  (Sigma). 
Amplification  was  done  in  a  thermo  cycler  as  described  in  Section  2.6.4  by 
predenaturation at 94°C for 4 min and then 35  cycles of denaturation at 94  °C 
for  30s,  annealing  at  50°C for  45s  and  extension  at  72°C for  lOs.  Ten 
microlitres  of amplified  products  were  electrophoresed  in  agarose  3%  (w/v) 
according to Section 2.6.5. 
2.5.9 Southern blotting 
All  DNA-DNA  hybridisations  were  detected  non-radioactively  usmg  the 
Boehringer-Mannheim  DIG-system  kit,  essentially  as  described  in  the  "DIG 
System User's Guide" (van Miltenburg et al.,  1995). 
2.5.9.1 Digestion ofgenomic DNA 
Genomic  DNA  was  purified  according  to  the  QIAGEN  Genomic  DNA 
(Genomic-tip  20/G) protocol  (Cat.  No.  19060)  (QIAGEN  Ltd,  West  Sussex, 
UK) (see section 2.6.1), for avian S.  aureus (strains 31179 and 24) and human S. 
aureus (strains RN4220 and 8530) and six restriction digests (with EeoRl, Xbal, 
Sal!,  Rsal,  BamHI and  HindII!)  were  set  up  separately  using  the  following 
protocol: 
Genomic DNA  10 III 
Restriction enzyme (10 U/IlI)  2 III 
Restriction enzyme buffer  3 III 
Deionised distilled H20  15 III 
Total  30,..11 
The above were mixed gently and incubated at 37°C for  16-18 h.  Agarose gel 
electrophoresis was performed with 10  III of each reaction mixture to  examine 
for digestion. 83 
2.5.9.2 Solutions 
Southern  blotting,  DNA probe  preparation,  hybridisation  and  detection  were 
performed with the reagents detailed in Table 2.10. 
2.5.9.3 Probe labelling 
The required probes were labelled using an intra-PCR DIG-labelling method. 
The standard PCR dNTP mixture (section 2.5.8) was replaced with PCR DIG 
labelling mix (Boehringer Mannheim). This labelling mix has a reduced amount 
of dTTP  (1.9  mM)  supplemented  with  0.1  mM  Dig-ll-dUTP  (digoxigenin 
linked to dUTP with an II-atom spacer arm). The DIG labelled dUTP molecules 
are incorporated into the amplified DNA during the PCR reaction leading to a 
highly DIG-labelled probe DNA. The DIG-labelled DNA probes were purified 
to  homogeneity using  agarose  gel  electrophoresis,  where  the  degree  of label 
incorporated  can  be  assessed by  comparing  the  migration of the  probe  to 
unlabelled PCR product. The incorporated DIG label increases the mass of the 
probe DNA that can lead to low yields of  DNA in purification using Silica based 
Qiaex II kit (Cat. No. 20051) (QIAGEN Ltd, West Sussex, UK). Therefore the 
probe was excised from the agarose and boiled in detection buffer (see Table 
2.10) prior to hybridisation. 
2.5.9.4 Blotting via capillary action 
A  agarose  0.8%  (w/v)  gel  containing  restriction  digests  of the  appropriate 
chromosome samples was depurinated in 0.25 M HCI for  15  min.  After rinsing 
in water the DNA samples were denatured for 30 min in 0.5  M NaOH,  1.5  M 
NaCl.  The  gel  was  rinsed  in  distilled  water  and  neutralised by two  15  min 
washes (with shaking) in 0.5 M Tris-HCI, 3 M NaCl. 
A  raised  gel  support was  placed into  a  dish and covered  with  a  filter  paper 
(Whatmann 3 MM) wick.  The filter paper was saturated with 20x SSC  (3  M 
NaCI,  0.3  M  sodium  citrate,  pH  7.0).  This  buffer  was  also  used  to  fill  the 
reservoir  around  the raised gel  support. The  gel was  placed onto the wick and 84 
Table 2.10 Solutions for Southern blotting 
Solution 
adNTP DIG labelling 
mixture (lOx) 
20 x SSC 
Southern Buffer 1 
aSouthern Buffer 2 
Southern Buffer 3 
aNBT solution 
aX-Phosphate,4-toluidine 
salt 
Prehybridisation solution 
In 5x SSC was added: 
Detection Buffer 
Reagents 
2mMdATP 
2mMdCTP 
2mMdGTP 
1.9 mM dTTP 
0.1 mM DIG-ll-dUTP 
pH 7.0 
3MNaCI 
300 mM sodium citrate, pH 7.0 
150 mMNaCI 
100 mM maleic acid, pH7.5 
1  % (w/v) nucleic acid blocking reagent in 
Buffer 1 
100 mM Tris-HCI, pH 9.5 
100mMNaCI 
50 mMMgClz 
92 mM (75 mg/ml) nitroblue tetrazolium salt 
in 70% (v/v) dimethylformamide 
115 mM (50 mg/ml) 5-bromo-4-
chloro-3- indoyl phosphate 
4-toluidine salt in dimethylformamide 
N-Iaurylsarcosine 0.1 % (v/v) 
SDS 0.02% (v/v) 
aBlocking reagent 1  %  (v/v) 
0.1 Tris-HCI, pH 9.5 
0.1 M NaCI 
a  All reagents were obtained from Boehringer Mannheim, Germany. 85 
bubbles were removed by using a glass rod. A piece of positively-charged nylon 
membrane (Hybond N+, Amersham International, Amersham, UK) cut to a size 
slightly larger than the gel and soaked in 20x SSC was placed on the gel. Three 
sheets  of 3  MM paper  (pre-soaked  in  20x  SSC)  were  placed  on  top  of the 
membrane. A stack of paper towels cut to the size of the gel was placed on top 
of the  3 MM paper and  a weight of approximately  1 kg  was  placed onto the 
paper towels. The blot  apparatus was  wrapped in  cling-film and  left overnight. 
The  apparatus was  dismantled and the  DNA markers  were identified (on  UV 
transilluminator Model TM-40, UVP Inc., San Gabriel, California, USA) on the 
blot using a pencil (see section 2.6.6). The membrane was washed in 2x SSC at 
room temperature (1  min), wrapped in cling film and UV crossed linked (3  min 
on each side on UV transilluminator). 
2.5.9.5 Preltybridisation and Itybridisation 
The  membrane  was  prehybridised  in  a  rolling  hybridisation  oven  (model 
FH1DE,  Techne  Ltd,  Duxford  Cambridge,  UK)  for  2-3  h  with  20  ml  of 
prehybridisation solution at 65°C. The probe was hybridised with the blot by 
incubating at 65°C for  6-18  h in the hybridisation oven before removing the 
probe. After hybridisation, probes were saved and stored at -20°C for future re-
use.  Excess  probe  was  washed  off the  blot  with  two  5  min  washes  in  2  x 
SSC/SDS 0.1 % (w/v). Two low stringency washes of 15 min at 65°C, using 2 x 
SSC/SDS 0.1% (w/v), were followed by two higher stringency washes of2x 15 
min at 65°C, using O.lx SSC/SDS 0.1 % (w/v). 
2.5.9.6 Detection 
The  filter  was  washed  briefly  in  Southern  Buffer  1  (see  Table  2.10)  and 
incubated with Southern Buffer 2 (see Table 2.10) for 30 min (blocking). I III of 
anti-digoxigenin  (ovine  Fab)  conjugated  to  alkaline  phosphatase  (Boehringer 
Mannheim, Gennany) was  added in  5 ml  of Southern Buffer  I  and incubated 
with the  membrane for  30  min.  Two  15  min  washes  with  Southern Buffer  1 
removed excess  antibody,  followed by a 5 min wash  in  Southern Buffer 3 to 86 
prepare  the  membrane  for  colour  development.  A  volume  of NBT  solution 
(Boehringer Mannheim)  (45  ~l) and  35  ~l X-phosphate  solution  (Boehringer 
Mannheim)  in  10  ml  Southern  Buffer  3  were  added,  and  colour  allowed  to 
develop in the dark. The reaction was stopped by washing the membrane in TE 
(10 mM Tris-HCI, pH, 7.6,  1 mM EDTA, pH, 8.0), and allowing the membrane 
to dry. 
2.5.9.7  Amplification of  cysteine protease gene of  S. epidermidis 
N-terminal  sequence  data  was  obtained  for  the  22  kDa protein  found  in  the 
culture supernate of avian S.  aureus strain 31179. No match was found in any of 
the S.  aureus protein databases but, very recently, this sequence was matched in 
the  protein database  (NCBI)  with an  extracellular cysteine proteinase  from  S. 
epidermidis isolate 6746  (accession number AJ298299).  Using  this  sequence, 
primers SACP-1  and SACP-2 were designed in this  study (Table 2.11).  DNA 
was prepared for this PCR amplification as described section 2.6.1. The reaction 
mixtures  (50  ~l)  contained  45  ~l  of  master  mix;  1.25  units  Taq  DNA 
polymerase,  75  mM Tris-HCI  (PH  8.8  at 25°C), 20 mM (NH4hS04,  1.5  mM 
MgCh, 0.01 % (v/v) Tween 20, 0.2 mM of each dNTP (AB gene, Surrey, UK), 
for S.  aureus isolates plus 1.0 mM of MgCh (final concentration of MgCh was 
2.5 mM) for S.  aureus and 1.5 mM (MgCh) for S.  epidermidis isolates, 50 pM of 
each  primers,  1  ~l  of template  DNA  preparation  (diluted  1  in  20).  All 
amplifications were accomplished by pre  denaturing at 94°C for 4 min followed 
by 30 cycles of 30s for denaturing, 30s at 52°C for annealing and 1 min at 72 °c 
for  extension  step  followed  by  single  cycle  of 72°C for  5  min.  The  PCR 
products were separated by electrophoresis of 15  JlI  of the reaction mixtures in' 
ethidium bromide-stained agarose 1.2% (w/v) gels as described in Section 2.6.6. 87 
2.6 CHARACTERISATION OF ISOLATES BY PCR METHODS 
The main objective of this study was to identify and characterise the test isolates 
by  PCR-fingerprinting  and  to  characterise  strains  by  their  virulence-related 
genes. 
2.6.1 Preparation of template DNA 
Chromosomal DNA was extracted by a modification of the QIAGEN Genomic 
DNA (Cat. No.  19060) (QIAGEN) method. The 18 h liquid cultures (10 ml) of 
staphylococci in BHI broth were harvested by centrifugation at 15,000 x g for 5 
min  and the  pellet resuspended  in  3.5  ml  of buffer Bl  containing  50  Ilg/ml 
RNase A (Sigma) (i.e.  17.5  III of 10 mg/ml). The mixture was vortexed to give a 
homogenous suspension and then 17.5  III  of lysostaphin stock (Sigma) solution 
(5  mg/ml, final concentration 25  Ilg/ml) was added and incubated for  15  min at 
37°C. The suspension cleared, although it remained slightly cloudy. It may be 
incubated  longer  if required.  Protease  stock  solution  (pronase  20  mg/ml) 
(Sigma), 100 Ill, was then added and the mixture incubated at 37°C for a further 
15 min (it should go totally clear at this stage). Buffer B2, 1.2 m! was then added 
and the  mixture vortexed for  several seconds to  mix thoroughly.  The mixture 
was then incubated at 50°C for 2 h.  Finally 1 III  aliquots of the mixture were 
diluted with 19 III of  distilled water and stored at -20°C. 
2.6.2 Primers for PCR fingerprinting 
The primers for the  PCR were obtained from Gibco BRL, Paisley, UK.  Their 
sequences are listed in Table 2.11. They were dissolved in sterile distilled water 
to  give  a  final  concentration  of 50  pmol/Ill.  Schematic  representation  of the 
amplification of  some of the different region of  the S.  aureus genome are shown 
in Appendix II. 
2.6.3 Optimisation of PCR 
As  PCR  is  a  highly  sensitive  technique,  its  performance  may  be  adversely 
affected by  slight variation  of  the  components  of  the  reaction  mixture and the 88 
Table 2.11 Primers used in PCR methods 
PCR  Primer  Seguence
a (5' -3'}  Reference 
PCR- GIRRN  GAAGTCGTAACAAGG  Jensen et ai.  (1993) 
ribotYl2ing  LIRRN  CAAGGCATCCACCGT 
PCR- STAA-AVI  TCTTCAGAAGATGCG  Forsman et ai.  (1997) 
ribotyping  GAATA 
STAA-AVII  TAAGTCAAACGTTAA 
CATACG 
REP-PCR  RW3A  TCGCTCAAAACAACG  DelVecchio et ai.  (1995) 
ACACC 
Coagulase  COAG2  CGAGACCAAGATTCA  Goh et ai.  (1992) 
gene  ACAAG 
COAG3  AAAGAAAACCACTCA 
CATCA 
Protein A  PROTAI  TGTAAAACGACGGCC  Frenay et ai.  (1994) 
gene  AGTGCTAAAAAGCTA 
AACGATGC 
PROTA2  CAGGAAACAGCTATGA 
CCCCACCAAATACAG 
TTGTTACC 
Nuclease  NUCI  GCGATTGATGGTGAT  Brakstad et ai. (1992) 
gene  ACGGTT 
NUC2  AGCCAAGCCTTGACG 
AACTAAAGC 
agrP2  AGR-l  ATCAACTATTTTCCA  Kornblum et al.  (1990) 
TCACATCT 
AGR-2  TTACACCACTCTCCT 
CACT 
agrBDC  AGRD123F  TATGCACCTGCAGCT  t Personal communication 
ACTAA 
AGRD123R  TCATGACGGAACTTG 
CGC 
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Table 2.11 Continued ... 
PCR  Primer  Seguence
a {5' -3'}  Reference 
sarA  SAR-1  GCAATTACAAAAATC  Chien et al.  (1998) 
AATGATTGC 
SAR-2  TTATAGTTCAATTTC 
GTTGTTTGC 
entA
b  SEA-1  TGGGAAACGGTTAAA  Johnson et al.  (1991) 
ACGAA 
SEA-2  GAACCTTCCCATCAA 
AAACA 
entB
C  SEB-3  GTATGGTGGTGTAAC  *Personal communication 
TGAGC 
SEB-4  CCAAATAGTGACGAG 
TTAGA 
entC  SEC-3  CTCAAGAACTAGACA  Becker et al. (1998) 
TAAAAGCTAGG 
SEC-4  TCAAAATCGGATTAA 
CATTATCC 
entD
e  SED-3  CTAGTTTGGTAATAT  Becker et ai.  (1998) 
CTCCTTTAAACG 
SED-4  TTAATGCTATATCTT 
ATAGGGTAAACATC 
entEf  SEE-3  CAGTACCTATAGATA  Becker et at. (1998) 
AAGTTAAAACAAGC 
SEE-2  TAACTTACCGTGGAC  Johnson et ai.  (1991) 
CCTTC 
eta
g  ETA-1  CTATTTACTGTAGGA  Sakurai et al.  (1995) 
GCTAG 
ETA-2  ATTTATTTGATGCTC 
TCTAT 
etb
h  ETB-1  ATACACACATTACGG  Sakurai et al.  (1995) 
ATAAT 
ETB-2  CAAAGTGTCTCCAAA 
AGTAT 
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PCR  Primer  Seguencea (5/ -3/}  Reference 
tsst-i  TST-3  AAGCCCTTTGTTGCT  Becker et at.  (1998) 
TGCG 
TST-6  ATCGAACTTTGGCCC 
ATACTTT 
htd  HLA-1  GATATTAATATTAAA  This study 
ACCGG 
HLA-2  TTCTGAAGAACGATC 
TGTCC 
htb
k  HLB-1  ACTTAAATGTCATAA  This study 
CAAC 
HLB-2  CGTCCTTTTAGAACG 
AAGCG 
htgl  HLG-1  AGCTCAACTTTATTA  This study 
ACTTC 
HLG-2  CTTACAGATAAAGTT 
GTAGC 
hter  HLD-1  TTTAGTACTATACGA  Janzon et at. (1989) 
AGAT 
HLD-2  CCCTAATCGTACTTG 
C 
16S rRNA  C70  AGAGTTTGATYMTGG  Davies et at. (1996) 
C 
cn  GYTACCTTGTTACGA 
CTT 
R.I.S.a
n  SA442-1  AATCTTTGTCGGTAC  Martineau et at.  (1998) 
ACGATATTCTTCACG 
SA442-2  CGTAATGAGATTTCA 
GTAGATAATACAACA 
N-terminal  PRS-1  GTIMGIGCNCARTAY  This study 
sequence 
of 22kDa band 
PRS-2  YTGIGTYTCICKDAT 
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PCR  Primer  Sequence
a (5'-3')  Reference 
Cysteine  SACP-l  ATGMGAGCACAATAT  This study 
protease  GTAAATCAATTAAAG 
SACP-2  ATAACCATAAATTGA 
TGCATACCATTCATA 
GTG 
aA:  adenine; T: thymine; C: cytosine; G: guanine; I: inosine; M: A+C; N: A+C+  T  +G; 
R:  A+G;  Y:  C+T;  K:  T+G;  D:  A+T+G.  bentA: enterotoxin A;  centB:  enterotoxin B; 
dentC, enterotoxin C, eentD, enterotoxin D, fentE, enterotoxin E, geta, exfoliatin A,  hetb: 
exfoliatin B;  itsst-l: toxic shock syndrome toxin-I; jhla:  a-haemolysin (a-toxin); khlb: 
~-haemolysin  (~-toxin);  'hlg:  y-haemolysin  (y-toxin);  '11ld:  o-haemolysin  (o-toxin); 
°RI.S.a:  Rapid  Identification  of  S.  aureus;  tpersonal  communication:  Dr.  Phil 
McDowell,  Institute  of Infections  and  Immunity,  The  University  of  Nottingham, 
Queens  Medical  Centre,  Nottingham;  *Personal  communication:  Prof.  C.  Gemmell, 
Department of Bacteriology, Glasgow Royal Infirmary. 92 
reaction  conditions.  Each  new  application  of PCR may  require  optimisation. 
Inadequate functioning ofPCR may be observed as no detectable product or as a 
low yield of the target band, as  high level of background due to mispriming or 
misextension of the  formation  of the  primers  or by  the  formation  of primer-
dimers.  The  concentration  of  the  polymerase  enzyme,  deoxynucleotide 
triphosphate  and  magnesium  ions  are  reported  as  critical  components  to  be 
optimised in the PCR reaction (Innis and Gelfand, 1990). A simple procedure for 
optimisation of PCR based on orthogonal arrays was applied to avoid laborious 
steps (Cobb and Clarkson, 1994). 
2.6.4 Components of the PCR 
The  components  of the  PCR  were  different  for  each  specific  amplification. 
Before setting the components for each PCR, different concentration of MgCh, 
primers  and  template  DNA  were  explored  and  the  optimum  concentrations 
selected for each PCR. 
2.6.5 Conditions for PCR 
Amplification was done in a thermo  cycler (Touch Down, Hybaid Ltd, UK). The 
conditions  were  different  for  each  PCR  method.  Different  denaturing  and 
annealing conditions were used and the best conditions finally selected. 
2.6.6 Agarose gel electrophoresis 
The  amplified  products  (10-15  Jll)  were  mixed  with  1/6x  volume  of loading 
buffer (sucrose (BDH) 40% (w/v), bromophenol blue (Sigma) 0.25% (w/v) ) to a 
final  dilution  of Ix and  electrophoresed  in agarose  type  II-A  medium  EEO 
(Sigma) 0.7-3% (w/v) in 0.5 x Tris-borate EDTA buffer (Tris base 89 mM, boric 
acid  89  mM,  EDTA  2 mM,  pH  8.0)  containing ethidium  bromide  0.5  Jlg/ml 
(BioRad, UK) (Sambrook et al.,  1989) in a horizontal submarine electrophoresis 
apparatus (E-C Apparatus Corporation, USA). The  1 kb, X174 RF DNNHaeIII 
fragments and 25  bp ladders (GibcoBRL) were used as DNA molecular weight 
markers. The amplimers were visualised and photographed under UV light on a 93 
transilluminator (Model TM-40, UVP Inc.,  San Gabriel, California, USA). The 
photographs  were  captured  and  scanned with Fotolook (version  2.07.2  Agfa, 
UK) using a scanner Studioscan IIsi,  Agfa,  or documented using Ultra Violet 
Products  Gel  Documentation  System-Image  Store  5,000,  Version  7.2  (Ultra 
Violet Products Ltd., Cambrige) 2.5.1 and the labelling of  images was done with 
Claris Draw Version 7.5.1.  Photographs were  inspected visually and different 
band profiles  were  given  a  number or letter whenever a  distinct  pattern was 
observed. 
2.6.7 Gel extraction procedure 
DNA  was  purified  from  agarose  gels  usmg  the  Qiaex®II  purification  kit 
(QIAGEN) according to manufacturer's instruction.  The band of interest was 
excised from the gel and solubilised in Buffer QX1  (usually 3 volumes of  buffer 
to one volume of gel).  Qiaex resin (10-15  ~l) was introduced and the mixture 
incubated at 50°C for 10 min.  Following centrifugation for 1 min at 10,000 x g 
the supernate was removed.  The pellet was  then washed once with 500  ~l of 
Buffer QX1  and twice with 500  ~l of Buffer PE, with centrifugation as  before. 
The resinJDNA pellet was air-dried, 5-25  ~l of sterile distilled water was added 
and, after incubation for 5 min at 50°C, the resin was removed by centrifugation 
as before and the eluted DNA was retained 
2.6.8 Prevention of contamination of DNA and decontamination 
In order to minimise the cross contamination of reagents, sample etc.  and false 
positive  results,  the  guidelines  suggested by  Kwok  and  Higuchi  (1989)  were 
followed.  All  equipment such  as  micropipettes  (Models  P2,  P10,  P20,  P200, 
P1000, P5000, Anachem Ltd., Luton, Beds, UK) and tips, and different areas in 
the  laboratory  were  dedicated  to  the  different  stages  of sample  preparation, 
sample  addition,  setting  up  of  PCR  reactions,  amplification  and  product 
detection. 
All  samples, reagents and amplified products were stored in assigned boxes in 94 
separate -20°C freezers in aliquots.  The double-processed tissue culture water 
(distilled water) for the reaction mixture was prepared by filtration  through a 
0.22  /-lm  filter  (Millipore  S.  A.,  Molshiem,  France)  before  autoclaving  with 
single-use plastic materials and containers. All microfuge tubes and pipette tips 
were autoclaved to avoid the risk of nuclease activity. All the PCR experiments 
included negative controls without added DNA. 
2.6.9 Molecular typing 
2.6.9.1 PCR-rihotyping 
The primers used were two  different sets:  GIRRN and LIRRN for  method  1; 
STAA-AVI and STAA-AVII for method 2 (Table 2.11). The reaction mixture 
(50  /-ll)  contained 45  /-ll  of master mix (AB  gene, Surrey, UK).  50 pM of each 
primer, 1 /-ll  of template DNA preparation (diluted 1 in 20) and 2 /-ll  of distilled 
water (double-processed tissue culture water). Amplifications were 30 cycles of: 
denaturation at 94°C for 15s; annealing at 55°C for 30s; extension at 72°C for 
1 min and 30s and then extension at 72°C for  20  min.  Fifteen microlitres of 
amplified products were analysed by electrophoresis in 1.2% agarose. 
2.6.9.2 REP-PCR 
The primer used was RW3A (Table 2.11). The REP-PCR was carried out in 25 
/-ll  reaction volumes with Ready-To-Go Beads (Amersham Pharmacia biotech, 
UK). Each reaction mixture contained 1.5 unit of Taq DNA polymerase, 10 mM 
Tris-HCl, (PH 9.0 at room temprature), 50 mM KCl, 1.5 mM MgCb, 200 mm of 
each  dNTP,  75  pM  of primer,  1  /-ll  of 1  in  20  diluttion  of template  DNA 
preparation  and  22.5  /-ll  of distilled  water  (double-processed  tissue  culture 
water). Amplification was done in a thermocycler as above by predenaturation at 
94°C for 3 min and then 30 cycles of denaturation at 94 °C for 1 min, annealing 
at 54°C for 1 min and extension at 72 °C for 2 min followed by a final extension 
at 72°C for 5 min. Ten microlitres of amplified product were electophoresed in 
an agarose 1.2% (w/v) gels as above. 95 
2.6.9.3 PeR/or coagulase, protein A and nuclease genes 
The primers used were COAG2 and COAG3  for  the coagulase gene, PROTAI 
and PROTA2 for X-region of the protein A gene and NUCI and NUC2 for the 
nuclease  region  (Table  2.11).  The  reaction  mixture  (50  Jll)  for  all  of them 
contained 45  /-tl  of master mix (AB  gene, Surrey, UK), plus  1.0 mM of MgCh 
(final  concentration of MgCh was  2.5  mM),  50  pM of each primers,  1 /-tl  of 
template  DNA  preparation  (diluted  1  in  20).  All  amplifications  were 
accomplished by predenaturing at 95°C for 4 min followed by 30 cycles of 30s 
for denaturing, 30s at 55°C for annealing and 1 min at 72 °C for the extension 
step followed by a single extension at 72°C for 5 min. The PCR products 15  JlI 
were separated by electrophoresis as above. 
2.6.9.4 PeR/or 16S rRNA gene 
Some  avian  and  human  S.  aureus  isolates  were  selected  (Table  2.12)  for 
sequence  analysis  of this  gene.  The  primers  used were  C70  and  C72  (Table 
2.11).  The reaction mixture (50  /-tl)  contained 45  JlI  of master mix (AB  gene, 
Surrey, UK), plus 1.0 mM of  MgCh (final concentration of MgCh was 2.5mM), 
50 pM of each primers, and I  /-tl  of template DNA preparation (diluted 1 in 20). 
All  amplifications  were  accomplished  by predenaturing  at  94°C for  10  min 
followed by 30 cycles of  45s at 94°C for denaturing, 45s at 50°C for annealing 
and  45s  at 72°C and  a final  extension  step  of 72  °C  for  10  min.  The  PCR 
products  15  JlI  were separated by electrophoresis of 15  /-tl  agarose  1.2% (w/v) 
gels as above. 
2.6.9.5 Identification o/S. aureus by peR 
The  primers  used  were  Sa442-1  and  Sa442-2  (Table  2.11).  The  reactions 
mixture (50  /-tl)  contained 45  /-tl  of master mix (AB gene, Surrey, UK), plus 0.5 
mM  of MgCh (final  concentration  of MgCh was  2.0  mM),  50  pM  of each 
primers, 1 JlI  of template DNA preparation (diluted 1 in 20). The PCR mixtures 
were subjected to thermal cycling for 3 min at 96°C and then 30 cycles of Is at 
95 °c for the denaturation step and 30s at 55°C for the annealing-extension step. 96 
Fifteen  microlitres  of the  PCR-amplified  reaction  mixture  was  resolved  by 
electrophoresis through an agarose 2% (w/v) gel as above. 
2.7  CHARACTERISATION OF VIRULENCE  REGULATORY GENES 
BYPCR 
2.7.1 agrP2, agrBDC and sarA 
The  primers  used  were  AGR-I  and  AGR-2  for  agrP2,  AGRDl23F  and 
AGRDl23R for  agrBDC,  SAR-I  and  SAR-2  for  sarA  (Table  2.11).  Three 
separate PCRs were carried out in 50  III reaction volume. Each reaction mixture 
contained 45  III  of master mix (AB  gene,  Surrey, UK), plus  1.0 mM of MgCh 
(final  concentration of MgCh was  2.5  mM),  50  pM of each primers,  1  III  of 
template DNA preparation (diluted 1 in 20). Amplifications were 30 cycles of 1 
min at 95°C for denaturing, 1 min at 55°C for annealing and 2 min at 72 °C for 
extension. Fifteen microlitres of each amplified product were electrophoresed in 
an 1.2% (w/v) agarose gels as above. 
2.8  RESTRICTION  FRAGMENT  LENGTH  POLYMORPHISM 
ANALYSIS 
The 20 III  of reaction mixture contained 10  III  of purified PCR product (section 
2.6.7),  1  III  (10  units)  of restriction  enzyme  (New  England  Biolabs  Ltd., 
Hertfordshire, UK), 5 III  of 1 x NEB Buffer 2 (50 mM NaCl,  10 mM Tris-HCl, 
10 mM MgCh, 1 mM DTT, pH 7.9 at 25°C) and 4 III of distilled water (double-
processed tissue culture water). The reaction conditions were 37°C in a heated 
block for  16 h.  The sizes of the resulting bands were assessed after running the 
digest  in  an  agarose  3%  (w/v)  gel  with  ethidium  bromide  0.5  mg/ml  and 
visualisation under UV light (UVP INC.) as above. 
For analysis of the agrBDC region, restriction enzyme MseI was  used.  For the 97 
coagulase gene A  luI was used and for protein A gene Rsal  was used. 
2.9 TOXIN DETECTION 
2.9.1 Molecular methods 
2.9.1.1 Multiplex peR for enterotoxins A-E, exfoliative toxins A-B and toxic 
shock syndrome toxin-1 (TSST-1) 
This was based on two separate multiplex peR for enterotoxins A-E, exfoliative 
toxins  A-B  and  toxic  shock  syndrome  toxin-l  (TSST-l)  genes  (Prof.  C. 
Gemmell,  Department  Bacteriology,  Glasgow  Royal  Infirmary,  personal 
communication) but different reaction conditions and peR protocol were used. 
A multiplex peR was  developed in  this  study for  these  eight different target 
genes. The primers used were SEA-l and SEA-2 for enterotoxin A,  SEB-3  and 
SEB-4 for enterotoxin B, SEC-3 and SEC-4 for enterotoxin e, SED-3 and SED-
4 for enterotoxin D, SEE-2 and SEE-3 for enterotoxin E, ETA-l and ETA-2 for 
exofoliative toxin A,  ETB-l and ETB-2 for exfoliative toxin Band TST-3  and 
TST-6 for toxic shock syndrome toxin-l (Table 2.11). The PCR Reaction Mix 
prepared with  45  III  of 1.1  X  PCR master mix  (3.0  mM MgCh) (AB  gene, 
Surrey, UK) contained;  1.25 units Taq DNA polymerase, 75  mM Tris-HCI (pH 
8.8 at 25°C), 20 mM (NH4)2 S04, 3.0 mM MgCh , Tween 20, 0.01 % (v/v), 0.2 
mM of  each dNTP. The concentration of  primers were: for sea, seb, sec, see and 
tst,  10 pM; for sed, 20 pM; for etb, 30 pM; and for eta, 50 pM. Template DNA 
was 1 III  of 1 in 20 dilution. Positive controls included the template DNA of 6 
different control strains HUM-Gl to  G6 which were mixed together and then 1 
III  of DNAs  mixture  was  used.  The  peR amplification  was  30  cycles  of: 
denaturation at 95  DC for 30s, annealing at 55  DC for 30s, and extension at 72  DC 
for 1 min, followed by a final cycle of 72 DC  for 5 min. Fifteen microlitres of  the 
PCR-amplification  products  were  analysed  by  electrophoresis  by  using  an 98 
agarose 1.5% (w/v) gel as above. 
2.9.1.2 Multiplex PCR/or ~  rand t5-toxin genes 
A multiplex PCR was developed in this study for these three genes. The primers 
used were HLA-1  and HLA-2 for  a-toxin, HLG-1  and HLG-2 for y-toxin and 
HLD-1 and HID-2 for 8-toxin (Table 2.11). The PCR reaction mix was prepared 
with the use of Ready-To-Go PCR Beads (Amersham Pharmacia Biotech, UK). 
The multiplex PCR was carried out in a 25  III  reaction volume.  Each reaction 
mixture contained 1.5 U of Taq  DNA polymerase, 10 mM Tris-HCI, (PH 9.0 at 
room temperature), 50 mM KCI and 1.5 mM MgClz, and 200 IlM of  each dNTP. 
The concentration of  primers was: for HLA and HLD, 100 pM; for HLG, 25 pM. 
Template DNA was 4 III of 1 in 20 dilution in distilled water (double-processed 
tissue culture water). Amplification was done by pre  denaturation at 94 DC  for 3 
min and then 30 cycles of:  denaturation at 94  DC  for 1 min 30s, annealing at 55 
DC for 2 min and extension at 72  DC for 3 min. A final extension at 72  DC  for 5 
min was used.  Fifteen microlitres of PCR products were electrophoresed in an 
agarose 1.2% (w/v) gel as above. 
2.9.1.3 PCR/or fJ-toxin gene 
The  primers  used  were  HLB-1  and  HLB-2  (Table 2.11).  The  PCR reaction 
mixture contained 45  III  of master mix (AB  gene, Surrey, UK), plus 1.0 mM of 
MgClz (final concentration of  MgClz was 2.5 mM). The concentration of  primers 
were  100  pM,  and  2  III  of template  DNA  used.  Amplification  was  done  by 
pre  denaturation at 94  DC  for 3 min and then 30 cycles of:  denaturation at 94 DC 
for 1 min 30s, annealing at 55  DC for 2 min and extension at 72  DC for 3 min. A 
final extension at 72 DC for 5 min was used. Fifteen microlitres of PCR products 
were electrophoresed in an agarose 1.2% (w/v) gel as above. 99 
2.9.2 Biological methods 
2.9.2.1 Enterotoxins A-D 
The  detection  of staphylococcal  enterotoxins  A,  B,  C  and  D  was  done  with 
Staphylococcal  enterotoxin  reversed  passive  latex  agglutination  (SET-RPLA) 
TD900  kit  (Oxoid)  according to  the  manufacturer's  instruction.  Isolates  were 
inoculated into Tryptone soya broth and incubated at 37  DC  for  18-24 h.  After 
growth,  test  samples  (culture  supernates)  were  prepared  by  centrifugation  at 
15,000 xg for 3 min and then filtration through a 0.22 /lm filter (Millipore). This 
assay depends on the agglutination of latex beads coated with antibody specific 
for the toxins. 
2.9.2.2 aand fJ-toxins 
The organisms were inoculated on Blood Agar Base No.  2 (Oxoid) containing 
washed rabbit red blood cells  5%  (v/v)  and incubated overnight at 37  DC  for 
detection of a-toxin. 
For detection of  ~-toxin, the organisms were streaked onto Blood Agar Base No. 
2,  (Oxoid)  containing washed  sheep  red blood  cells  5%  (v/v)  and  incubated 
overnight at 37 DC. Haemolytic activity of  this toxin was enhanced by incubation 
below  10  DC  after  treatment  at  37  DC,  to  detect  the  "hot-cold"  haemolysin 
(Glenny and Stevens, 1935). 
2.10 GROWTH OF S. aureus STRAINS AT HIGH TEMPERATURES 
Twelve typical avian, 12 atypical avian and 11  human strains (Table 2.12) were 
cultured  overnight  at  37  DC  on  nutrient  agar  plates  then  one  colony  was 
inoculated into 10 ml of nutrient broth in a universal bottle. These cultures were 
incubated in a water bath with shaking at 150 rpm at 44-45 DC or 46-47 DC.  The 
turbidity of  the culture was recorded after overnight incubation. 100 
Table 2.12 Growth of S. allrellS strains at 44-45 °C or 46-47 °C 
Type 
Typical avian 
Atypical avian 
Human 
Isolates  No. of isolates 
24,52,53,85,99,100,105,  12 
122,123,170,329,330 
82,83,86,496,525,562,  12 
199,214,217,235,31178, 
32528 
CN4575, RN4220, 8530, 
HUM-G1, HUM-G2, HUM-G3, 
HUM-G4, HUM-G5, HUM-G6, 
HUM-11, HUM-BB 
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2.11 SEQUENCE ANALYSIS 
2.11.1 Sequencing reactions 
PCR products from the agrBDC,  coagulase,  16S  rRNA and cysteine protease 
genes from a variety of isolates, some avian and some of human origin (Table 
2.13) were purified as above (Section 2.6.6) and reaction mixtures shown below 
were  assembled in  thin-walled  0.5  ml  tubes  and provided to  the  sequencing 
service at the  Molecular Biology  Support Unit (MBSU)  at the  University  of 
Glasgow. 
Terminator Ready Reaction Mix (Perkin-Elmer, UK) 
Double stranded DNA 
Primer (each PCR product) 
Distilled water 
Final Reaction Volume 
8 III 
250-500 ng 
3.2 pmol 
variable 
20 III 
Primers for each of these sequencing reactions were the same as those used for 
PCR detection of  these genes (Table 2.11). 
2.11.2 Running the sequencing gel 
An  Applied  Biosystems  377  or  373  automated  sequencing  machine  (Perkin 
Elmer, UK) was used for all sequencing reactions. The sequencing service at the 
Molecular  Biology  Support  Unit  (MBSU)  at  the  University  of  Glasgow 
performed the gel run and results were posted electronically. Briefly, the dried 
pellet was resuspended by vortexing in 4 III  of loading solution (Perkin-Elmer) 
containing deionised formamide and 50 mM EDT  A in the ratio 5: 1. The samples 
were then heated to 90°C for 2 min and placed on ice until ready to load. 102 
Table 2.13 Sequencing of different genes in S. alireliS isolates 
Sequence 
16S rRNA 
Coagulase 
agrBDC 
Isolates
3  No. of isolates 
24, 85,99, 34,98, 82, 496, RN4220  8 
24, 85, 99, 2B, 31174,PD27,34,38,  17 
82,83,86,562,496,217,235,525, 
RN4220 
24,85,99, 2B, 31174, PD27, 34, 38, 
104,595,98,35,82,83,86,562,496, 
32528, 31178, 217, 235, 525, RN4220 
23 
aAll isolates were avian except strain RN4220 which was from a human. 103 
2.11.3 Analysis of  sequence 
2.11.3.1 ABI  Prism 7MEdit View 
ABI Prism™ Edit View was used to check the parameters used for the gel run, to 
allow the signal strengths to  be evaluated and also  to  allow the quality of the 
sequence data to be verified manually. 
2.11.3.2 SeqEd 
Contiguous  sequences  were  generated  using  SeqEd  Vl.O.3.  The  ABI 
electropherograms were loaded into the program,  filtered  to remove any low 
quality data and then assembled to generate a consensus sequence. Finally any 
anomalies were rectified by evaluation of  the trace data. 
2.11.3.3 Genejockey II 
Genejockey II  sequence processor (Biosoft,  Cambridge,  UK) was used for  a 
wide variety of purposes.  For example,  nucleotide  sequences (not trace  data) 
were aligned, translated or restriction sites identified.  Peptide sequences were 
also analysed as appropriate. For example, peptide plots could be derived and 
amino acid sequences compared. 
2.11.4 Internet tools 
2.11.4.1 National Center for Biotechnology In/ormation (NCBl) 
Query  sequences  were  routinely  compared  to  those  at  the  NCBI 
(http://www.ncbi.nlm.nih.govl) using the Basic Local Alignment Tool (BLAST) 
search  engines.  Sequences  of interest  were  downloaded  and  manipulated  as 
Genejockey II files. 
2.11.4.2 S. aureus genomic databases and tools 
Query sequences were compared to the incomplete S.  aureus genome database 
at: 104 
(http://www.sanger.ac.  uklProj ects/S  _ aureusl) 
Contigs were searched using the Alpha-powered BLAST search engine using the 
TBLASTN blast executable at: 
(http://www.sanger.ac.uklProjects/S_  aureus/blast_  server.shtml). 
Contigs of  interest were downloaded and manipulated as Genejockey files. 
The NCBI web site was also used to identify and further characterise microbial 
genomes. A list of  genomes can be found at: 
http://www  .ncbi.nlm.nih.  govlMicrob  _  blastlunfinishedgenome.html 3. RESULTS 105 
3.1 IDENTITY OF ISOLATES 
During the course of this  study a total of 86  avian isolates of S.  aureus were 
obtained at  different times  and  from  different  sources.  Some  of these  strains 
were provided as avian S.  aureus and had already been well characterised  (e.g. 
N. Ireland isolates from Dr. McCullagh). Others were less well characterised. In 
additional a number of other avian,  human and animal coagulase-positive and 
coagulase-negative species were obtained, to  serve as  control organisms in the 
various test procedures. The identity of most strains, except some of the isolates 
already  typed  by  PFGE  by  McCullagh  et  ai.  (1998),  was  determined  or 
confirmed by cultural and biochemical tests. 
3.1.1 Cultural and biochemical properties 
On tryptic soy agar, nutrient agar, non-selective blood agar, brain heart infusion 
agar and mannitol salt agar, isolated colonies of all isolates were 1 to  3 mm in 
diameter within 24-48  h at 37°C. The  colonies of all  strains were pigmented 
yellow, except for the avian S.  cohnii isolate 3B and the avian S.  sciuri isolates 
31038, 31040 and 31041. These produced cream colonies. Microscopically, the 
bacteria were Gram-positive cocci forming "grape-like" clusters, non-motile and 
non-spore  forming.  The  DNase  test  was  positive  for  all  coagulase-positive 
isolates. The catalase test was positive for all isolates. 
3.1.2 Biotyping of N. Ireland strains 
The biotyping results of the  40 avian S.  aureus N.  Ireland strains were kindly 
provided by Dr.  J.  J.  McCullagh and  are  summarised in Table 3.1.  Biotyping 
was done according to the schemes of Devrise (1984) and Isigidi et ai.  (1990). 
According  to  these  results,  32  of the  strains  had the  poultry biotype,  seven 
strains  had  the  non-host  specific  (NHS)  biotype  and  one  strain  had  the 
slaughterhouse biotype. 106 
Table 3.1 Biotyping results for the avian S. aureus strains from 
N. Ireland (Dr J. J. McCullagh) 
Biotype  Isolate  No. of isolates 
Poultry  24,35,36,38,77,82,83,85,86,98, 
99,100,104,105,122,123,564,572, 
580,582,595,596,597,598,3,20, 
25,30,48,51,52,53 
11,34,496,31,33,47,525 
Slaughterhouse  562 
aNon-host specific biotype. 
32 
7 
1 107 
3.1.3 Rapidec Staph 
Rapidec  Staph  (bioMerieux)  is  designed  for  the  identification  of the  main 
staphylococcal  species  isolated  from  human  specimens.  The  results  for  the 
different  avian  isolates  and  other,  control  strains  used  in  this  study  are 
summarised in Table 3.2. All of the avian isolates were confirmed as  S.  aureus 
except  for  isolate  SV132,  obtained  from  a  Harris  Hawk,  which  was  S. 
intermedius. Also this system was not able to identify isolates 3B, 31037, 31038, 
31040, 31041 and 31051 to species level. All avian, human and animal S.  aureus 
strains  (Table  3.2)  gave  an  identical  biochemical  profile  by  Rapidec  Staph 
included positive  fluorescent  reaction,  positive  reaction  (yellow)  for  alkaline 
phosphatase  (PAL)  test,  positive  reaction  for  catalase  test,  negative  reaction 
(yellow)  for  ~-galactosidase  (~ GAL)  test,  except  for  these  strains:  1)  avian 
strain  31039  showed  a  negative  reaction  (  colourless)  for  the  alkaline 
phosphatase  (PAL)  test  but  the  other  tests  were  similar  to  other  S.  aureus 
isolates. 2) bovine strain BOV-32276 showed a red colour for  ~-galactosidase W 
GAL)  test,  but  according  to  the  manufacturer's  report  for  S.  aureus  strains 
reaction for this test is  colourless (negative) and for  S.  intermedius, S.  xylosus 
and S. saprophyticus it is pink or red. 
3.1.4 API Staph 
Identification was made by using the Analytic Profile Index with the API Staph 
(bioMerieux) system. The pattern of the reactions are obtained and coded into a 
7-digit numerical profile.  The results for the  different avian isolates and other 
controls strains used in this study are summarised in Table 3.3. All of the avian 
isolates were confirmed as  S.  aureus except for:  isolate SV132 obtained from a 
Harris  Hawk  which  was  S.  intermedius;  isolates  31037  and  3B  that  were 
obtained from  chickens  and were  S.  cohnii;  isolates  31038,  31040 and  31041 
that were obtained from chickens and were S.  sciuri; and isolate 31051 that was 
obtained from chicken and was S.  caprae. According to  these results all  avian, 
human  and  animal  S.  aureus  strains  (Table 3.3)  gave  analytic  profile  index 
6736153,  except  for  avian  isolates  31036,  31039,  E and  32528  which  gave 108 
Table 3.2 Results of Rapidec Staph for different isolates of staphylococci 
Isolate 
2A, 2B, 3A, 4, 5, 6, 7  A, 7B, 8, 31174, 
31175,31176,31177,31178,31179, 
31180,31181,31182,31183,31036, 
31039,32528, E, K, SV6, SV289, NFR, 
199,214,217,235, PD486, PD458, 
PD380, PD27, 24, 34,35, 36, 38, 77, 82, 
83,85,86,98,99,100,104,105,122, 
123,496,562,564,572,580,582,595, 
596,597,598,3,11,20,25,30,48,51, 
52,53,88,170,172,259,329,330,352, 
373,390,410,451,31,33,47,525, HUM-2, 
HUM-3, CN4575, HUM-II, 8530, RN4220, 
HUM-108, HUM-109, HUM-G1, HUM-G2, 
HUM-G3, HUM-G4, HUM-G5, HUM-G6, 
HUM-271, HUM-275, HUM-282, HUM-284, 
HUM-294, HUM-298, HUM-BB, HOR-31912, 
BOV-32276, ZM-7, BOV-65, BOV-66, BOV-67 
SV132, DOG-32236, RAB-32253 
134, 1-T1, BOV-32298, BOV-32304 
132 
31037,31038,31040,31041, 31051,3B, 
DUK-31915, BOV-32265 
Species (No. of isolates) 
S.  aureus (113) 
S.  intermedius (3) 
S.  epidermidis (4) 
S.  saprophyticus (1) 
Staphylococcus spp. (8) 109 
Table 3.3 Results of API Staph for different isolates of staphylococci 
Isolate  Species (No. of isolates) 
2A, 2B, 3A, 4, 5, 6, 7  A, 7B, 8, 31174, 
31175,31176,31177,31178,31179, 
31180,31181,31182,31183,31036, 
S.  aureus (113) 
31039, 32528, E, K, SV6, SV289, NFR, 
199,214,217,235, PD486, PD458, 
PD380, PD27, 24, 34, 35, 36, 38, 77,82, 
83,85,86,98,99,100,104,105,122, 
123,496,562,564,572,580,582,595, 
596,597,598,3,11,20,25,30,48,51, 
52,53,88,170,172,259,329,330,352, 
373, 390,410,451,31, 33,47, 525,fnJ11-2, 
HU11-3, CN4575, fnJ11-11, 8530,RN4220, 
HU11-108, HU11-109, HU11-G1, HU11-G2, 
HU11-G3, HU11-G4, HU11-G5, HU11-G6, 
HU11-271, HU11-275, HU11-282, HU11-284, 
HU11-294, HU11-298, HU11-BB, HOR-31912, 
BOV-32276, Z11-7, BOV-65, BOV-66, BOV-67 
SV132, DOG-32236, RAB-32253 
31037,3B 
31038,31040,31041 
31051 
134, 1-Tl, BOV-32298, BOV-32304 
132 
DUK-31915 
BOV-32265 
S.  intermedius (3) 
S.  cohnii (2) 
S.  sciuri (3) 
S.  caprae (1) 
S.  epidermidis (4) 
S.  saprophyticus (1) 
S.  hominis (1) 
S.  warneri (1) 110 
profiles of 6736113,  6736113, 6736173  and  6726153  respectively, and human 
isolates  HUM-l08  and  HUM-109  which  gave  6736111  and  6736143 
respectively,  and  animal  isolate  HOR-31912  which  gave  6336151.  However, 
these numerical profiles still gave acceptable identification as S.  aureus. 
3.1.5 Identification of  S. aureus by peR 
Nucleic  acid  amplification  by  PCR  has  been  applied  to  the  detection  and 
identification  of microbes  and  is  becoming  widely  used  for  detection  for 
diagnostic purposes in clinical research and diagnostic laboratories. Some PCR 
methods have been developed for rapid identification of  S.  aureus strains. 
3.1.5.1 The S. aureus-specific peR assay 
The S.  aureus-specific PCR assay has been developed for rapid identification of 
S.  aureus  isolates  by  Martineau  et  at.  (1998).  In  the  present  study, 
oligonucleotide primers  SA442-1  and  SA442-2  (Table 2.11)  as  described by 
Martineau et at.  (1998) were used. The PCR condition described by Martineau et 
at.  (1998) were optimised for use  with the  avian,  human or animal S.  aureus 
strains. 
All the avian, human and animal isolates identified as  S.  aureus in the present 
study gave a single similar amplimer of the expected size of 108 bp.  Examples 
of  the results obtained by this PCR method are shown in Figure 3.1. None of  the 
avian,  human or  animal  coagulase-negative or S.  intermedius isolates showed 
any fragment by this method (e.g. lanes 11,  14, 15 in Figure 3.1). 
3.1.5.2 PeR/or nuclease region 
The nuclease gene product is an extracellular thermostable endonuclease which 
degrades both DNA and RNA. S.  aureus-specific nuclease primers were NUCI 
and NUC2 (Table 2.11) and were expected to give an amplimer of  size 0.3 kb as 
described  previously  by  Brakstad  et  at.  (1992).  This  study  optimised  and 
modified the PCR conditions described by Brakstad et at.  (1992). bp 
603 
310 
281,  27 
234 
194 
118 
111 
Figure 3.1 peR for rapid identification of S. aureus isolates. 
Lanes M:  <j>X174 RF DNA/Hae III Fragments DNA Ladder. 
Lanes 1-10: avian S.  aureus, isolates 24, 34, 35, 36,  38, 77,82, 
83, 86 and 98, respectively. Lane 11: avian S.  cohnii, isolate 
31037.  Lanes 12: human S. aureus, isolate  RN4220. Lane 13: 
animal S.  aureus, isolate HOR-31912. Lane 14: human S. 
epidermidis, isolate 134. Lane 15: animal S.  warneri, isolate 
BOV-32265. 
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All  the  86  avian,  human and  animal  S.  aureus  isolates  gave  a  single  similar 
amplimer of size  0.3  kb  (Figure  3.2).  The  results  agreed with the  biological 
method for  nuclease detection in the  DNase test except that a  human isolate 
HUM-G5 did not give a positive peR result but gave a positive result with the 
biological method. None of the avian and animal S.  intermedius isolates SV132, 
DOG-32236 and RAB-32253 and the six avian and the three human coagulase-
negative isolates or the animal S.  hominis isolate DUK-31915 showed a nuclease 
gene amplimer (e.g. lane 35 in Figure 3.2). 
3.2 PLASMIDS 
Plasmid profile analysis is technically simple and represents the first DNA-based 
typing method applied to  S.  aureus  (McGowan et at.,  1979;  Locksley et at., 
1982). This study investigated the use of this method for discrimination between 
avian isolates of  staphylococci. 
3.2.1 Plasmid DNA extraction 
The plasmid preparation was done with a QIA Prep Spin Plasmid Kit (QIAGE). 
This method is normally used for Gram-negative organisms but, in this study, 
was modified for  staphylococci by including lysostaphin in the  lysis  step (See 
Section 2.4.1). 
Seventy five  avian S.  aureus  strains isolated from  five  different sources were 
examined for their plasmid content using the above method, followed by agarose 
gel electrophoresis to  visualise  the plasmid bands.  Plasmids were  detected in 
95% of  the strains and only isolates 31178, 32528, 199 and 214 did not have any 
plasmids. Examples of some profiles are shown in Figure 3.3. The size of the 
plasmid  bands  ranged  from  1.6  kb  to  16  kb.  Seven  different  profiles  were 
evident in the avian S.  aureus isolates (Table 3.4). Five of the 75 avian S.  aureus 
isolates (7%) contained a single plasmid.  These isolates were 31039,  82,  496, 
562 and 525. Twelve  ofthe 75  avian  S.  aureus  isolates  (16%)  contained two 113 
bp  M 12 34  567  8  9  1011121314151617181920212223242526272829303132333435M 
Figure 3.2 Examples of peR amplification of nuclease gene 
fragment for S. aureus isolates. Lanes M:  <l>X174 RF DNAfHae III 
Fragments DNA Ladder. Lanes 1-10 and 12-29: avian S.  aureus 
isolates 24, 34, 35, 36, 38, 77, 82, 83, 85, 86, 98, 99, 100, 104 105, 
122, 123,496, 562, 564, 572, 580,582, 595, 596, 597, 2B, SV289 
and SV6, respectively. Lane 11: avian S.  cohnii isolate 31037. Lane 
30: avian S.  sciuri isolate 31040. Lanes 31-32: animal S.  aureus 
isolates HOR-31912 and ZM-7, respectively. Lanes 33-34: human S. 
aureus isolates  RN4220 and HUM-05, respectively. Lane 35: animal 
S.  hominis isolate DUK-31915. 
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plasmid bands but of different sizes:  1.6 kb,  1.8,2.8 kb, 4.4 kb or 16 kb. Forty-
nine of the 75 avian S.  aureus isolates (65%) had three plasmid bands ranging in 
size from 1.6 kb, 1.8 kb, 2.2 kb, 3 kb, 4.4 kb and 16 kb. Five of the 75  avian S. 
aureus isolates (6%) had four plasmid bands and the sizes were 1.6 kb,  1.8 kb, 
3.5 kb, 3 kb, 4.4 kb, 6 kb or 16 kb. 
The results show that most of the avian N.  Ireland S.  aureus isolates related to 
PFGE type 24 and those closely related to type 24 according to McCullagh et al. 
(1998), and most of  Scottish and Sri Lankan isolates gave three plasmid bands of 
1.6 kb, 4.4 kb and 16 kb (Table 3.4). 
Plasmids  profiles  from  aVIan  coagulase-negative  and  human  and  animals 
coagulase positive and negative staphylococci are shown in Tables 3.5, 3.6, 3.7 
and  3.8.  There  were  some  plasmid bands  of similar  size  in  avian  S.  aureus 
isolates and avian coagulase-negative, human and animal coagulase-positive and 
negative isolates (Tables 3.5, 3.6, 3.7 and 3.8). 
3.2.2 Transformation of  plasmids by electroporation 
This  was  done  to  confirm that  a 4.4  kb  plasmid common in avian  S.  aureus 
conferred tetracycline resistance (See  Section 3.3).  The  method of Lee  (1995) 
was used. A 4.4 kb from avian S.  aureus isolate 7  A was extracted by the QIA 
Prep Spin Plasmid Kit (QIAGEN) as  described in section 2.4.1  and transferred 
to  avian S.  aureus isolate 6 and human S.  aureus isolate RN4220 tetracycline-
sensitive strains by electroporation. Selection for tetracycline resistance followed 
by re-extraction of the plasmid and agarose gel electrophoresis demonstrated the 
presence of  the 4.4 kb plasmid. The plasmid profiles of avian S.  aureus 6, before 
and after transformation, and of  donor strain 7  A are shown in Figure 3.4. 115 
Table 3.4 Distribution of plasmids in avian S. alireliS isolates 
Plasmid bands  Isolate  No. of 
{kb}  isolates 
a  31178,32528,199,214  4 
1.6  31039,82  2 
2.2  496,525  2 
16  562  1 
1.6+4.4  PD458  1 
1.8+16  217  1 
1.6+16  3A, 6,235, 35, 36, 77,104,580,595  9 
2.8+16  K  1 
1.6+4.4+16  2A,2B,4,5, 8,31174, 31175,31176  45 
31176,3177,31179,31180,31181, 
31182,31183,31036, PD486, PD380, 
24,34,38,85,86,99,100,105,122, 
123,572,582,596,3,11,20,25,30,31, 
33,47,48,51,52,53,170,172 
1.6+ 1.8+ 16  E  1 
1.6+2.2+16  598  1 
1.6+3+16  SV6,597  2 
1.6+3+4.4+16  7A, 7B, 564  3 
1.6+1.8+3.5+16  98  1 
1.6+ 1.8+6+ 16  83  1 
a These isolates did not have plasmids. bp  M1  1  23  4  5  6  78  91011 12131415161718192021222324252627282930313233 34353637M2M3  bp 
16,210 
14,174 
12,138 
10,102 
8,066 
7,045 
6,030 
5,012 
3,990 
2,972 
2,067 
Figure 3.3 Examples of plasmid profiles of  S. aureus isolates. Lane M1: Supercoiled 
DNA Ladder. Lanes 1-34: avian isolates, 2A, 4,6, 7A, 31174,11, 105,31036,31039, 
564,595, 104,580,35,98,597,598, PD458, PD486, PD380, E, K, SV6, 82, 83, 86, 
562,496,525,32528,31178, 199,214 and 217, respectively. Lanes 35-36: human 
isolates, HUM-3 and HUM-G3. Lane 37: animal isolate HOR-31912. Lane M2: 5 Kb 
DNA Ladder. Lane M3: 1 Kb DNA Ladder. (see Tables 3.4, 3.6 and  3.7) 
16,210 
14,174 
12,138 
10,102 
8,066 
7,045 
6,030 
5,012 
3,990 
2,972 
2,067 
........ 
........ 
0\ 117 
Table 3.5 Distribution of plasmids in avian coagulase-negative staphylococci 
Plasmid bands  Isolate 
* 
(kbl 
a31037,b31038,b31041 
3  b31040 
6.1  c31051 
2.4+3  a3B 
* These isolates did not have plasmids. 
as  h"  bS  .  . Cs  . co  lUl,  . SClUn,  . cap  rae 
Table 3.6 Distribution of plasmids in human S. alireliS isolates 
Plasmid bands 
(kbl 
16 
* 
Isolate 
CN4575, 8530, HUM-II, HUM-GI, 
HUM-G2, HUM-G3, HUM-G4, 
HUM-3 
RN4220 
* This isolate did not have plasmids. 
No. of 
isolates 
3 
I 
I 
I 
No. of 
isolates 
8 
I 118 
Table 3.7 Distribution of plasmids in animal coagulase-positive staphylococci 
Plasmid bands  Isolate  No. of 
{kb}  isolates 
5+9.1  aBOV-32276  1 
7+16  bRAB-32253  1 
*  aHOR-31912, aBOV-65  2 
as.  aureus, bS. intermedius 
* These isolates did not have plasmid. 
Table 3.8 Distribution of plasmids in animal coagulase-negative staphylococci 
Plasmid bands  Isolate  No. of 
{kb}  isolates 
5  aBOV-32304, bBOV-32268  2 
5+16  aBOV-32298  1 
1.6+2.4+3.7+5+  16  cBOV-32265  1 
as.  epidermidis,  as.  chromogenes, CS.  warneri 4.4 kb plasmid 
119 
1  2  3  M 
Figure 3.4  Plasmid profiles showing transformation of 
the 4.4 kb plasmid of  S. aureus by electro  po  ration. Lane 
1: recipient avian isolate, 6 (before electroporation). Lane 2: 
recipient avian isolate, 6 (after electroporation). Lane 3: 
avian isolate, 7  A (donor of 4.4 kb plasmid). Lane M: 
Supercoiled DNA Ladder. 
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3.3 ANTIBIOTIC SENSITIVITY PATTERNS 
These were determined to see if  they could be used for differentiation of avian S. 
aureus  isolates  and  to  find  any  relationship  between  antibiotic  sensitivity 
patterns and plasmid profiles. 
The antibiotic sensitivity results indicated that three of the 78  avian S.  aureus 
isolates  were  sensitive  to  all  the  eighteen  antibiotics  tested  by  the  A  TB 
ANTIBIOGRAM (bioMerieux) method. These isolates were 31178, 31039 and 
K. Seventy-five (96%) of the 78  isolates were resistant to  one or more of the 
antibiotics  tested.  Eleven  (14%)  of the  78  isolates  were  resistant  to  one 
antibiotic, either penicillin G, tetracycline or pefloxacin (Table 3.9). Ten (13%) 
of the  isolates  were  resistant  to  two  antibiotics  that  included  tetracycline, 
pefloxacin,  nitrofurantoin  and  erythromycin.  Four (5%)  of the  isolates  were 
resistant  to  three  antibiotics  namely  kanamycin,  tobramycin  and  gentamicin. 
Seventeen (22%) of the isolates were resistant to four antibiotics that included 
kanamycin,  tobramycin,  gentamicin,  erythromycin,  pefloxacin,  lincomycin, 
tetracycline or penicillin G.  Twenty-nine (37%) of the isolates were resistant to 
five  antibiotics  that included kanamycin,  tobramycin,  gentamicin,  tetracycline 
and pefloxacin.  Four (5%) of the  78  isolates  were resistant to  six  antibiotics 
included  kanamycin,  tobramycin,  gentamicin,  pefloxacin,  tetracycline  and 
penicillin G (Table 3.9). 
Of the 75  avian S.  aureus isolates resistant to  different antibiotics,  fifty-three 
(71 %)  isolates  were  resistant  to  tetracycline,  kanamycin,  tobramycin  and 
gentamicin,  fifty  (67%)  isolates  were  resistant to  pefloxacin,  fourteen  (19%) 
were resistant to penicillin G, two (3%) were resistant to erythromycin, one (1 %) 
was resistant to nitrofurantoin and one (1 %) isolate was resistant to lincomycin 
(Table 3.9). 
The results showed that most of avian N.  Ireland S.  aureus  isolates related to 
PFGE  type  24  and  closely  related to  type  24  according  to  McCullagh et al. 121 
Table 3.9 Antibiotic resistance patterns of avian S. aurellS isolates 
Antibiotic  Isolate  No. of 
resistance  isolates ( %) 
Tetracycline  7A,7B,3117~31175,31176,31177,  8 (10) 
31180,31181 
Pefloxacin  3A,6  2 (3) 
Penicillin G  32528  I (I) 
Tetracycline+Pefloxacin  2A, 2B, 4, 5, 31179, 31182, 31183,  8 (10) 
31036 
Tetracycline+Nitrofurantoin  8  1(1) 
Erythromycin+Pefloxacin  SV6  I (1) 
Kanamycin+  Tobramycin+ 
Gentamicin  82,83,496,525  4 (5) 
Kanamycin+  Tobramycin+ 
Gentamicin+Pefloxacin  199,214,217,235,77  5 (6) 
Kanamycin+  Tobramycin+ 
Gentamicin+  Tetracycline  582,596  2 (3) 
Kanamycin+  Tobramycin+ 
Gentamicin+Penicillin G  35,36,98,104,562,597,580,595,  9 (12) 
598 
Tetracycline+Erytromycin+ 
Lincomycin+Pefloxacin  E  I (I) 
Kanamycin+  Tobramycin+ 
Gentamicin+  Tetracycline+ 
Pefloxacin  PD486, PD458, PD380, PD27, 24, 34,  29 (37) 
38,85,99,105,122,123,3,11,20,25, 
30,31,33,47,48,51,52,53,88,170,172, 
410,451 
Kanamycin+  Tobramycin+ 
Gentamicin+  Tetracycline+ 
Pefloxacin+Penicillin G  86,100,564,572  4 (5) 122 
(1998),  and  most  of  Scottish  and  Sri  Lankan  isolates  were  resistant  to 
tetracycline, kanamycin, tobramycin, gentamicin and pefloxacin (Table 3.9). 
There was a strong correlation between the presence of a 4.4 kb plasmid as seen 
in  the  plasmid profile,  and  tetracycline  resistance  in  avian  S.  aureus  isolates 
(except  for  isolate  E  that did  not  apparently  have  a 4.4  kb  plasmid but was 
resistant to tetracycline). This relationship was confirmed by plasmid transfer as 
described in section 3.2.2. 
Antibiotic  sensitivity  patterns  were  also  examined  for  the  aVIan  coagu1ase-
negative,  human  S.  aureus  and  animal  coagulase-positive  and  coagu1ase-
negative isolates. Of the six avian coagulase-negative strains, isolates 31037 and 
31051  were  sensitive  to  all  18  antibiotics  but  isolate  31038  was  resistant  to 
fusidic  acid.  Isolate  31040  was  resistant  to  pefloxacin,  isolate  31041  was 
resistant  to  lincomycin,  and  isolate  3B  was  resistant  to  fusidic  acid  and 
lincomycin.  Of the  seven human  S.  aureus  isolates,  CN4575,  8530,  RN4220 
were sensitive to all  18  antibiotics, but isolates HUM-2, HUM-3  and HUM-II 
were resistant to penicillin G, isolate HUM-108 was resistant to penicillin G and 
erythromycin and  pefloxacin.  Of the  five  animal  coagulase-positive  isolates, 
HOR-31912  and  ZM-7  were  sensitive  to  all  18  antibiotics  but  isolate  BOV-
32276  was  resistant  to  penicillin  G,  isolate  DOG-32236  was  resistant  to 
penicillin G and tetracycline, and isolate RAB-32253 was resistant to penicillin 
G,  lincomycin,  pefloxacin  and  fusidic  acid.  Of the  five  animal  coagu1ase-
negative  isolates,  BOV-32268  and  BOV-32304  were  sensitive  to  all  18 
antibiotics  but isolate DUK-31915  was  resistant to  tetracycline,  isolate BOV-
32265  was  resistant  to  fosfomycin  and  isolate  BOV-32298  was  resistant  to 
penicillin G. 
3.4 EXOPROTEINS PROFILES 
Staphylococci  produce  a  variety  of different  extracellular  proteins  acting  as 123 
either  toxins,  non-toxic  enzymes,  or  enzyme  activators.  In  this  part  of the 
project,  extracellular proteins of avian  S.  aureus  isolates  were  investigated to 
determine their usefulness in strain differentiation. 
3.4.1 SDS-PAGE gels 
After  concentration  of  staphylococcal  culture  supemates,  the  exoprotein 
variation  between  sixty-seven  avian  S.  aureus  isolates  was  examined.  For 
comparison,  an  avian  S.  intermedius  isolate,  three  avian  coagulase-negative 
isolates,  six  human S.  aureus  isolates  and  two  human  S.  epidermidis  isolates 
were  included.  Examples  of exoprotein  profiles  are  shown  in  Figure  3.5. 
Whereas the human strains (e.g. lanes 11  and 12, Figure 3.5) generally produced 
complex exoprotein profile, the profiles of  the avian strains contained few bands. 
Also,  the  avian  S.  intermedius strain and the  human  S.  epidermidis produced 
complex exoprotein profiles (lanes 3 and 4, Figure 3.6). A notable feature of  the 
exoprotein  profiles  was  that  a  single  dominant  protein  band  of 22  kDa  was 
common to the majority of avian S.  aureus strains. Only seven avian S.  aureus 
isolates, 31177, 31178 (lane 5, Figure 3.5),31039,32528, K, 82 (lane 3, Figure 
3.5), and 496 appeared to  lack this band (Table 3.10). None of the three avian 
coagulase-negative, six human S.  aureus (e.g. lanes 11  and 12, Figure 3.5, lanes 
5  and  6,  Figure  3.6)  avian  S.  intermedius  isolate,  or  the  two  human  S. 
epidermidis  isolates  (lanes  3  and  4,  Figure  3.6)  examined  by  SDS-PAGE 
showed a band at the 22 kD position (Table 3.10). 
3.4.2 Determination of N-terminal amino acid sequence of 22 kDa band 
In view of the finding of a single major exoprotein produced by the majority of 
S.  aureus  avian  strains,  this  protein,  a  putative  virulence  factor,  was  further 
investigated. 
Concentrated culture  supemates  of avian strain  31179 was  subjected to  SDS-
PAGE as above and bands were transferred onto a PVDF membrane (Bio-Rad) 
by  the  method  of  Matsudaira  (1987).  After  brief staining  with  Coomassie kD 
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Figure 3.5  SDS-PAGE gel for exoproteins in S. aureus 
isolates. Lane M:  10 kDa Protein Ladder. Lanes 1-10 avian 
isolates 2B, 24, 82, 31174, 31178,  31179,  E, 85, 35 and 86 
respectively. Lane 11-12: human isolates RN4220 and 8325 (see 
Table 3.10). kD 
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Figure 3.6  SDS-PAGE gel for exoproteins in S. aureus and S. 
epidermidis isolates. Lane M: Unstained Protein Ladder (Bio-Rad 
Laboratories UK). Lanes 1-2: avian S.  aureus isolates 24 and 
31179, respectively. Lanes 3-4: human S.  epidermidis isolates 134 
and 1-TL, repectively. Lanes 5-6: human S.  aureus isolates 8530 
and RN4220, respectively (see Table 3.10). 126 
Table 3.10 Presence of 22kDa protein band in avian and human staphylococcal 
isolates as determined by SDS-PAGE 
22kDa protein band  Isolates 
Positive  2A, 2B, 3A, 4, 5, 6, 7  A, 7B, 8, 31174, 
(avian S.  aureus) 
Negative 
(avian S.  aureus) 
Negative 
(avian S.  intermedius) 
Negative 
31175,31176,31179,31180,31181, 
31182,31183,31036, E, SV6, SV289, 
24,34,35,36,38,77,83,85,86,98, 
99,100,104,105,122,123,562,564, 
572,580,582,595,596,597,598,3, 
11,20,25,48,51,52,53,170,172, 
330,390,410,451 
31177, 31178, K, 31039, 32528, 82,496 
SV132 
(avian coagulase-negative) 
Negative 
(human S.  aureus) 
HUM-2, HUM-3, CN4575, HUM-11, 
8530, RN4220 
Negative  134, 1-TL 
(human S.  epidermidis) 
as.  cohn  ii,  bS. sciuri 
No. of isolates 
60 
7 
1 
3 
6 
2 127 
brilliant blue R-250, the area of the membrane containing the band of interest 
(22 kDa band) was cut out and sent for N-terminal sequencing at the Protein and 
Nucleic  Acid Chemistry Laboratory  (PNACL)  at  the  University  of Leicester. 
The  N-terminal  amino  acids  sequence  of the  22  kDa  band  was  found  to  be 
VRAQYVNQLKN. At the time this information was obtained (September 1999) 
no match was found  in the protein databases (NCBI). However, in a paper by 
Takeuchi et ai.  (1999) published in June of that year,  a protease was  purified 
from  the  culture supemates of an avian  strain of S.  aureus.  The protease had 
been characterised as  a thiol (cysteine) protease and the N-terminal amino acid 
sequence  was  given  as  RAQYVNQLKNFKIRETQ.  From  these  results,  it 
appeared likely that the 22 kD band in culture supemates from avian S.  au reus 
isolates  represented  an  extracellular  cysteine  protease.  This  possibility  was 
investigated further. 
3.4.3 Screening for protease activity 
3.4.3.1 Skim milk agar plates 
Protease production by the 86 avian S.  aureus isolates was examined by culture 
on skim milk agar plates. A clear zone was formed around the colonies of 80 of 
the isolates on skim milk agar plates. When protease-producing ability of these 
isolates was classified from + to +++ by the size of the clear zone, most of the 
isolates were judged to  be  +++.  There was  no  clear zone around six avian  S. 
aureus isolates,  31178, 31039, K,  32528,  82  and 496 or an  avian isolate of S. 
intermedius. Most of these strains are the ones that lack a 22 kD band. The result 
therefore agreed with the presence of a 22  kD  protease band by SDS-P  AGE, 
except for isolate 31177, that was negative by SDS-PAGE gel but was positive 
on skim milk agar. Of the nine human S.  aureus and four of the avian coagulase-
negative isolates  examined by skim milk agar plate culture,  all  of them were 
negative. 128 
To  detennine whether the  protease  activity  seen  on  skim milk was  due  to  a 
cysteine protease or to some other type of protease, a specific cysteine protease 
inhibitor was used. Bacterial strains were streaked across skim milk agar plates 
and filter paper strips soaked in the specific cysteine protease inhibitor E64 at a 
concentration of 28  11M  was  laid  across  the  streaks.  After incubation,  it  was 
found  that  the  specific  cysteine  protease  inhibitor E64  inhibited  the  zone  of 
clearing (protease activity) near to the filter paper strip where the inhibitor had 
diffused out into  the  medium  (Figure 3.7).  From these results,  it appears  the 
protease activity of the avian S.  aureus strains seem on skim milk agar was due 
to a cysteine protease. 
3.4.3.2 Effect of  different reagents 011 protease activity 
In  further  experiments  to  characterise  the  protease  activity  III  aVIan  strains 
different  protease  inhibitors  (Roche  Molecular  Biochemicals,  Gennany)  at 
recommended concentrations were investigated for their effect on the activity of 
culture supemates of avian S.  aureus isolate 31179 that had a prominent 22 kD 
band. The protease activity was measured in a dye-release assay with azocasein 
as the substrate. Results are shown in Table 3.11. According to these results, the 
metalloprotase inhibitor (EDTA-Na2) did not inhibit or stimulate the activity of 
protease.  Protease  activity  was  however,  stimulated  by  the  addition  of L-
cysteine.  Cysteine  protease  inhibitor  E64  (N-(N-(L-3-trans-carboxirane-2-
carbonyl)-L-Ieucyl)-agmatine)  almost  completely  inhibited  the  activity  of the 
protease,  whereas  other  protease  inhibitors  including  pepstatin  (aspartic  acid 
protease  inhibitor),  APMSF  [( 4-amidino-phenyl)  methane-sulfonyl  fluoride] 
(serine  protease  inhibitor)  and  bestatin  (amino  peptidase  inhibitor)  had  only 
minor inhibitory effects. These results confinn that the protease activity in the 
culture  supemates of the avian strain is  mainly due  to a  cysteine  protease and 
that this protease is  probably identical to  the 22  kDa protein band seen in the 
culture supemates. 129 
Figure 3.7 Demonstration of inhibition of protease 
activity of avian S. aureus  isolates (from top to 
bottom, strains 2B,  24 and 85) by the cysteine 
protease inhibitor E64.  The filter paper strip in the 
middle contained the cysteine protease inhibitor E64. 130 
Table 3.11 Effect of specific inhibitors on the activity of the protease 
of S. aureus strain 31179 measured in dye release assay with 
azocasein as substrate 
Reagent  Concentration  Effect (%) 
None  100 
L-cysteine  SOmM  137.1 
EDTA  1.3 mM  100 
Pepstatin  88.6 
APMSF  82.8 
Bestatin  77.1 
E64  8.S 131 
3.4.3.3 Amplification of  N-termin  al sequence of  cysteine protease 
After  determination  of the  N-terminal  amino  acid  sequence  of the  22  kD 
exoprotein band, an attempt was made to clone and sequence  the  gene encoding 
the  protease.  Primers  PRS-l  and  PRS-2  (Table  2.11)  were  designed  from  a 
combination of both N-terminal amino acids sequences (this study and Takeuchi 
et at.)  1999) to amplify an expected 54 bp fragment of  the N-terminal amino acid 
sequence.  A  number  of avian  and  human  S.  aureus  isolates  and  human  S. 
epidermidis isolates that were positive and negative for 22 kD band (Table 3.10) 
were selected for this test. These included avian S.  aureus isolates 31179, 24 and 
85  (which produce the 22  kDa band) and avian S.  aureus isolate 82,  human S. 
aureus isolates 8530 and RN4220 and human S.  epidermidis isolate  134 (all of 
which were negative for 22 kDa band). 
With  avian  S.  aureus  isolates  31179,  24  and  85,  shown  by  SDS-PAGE  to 
produce the 22 kD exoprotein, a 54 bp amp Ii con was obtained. Examples of  this 
result are  shown in Figure 3.8.  The other avian  and human  S.  aureus and  S. 
epidermidis strains that lacked the 22 kD exoprotein were negative by PCR (e.g. 
lanes 3 and 4 Figure 3.8).  In all strains amplified by this  method,  there were 
some other non-specific bands of  different sizes (data not shown). 
3.4.3.4 Southern blot analysis of  the S. aureus genome 
Next,  the  intention was  to  use  the  digoxigenin-Iabelled  54  bp  fragment  as  a 
Southern blot probe (section 3.4.3.3) to  detect the protease gene in the genome 
of  avian S.  aureus and then to clone the protease gene in a suitable vector. 
Using  the  method  described  in  Chapter  2,  Section  2.5.8,  the  54  bp  probe 
produced from avian S.  aureus isolate 31179 was hybridised to the genomes of 
avian S.  aureus isolate  31179 and  human S.  aureus  isolate  RN4220. The latter 
was used as a control as it did not produce the 22 kDa exoprotein (Table 3.10). 
Figure 3.9 shows the hybridisation results when the chromosomes were cut with 
HindIII, XbaI and BamHI. There  were  two  bands, of  about 1 and 2.3 kb  when bp 
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Figure 3.8  peR of the N-terminal 
sequence of the 22 kDa protease for S. 
aureus and S. epidermidis isolates. Lane M: 
25 bp DNA Ladder. Lane 1-2: avian S. 
aureus isolates, 31179 and 24. Lane 3: 
human S.  epidermidis isolate, 134. Lane 4: 
human S.  aureus isolate, RN4220. 3  ---. 
2  ---. 
1  ---. 
133 
1  2  3  4  5  6  7  M 
11  --
,  ", 
..  ..  -
. 
Figure 3.9 Hybridisation of a 54 bp probe derived 
from the 22 kDa protease of avian S. aureus isolate 
31179 against chromosomal DNA of  S. aureus. Lanes 1, 
3,5: human S.  aureus isolate, RN4220 restricted by 
HindIII, XbaI and BamHI repectively. Lanes 2, 4 and 6: 
avian S.  aureus isolate, 31179 restricted by HindIII, XbaI 
and BamHI respectively. Lane 7: S.  aureus isolate, 31179 
(labelling probe) (54bp N-terminal band) (the band ran out 
of the gel). Lane M: DNA Molecular-Weight Marker II 
DIG-labeled. 
bp 
23130 
9416 
6557 
4361 
2322 
2027 
564 134 
genomic DNA from  avian S.  aureus  isolate  31179  was  cut with HindII!,  but 
these  were not present in  the  human  isolate  (arrows  1 and  2  in  Figure 3.9). 
There was also one extra band of about 4 kb  when human isolate RN4220 was 
cut with Xba! (arrow 3 in Figure 3.9) and there was one extra band of high mol. 
wt in the  avian  isolate  when  cut  with  BamH! (arrow  4  in  Figure 3.9).  The 
labelling probe (54 N-terminal band) (lane 7 in Figure 3.9) did not show a band 
because its size was too small. These results indicated that it might be feasible to 
clone a 2.3 kb HindII! DNA fragment which might incorporate all or part of the 
protease gene. However, a different strategy was decided in the  light of recent 
information, because the 54 bp of the N-terminal sequence was matched with a 
sequence identified as part of the ecp (extracellular cysteine proteinase) gene of 
human S.  epidermidis strain 6746 (GenBank accession number AJ298299). 
3.4.3.5 Amplification of  cysteine protease gene 
As stated above, the 54 bp N-terminal sequence of 22 kD exoprotein band was 
found  to  be  72%  (39/54  bp)  identical  with  regions  of the  ecp  (extracellular 
cysteine  proteinase)  gene  of S.  epidermidis  isolate  6746  (GenBank accession 
number AJ298299). From this information, primers SACP-l and SACP-2 were 
designed (Table 2.11) to amplify a 522 bp region of  the cysteine protease gene. 
With this  PCR method,  avian  S.  aureus  isolates  31179 and 24  and human S. 
epidermidis strain  134 gave a single similar amp  Ii con of size  ~500 bp (Figure 
3.10).  All these products were  sequenced by Molecular Biology Support Unit 
(MBSU) at the  University of Glasgow (see  section 2.10.1).  Human S.  aureus 
isolates  RN4220  and  8530  did  not  show  bands  of this  size  with  the  above 
prImers. 
3.4.3.6 Sequence analysis of  cysteine protease gene 
Regions  of cysteine  protease  consensus  sequences  of the  522  bp  sequence 
obtained for  avian  S.  aureus isolates  24  and  31179  and the  522  bp  sequence 
obtained  for  the  human  S.  epidermidis  isolate  134  were  compared  to  other bp 
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Figure 3.10 peR amplification of extracellular 
cysteine protease gene. Lane M: <l>X174 RF 
DNAIHae III  Fragments DNA Ladder. Lane 1: 
human S.  epidermidis isolate 134. Lanes 2-4: avian S. 
aureus isolates 31179, 24 and 85, respectively. Lanes 
5-6: human S.  aureus isolates 8530 and RN4220, 
respectively. 136 
sequences in the GenBank using the BLASTn search engine. The sequences for 
strains 24  and 31179 were 100 % identical (Appendix III-a) and showed 80% 
(4201522  bp)  identity with the  published sequence for  the  S.  epidermidis  ecp 
gene of isolate 6746 (GenBank accession number AJ298299), 42% (2211522 bp) 
identity with the scp cysteine protease (staphopain)  gene  of human S.  aureus 
subsp. aureus isolate N315 (GenBank accession number AP003135). Similarly, 
there was 42% (2211522 bp) identity with the scp cysteine protease (staphopain) 
gene  of human  S.  aureus  subsp.  aureus  strain  Mu50  (GenBank  accession 
number AP003363). The corresponding sequence of the ecp gene of human S. 
epidermidis isolate 134 used in the present study showed 100% identity with the 
published sequence for S.  epidermidis ecp gene of  isolate 6746. 
3.4.3. 7 Gelatin gels 
In section 3.4.1, it was reported that a 22 kDa band representing an extracellular 
cysteine protease was found in the culture supernates of the majority of avian S. 
aureus strains. An investigation was therefore undertaken to determine whether 
differences  in  extracellular  proteases  could  be  used  as  an  aid  to  strain 
discrimination.  For  this  investigation,  strains  belonging  to  PFGE  type  24 
(McCullagh et at.)  1998) were chosen. This is the commonest PFGE type and, to 
date,  there  is  no  known  way  to  discriminate  between  these  strains.  When 
protease activity in culture supernates was examined by the gelatin gel method, 
most of the  isolates  examined  showed similar protease profiles.  Examples  of 
such profiles  are  shown  in  Figure 3.11.  Although  the  manner  in  which  the 
protease  separated  on  the  gel  was  not  ideal,  some  differences  were  evident 
between avian S.  aureus strains of PFGE type 24. For example, isolates 85,  123, 
572,  582  and  31174  had  slightly  different  patterns  from  those  of the  other 
isolates  examined  by  this method  (lanes 1,4,5,6 and  9,  Figure 3.11). These 
thirteen isolates examined here were identical by other biological and molecular 
typing methods. This procedure therefore seemed to offer the possibility of some 
discrimination between type 24 isolates, but this would need to be established by 
repeat analysis. 1  2  3  4  5  6  7  8  9  10  11  12  13 
Figure 3.11 Gelatin gel for protease activity in culture supernates of 
avian S. aureus isolates ofPFGE type 24. Lanes 1-13: isolates 85, 
105, 122, 123,572,582,596,4,31174, 31175,31176, 31179 and 
31180, respectively. 
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3.5 FINGERPRINTING OF ISOLATES BY PCR METHODS 
One of the main aims of this project was to  develop rapid and discriminating 
methods for the characterisation of avian isolates of  S.  aureus and to  determine 
how these isolates differ from S.  aureus strains from other sources. A number of 
PCR fingerprinting methods were investigated. 
Some strains were typed by these methods on several occasions with essentially 
the  same  results,  showing  that  the  methods  were  highly  reproducible.  PCR 
products from a selection of  the following strains e.g. avian S.  aureus strains 24, 
34,11,77,85,82,83,86,496,562,595, 2A, 2B, 31174, 31177, 31181, human 
isolates 8530 and RN4220 or animal isolate BOV  -65  were included in all gels, 
as "in-house" standards to facilitate the comparison between strains and for the 
identification of  particular types of  profile. 
3.5.1 PCR-ribotyping 
PCR-ribotyping method  1 involved the  use  of universal  primers  GIRRN  and 
LIRRN (Table 2.11) that were designed to  amplify the spacer region between 
the  16S  and 23S rRNA genetic loci as  described by Jensen et al.  (1993). This 
study modified and optimised the PCR conditions described by Appuhamy et al. 
(1997) for use with Haemophilus somnus isolates (section 2.6.9.1). 
All 86 avian S.  aureus isolates gave fingerprints with approximately nine major 
bands ranging from  ~0.4-~0.8 kb.  Examples are shown in Figure 3.12. On the 
basis of six distinct bands, twelve  groups were recognised for the 86  avian S. 
aureus isolates and each was assigned a number (Table 3.12). Group 1 included 
the  majority,  63  (73%)  of the  isolates.  When  the  N.  Ireland  isolates  were 
examined, the results showed that all isolates designated as type 24 and closely-
related to type 24 (according to McCullagh et al.,  1998) were in group 1. Also, 
most of the Scottish isolates except isolates 31178, 31039 and 32528 and most 
of the  English isolates  except  isolates K  and  NFR  and  all  of the  Sri  Lankan 
isolates were in this group (Table 3.12). Group 2, contained eight (9%) isolates; 139 
of the N.  Ireland isolates,  all  isolates  designated as  possibly-related to  PFGE 
type 24 and some of  the isolates designated as unrelated to type 24 (according to 
McCullagh et al.,  1998)  were  in this  group.  Group 3  contained  four  isolates 
(5%). All isolates in this group were N. Ireland strains designated as unrelated to 
PFGE type 24 (according to McCullagh et al.,  1998). Groups 4 and 5 contained 
two (2%) isolates each. Two of the American isolates were in group 4 and two 
N.  Ireland isolates unrelated to PFGE type 24 (according to McCullagh et at., 
1998) were in group 5. Groups 6, 7, 8, 9, 10, 11 and 12 each contained one (1 %) 
isolate, from different sources (Table 3.12). 
The amplified products of  eight human S.  aureus isolates (e g.  lanes 35 and 36 in 
Figure 3.12) showed four different patterns which were distinct from  those of 
avian S.  aureus isolates, except for isolates HUM-2 and HUM-3. These strains 
gave patterns that were similar to group 1 of the avian S.  aureus isolates (Table 
3.12).  Avian coagulase-negative isolates  (e.g.  lane 38  in Figure 3.12), animal 
coagulase-positive and negative and human coagulase-negative (e.g. lane 37 in 
Figure 3.12), also showed distinct patterns (Table 3.12). 
Results  obtained with PCR-ribotyping method  1 for  the  chicken isolates of S. 
aureus from N.  Ireland and the other, atypical avian strains not from N.  Ireland 
are included in summary Tables 3.20 and 3.21, respectively. 
PCR-ribotyping method 2 was  done  with species-specific primers  ST  AA-A  VI 
and STAA-AVII (Table 2.11) as designed by Forsman et at.  (1997) for use with 
bovine mastitis S.  aureus strains. The primers are complementary to conserved 
sequences near the  3' end of the  16S  and the  5' end of the 23S rRNA genes, 
respectively, and were used to amplify the 16S-23S intergenic spacer regions for 
bovine  mastitis  pathogens  (Forsman  et at.,  1997).  This  study  modified  and 
optimised  the  PCR  conditions  described  by  Forsman  et  at.  (1997)  (section 
2.6.9.1). 140 
Table 3.12 Typing of S. aureus isolates by PCR-ribotyping method 1 
Type 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
*  Isolate  No. of isolates 
2A, 2B, 3A, 4, 5, 6, 7A, 7B, 8, 31174,  65 
31175,31176,31177,31179,31180, 
31181,31182,31183,31036, E, SV6, 
SV289, PD486, PD458, PD380, PD27, 
24,34,38,77,85,99,100,105,122, 
123,564,572,582,596,3,11,20,25, 
30,48,51,52,53,88,170,172,259, 
329,330,352,373,390,410,451,31,33, 
47, aHUM-2, aHUM-3 
35,36,98,104,580,595,597,598  8 
82,83,86,562  4 
199,214  2 
496,525  2 
217  1 
235  1 
31178  1 
32528  1 
K  1 
NFR  1 
31039  1 
aCN4575, a8530  2 
aHUM-11, aHUM-G3  2 
aRN4220  1 
aHUM-108  1 
aHUM-284  1 
aHUM-294  1 
bBOV-65  1 
bBOV-66  1 
bBOV-67  1 
bBOV-32276  1 
cZM-7  1 
dHOR-31912  1 
* All are avian isolates except: 
a:  Human isolate 
b:  Bovine isolate 
c:  Zoo mouse isolate 
d; Horse isolate bp  M12  345678 9  1011121314151617181920212223242526272829303132333435363738M  bp 
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Figure 3.12 Examples of fingerprints obtained by PCR-ribotyping (method 1). Lanes M: 
<j>X174 RF DNAJHae III Fragments DNA Ladder. Lanes 1-34: (except lane 32 is negative 
control) avian S. aureus  isolates, 24, 11, 3A, 4, 6, 7  A, 31175, 31179, PD486, PD27, 31036, 
31039,E,K,NFR,SV6,SV289,34,595, 104,35,98,82,83,86,562,496,525,31178, 
32528,214,217 and 235 respectively. Lanes 35 and 36: human S. aureus isolates, CN4575 
and RN4220 respectively. Lane 37: human S.  epidennidis isolate, 134. Lane 38: avian S. 
cohnii isolate, 31037. The profiles have been arranged so that isolates of the same type are 
grouped together. Lanes 1-11, 13, 16-18 (type 1), lanesl9-22 (type 2), lanes 23-26 (type 3), 
lane 32 (type 4), lanes 27 and 28 (type 5), lane 33 (type 6), lane 34 (type 7), lane 29 (type 8), 
lane 30 (type 9), lane 14 (type 10), lane 15 (type 11), lane 12 (type 12), lane 35 (type 13), lane 
36 (type 15) (see Table 3.12). 
f: 
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With this method a very simple profile was  obtained, containing between  1-3 
bands ranging from ~0.4-~O.5 kb, but only with twelve of  the avian isolates. The 
other 74  avian S.  aureus isolates  did  not show any amplimer with this  PCR-
ribotyping method.  Examples of these  results  are shown in Figure 3.13.  Four 
groups  were recognised for  the  twelve  avian S.  aureus isolates  (Table 3.13). 
Group  'a' included five  isolates.  Four of the  N.  Ireland  isolates  unrelated to 
PFGE type 24 (according to McCullagh et al.,  1998) and one of the American 
isolates were in this group. Group 'b' included four isolates, three American and 
one  Scottish isolate.  Group  'e' contained two  isolates,  which were  N.  Ireland 
isolates  unrelated to  PFGE  type  24.  Group  'd' included  one  Scottish  isolate. 
None of the  N.  Ireland  avian  S.  aureus  isolates  related  to  PFGE type  24  or 
closely-related or possibly related to  type  24  and  some of unrelated isolates, 
most of the Scottish isolates, all of  the English isolates and all of  the Sri Lankan 
isolates gave a product with this PCR method. Between the 13 human S.  aureus 
isolates tested with this method, only isolates HUM-2 and HUM-3 did not show 
any band by this method. According to the results of PCR-ribotyping method 1, 
these two  human strains had profiles similar to  group  1 avian isolates  (Table 
3.12). Some of the human and animal S.  aureus isolates had bands in common 
with the  avian  S.  aureus  strains  (Table 3.13).  None  of the  avian  coagulase-
negative,  human and  animal  coagulase-negative  isolates  gave  a  product  with 
PCR-ribotyping method 2. 
Results obtained with PCR-ribotyping method 2 for  the  chicken isolates of S. 
aureus from N.  Ireland and the other, atypical avian strains not from N.  Ireland 
are included in summary Tables 3.20 and 3.21, respectively. 
3.5.2 REP-peR 
A  REP-PCR  has  been  described  for  the  molecular  genotyping  of human  S. 
aureus  isolates  (Del  Vecchio  et  al.,  1995).  This  high-stringency  PCR 
fingerprinting method is  based on a repetitive sequence found  in Mycoplasma 
pneumoniae  (Wenzel and Hermann, 1988),  but it  also generated strain-specific 143 
Table 3.13 Typing of S. alireliS isolates by PCR-ribotyping method 2 
Typef  Isolate * 
'a'  82,83,86,562,217 
fbI  31178, 199,214,235, aRN4220, 
bBOV-65 
leI  496,525, aHUM-11, aHUM-G3, 
aHUM-284, aHUM-298,aHUM-275, 
bBOV-66, bBOV-67 
'd'  32528, aCN4575, a8530, cZM-7 
Ie'  aHUM-BB 
'f  aHUM-271 
f: See figure 3.13 
* All are avian isolates except: 
a:  Human isolate 
b:  Bovine isolate 
c:  Zoo mouse isolate 
No. of 
isolates 
5 
6 
9 
4 
1 
1 bp 
603 
310 
144 
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Figure 3.13 Examples of fingerprints obtained by PCR-ribotyping 
(method 2) for S. aureus isolates. Lanes M:  <l>X174 RF DNNHae III 
Fragments  DNA Ladder. Lanes 1-19: avian S.  aureus isolates, 24, 77,85, 
99, 100, 105, 122, 123, 34, 38, 104, 35, 36, 98, 82, 83, 86,496 and 562 
respectively. Lanes 20-24: human S. aureus isolates, 8530, HUM-ll, 
CN4575, HUM-G3 and RN4220 respectively. Lanes 15-17 and 19 (type 
'a'), lane 24 (type 'b'), lanes 18,21 and 23 (type 'c'), lanes 20 and 22 (type 
'd')  (see Table 3.13). 
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DNA  fragments  when  human  S.  aureus  DNA  was  used  as  an  amplification 
template. Primer R  W3A (Table 2.11) was used as  described previously by Del 
Vecchio  et al.  (1995).  The  PCR conditions  described by Van Der Zee  et al. 
(1999) were optimised for use with the avian, human or animal S.  aureus strains 
(section 2.6.9.2). 
With  this  method, the  profiles of S.  aureus  strains  revealed  complex patterns 
containing up  to  16  bands  ranging from  ~O.l5-~3 kb  with various  intensities. 
Example  of these  profiles  are  shown  in  Figure  3.14.  Seven  groups  were 
recognised for the 86 avian S.  aureus isolates (Table 3.14). Group A contained 
the majority,  67  (80%) of isolates.  All N.  Ireland S.  aureus isolates related to 
PFGE type 24  and  closely-related to  type  24  and possibly-related to  type  24 
(according to  McCullagh et at.  1998) were  in  group A.  Most of the  Scottish 
isolates  except isolates  31178  and 32528,  most  of the English isolates  except 
isolate NFR, and all of  the Sri Lankan isolates were also in this group.  Group B 
contained 6 (7%) isolates.  Some of the N.  Ireland isolates unrelated to PFGE 
type 24 were in this group.  Group C contained five  (6%) isolates. Some of the 
N. Ireland isolates unrelated to PFGE type 24 and one English isolate NFR were 
in this group. Group D contained four (5%) isolates. All of  the American isolates 
were in this group. Group E contained two (2%) isolates, both of which were N. 
Ireland isolates unrelated to PFGE type 24.  Groups F and G contained one (1 %) 
isolate  each,  from  Scottish  sources.  Of the  five  human  S.  aureus  isolates 
examined by  this  method,  some  of them  had patterns  similar to  the  avian S. 
aureus isolates and some of them had different patterns (Table 3.14 and Figure 
3.14 lanes 24-28). 
Results obtained with REP-PCR for the chicken isolates of  S.  aureus from N. 
Ireland and the other, atypical avian S.  strains not from N. Ireland are included in 
summary Tables 3.20 and 3.21, respectively. 146 
Table 3.14 Typing of S. allreus isolates by REP-PCR 
REP-PCR 
type 
A 
B 
C 
D 
E 
F 
G 
H 
Isolate" 
2A, 2B, 3A, 4, 5, 6, 7A, 7B, 8, 31174, 
31175,31176,31177,31179,31180, 
31181, 31182,31183,31036, 31039,E,K, 
SV6, SV289, PD486, PD458, PD380, PD27, 
24,34,38,77,85,99,100,104,105,122,123, 
564,572,582,595,596,3,11,20,25,30, 
48,51,52,53,88,170,172,259,329,330, 
352,373,390,410,451,31,33,47 
35,36,98,580,597,598 
82,83, 86, 562,NFR 
199,214,217,235 
496,525 
32528, aCN4575, a8530 
31178 
aHUM-11, aHUM-G3, aRN4220 
*  All are avian isolates except for,  a:  Human isolate 
No of 
isolates 
67 
6 
5 
4 
2 
3 
1 
3 bp 
506, 
396 
344 
298 
220 
201 
154 
147 
Figure 3.14 Examples of fingerprints obtained by REP· 
peR for S. aureus isolates. Lanes M:  1 Kb DNA Ladder. 
Lanes 1-23: avian S.  aureus isolates, 24, 77, 85, 99, 100, 
105,122,123,572,582,596,34,38,104,35,36,98,580, 
82, 83, 86,496 and 562 respectively. Lanes 24-28: human S. 
aureus isolates, HUM-ll, 8530, CN4575, HUM-G3 and 
RN4220 respectively. Lanes 1-14 (type A), lanes 15-18 
(type  B), lanes 19-21 and 23 (type C), lane 22 (type E), 
lanes 25-26 (type F), lanes 24 and 27-28 (type H) (see Table 
3.14). 
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3.5.3 peR for coagulase gene 
The coagulase protein is  an important virulence factor of S.  aureus encoded by 
the  coa  gene  and  the  expected  size  of the  amplimer  was  ~0.4-~O.9 kb.  The 
variable  region  of coa  is  comprised  of 81-bp  tandem  short  sequence  repeats 
(SSRs) (van Belkum et al., 1997) that are variable in both number and sequence 
(Goh et aI.,  1992), as  determined by restriction fragment length polymorphism 
(RFLP) analysis ofPCR products (Goh et aI.,  1992; Hookey et al.,  1998; 1999). 
These repeat regions have been used for differentiating human S.  aureus isolates. 
Amplification  of the  3'  end  of the  coagulase  gene  was  done  with  pnmers 
COAG2 and COAG3 (Table 2.11) as described previously by Goh et al.  (1992) 
for  human  S.  aureus  isolates.  This  study  modified  and  optimised  the  PCR 
conditions as described by Goh et al.  (1992), van Belkum et al.  (1997) and Su et 
al.  (1999). 
All the 86 avian S.  aureus isolates produced a single band but with sizes ranging 
between  ~O.6-~O.9 kb  (Figures  3.15a  and  b).  Group  I  included  73  (85%) 
isolates and the amplimer had a size of  ~O.8 kb.  All N.  Ireland avian S.  aureus 
isolates related to PFGE type 24, closely-related to type 24 and possibly-related 
to  type  24 and some of the unrelated strains were in  group I. This group also 
included  most of the  Scottish  isolates  except  isolate  32528  and  most of the 
English isolates except isolates NFR and E and all Sri Lankan isolates. Group II 
contained nine isolates (10%) and the amplimer had a size of  ~O.7 kb.  Some of 
the N.  Ireland isolates unrelated to  PFGE  type 24,  two  American isolates and 
one English isolate were in this group. Groups III include two isolates (2%) and 
the amplimer had a size of  ~O.9 kb. Two American isolates were in this group. 
Group IV  contained  two  isolates (2%) and  the size  of amplimers was ~O.6 kb. 
One  English  and  one  Scottish  isolate  were  in  this  group.  Some  human  and 
animal S.  aureus isolates showed bands of the same size as  the avian S.  aureus 
isolates  but  some  of them  were  different  (Table 3.15).  None  of the  avian 149 
Table 3.15 PCR amplification of coagulase gene region of S. aureus 
isolates 
Coagulase gene 
type 
*  Isolate 
I 
II 
III 
IV 
v 
VI 
2A, 2B, 3A, 4,5,6, 7A, 7B, 8, 31174, 
31175,31176,31177,31178,31179, 
31180,31181,31182,31183,31036, 
31039, K, SV6, SV289, PD486, PD458, 
PD380, PD27, 24, 34, 35, 36, 38, 77, 85, 
98,99,100,104,105,122,123,564,572, 
580,582,595,596,597,598,3,11,20,25, 
30,48,51,52,53,88,170,172,259, 
329,330,352,373,390,410,451,31, 
33,47, aCN4575, a8530 
82, 83, 86,496,562, 525,217, 235,NFR, 
aHUM-ll, aHUM-G3, aHUM-G5, 
aRN4220, bBOV -65 
199,214, aHUM-2, aHUM-3, aHUM-Gl, 
aHUM-G2 
E,32528 
CZM-7, bBOV-32276 
dHOR-31912 
*  All are avian isolates except: 
a:  Human isolate 
b: Bovine isolate 
c:  Zoo mouse isolate 
d: Horse isolate 
No. of 
isolates 
75 
14 
6 
2 
2 
1 bp 
872 
603 
150 
Figure 3.15a Examples of peR amplification of coagulase gene 
region for S. aureus isolates. Lanes M:<\>X174 RF DNNHae III 
Fragments DNA Ladder. Lanes 1-19: avian S.  aureus isolates, 24, 77, 
85,99,100,105,122, 123,34,38, 104,35, 36,98, 82, 83, 86,496 and 
562 respectively. Lanes 20-24: human S.  aureus isolates, 8530, HUM-
11, CN4575, HUM-G3 and RN4220 respectively. Lanes 1-14,20 and 
22 (type I), Lanes 15-19,21,23 and 24 (type II) (see Table 3.15). 
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Figure 3.15b Examples of peR amplification of coagulase gene 
region for S. aureus  isolates. Lanes M:  <j)X174 RF DNA/Hae III 
Fragments DND Ladder. Lanes 1-18,20-28 and 30-34: avian S. 
aureus  isolates 24,564,595,580,597,598, 11,31, PD486, 47, 525, 
85, PD27, 199,214,217,235, SV6, SV289, NFR, 31036, 31039, E, 
K, 31174, 31178, 32528,104,98,82,496, and 562 respectively. 
Lane 19: avian S.  cohnii isolate 31037 (negative control). Lane 29: 
bovine S.  aureus isolate BOV-65. Lanes 35 and 36: human S.  aureus 
isolates CN4575 and RN4220 respectively. Lanes 1-10, 12-13, 18, 
20,22-23,25-27,30-31 and 35 (type I), lanes 11, 16-17,21,29 and 
32-34 (type II), lanes 14-15 (type III), lanes 24 and 28 (type IV) (see 
Table 3.15). 
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coagulase-negative  isolates  showed  an  amplimer  with  the  coagulase  gene 
primers (Figures 3.15a and b). 
Results  obtained with the  coagulase gene region for  the  chicken isolates  of S. 
aureus from N.  Ireland and the other, atypical avian strains not from N.  Ireland 
are included in summary Tables 3.20 and 3.21, respectively. 
3.5.3.1 Restriction enzyme digestion of  the peR  product of  the coagulase gene 
In order to further improve the discrimination between avian and other isolates 
of S.  aureus  by the  various  PCR fingerprinting  methods,  some  of the  PCR 
products from analyses where only 1 or 2 bands fragments were produced were 
treated with particular restriction enzyme and the resulting patterns analysed. 
With the  coagulase gene  amplimer,  the  50  avian  S.  aureus  isolates that were 
investigated produced a number of different restriction patterns when AluI (Goh 
et al' J  1992) was used.  The fragments sizes ranged from  ~0.1--0.6 kb (e.g. see 
Figure 3.16). On the basis of the patterns, eight groups were recognised for the 
50 isolates and each was assigned a letter (lower case) (Table 3.16). Group 'aa' 
included 28  (56%) of the isolates. All the N.  Ireland avian S.  aureus related to 
PFGE  type  24,  closely-related  to  type  24  and also  most  of Scottish  isolates 
except for  31178  and 32528,  all  Sri  Lankan isolates  and  some of the  English 
isolates  tested were  in  this  group.  Group  'bb' included  eight  (16%)  isolates. 
Some of the N.  Ireland strains unrelated to  PFGE type 24 were in this  group. 
Group  'cc' included seven (14%) isolates.  Some of the N.  Ireland unrelated to 
PFGE type 24, two American and one English isolate were in this group. Group 
'dd' and 'ee' each included two (4%) isolates and groups 'fr, 'gg' and 'hh' each 
contained one (2%) isolate. 
Comparison  of the  coagulase  gene  restriction  fragment  length polymorphism 
(RFLP)  patterns  with  PCR results  for  the  coagulase  gene  revealed  that  the 
former  method  was  much  more  discriminating  than  the  latter.  For  example 153 
Table 3.16 Restriction analysis of the peR product of the coagulase 
gene of  S. allrellS isolates by Alul 
Type  Isolate  * 
aa  5, 7A, 31174, 31036, 31039, K 
PD458, PD380, PD27, SV6, 
SV289, 24, 11, 77, 85, 99, 100, 
105,122,123,3,20,31,33,47, 
34,38,564 
bb  595,104,35,36,98,580,597, 
598 
cc  82, 83, 86, 562,217, 235,NFR 
dd  496,525 
ee  199,214 
ff  32528, aRN4220, aHUM-11, 
aHUM-G3 
gg  31178 
hh  E 
ii  a8530, aCN4575 
*  All are avian isolates except: 
a:  Human isolate 
No. of 
isolates 
28 
8 
7 
2 
2 
4 
1 
1 
2 154 
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Figure 3.16 Examples of band patterns obtained for S. aureus 
isolates after peR amplification of coagulase gene region and 
restriction with AluI . Lanes M:  <j>X174 RF DNAlHae III 
Fragments DNA Ladder. Lanes 1-19: avian S.  aureus isolates, 24, 
77,85,99,100,105,122,123,34,38,104,35,36,98,82,83,86, 
496 and 562 respectively. Lanes 20-24: human S.  aureus isolates, 
8530, HUM-11, CN4575, HUM-G3 and RN4220 respectively. 
Lanes 1-10 (type aa), lanes 11-14 (type bb), lanes 15-17 and 19 
(type cc), lane 18 (type dd), lanes 20 and 22 (type ii), lanes 21, 23 
and 24 (type ff) (see Table 3.16). 
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isolate 31178 by the PCR method had a band similar to that of isolates in group 
'aa' (Table 3.15) but by RFLP had a different pattern (Table 3.16).  Similarly, 
isolates 35, 36, 98, 104, 595, 580, 597 and 598 were indistinguishable from other 
isolates  in group  'aa' by PCR but,  after restriction by AluI,  they had distinct 
patterns (Table 3.16). Isolates 496 and 525  grouped with isolates  'cc' by PCR 
but,  after restriction of the  coagulase gene,  they had different patterns  (Table 
3.16).  Isolates  E  and  32528  were  identical  to  each  by PCR,  but  again,  after 
restriction, they had different patterns (Table 3.16). Also, some of the human S. 
aureus isolates after restriction showed differences that were not apparent from 
the PCR product of  the coagulase gene (Tables 3.15, 3.16 and Figure 3.16). 
Results  obtained  with  restriction  of the  PCR product  of the  coagulase  gene 
region  for  the  chicken  isolates  of S.  aureus  from  N.  Ireland  and  the  other, 
atypical avian strains not from N.  Ireland are included in summary Tables 3.20 
and 3.21, respectively 
3.5.4 peR for X-region of the protein A gene 
Protein A is another virulence factor of  S.  aureus and forms an immunoglobulin-
binding capsule around the bacterium. Briefly the repetitive X-region within the 
gene of expected size ~0.3- ~0.6 kb was amplified with oligonucleotide primers 
PROTAI and PROTA2 (Table 2.11) as described by Frenay et al.  (1994). This 
study modified and optimised the PCR conditions described previously Frenay 
et al.  (1994) for human S.  aureus isolates. 
PCR for the protein A gene of  the 86 avian S.  aureus isolates gave a single band 
ranging  between  ~0.3-~0.6 kb  (Figure  3.17).  The  avian  isolates  could  be 
differentiated into five  groups.  Group  'A', contained the majority of 72  (83%) 
isolates. All of  the N. Ireland  avian S.  aureus  related  to PFGE type 24, closely-
related to type 24, possibly-related to type 24 and some of unrelated to type 24 
according  to  McCullagh  et  al.  (1998)  were  in  group  'A'.  Most  of Scottish 
isolates except for 31178, 31036  and 32528  and all Sri Lanka isolates and some 156 
Table 3.17 peR amplification of X-region of the protein A gene of S. aureus 
isolates 
Protein A gene 
type 
*  Isolate 
'A' 
'B' 
'C' 
'D' 
'E' 
'F' 
'G' 
2A, 2B, 3A, 4, 5, 6, 7A, 7B, 8, 31174, 
31175,71176,31177,31179,31180, 
31181,31182,31183,31039, E, SV289, 
PD486, PD458, PD380, PD27, 235, 24, 
34,35,36,38,77,85,98,99,100,104, 
105,122,123,562,564,572,580,582, 
595,596,597,598,3,11,20,25,30,48, 
51,52,53,88,170,172,259,329,330, 
352,373,390,410,451,31,33,47, 
aHUM-2, aCN4575, uHUM-11, u8530, 
uHUM-G3, aHUM-G4 
82,83,86, 199,214,217, NFR 
32528, 496, 525, uHUM-3, uHUM-G2, 
bHOR-31912 
SV6, K, uHUM-G5, uRN4220, 
cZM-7 
31178,31036, aHUM-G1, aHUM-G6 
dBOV-32276 
dBOV-65 
* All are avian isolates except: 
u:  Human isolate 
b:  Horse isolate 
c:  Zoo mouse isolate 
d:  Bovine isolate 
No. of 
isolates 
78 
7 
6 
4 
4 
1 
1 bp 
872 
603 
310 
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Figure 3.17 Examples of peR amplification of X-region of the 
protein A gene for S. aureus  isolates. Lanes M:  <l>X174 RF DNAlHae 
III Fragments DND Ladder. Lanes 1-18,20-28 and 30-34: avian S. 
aureus  isolates 24, 564, 595, 580, 597, 598, 11,31, PD486, 47, 525,85, 
PD27, 199,214,217,235, SV6, SV289, NFR, 31036, 31039, E, K, 
31174,31178,32528,104,98,82,496, and 562 respectively. Lane 19: 
avian S.  cohnii isolate 31037. Lane 29: bovine S.  aureus isolate BOV-
65. Lanes 35 and 36: human S.  aureus isolates CN4575 and RN4220 
respectively. Lanes 1-10, 12-13, 17,20,23-24,26,30-31 and 34-35 
(type 'A'), lanes 14-16,21 and 32 (type 'B'), lanes 11,28 and 33 (type 
'C'), lanes 18,25 and 36 (type 'D'), lanes 22 and 27 (type 'E'), lane 29 
(type 'G'). (see Table 3.17). 
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English isolates and one American isolate were also in this group (Table 3.17). 
Group  'B',  contained  seven  (8%)  isolates.  Some  of the  N.  Ireland  isolates 
unrelated to type 24 three American isolates and one English isolate were in this 
group.  Group 'C', contained three (3%) isolates. Two of the N.  Ireland isolates 
unrelated to  type 24 and one Scottish isolate were in this group.  Group 'D' and 
'E' had two (2%) isolates each. Again some of the human and animal S.  aureus 
isolates had similar or different bands to the avian isolates (Table 3.17). None of 
the  avian,  human or animal coagUlase-negative isolates produced an amplicon 
for the protein A gene under these peR conditions (e.g. lane 19, Figure 3.17). 
Results obtained with the protein A gene for the  chicken isolates of S.  aureus 
from  N.  Ireland  and  the  other,  atypical  avian  strains  not from  N.  Ireland are 
included in summary Tables 3.20 and 3.21, respectively. 
3.5.4.1 Restriction of  the peR product of  X-region of  the protein A gene 
RLFP  analysis  of the  protein  A  gene  of 41  avian  S.  aureus  isolates  with 
restriction enzyme RsaI (van Belkum et al.,  1997) identified five different types 
(Table 3.18).  The fragments  sizes  ranged from  ~O.1-~0.4 kb  (e.g.  see Figure 
3.18).  Comparison of the  protein A RFLP  patterns  with peR results  for  the 
protein  A  gene  revealed  that  they  were  similar  to  each  other  in  that  RFLP 
analysis  was  no  more  discriminating  than  the  PCR typing  method  for  these 
isolates.  Group  AA  included  27  (66%)  isolates,  group  BB  contained  seven 
(17%)  isolates,  group  CC had  three  (7%)  isolates  and  groups  DD and  EE 
included two (5%) isolates each. Again, results with four human and a bovine S. 
aureus isolate showed that RFLP was no  more discriminating than peR typing 
method for protein A (Table 3.18 and Figure 3.18). 
Results obtained with restriction of the peR product of the protein A gene for 
the chicken isolates of S.  aureus from N.  Ireland and the other, atypical avian 
strains  not from  N.  Ireland  are  included  in  summary  Tables 3.20  and  3.21, 
respectively. 159 
Table 3.18 Restriction analysis of peR product of X-region of the 
protein A gene of S. alireliS by RsaI 
Type 
AA 
BB 
CC 
DD 
EE 
FF 
*  Isolate 
5, 7A, 31174, 31039, PD4458, 
PD380,E,24, 11,77,85,31,33, 
47,34,38,564,595,104,35,36, 
98,580,597,598,562,235, 
aCN4575, aHUM-ll,aHUM-G3 
199,214,217,82,83,86,N~ 
32528,496,525 
K, SV6, aRN4220 
31178,31036 
bBOV-65 
*  All are avian isolates except: 
a;  Human isolate 
b; Bovine isolate 
No. of 
isolates 
30 
7 
3 
3 
2 
1 160 
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Figure 3.18 Examples of band patterns obtained for S. 
aureus  isolates after peR amplification of X-region of the 
protein A gene and restriction with RsaI • Lanes M:  <j>X174 
RF DNA/Hae III Fragments DNA Ladder. Lanes 1-10: avian 
S.  aureus isolates, 24, 82,496,525,199,217,31036, K, SV6 
and NFR respectively. Lane 11: bovine S.  aureus isolate BOV-
65. Lane 12: human S.  aureus isolete RN4220. Lane 1 (type 
AA), lanes 2, 5-6 and 10 (type BB), lanes 3-4 (type CC), lanes 
8-9 and 12 (type DD), lane 7 (type EE), lane 11  (type FF) (see 
Table 3.18). 
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3.6  CHARACTERISATION  OF  VIRULENCE-REGULATORY  GENES 
BYPCR 
The synthesis of  virulence factors and other extracellular proteins by S.  aureus is 
globally  controlled  by  the  agr  and  sar  loci.  agr  encodes  a  two-component 
signalling  pathway  whose  activating  ligand  is  an  agr-encoded  autoinducing 
peptide. sarA is  a DNA-binding protein with binding specificity for the P2 and 
P3  interpromoter region of agr.  In this study, three regions of these virulence 
regulatory genes were targeted, namely agrP2, sarA and agrBDC.  (see Figure 
1.1). 
3.6.1 PCR for agrP2, sarA and agrBDC 
The  primers  used  were  AGR-l  and  AGR-2  for  agrP2,  AGRD123F  and 
AGRD123R for agrBDC, SAR-l and SAR-2 for sarA (Table 2.11) as described 
previously  by  Kornblum  et  al.  (1990),  (personal  communication,  Dr.  P. 
McDowell, Institute of Infection and Immunity, The University of Nottingham, 
Queens Medical Centre, Nottingham), and Chien et al.  (1998), respectively. In 
this study the conditions for these three individual PCRs were optimised. 
According to these PCR methods, all the 86 avian, human and animal S.  aureus 
isolates had a single similar band for each PCR.  The fragment size for  agrP2 
was 235 bp, for sarA was 372 bp and for agrBDC was ~1 kb (Figures 3.19, 3.20 
and 3.21, respectively). None of the six avian coagulase-negative isolates and an 
animal  S.  intermedius  isolate BOV  -32236 and six different species  of animal 
coagulase-negative isolates, when examined by these PCR methods, gave  any 
agrP2, sarA or agrBDC amplimers. 
3.6.1.1 Restriction enzyme digestion of  the PCR product of  agrBDC region 
Restriction sites in the sequence for the agrBDC region in GenBank (accession 
number  AFOOI783)  were  examined  using  Genejockey  II  sequence  processor 
(Biosoft, Cambridge, UK). Results  showed that  MseI cut more  frequently  than bp 
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Figure 3.19 Examples of peR amplification of  agrP2 
fragment for S. aureus isolates. Lanes M:  <1>X174 RF 
DNAlHae III Fragments DNA Ladder. Lanes 1-10 and 12-29 
avian S.  aureus isolates 24, 34, 35, 36, 38, 77, 82, 83, 85, 86, 
98,99,100,104105,122,123,496,562,564,572,580,582, 
595, 596, 597, 2B, SV289 and SV6 respectively. Lane 11: 
avian S.  cohnii isolate 31037. Lane 30: avian S.  sciuri isolate 
31040. Lanes 31-32: animal S.  aureus isolates HOR-31912 and 
ZM-7 respectively. Lane 33: human S.  aureus isolate  RN4220. 
Lane 34: animal S.  hominis isolate DUK-31915. 
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Figure 3.20 Examples of peR amplification of sarA fragment 
for S. aureus isolates. Lanes M:  <1>X174 RF DNA/Rae III 
Fragments DNA Ladder. Lanes 1-2 and 4-6: avian S.  aureus 
isolates 2A, 3A, 6, 7B and 31178, respectively. Lanes 3 and 10: 
avian S.  cohnii isolates 3B and 31037, respectively. Lanes 7-9: 
human S.  aureus isolates RUM-3, 8530 and RN4220, 
respectively. Lane 12:  animal S.  epidermidis isolate BOV-
32304. 
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Figure 3.21 Examples of peR amplification of agrBDC region  for S. 
aureus isolates. Lanes M:  <l>X174 RF DNA/Hae III Fragments DNA 
Ladder. Lanes 1-19: avian S.  aureus isolates 24, 77,85,99,100,105, 
122, 123, 34, 38, 104,35, 36,98,82,83, 86,496 and 562, respectively. 
Lanes 20-24: human S.  aureus isolates 8530, HUM-ll, CN4575, HUM-
03 and RN4220, respectively. 
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other enzymes, so this enzyme was selected for restriction analysis of the peR 
products of  the agrBDC region. 
MseI was used to digest the peR products from the agrBDC region of 39 avian 
S.  aureus  isolates.  The  size of the  restriction fragments  ranged from  ~  100  to 
~300 bp  (e.g.  see Figure 3.22). The isolates could be differentiated into three 
groups (Table 3.19). Most isolates were fitted into group  'II' that included 28 
(72%) isolates.  Isolates in this  group included the N.  Ireland strains related to 
PFGE type 24, and closely-related, possibly-related, and some unrelated strains. 
Also  included were  the  Scottish,  English,  American and  Sri  Lankan isolates. 
Group 'I' contained seven (18%) isolates.  Isolates this group included some of 
the N.  Ireland strains unrelated to PFGE type 24, two of the American and one 
of the English isolates. Group 'III' included four (10%) isolates. Isolates in this 
group included two of the N. Ireland strains unrelated to PFGE type 24 and two 
of the Scottish isolates. Of the four human S.  aureus samples restricted by MseI, 
two isolates were included in each of  groups 'I' and 'III' (Figure 3.22 and Table 
3.19). 
Results obtained with restriction of the peR product of the agrBDC region for 
the chicken isolates of S.  aureus from  N.  Ireland and the other,  atypical avian 
strains  not  from  N.  Ireland  are  included  in  summary  Tables 3.20  and  3.21, 
respectively. 
3.7 TOXIN DETECTION 
Prior to this study, there was little published information on which toxins, if any, 
are produced by avian isolates of S.  aureus. This was investigated by molecular 
methods, peR amplification of  toxin genes, and by biological assay. 166 
Table 3.19 Restriction analysis of peR product from agrBDC 
region of S. aureus by MseI 
Type 
'I' 
'II' 
'III' 
*  Isolate 
82,83,86,562, NFR, 217, 
235, aRUM-G3, aRN4220 
2A, 2B, 5, 7A, 7B, 31174, 
31036,31039, E, K, PD27, 
PD458, PD380, 199,214, 
24,77,85,99,100,122, 
123,34,38,595,104,35, 
98 
496,525,31178,32528, 
aCN4575, a8530 
* All are avian isolates except for, a:  Ruman isolate 
No. of 
isolates 
9 
28 
6 bp 
310 
281,271 
234 
194 
118 
72 
167 
Figure 3.22 Examples of band patterns obtained for S. aureus 
isolates after peR amplification of agrBDC region and restriction 
with MseI. Lanes M:  <j>X174 RF DNNHae III Fragments DNA 
Ladder. Lanes 1-19: avian S.  aureus isolates, 24, 77,85,99,100,105, 
122, 123,34,38, 104,35,36,98,82,83,86,496 and 562 respectively. 
Lanes 20-24: human S.  aureus isolates, 8530, HUM-Il, CN4575, 
HUM-G3 and RN4220 respectively. Lanes 1-14 (type 'II'), lanes 15-
17,19,23-24 (type '1'), lanes 18,20 and 22 (type 'III') (see Table 
3.19). 
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Table 3.20 Summary of results of genotyplng fingerprinting methods for chicken isolates of  S  aureus from N  I  I  re an  d 
No.  Number 0 f  PFGE  Biotype  PCR·ribotyping  PCR·ribotyping  REP-PCR  PCR for  Restriction  PCR for  Restric.tion  Restriction  Haemolysin 
isolate  type  method I  method 2  coagulase  of  coagulase  protein A  of  protein A  of I kb agrBDC 
ree:ion  region-IAluI) 
genes 
region  region (Rsa n  region IMse n 
I  24  24  Poultrv  I  o  (No band)  A  [  aa  'A'  AA  .['  ali:V 
2  77  24  Poultry  I  0  A  I  aa  'A'  AA  'I'  a, Ii. v 
3  85  24  Poultry  I  0  A  [  aa  'A'  AA  'I'  a,li. v 
4  99  24  Poultry  I  0  A  I  .a  'A'  I  '['  a  Ii,v 
5  100  24  Poultry  1  0  A  I  aa  'A'  I  'I'  a  Ii. v 
6  105  24  Poultri  1  0  A  I  a.  'N  I  '['  a  Ii.y 
7  122  24  Poultri  I  0  A  1  aa  'N  I  '['  a  Ii.y· 
8  123  24  Poultrv  1  0  A  I  aa  'N  I  '['  a  Ii. y 
9  572  24  Poultrv  1  0  A  I  .a  'A'  I  I  a  Ii." 
10  582  24  Poultry  1  0  A  I  aa  'N  I  I  a  Ii.y· 
11  596  24  Poultry  1  0  A  1  aa  'A'  I  I  a  Ii.v 
12  3  24  Poultrv  1  0  A  I  aa  'A'  I  I  a  Ii.v 
13  20  24  Poultrv  I  0  A  I  aa  'A'  I  I  a  1i:V 
14  25  24  Poultrv  I  0  A  I  I  'A'  I  I  ali:V 
15  30  24  Poultrv  I  0  A  I  I  'N  I  I  a  1i;Y-
16  48  24  Poultry  1  0  A  I  I  'A'  I  I  a,S:V 
17  51  24  Poultry  I  0  A  I  I  'N  I  I  a  s:V 
18  52  24  Poultry  1  0  A  I  I  'N  I  I  a. Ii. v 
19  53  24  Poultry  1  0  A  I  I  'A'  I  I  a  S,y 
20  88  24  Nff  1  0  A  I  I  'N  I  I  a  Ii.v 
21  170  24  Nff  1  0  A  I  I  'A'  I  I  a  S,Y 
22  172  24  Nff  1  0  A  I  I  'A'  I  I  a  Ii.v 
23  259  24  Nrr  1  0  A  I  I  'N  I  I  a  S,y 
24  329  24  Nrr  I  0  A  I  I  'A'  I  I  a  Ii,v 
25  330  24  Nff  I  0  A  I  I  'A'  I  I  a  S.y 
26  352  24  Nff  1  0  A  I  I  'A'  I  as:V 
27  373  24  Nrr  I  0  A  I  I  'A'  I  I  a  Ii,v 
28  390  24  Nff  I  0  A  I  I  'N  I  I  a  S,v 
29  410  24  Nff  I  0  A  I  /  'N  I  I  a,li.v 
30  451  24  Nff  1  0  A  I  I  'A'  I  I  a  Ii.y 
31  II  24  NHS  I  0  A  I  .a  'A'  AA  'I'  a  1i:V 
32  31  24  NHS  I  0  A  I  aa  'A'  AA  '['  <t,1i:V 
33  33  24  NHS  I  0  A  I  aa  'A'  AA  '['  u. Ii, y 
34  47  24  NHS  1  0  A  I  a.  'A'  AA  '['  a  Ii.Y 
35  34  CR  NHS  1  0  A  I  a.  'A'  AA  '['  a  Ii.Y 
36  38  CR  Poultry  1  0  A  I  aa  'A'  AA  '['  a  Ii.y 
37  564  CR  Poultrv  I  0  A  I  aa  'A'  AA  '['  a  Ii,Y 
38  595  CR  Poultry  2  0  A  I  bb  'A'  AA  '['  a  Ii.y 
39  104  PR  Poultry  2  0  A  I  bb  'A'  AA  l'  a,S:y 
40  35  UR  Poultry  2  0  B  I  bb  'A'  AA  '['  a  S,y 
41  36  UR  Poultry  2  0  B  I  bb  'A'  AA  '['  a  Ii,y 
42  9&  UR  Poultry  2  0  B  I  bb  'A'  AA  'I'  as 
43  580  UR  Poultrv  2  0  B  I  bb  'N  AA  l'  a,S-:y" 
44  597  UR  Poultry  2  0  B  I  bb  'A'  AA  '['  a  S. Y 
45  598  UR  Poultry  2  0  B  I  bb  'A'  AA  l'  a,S,y 
46  82  UR  Poultrv  3  'a'  C  II  cc  'B'  BB  11'  a  0 
47  &3  UR  Poultrv  3  '.'  C  II  cc  'B'  BB  1['  ao 
48  86  UR  Poultri  3  'a'  C  II  cc  'B'  BB  'II'  a  Ii 
49  562  UR  Slaughter  3  '.'  C  II  cc  'A'  AA  'II'  a  0.(6) 
50  496  UR  NHS  5  'c'  E  11  dd  'c'  CC  'III'  a  Ii. B 
51  525  UR  NHS  5  'c'  E  II  dd  'C'  CC  'III'  a  Ii,B 
I 24= Isolate type 24, CR  CI?sely.related to isolate type 24, PR  Possibly related to isolated  24  UR  U  I  type 24  NHSz N  h  Ii  b  type,  nrc ated to Isolate 
Ii= DeI;a haemoI:'~  o~ ci'  IC ~o~'  ~Iaug~ter=  Slaughterh~use biotype, I = Not done, N!f= Not biotyped. a= Alpba-haemolysin, 
Isolates 496 and 52~'p:du::;::te=~~'  ~- Beta haemolysm, (P)= Beta h.emolysin detected by biological method but not by PCR for toxin gene. 
Table 3,21 Summary of results of genotyping fingerprinting methods for atypical avian S, aureus Isolates not from N, Ireland 
PCR  -ribotyping  REP-PCR PCRfor  Restriction  PCRfor  Restriction  Restriction  Haemolysin 
No. Designation  Sour- Geogra- PCR-rihotyping 
method 2  coagulase  of  coagulase  protein A  of  protein A  of 1 kb agrBDC  gene 
of  isolate  ce  phical  method 1 
oriltion  reltion  reltion (AluI)  region  region (&aI) region (Msel) 
1  31036  Chick.  Scotland  I  0  A  I  aa  'E'  EE  'I' 
2  31039  Chick.  Scotland  12  0  A  I  aa  'N  AA  'I' 
3  E  Gosh.  England  I  0  A  IV  hh  'A'  AA  'I' 
4  K  Saker  England  10  0  A  I  aa  '0'  DD  'I' 
5  NFR  GyrF.  England  11  0  C  II  cc  'B'  BB  'II' 
6  31178  Chicle.  Scotland  8  'b'  G  I  -~g  'E'  EE  111' 
7  32528  Cock.  Scotland  9  'd'  F  IV  ff  'C'  CC  'III' 
8  199  Duck  USA  4  'b'  0  III  eo  'B'  BB  'I' 
9  214  Duck  USA  4  'b'  0  III  ee  'B'  BB  '[' 
10  217  Duck  USA  6  'a'  0  II  cc  'B'  BB  'II' 
II  cc  'N  AA  'II' 
II  235  Duck  USA  7  'b'  D 
Chlck.= ChIcken, Gosh.- Goshawk, Saker- Saker Falcon, Cock.- Cockatoo, Gyr F.- Gyr Falcon, (1= Alpha-haemolysm. Ii= Delt. haemolysm, 
y:  Ganuna h.emolysin, P= Beta haemolysin, (~)= Beta h.emolysin detected by biological method but not by PCR for toxin gene,  isolate 31178 produced 
enterotoxin B, isolate 32528 produced enterotoxin A, toxic shock syndrome toxin-I (TSST-I) and exfoliative toxin B 
a  S,y 
a  S~(P) 
a  S.y 
a,S,Y 
a,S 
a  Ii.Y 
a  S.y. B 
a  S,y 
a  S, Y 
a,S 
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3.7.1 Molecular methods 
3.7.1.1 Multiplex peR for enterotoxins A-E, exfoliative toxins A-B and toxic 
shock syndrome toxin-1 (TSST-1) 
When serious staphylococcal infections occur there is an essential need for rapid 
and specific detection of the toxins that are present. Conventional methods such 
as immunodiffusion, enzyme-linked immunosorbent assay (ELISA), and reverse 
passive agglutination are commonly used, where the actual toxins are identified 
using antibodies. However, this approach has disadvantages in that it may take 
too long to get the results, as in the ELISA, or more importantly, the tests do not 
detect low concentrations of toxin or the toxins may not be detected because of 
the presence of interfering bacterial products so giving false negative results. On 
the other hand, with the use of PCR, it is the genes that encode the toxin that are 
detected. Multiplex PCR allows for the detection of  several genes in the one test 
and, in this study, one multiplex PCR assay was developed to identify the genes 
of the eight toxins. At the time of this study, there was no report of a multiplex 
PCR able  to  amplify  these  eight toxin  genes  in  a  single  PCR reaction.  The 
reaction conditions for the multiplex PCR assay were optimised to ensure that all 
of the  target  gene  sequences  were  satisfactorily  amplified.  The  primers  used 
were SEA-l and SEA-2 for enterotoxin A,  SEB-3 and SEB-4 for enterotoxin B, 
SEC-3 and SEC-4 for enterotoxin C, SED-3 and SED-4 for enterotoxin D, SEE-
3 and SEE-2 for enterotoxin E, ETA-l and ETA-2 for exfoliative A, ETB-l and 
ETA-2 for exfoliative Band TST-3 and TST-6 for toxic shock syndrome toxin-l 
(Table 2.11) as described by Johnson et al.  (1991); Sakurai et al.  (1995); Becker 
et al.  (1998); and personal communication (Prof. C.  G. Gemmell, Department of 
Bacteriology, Glasgow Royal Infirmary). 
The individual primer pairs used for  the  amplification of regions  in  the  eight 
toxin genes were first tested with their corresponding bacterial control cultures 
and all gave positive reactions, the PCR products for the genes being present at 
the correct size. These individual reactions were then combined into a multiplex 
PCR assay and an example of the results with the control preparation, a mixture 170 
of DNA from known positive strains,  is  shown in Figure 3.23  lanes C.  When 
this multiplex PCR method was applied to the  86  avian S.  aureus strains,  only 
four isolates (5%) gave an amplimer with primers for one or more of the toxins 
genes. Isolate 31178 gave an amplimer for the enterotoxin B gene, isolate 32528 
had  three  toxin  genes:  those  for  TSST-l  (toxic  shock  syndrome  toxin-I), 
enterotoxin A  and  exfoliative  toxin B  and two  isolates 496  and  525  gave an 
amplimer for  the  enterotoxin A gene  (Figure 3.23).  All  of these  isolates  had 
shown  bands  with  the  PCR-ribotyping  method  2  and  were,  therefore,  not 
considered to be typical avian strains. The sizes of  the amplimers for all of  these 
isolates were similar to those obtained with the human strains and were of the 
expected size (Table 3.22).  Of the  17  human S.  aureus isolates  examined for 
these toxins, nine isolates (53%) produced amplimers for different toxin genes: 
Isolates HUM-2  and HUM-27l  (enterotoxin A),  isolate HUM-Gl  (exfoliative 
toxin A), isolate HUM-G2 (exfoliative toxin B), isolate HUM-G3  (enterotoxins 
A and B),  isolate HUM-G4 (enterotoxin D),  isolate HUM-G5  (enterotoxin E), 
isolate HUM-G6 (enterotoxin C and TSST-l), isolate CN4575 (enterotoxin B). 
Human isolates RN4220, HUM-II, 8530, HUM-275, HUM-294, HUM-298 and 
HUM-BB  did not produce any toxins  amplimers.  Of the  six animal  S.  aureus 
examined by this method, only horse isolate HOR-3I9I2 produced TSST-I, but 
isolates  BOV-32276, ZM-7,  BOV-65,  BOV-66  and BOV-67  did  not produce 
any toxin amplimers. None of the avian coagulase-negative strain gave products 
corresponding to any of  these toxin genes. 
3.7.1.2 Multiplex PeR/or a; rand tStoxin genes 
The haemolysins of  S.  aureus are cytotoxic agents which, as  a class, may well 
function to promote invasion of tissues. They can be divided into four classes, 
namely alpha, beta, delta and gamma haemolysins or toxins. 
In this  study,  a mUltiplex  PCR was  developed  for  the  detection  of the  alpha, 
delta  and  gamma  toxin genes. The  beta  toxin  gene was  detected in a separate 171 
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Figure 3.23 Multiplex peR for enterotoxins A-E, 
TSST-l and exfoliative toxins A and B for S.  alireliS 
isolates. Lane C: Positive control for all eight toxins, 
lanes 1-4: avian isolates, 31178, 32528, 496 and 2B 
respectively. 
Exfoliative A 
Exfoliative B 
TSST-l 
Enterotoxin D 
Enterotoxin C 
Enterotoxin E 
Enterotoxin B 
Enterotoxin A 172 
Table 3.22 peR for staphylococcal toxin genes 
Toxin genes  Predicted 
size (bp) of 
amplimer 
Enterotoxin A (sea)  120 
Enterotoxin B (seb)  163 
Enterotoxin C (sec)  271 
Enterotoxin D (sed)  319 
Enterotoxin E (see)  178 
TSST -1  (tst)  445 
Exfoliative toxin A (eta)  741 
Exfoliative toxin B (eta)  629 173 
PCR assay because the  size of the  amplimer was similar to  that of the gamma 
amplimer.  At the time of this  study there was  no  reported method to  amplify 
these genes in a multiplex PCR.  The primers HLA-l  and HLA-2 for the alpha 
toxin gene and HLG-1  and HLG-2 for the gamma toxin gene were designed in 
this study. The primers HLD-1  and HLD-2 used for the delta toxin gene were as 
described previously by Janzon et at.  (1989) (Table 2.11).  The conditions for 
this multiplex PCR were developed in the present study. 
According to this mUltiplex PCR method, of the 86 avian S.  aureus isolates, 74 
(87%)  showed single bands  corresponding to  a-(  ~o.  9 kb),  J"(  ~  1. 8 kb)  and  c5-
(~0.5 kb) toxin genes. Twelve isolates gave no amplimers for J"toxin but all of 
these  gave bands  for  a and  c5-toxin  genes.  These  isolates  were  31039, NFR, 
PD458,  217,  235,  82,  83,  86,  98,  496,  525  and 562  (Table 3.23  and e.g.  see 
Figure 3.24). Of  the three avian coagulase-negative isolates tested, none of them 
showed  reactions  for  a,  y and  c5-toxin  genes.  Of the  13  human  S.  aureus 
examined by this method, eight isolates gave bands for  a, y and c5-toxins genes. 
These  isolates  were HUM-2,  CN4575,  8530,  HUM-G4,  HUM-G6,  HUM-271 
and HUM-BB. Five isolates HUM-3, HUM-II, RN4220, HUM-294 and HUM-
G3 gave bands for a and c5-toxins genes but these isolates did not give bands for 
the J"toxin gene  (Table 3.23  and Figure 3.24).  Of the  four  animal  S.  aureus 
isolates tested by this method, only isolate HOR-31912 gave bands for a, y and 
c5-toxin  genes. Isolates  BOV-32276, BOV-66 and ZM-7  gave  bands only for a 
and c5-toxins (Table 3.23). Human S.  epidermidis isolate 134 did not show bands 
for a;  yand 5 -toxin genes. 
3.7.1.3 PeR/or p-toxin gene 
Primers HLB-l  and HLB-2 (Table 2.11)  were  designed in this  study and  the 
PCR conditions optimised. According to the design of the primers, the expected 
size of  the gene fragment amplimer was ~1.8 kb. 174 
Table 3.23 Detection of «, p, y and () toxin genes of  S. alireliS by peR 
Gene 
detected 
a, y and 0 
a and 8 
P  (l.8kb) 
~ (1.2 kb) 
7 
*  Isolate  No. of 
isolates 
2A, 2B, 3A, 4, 5, 6, 7A, 7B, 8, 31174, 31175,  84 
31176,31177,31178,31179,31180,31181, 
31182,31183,31036,32528, E, K, SV6, SV289, 
199,214, PD486, PD380, PD27, 24, 34, 35, 36, 
38,77,85,99,100,104,105,122,123,562,564, 
572,580,582,595,596,597,598,3,11,20,25, 
30,48,51,52,53,88,170,172,259,329,330, 
352,373,390,410,451,31,33,47, aHUM-2, 
aCN4575, a8530, aHUM-G4, aHUM-G5, 
aHUM-G6, aHUM-271, aHUM-BB, bHOR-31912 
31039,NFR, PD458, 217, 235, 82, 83,86,98,  20 
496,525,562, aHUM-3, aHUM-ll, aRN4220, 
aHUM-G3, aHUM-294,  cBOV-32276, cBOV-66, 
dZM-7 
31178,32528,496,525, aHUM-G1, aHUM-G4,  7 
cBOV-32276 
aHUM-G2, aHUM-G3, aHUM-G5, aHUM-BB, 
aRN4220, bHOR-31912, cBOV-66 
* All are avian isolates except: 
a:  Human isolate 
b:  Horse isolate 
c:  Bovine isolate 
d: Zoo mouse isolate bp 
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Figure 3.24 Examples of multiplex peR for cx., y and a-toxin genes 
in S. aureus isolates. Lanes M1  and M2 : 1 Kb DNA Lader and 
<!>X174 RF DNA/Hae III Fragments DNA Ladder respectively. Lanes 
1-24: avian S.  aureus isolates 4,6,8,31175,31176,31179,31180, 
31181, 31182,31183, 31036, 31039, PD458, PD380, 199,217,235, 
53,30, 170, 11,31,47 and 525, respectively. Lanes 25-26: human S. 
aureus isolates HUM-271 and HUM-294, respectively. Lane 27: avian 
S.  cohnii isolate 31037 (see Table 3.23). 
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The results showed that only four of the 86 avian S.  aureus isolates (5%) gave a 
single band  (~1.  8 kb) for the  p-toxin gene.  These isolates were 31178, 32528, 
496 and 525 (Table 3.23 and e.g.  see Figure 3.25). Of the two avian coagulase-
negative  isolates examined by  this  method,  neither showed any band.  Of the 
twelve human S.  aureus isolates tested,  seven isolates (58%)  showed a single 
band but with two different sizes  (~1.8 kb and ~1.2 kb). The size of the band for 
isolates HUM-G 1 and HUM-G4 was  1.8 kb but the size of the band for isolates 
HUM-G2,  HUM-G3,  HUM-G5,  HUM-BB  and  RN4220  was  1.2  kb.  Isolates 
HUM-2, HUM-3, CN4575, HUM-II and 8530 did not produce a p-toxin band 
(Table 3.23). Human S.  epidermidis isolate 134 did not show any band. Of the 
three animal S.  aureus isolates examined, all of them had the p-toxin band. The 
size for isolate BOV-32276 was 1.8 kb but the size for isolates HOR-31912 and 
BOV  -66 was 1.2 kb (Table 3.23). 
3.7.2 Biological methods 
For confirmation of the results of the molecular methods reported above, some 
of the  positive  and  negative  isolates  were  further  investigated  by  biological 
assays for the toxins. 
3.7.2.1 Enterotoxin A-D 
Results from the commercially available  test using  the  SET-RPLA TD900 kit 
(Oxoid) for the detection of staphylococcal enterotoxins A,  B,  C and D agreed 
completely with the  findings  of  the  multiplex  PCR method for detection of  the 
toxin  genes.  Avian  S.  aureus  strains  31178  and  32528  were  positive  for 
enterotoxin B and A respectively by both methods and strains 2A, 2B, 3A, 4,  5, 
6, 7  A, 7B, 8, 31174, 31177 and 31181 were negative for all enterotoxins by both 
methods. 
3.7.2.2 a-toxin 
The  production  of staphylococcal  a-toxin  can  be  demonstrated  by  zones  of 
clearing (haemolysin) around the colonies growing on agar containing 5% rabbit 177 
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Figure 3.25 Examples of peR amplification of  ~-toxin gene 
for S. aureus isolates. Lane M:  <j>X174 RF DNAfHae III 
Fragments DNA Ladder. Lanes 1-24: avian S.  aureus isolates 4, 
6,8,31175,31176,31179,31180,31181,31182,31183,31036, 
31039,PD458,PD380, 199,217,235,53, 170,30, 11,31,47 
and 525, respectively. Lanes 25-26: human S.  aureus isolates 
HUM-G2 and HUM-G3, respectively (see Table 3.23). 
~-toxin 178 
blood. There was good correlation between this method and the PCR method for 
detecting  the  a-toxin gene  for  all  86  avian,  twelve human and  six  animal  S. 
aureus isolates except that two avian S.  aureus isolates 82 and 83  did not give a 
positive result with the biological method but they gave a positive result with the 
molecular method. 
3.7.2.3 p-toxin 
The  production  of staphylococcal  ~-toxin can  be  demonstrated  by  zones  of 
clearing (haemolysin) around the colonies growing agar on containing 5% sheep 
blood.  Again  there  was  good correlation  between  this  method  and  the  PCR 
method  for  detecting the  ~-toxin gene  for  all  86  avian,  ten human and  five 
animal S.  aureus isolates except that two avian S.  aureus isolates 31039 and 562 
did not give a positive result with the molecular method but they gave a positive 
result with the biological method. 
Results for detection of  toxin and haemolysin genes in the chicken isolates of  S. 
aureus from N.  Ireland and from the other,  atypical avian strains not from N. 
Ireland are included in summary Tables 3.20 and 3.21, respectively. 
3.8 GROWTH OF S. aureus STRAINS AT HIGH TEMPERATURES 
The rationale for this experiment is that the body temperature of birds is  42°C 
and that of humans is  37 °c. S.  aureus strains adapted to birds may be able to 
tolerate higher growth temperatures. According to the literature (Kloos,  1998), 
the temperature growth range of  S.  aureus is 18-40 °c. 
The results  in Table 3.24  at  44-45  °c indicates  a difference between typical 
avian and some human and atypical avian strains. According to these results all 
typical avian and some of the atypical strains had heavy growth (+++) at 44-45 
°c, but some of  atypical and human strains had low growth (±). 179 
The  results  in Table  3.25  at  46-47  °C  showed  that  only  slight  growth  was 
observed with typical  avian  isolates  52,  53,  85,  105,  123,  170  and  329  and 
atypical strains  83,  562,  214,  217  and  32528.  None of the  human strains  nor 
typical avian strains 24, 99,  100,  122 and 330 nor atypical avian strains 82, 86, 
496, 525, 199,235 and 31178 showed any growth at this temperature. However, 
when broth cultures  from  46-47  °C  were  transferred  to  37°C and  incubated 
overnight, all became turbid, and colonies were formed from all strains when the 
broth cultures from overnight at 46-47 °C were plated onto nutrient agar. 
It appears that 46-47 °C  is  the  growth limiting temperature  for  all  strains but 
there was an indication from these results that some avian (typical and atypical) 
may be able  to  grow at  slightly higher temperatures  than human strains.  It is 
interesting to note that none of the cultures were killed completely at 46-47 °C 
overnight and survivors were able to grow. 
3.9 SEQUENCE ANALYSIS 
For further  analysis  of the  differences  between avian  and  other  strains  of S. 
aureus, the complete sequence of a number of selected genes was determined, 
for typical and atypical avian strains and for some control strains. 
Regions  of the  16S  rRNA (section 2.6.9.4),  coagulase,  agrBDC and cysteine 
protease  consensus sequences  of some of isolates in Table 2.13 were compared 
to  other  sequences  in  the  GenBank  using  the  BLASTn  search  engine.  Such 
analyses revealed that some of the  sequences  were  novel but were  similar to 
published sequences for other strains of  staphylococci. 
3.9.1 Sequence analysis of 16S rRNA gene 
Regions  of the  16S  rRNA  genes  were  amplified  with  primers  C70  and  C72 
(Table 2.11) as previously  described by  Davies et at.  (1996) for  comparison of 180 
Table 3.24 Growth of S. aurellS strains at 44-45 °C 
Type 
Typical avian 
Atypical avian 
Atypical avian 
Human 
Human 
Isolates 
24,52,53,85,99,100,105, 
122,123,170,329,330 
82,83,86,496,525,562, 
199,214,235,31178 
217,32528 
RN4220, 8530, HUM-G3, 
HUM-G4, HUM-G5, HUM-G6, 
HUM-BB 
CN4575, HUM-Gl, HUM-G2, 
HUM-II 
*  +++: Heavy growth, ±: Low growth 
*  Growth result 
+++ 
+++ 
± 
+++ 
± 181 
Table 3.25 Growth of S. alireliS strains at 46-47 °C 
Type 
Typical avian 
Typical avian 
Atypical avian 
Atypical avian 
Human 
Isolates 
52,53,85,105,123,170,329 
24,99,100,122,330 
83,562,214,217,32528 
82,86,496,525,199,235,31178 
RN4220, 8530, HUM-G1, 
HUM-G2, HUM-G3, HUM-ll 
HUM-G4, HUM-G5, HUM-G6, 
HUM-ll, HUM-BB, CN4575 
*  ±: Low growth, -: No growth 
*  Growth result 
± 
± 182 
the  16S  rRNA  gene  sequences  of  isolates  of  Pasteurella  (Mannheimia) 
haemolytica and Pasteurella trehalosi. 
A  1439 bp region from  the  16S  rRNA gene of selected S.  aureus strains was 
sequenced. When the sequences of  avian S.  aureus strains 24, 85, 99, 34, 98, 82, 
496  and  human  S.  aureus  isolate  RN4220  were  compared,  all  were  100% 
identical  and  also  identical  to  that of another  human  S.  aureus  strain A Tee 
12600 published in GenBank (accession number L37597).  The sequence of the 
16S  rRNA  gene  of bovine  P.  haemolytica  PH2  was  also  determined,  as  a 
positive control, and the expected sequence was obtained (Davies et aI.,  1996). 
The peR products of this region of the  16S rRNA gene of the S.  aureus strains 
examined were also indistinguishable (e.g. see Figure 3.26). 
3.9.2 Sequence analysis of coagulase gene 
A region of approximate 759  bp  from peR product of the  coagulase gene of 
avian S.  aureus strains 24  and  85  was also sequenced.  When the sequences of 
typical  avian  strains  24  and  85  were  compared  (Appendix  III-b), they were 
100% identical but they were 97% identical to that of a human S.  aureus isolate 
213 (accession number X16457 published in GenBank) (not shown). 
Atypical avian  S.  aureus strain  82  and  human  S.  aureus  strain RN4220  gave 
smaller peR amplimers for the coagulase gene, of 684 bp which was sequenced 
(Appendix III-b). The sequence for avian strain 82 was 94% identical to that of 
human S.  aureus isolate 213 listed in GenBank (accession number X16457) (not 
shown).  The sequence for  human isolate RN4220  (Appendix III-b)  was  94% 
identical  to  that  of the  human  S.  aureus  isolate  BB  sequence  (GenBank 
accession number D00184; not shown). 
Atypical avian S.  aureus strains 496 yield a 685 bp sequence from the coagulase 
gene (Appendix III-b). When  the  sequence  of this  strain was  compared  with bp 
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Figure 3.26 peR of 168 rRNA gene for S. aureus isolates. 
Lane M:  1 Kb DNA Ladder. Lanes 1-5: avian S. aureus isolates 
24,85,99,34 and 82, respectively. Lanes 6-7: human S. aureus 
isolates CN4575 and RN4220, respectively. 184 
GenBank, it was 95% identical to the human S.  aureus isolate 213 sequence with 
accession number X16457 published in GenBank. 
The coagulase gene region of the other avian S.  aureus strains (Table 2.13) was 
also sequenced. Sequence data for strains 99, 2B, 31174, PD27, 34 and 38  was 
100%  identical to  that of strains 24  and 85.  Strains 83,  86,  562,  217  and 235 
were 100% identical to isolate 82. Also isolate 525 was 100% identical to strain 
496. 
3.9.3 Sequence analysis of agrBDC region 
A region of 1005 bp from peR product of the agrBDC region (section 3.6.1) of 
selected avian S.  aureus  strains  24  and  85  was  sequenced (Appendix III-c). 
When the sequences of these isolates were compared, they were 100% identical 
but were 98%  identical to  that of human  S.  aureus isolate SA502A  sequence 
published in GenBank (accession number AFOOI782;  not shown).  Analysis of 
the  144 bp sequence of the agrD region of 24 and 85  isolates (Appendix III-d) 
showed  that  they  belonged  to  group  II  of the  autoinducing  peptides  [AlPs] 
processed from a propeptide encoded by agrD (see section 1.3). 
A region of 983 bp from peR product of  the agrBDC region of  selected avian S. 
aureus strain 82  was  sequenced (Appendix III-c). When the sequence of this 
isolate  was  compared in  GenBank,  it  was  98%  identical to  that of human  S. 
aureus isolate RN4282 (accession number U85097; not shown). Analysis of the 
141  bp  sequence of the  agrD of this  isolate (Appendix III-d) showed that it 
belonged to group I of  the AlPs. 
A region of  992 bp from peR product of the agrBDC region of  human S.  aureus 
strain  RN4220  was  sequenced  (Appendix III-c).  When  the  sequence  of this 
isolate  was  compared,  in GenBank it was  99%  identical  to  that of human  S. 
aureus RN4282 (accession number U85097; not shown). Analysis of the 141  bp 
sequence of the agrD of  this isolate (Appendix III-d) showed that it belonged to 
group I of  the AlPs. 185 
A region of 1005 bp from peR product of the agrBDC region of selected avian 
S.  aureus strain 496 was sequenced (Appendices III-c). When the sequence of 
this isolate was compared in GenBank, it was 99% identical to that of human S. 
aureus isolate RN8462 (accession number AFOOI783;  not shown).  Analysis of 
144 bp sequence of the agrD of this isolate (Appendices III-d) showed that it 
belonged to group III of  the AlPs. 
The agrBDC region of the other avian S.  aureus strains (Table 2.13) was also 
sequenced. Sequence data for strains 99, 2B, 31174, PD27, 34, 38,104,595,35 
and 98 was 100% identical to that of strains 24 and 85.  Strains 83, 86, 562,217 
and  235  were  100% identical  to  isolates  82  and  RN4220.  Also  isolates  525, 
31178 and 32528 were 100% identical to strain 496. 
According to  these results,  typical  avian isolates  are  in  group  II,  but atypical 
avian and human isolates are  in groups I and III, of the autoinducing peptides 
[AlPs] processed from a propeptide encoded by agrD (see section 1.4). 4. DISCUSSION 186 
4.1 THE ISOLATES 
There  was  no  type  strain  of avian  S.  aureus  available  in  the  major  culture 
collections but the strain selected as a control, S.  aureus strain 24, was obtained 
from a case of  proximal femoral degeneration in a broiler from Northern Ireland. 
This strain was used as a standard strain in a study by McCullagh et al.  (1998) in 
that the majority (85%) of isolates from diseased chickens in commercial flocks 
and 71 % of the hatchery isolates had a PFGE profile indistinguishable from that 
of strain  24  and were  therefore  classified  as  "type  24".  The  sources  of the 
isolates in the present study were Scotland, England, N. Ireland, America and Sri 
Lanka. More than half of the  isolates were from N.  Ireland. The isolates were 
mainly  from  clinically-diseased  birds  (Table  2.1).  Other  avian,  human  and 
animal  coagulase-positive  and  coagulase-negative  species  served  as  control 
organisms in the various test procedures. 
One of the main aims of this project was to  devise a simple, rapid and reliable 
typing method for avian isolates of  S.  aureus. 
Although phage-typing has been used to type S.  aureus from poultry (Shimizu, 
1978; Thompson et ai.,  1980a; Kibenge et ai.,  1982a; Shimizu et ai.,  1986), the 
poultry phage set has  not been widely  employed in recent years.  One  of the 
problems in applying a phage typing system on a national or international basis 
is its effectiveness in lysing strains from different geographic regions (Shimizu, 
1979). Another problem is that it is not a static system, as it must respond to the 
emergence of  new strains of staphylococci that are nontypable by the latest set of 
phages (Kloos and Lame,  1991).  Also, in some instances, the observation that 
phage  typing  systems  produce  illogical  or  inconsistent  results  may  indicate 
problems in methodology or interpretation (Kristjansson et ai.,  1994). 
Biotyping  in  many  clinical  microbiology  laboratories  is  now  routinely  and 
reliably performed using automated or standardised systems designed for species 
identification.  However,  attempts  to  use  biochemical  reactions  for  strain 187 
differentiation of  S.  aureus and of  coagulase-negative staphylococci have proved 
largely unsatisfactory both because of poor reproducibility among independent 
isolates representing the same strain and relatively weak discriminatory power 
(Mickelsen et al.,  1985; Tenover et al.,  1994). 
One of the most discriminatory methods for typing bacterial isolates in current 
use is PFGE analysis of genomic DNA that has been restricted with infrequent 
cutting  enzymes.  This  techniques  has  been  used  successfully  with  avian  S. 
aureus (Saulnier et al.,  1993; Tenover et al.,  1994; McCullagh et al.,  1998). For 
example,  McCullagh  et  al.  (1998)  used  the  PFGE  method  for  typing  avian 
isolates of S.  aureus  in N.  Ireland.  The bacterial  grouping was  based on the 
number  of similar  bands  present  between  restriction  fragment  patterns.  The 
groups  consisted  of strains  (a)  identical  to  type  strain  24,  showing  no  band 
differences,  (b)  closely  related,  showing  1-3  band  differences,  (c)  possibly 
related, showing 4-6 band differences and (d) unrelated,  showing more than 6 
band  differences.  McCullagh  et  al.  (1998)  used  PFGE  analysis  of Sma! 
restriction patterns to type 109 isolates of  S.  aureus collected from broiler farms 
and hatcheries in Northern Ireland. Forty-seven isolates from clinical conditions 
in broilers and 62  strains from hatcheries, were examined. The PFGE patterns 
demonstrated a similarity between 85% of strains from clinical sources and 71% 
of the hatchery isolates. The association of disease with the predominant strain 
type (type 24) and the presence of these same strains in the hatchery indicated 
that the  hatchery  was  a  potential  source  of the  infection  for  clinical  broiler 
disease.  Comparison  of a  number  of isolates  from  the  same  broiler  houses 
demonstrated the prevalence of one PFGE type per house, and was in agreement 
with  the  findings  of a  study  using  phage  typing  (Kibenge  et  al.,  1982a). 
Although the mechanism of spread of  S.  aureus infection through poultry flocks 
is  not  understood,  Thompson  et  al.  (1980b)  had  earlier  suggested  that  the 
hatchery played an important role in the spread of infection to rearing farms and 
has a role in the dissemination of S.  aureus in poultry. The eggs supplied from 
the broiler parent farm have been recognised as a potential source of salmonella 188 
infection in the hatchery (Davies and Wary,  1994), and could playa similar role 
in the spread of  S.  aureus infection associated with clinical disease in broilers. 
For the present study, a large number of avian isolates that had been biotyped 
and typed by PFGE were kindly provided by Dr McCullagh.  However PFGE 
typing  is  technically  demanding  and  time  consuming  (Maslow  et  at.,  1993; 
Birren and Lai 1993; Cookson et al.,  1996). The intention was to see if a simple 
rapid  typing  method  could  be  derived  that  was  as  discriminatory  or  more 
discriminatory than PFGE.  A collection of 51  PFGE-typed isolates were used, 
including a large number of  type 24 isolates. 
It  is  well  known  that  S.  aureus  strains  produce  various  extracellular  active 
substances, such as  coagulase, haemolysins, nuclease, acid phosphatase, lipase, 
proteases, fibrinolysin and various toxins. These active substances are thought to 
contribute to  the pathogenicity of the  organism and the majority of them have 
been  purified  and  their  biological  properties  extensively  examined  by  many 
researchers (reviewed by Dinges et al.,  2000).  The aim of this project was not 
only to investigate typing methods for avian strains but also to characterise some 
of the  virulence  properties.  By PCR  amplification  using  primers  for  known 
virulence-associated  genes,  it was  hoped  to  gain  insight  into  both  of these 
aspects. 
4.1.1 Biochemical properties of the isolates 
Conventional biochemical properties. The main purpose of determination of 
the biochemical activities of these isolates was to identify or, for most of them, 
to  confirm  their  identity,  before  use  in  other  experiments.  These  tests  were 
chosen on the basis of previous work where they were reported to  give clear 
positive  or negative  results  for  the  species  (Kloos  and  Lambe,  1991;  Kloos, 
1998).  With the biochemical tests  used,  results  for  coagulase-positive isolates 
were  very  similar to  those  for  coagulase-negative isolates,  in agreement with 189 
previous reports (Kloos and Schleifer, 1975a,b; Kloos and Lambe, 1991; Kloos, 
1998). 
The initial identification of the staphylococci were made on the basis of culture 
on  mannitol  salt  agar  (this  medium  inhibits  the  growth  of Gram-negative 
bacteria, but allows the growth of staphylococci and certain other Gram-positive 
bacteria). Gram stain and production of catalase were also used for preliminary 
identification  of staphylococcal  species.  Only  two  biochemical  tests,  namely 
coagulase (human and rabbit plasma) and DNase plate culture test, were able to 
differentiate coagulase-positive and coagulase-negative staphylococci (Bergey's 
Manual, 1974). All avian S.  aureus isolates in this study gave positive results for 
these tests, as reported previously for avian isolates (Hajek and MarsaIek, 1976; 
Devriese and van de Kerckhove, 1979). 
However,  biochemical  properties  have  been  used  to  differentiate  isolates  of 
coagulase-positive S.  aureus of  human, animal and avian origin. There were four 
different biotypes identified among the S.  aureus isolates and one biotype for S. 
intermedius  in  a  study  by  Hajek  and  MarsaIek  (1976).  Gibbs  et at.  (1978a) 
showed three biotypes for isolates of  S.  aureus. Devriese (1984) and Isigidi et at. 
(1990) showed five biotypes for S.  aureus, whereas Harvey et at.  (1982) showed 
two biotypes for S.  aureus. These observations of biotyping groups were based 
on panels of 6-9 different tests. In general, the biochemical methods are labour 
intensive and time consuming and poorly discriminatory. 
Usefulness  of Rapidec  Staph  and  API  Staph.  To  expedite  the  process  of 
identifying  staphylococcal  species  and  subspecies  in  the  clinical  laboratory, 
several manufacturers have  developed rapid  identification kits  and  automated 
systems requiring only a few  hours to  one  day  for  completing the tests.  With 
these products, identification of most species and subspecies can be made with 
an accuracy of  70->90% (Gemmell and Dawson, 1982; Bannerman et al.,  1993). 190 
The  Rapidec  Staph  system  has  been  used  for  the  identification  of the  main 
staphylococci species S.  aureus,  S.  epidermidis,  S.  saprophyticus, but it is  not 
able  to  differentiate  other staphylococcus  species.  The Rapidec  Staph  system 
was  used in  this  study  as  a  supplementary  method  for  the  confirmation  and 
identification of the isolates. The results obtained for the different species were 
very similar to the findings of Kloos (1998). In general, all S.  aureus isolates in 
the present study gave identical profiles in this panel of four tests. There were no 
differences between typical avian isolates and human or animal strains. 
API  Staph  is  an  identification  system  for  the  genera  Staphylococcus  and 
Micrococcus,  using  standardised  and  miniaturised  biochemical  tests  with  a 
specially  adapted  database.  In  this  study,  the  API  Staph  system  was  used 
primarily for confirmation and identification of the S.  aureus isolates and other 
species.  The  results  obtained by  API  Staph system for  the  species  were  done 
according to the manufacturer's (bioMerieux) instructions and were based on the 
classification of  Kloos and Schleifer (1975a, b), and Kloos and Lambe (1991). In 
general, all S.  aureus isolates in the present study gave identical profiles in this 
panel of 20 tests. These were no  differences between typical avian isolates and 
human or animal strains. Also, this system showed that all avian isolates,  like 
human strains, produced urease.  The only previous report of urease activity in 
avian S.  aureus isolates was in a comparison of strains from freshly slaughtered 
poultry and strains "endemic" to  processing plants (Mead et al.,  1989). It was 
reported that a higher proportion of "endemic" strains produced urease.  These 
results  therefore  differ from  the  present results  where  the  avian  isolates  were 
obtained from live birds and all produced urease. 
Rapidec  Staph  and  API  Staph  systems  are  useful  for  identification  of 
Staphylococcus  species  but  Watts  and  Yancey  (1994)  have  reported  that 
commercial  biochemical  kits  available  for  the  determination  of coagulase-
negative staphylococcal species are unreliable for the identification of veterinary 
pathogens, because they were developed for human isolates. 191 
Rapid identification of  S.  aurellS by peR: The rapid identification of  S.  aureus 
is  important so that the  appropriate antibiotic therapy can be initiated, and this 
bacterial species must be  differentiated from coagulase-negative staphylococci. 
Several methods for rapid identification of  S.  aureus have been evaluated. Some 
of these  methods  include  coagulase  tests  (Davis  et  at.,  1992),  a  panel  of 
commercial agglutination tests (Wilkerson et at.,  1997), a hybridization test for 
rRNA (Davis and Fuller,  1991)  and an enzymatic test for the  detection of the 
thermostable  nuclease  (Madison  and  Baselski,  1983).  Although  identification 
with the thermonuclease enzyme test has shown an excellent correlation with the 
conventional identification of S.  aureus isolates (Madison and Baselski,  1983), 
false-positive  results  due  to  thermonuclease  activity  in  some  strains  of 
coagulase-negative staphylococci may occur (Chesneau et al.,  1993;  Kloos and 
Bannerman, 1994). In addition, some streptococcal isolates may give a positive 
thermonuclease test (Park et at.,  1980). The hybridization test for rRNA showed 
excellent specificity for S.  aureus but demonstrated an evident lack of sensitivity 
for detection from blood cultures (Davis and Fuller, 1991). 
Brakstad et at.  (1992) have  developed a PCR assay  specific for  S.  aureus by 
targeting the nue gene coding for staphylococcal thermonuclease. This assay was 
shown to  be suitable for  diagnostic purposes and this method was used in the 
present study for identification S.  aureus isolates. Another simple and rapid PCR 
assay  that  Martineu  et  at.  (1998)  developed  for  the  diagnosis  of S.  aureus 
infections from blood culture or clinical specimens was also used in the present 
study.  These two rapid PCRs were applied to  all S.  aureus avian,  human  and 
animal isolates in this study and the results of the two methods gave complete 
agreement  with  each  other  and  with  the  other biochemical  and  conventional 
methods.  All  isolates  identified  as  S.  aureus  gave  positive  reactions  with 
identical bands at 300 bp and  108  bp for  the nuclease region and the species-
specific  chromosomal  DNA  fragment  of S.  aureus,  respectively.  None  of the 
avian,  human or animal  coagulase-negative or S.  intermedius  isolates  showed 192 
any  amplified bands  by these  methods.  These  rapid  and  specific  tests  for  S. 
aureus are therefore a good alternative to biochemical typing procedures. 
4.2 PLASMID PROFILE PATTERNS 
Plasmid profile analysis is a molecular fingerprinting method that has been used 
for discrimination between S.  aureus isolates (Dodd et ai.,  1987; 1988; Gillespie 
et ai.,  1990;  Jovanovicacute et ai.,  1991;  Matthews et ai.,  1992;  Montserrat et 
ai.,  1994;  Tenover et ai.,  1994;  Aarestrup et ai.,  1995b; Damiani et ai.,  1996; 
Yoshida et ai.,  1997; Lange et ai.,  1999). 
In a study of  S.  aureus isolates from different poultry processing plants (Dodd et 
ai.,  1987;  1988), plasmids were detected in 72% of strains but the proportion of 
plasmidless  strains  isolated varied amongst plants.  Plasmids were  detected  in 
76% of  strains from plant 1; 96% of strains from plant 2; but only 46% of  strains 
from plant 3 (Dodd et ai.,  1987).  Also Dodd et ai.  (1987;  1988), showed that 
plasmids  profiles  could  be  used  to  distinguish  endemic  strains  of S.  aureus 
present in processing plants from those of  the skin flora of turkeys and chickens. 
Earlier, differences in plasmid content were found between strains of S.  aureus 
associated with live poultry (Witte et ai.,  1977;  Thompson et ai.,  1980b)  and 
those  isolated  from  processed  poultry  which  were  termed  endemic  strains. 
However,  as  it  has  been shown that strains  other than  endemic types may be 
associated with processed poultry carcasses (Adams and Mead,  1983), it is  not 
clear whether these "endemic" strains were those truly indigenous to the plants 
or were part of the original skin flora.  Thompson and Holding (1986) showed 
that  plasmids  were  more  common  in  strains  of S.  aureus  characteristically 
associated  with  live  poultry  than with  strains  endemic  in  poultry  plants  and 
strains of human origin.  They also showed that a plasmid of size  1.65  kb  was 
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In the present study, plasmids of 1.6,4.4 and 16 kb were common in most of  the 
avian S.  aureus (Table 3.4) from different sources. 
A  high  proportion  (95%)  of avian  S.  aureus  isolates  had  plasmids  and  the 
profiles of most of the isolates were similar. Their sizes ranged from  1.6 to  16 
kb. All the avian N.  Ireland S.  aureus isolates related to PFGE type 24, except 
isolate 77,  and isolates  34  and  38  that were closely related to  PFGE type  24 
according  to  the  designation of McCullagh et ai.  (1998)  had similar plasmid 
profiles. The other N.  Ireland isolates that were possibly related or unrelated to 
type  24  according  to  the  McCullagh  et  ai.  (1998)  designation  had  different 
plasmid profiles (Table 3.4). 
The present study has also demonstrated a close correlation between tetracycline 
resistance  and  the  presence  of a 4.4  kb  plasmid.  A plasmid of this  size  was 
present  in  all  avian  S.  aureus  isolates,  from  different  geographic  regions, 
examined, that were resistant to tetracycline except isolate E. This isolate from a 
Goshawk had two other plasmids of 1.6 and 16 kb, and plasmids of these sizes 
were common in other isolates but they did not appear to  encode resistance to 
tetracycline (Table 3.4). 
The present study has  demonstrated a close correlation between those isolates 
resistant to  one  or more of penicillin G,  kanamycin,  tobramycin,  gentamicin, 
pefloxacin, erythromycin, lincomycin and nitrofurantoin and the presence of a 
plasmid of approximate  16 kb (Tables 3.4 and 3.9).  Of the strains resistant to 
any of these antibiotics, only strain 32528  did not have the  16  kb  plasmid but 
was  resistant to  penicillin  G.  It may  be  that  this  large plasmid is  commonly 
associated with antibiotic resistance genes, but this needs further investigation. It 
is interesting to note that the only plasmid common to the human strains used in 
this study also had a mol.wt of 16 kb. Laufs et ai.  (1978) and Kloos et ai.  (1981) 
had previously presented data  showing that S.  aureus strains of human origin 
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Coagulase-negative strains also possessed plasmids but,  in general, the profiles 
were distinct from those of the coagulase-positive strains.  The plasmid profiles 
results for avian coagulase-negative strains showed that only two isolates had a 3 
kb plasmid which was the same size as a plasmid in some of  the avian S.  aureus 
strains.  Further  work  would  be  required  to  determine  if these  plasmids  are 
similar and transmissible between strains (Tables 3.4 and 3.5). 
Some  of the  animal  staphylococcal (coagulase-positive  and  negative)  isolates 
possessed a plasmid of 16  kb,  similar in size to  that in  some avian  S.  aureus 
(Tables 3.7, 3.8 and 3.4). In general, however the plasmid profiles of the seven 
bovine  strains  examined  did  not  resemble  those  from  poultry  strains. 
Baumgartner et al.  (1984) studied plasmids in strains of  S.  aureus from mastitis 
cases  and  showed that  70%  of 97  strains  carried plasmids,  but  they  did  not 
record the sizes of  the plasmids. 
4.3 ANTIBIOTIC SENSITIVITY PATTERNS 
Resistance typing may also be a useful primary typing tool for S.  aureus isolates 
of unrelated  geographical  origins,  as  suggested  by  Struelens  et  al.  (1992). 
Aarestrup  et al.  (1995b)  have  suggested that antibiogram typing  and plasmid 
profiles  might  be  helpful  in  solving  epidemiological  problems  concerning 
strains, which are assigned to the same type by other typing techniques. 
The antibiotic sensitivity patterns of the avian S.  aureus isolates in the present 
study showed that 96% were resistant to most of the commonly used antibiotics 
(Table  3.9).  According  to  the  sensitivity  patterns,  71 %  were  resistant  to 
tetracycline, kanamycin, tobramycin and gentamicin,  fifty  (67%)  isolates were 
resistant to pefloxacin, fourteen (19%) were resistant to  penicillin G,  two (3%) 
were resistant to erythromycin, one (1 %) was resistant to nitrofurantoin and one 
(1 %)  was resistant to  lincomycin (Table 3.9).  85% of avian S.  aureus isolates 
were resistant to more than one of these antibiotics. All Irish, American and Sri 195 
Lankan avian S.  aureus isolates in the present study were resistant to kanamycin, 
tobramycin and gentamicin. 
Lukasova et  at.  (1986)  showed  that  more  than  50%  of the  S.  aureus  strains 
isolated from slaughtered poultry were resistant to penicillin, erythromycin, and 
streptomycin and  less  than 50%  resistant to  tetracycline.  Papadopoulou et at. 
(1997) showed that strains of  S.  aureus from eggs were resistant to penicillin G, 
tetracycline,  erythromycin,  clindamycin,  cefalosporins,  oxacillin,  gentamicin, 
chloramphenicol and  tobramycin.  Aarestrup et at.  (2000)  reported that  a high 
frequency  (30%)  of avian  S.  aureus  isolates  from  Denmark was  resistant  to 
ciprofloxacin but only 7%  of avian S.  aureus isolates were penicillin resistant. 
Resistance to  sulphamethoxazole was observed among 19% of avian S.  aureus 
isolates. 24% of the avian S.  aureus isolates were resistant to erythromycin and 
79% of these isolates contained the ermA gene, whereas the remaining isolates 
contained the ermC gene. 47% of the avian S.  aureus isolates were tetracycline 
resistant and all contained the tet(K) gene. A single avian S.  aureus isolate also 
contained  the  tet(M)  gene.  In  a  study by  Schwarz  et at.  (1998),  tetracycline 
resistance  was  observed  in  29.3%  of staphylococcal  isolates.  The  level  of 
tetracycline resistant isolates varied with respect to  the animal host:  75% from 
cats, 58.1 % from mink, 41.4% from pigeons, 28% from guinea pigs, 26.1 % from 
horses, 21.4% from ducks,  14.9% from rabbits and 11.8% from turkeys. Multi-
resistant isolates were more frequently isolated from horses, rabbits, mink and 
pigeons, mainly involving additional resistances to ampicillin, chloramphenicol 
or  erythromycin.  In  contrast,  multi-resistance  was  seldom  detected  in 
tetracycline  resistant  isolates  from  cats,  turkeys,  ducks  or  guinea  pigs.  The 
antibiotic resistance patterns depended on the staphylococcal species and on the 
animal host.  Moreover, the determination of antibiotic resistance patterns might 
provide important information towards specific control measures. 
Animal husbandry is an important user of antibiotics for growth promotion in a 
range  of animals  including poultry,  cattle,  salmon  and  catfish  (Levy,  1992). 196 
Taking into consideration also that antibiotics such as ampicillin, erythromycin, 
tetracycline, gentamicin and chloramphenicol have been used for the control of 
infections by large poultry breeders, and comparing the resistance of  the isolated 
bacterial strains to these specific antibiotics, it has been suggested that resistant 
strains could be passed to  humans though the food chain (Papadopoulou et ai., 
1997). Schwarz et ai.  (1998) suggested that there was a correlation between the 
number of  tetracycline resistant isolates in the staphylococcal population and the 
antibiotic usage in the respective  animal host.  Resistant isolates  from  animals 
which suffered from clinical staphylococcal infections such as canine pyoderma 
had most probably been in contact with antibiotics prior to sampling. Moreover, 
most  resistant  isolates  from  mink  were  from  animals  which  had  definitely 
received  tetracyclines  and/or  other  antibiotics.  Carrier  pigeons  from  which 
resistant staphylococcal isolates were obtained had also received antibiotics for 
prophylactic purposes prior to sampling. On the other hand, in turkeys and ducks 
raised  without  any  antibiotic  treatment  there  were  only  low  levels  of 
tetracycline-resistant staphylococci. The observation that no mupirocin resistant 
isolates  were  detected  strongly  reflected  the  restriction  of this  antibiotic  to 
exclusive use in human medicine. 
The present study showed that 71 % of  the avian S.  aureus and 70% of  the strains 
from  commercial  flocks  were  resistant  to  tetracycline,  suggesting  that  this 
antibiotic  is  widely  used  in  commercial  poultry rearing.  As  described  in the 
previous section, there was a strong correlation between tetracycline resistance 
and the presence of a 4.4 kb plasmid. Purification of  this plasmid and transfer by 
electroporation to a tetracycline sensitive strain conferred tetracycline resistance 
on  the  recipient  and  proved that the  plasmid  encoded tetracycline  resistance. 
This finding indicated that the 4.4 kb plasmid found in many strains is correlated 
with tetracycline resistance (Tables 3.4 and 3.9). In a study by Needham et al. 
(1994) of plasmids from human S.  aureus that mediate resistance to  mupirocin 
and  tetracycline,  five  isolates  showed  a  plasmid  of 4.4  kb,  two  isolates  had 
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a plasmid of about 20 kb. There are no previous published reports mentioning a 
plasmid of  4.4 kb conferring tetracycline resistant in avian strains of  S.  aureus. 
The  presence  of high  levels  of antibiotic  resistance  ill  aVian  S.  aureus  is 
worrying.  It may be that such strains could be passed to  humans via the  food 
chain as  suggested above although the pathogenic potential of avian strains for 
man  is  unknown.  Alternately,  it  may  be  that  antibiotic  resistant  genes  and 
antibiotic resistant plasmids can develop in avian strains and then be transmitted 
horizontally to human strains. 
4.4 FINGERPRINTING OF ISOLATES BY PCR METHODS 
In the present study peR typing methods were investigated for their suitability 
for avian strains because of  their successful application to typing S.  aureus from 
human cases. A number of  authors have proposed that peR typing methods are a 
suitable  replacement  for  conventional  phage  typing  methods  for  human  S. 
aureus strains (Saulnier et ai.,  1993; Tenover et ai.,  1994; Bamnerman, et ai., 
1995;  van  Belkum,  et  ai.,  1995;  Saruta  et  ai.,  1997;  Forsman  et  ai.,  1997; 
Deplano and Struelens, 1998; Deplano et ai.,  2000; Enright et ai.,  2000). 
The  ideal  system  for  the  typing  of S.  aureus  strains  should  be  easy,  rapid, 
reliable,  highly  discriminatory,  and  reproducible.  Furthermore,  it  should  be 
suitable for widespread use, so that the genotyping results obtained in different 
laboratories or countries can be compared. 
4.4.1 PCR-ribotyping 
peR  amplification  of the  16S-23S  spacer  regions  with  universal  primers 
(method  1)  showed that this  method readily distinguishes  most  avian isolates 
from human isolates. The simple peR assay presented in this study is useful for 
the  immediate  typing  of S.  aureus.  All  86  avian  S.  aureus  isolates  gave 
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basis of nine distinct bands, twelve groups were recognised for the 86  avian S. 
aureus  isolates  and  each  was  assigned  a  number  (Table  3.12).  These 
polymorphisms are presumably due to variations in the number of,  and distance 
between,  the  neighbouring  rrn  genetic  loci.  The  majority  (73%)  of avian  S. 
aureus  strains,  associated  with  clinical  infections  in  the  different  countries 
investigated  in  the  present  study,  had  a  PCR-ribotyping  pattern  like  that  of 
isolate 24 (Table 3.12). The ability to type avian S.  aureus isolates by this PCR 
method appeared to be similar to that of PFGE in that all PFGE type 24 strains 
had  the  same ribotype (type  1 by  method  1).  Strains  umelated to  type  24  by 
PFGE  had  different  ribotyping  profiles  (types  2,  3  and  5).  However,  this 
ribotyping method was  somewhat less  discriminatory  than PFGE  in  that  two 
strains "closely related" to type 24 by PFGE (distinguishable by PFGE) had the 
same ribotyping profile as  the type 24  strains, whereas one closely related and 
one  possibly  related  strain  had  the  same  ribotyping  profile  as  the  strains 
unrelated to type 24. 
The  results  obtained  in  the  present  study  demonstrated  the  potential  of this 
typing method especially in combination with other methods in epidemiological 
investigations (see summary Table 3.20). Application of this method was easy 
and  it has  advantages in terms of speed and simplicity over the  PFGE typing 
method.  In addition,  PCR-ribotyping  method  1 could differentiate two  of the 
avian strains, 496 and 525 which were classified as UR (umelated to type 24 by 
PFGE) from the rest of the UR strains (Table 3.20). Another group of atypical 
avian  strains,  which had not  been  typed  by  PFGE,  are  listed  in  Table 3.21. 
These  strains  mainly showed profiles  by  PCR-ribotyping  method  1 that were 
distinct from those of  the other avian strains (Table 3.12). 
The strains that reacted by ribotyping method 2 are discussed further in section 
4.8. The majority of the more typical avian strains did not react by this method 
and the implication of this, for distinguishing between typical avian strains of  S. 
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reaction of typical avian strains by PCR-ribotyping method 2 may be sequence 
variation between avian and other strains in the primer regions. A comparison of 
the full  sequence of this  16S-23S  spacer region of avian strains with those of 
human and animal strains could reveal other differences between these strains. 
Twelve avian S.  aureus strains resembled human and animal strains in giving a 
reaction with PCR-ribotyping method 2 (Table 3.13) (this is discussed further in 
section 4.8). This method investigates the level of  sequence variation in the 16S-
23S  spacer regions between different isolates  and has  clear potential use as  a 
rapid  means  of distinguishing  typical  avian  S.  aureus  isolates  from  atypical 
avian and non-avian S.  aureus isolates.  The conventional microbiological and 
biochemical methods for identifying and biotyping isolates are time consuming, 
by comparison with this type of  PCR method. 
4.4.2 REP-peR 
REP sequences were first described in E.  coli and Salmonella typhimurium but 
they  are  widespread  in  bacteria  (Stem  et  al.,  1984;  Hulton  et  al.,  1991; 
Versalovic  et al.,  1991).  The  repetitive  element  sequence-based  PCR (REP-
PCR) used in the present study was described for the molecular genotyping of 
human S.  aureus strains by DelVecchio et al.  (1995). This high-stringency PCR 
fingerprinting method was based on a repetitive sequence found in Mycoplasma 
pneumoniae (Wenzel and Hermann,  1988) but it was found to  generate strain-
specific  DNA fragments  when S.  aureus  DNA was  used as  an  amplification 
template.  van  der  Zee  et  al.  (1999)  reported  that  analysis  of a  collection of 
human Staphylococcus  strains,  described earlier by Tenover et al.  (1994)  and 
van Belkum et  al.  (1995),  showed that  the  REP-PCR typing  method  was  as 
discriminatory as  arbitrarily-primed PCR (AP-PCR)  and  PFGE.  AP-PCR is  a 
little  faster  to  perform  than  REP-PCR,  but  the  reproducibility  of REP-PCR, 
which is highly important when used for epidemiological purposes, was found to 
be better than that of AP-PCR.  If REP-PCR is  compared to  PFGE, the  most 
important  advantage  of REP-PCR  is  its  easy  and  fast  performance.  The 
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typing method for S.  aureus strains known as inter-IS256 PCR, which compares 
best to REP-PCR typing with regard to ease of  performance and reproducibility, 
has been described by Deplano et at.  (1997). On the other hand Deplano et al. 
(2000), suggested that it would be difficult to fully standardise these PCR typing 
methods  using  current  technology,  because  of equipment  variation  between 
laboratories. 
The  present  study  was  performed  to  assess  the  usefulness  of REP-PCR  for 
genotyping of avian S.  aureus strains and to  compare this with ribotyping and 
PFGE. Of the 86  avian S.  aureus strains, seven groups (A-G) were recognised 
(Table 3.14 and Figure 3.14). The patterns were complex, consisting of multiple 
bands ranging from 0.15-3 kb.  All avian S.  aureus isolates related to PFGE type 
24, closely and possibly related to  PFGE type 24  according McCullagh et al. 
(1998) were in group A and therefore REP typing was less discriminatory than 
PFGE.  All  of the  avian  S.  aureus  isolates  unrelated  to  type  24  according 
McCullagh et at.  (1998)  showed  different REP  profiles.  In comparison with 
other typing methods investigated in the present study, the discriminatory power 
ofREP-PCR in genotyping avian S.  aureus was less than that ofPCR-ribotyping 
method 1 (12 types) (Table 3.12) and RFLP analysis of the coagulase gene (8 
types)  (Table 3.16) but greater than that of a polymorphic locus,  e.g.  the x-
region of  the protein A gene (spa) (five types) (Table 3.18) (see below). 
Recent information from the S.  aureus genome sequence (Kuroda et at.,  2001) 
has shown the presence of unique repetitive sequences. According to this recent 
information, primers could be designed for use specifically with S.  aureus and a 
comparison made with REP-PCR. 
4.4.3  peR amplification and RFLP analysis of a  region of the coagulase 
gene 
Coagulase  production  is  an  important  phenotypic  determinant  used  for  the 
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are conflicting data concerning the importance of coagulase as a major virulence 
factor. It is currently believed that coagulase may not be an important virulence 
factor because mutants defective in coagulase production created by site-directed 
allele  replacement  were  not  reduced  in  virulence  in  a particular model  of S. 
aureus  infection  (Phonimmdaeng  et  ai.,  1990).  However,  because  of gene 
variability,  coagulase  genotyping  has  proven  to  be  a  simple  and  powerful 
epidemiological  tool  to  discriminate  between  coagulase-positive  human  and 
bovine S.  aureus strains (Goh et ai.,  1992;  Schwarzkopf et at.,  1994; Aarestrup 
et ai.,  1995a; van Belkum et ai.,  1997;  Su  et ai.,  1999;  Hookey et ai.,  1999; 
Shopsin et ai., 2000). 
Goh  et  ai.  (1992)  reported  that  the  coagulase  gene  exists  in  multiple  allelic 
forms, in part because of  the existence of variants within the 3'  -end of  the coding 
region.  This  contains  a  series  of repeating  81-bp  DNA sequences  and differs 
both in the number of tandem repeats and the location of AiuI restriction sites 
among different isolates. Goh et ai.  (1992) developed a novel typing method for 
human  S.  aureus  based  on  PCR  amplification  of the  variable  region  of the 
coagulase  gene  followed  by  AiuI restriction  enzyme  digestion.  There  was 
excellent correlation of the  RFLP  patterns of different strains  with  typing by 
multi-locus  enzyme  electrophoresis  at  chromosomal  loci.  Su  et  ai.  (1999) 
investigated the  coagulase  gene  polymorphism of S.  aureus  isolates  obtained 
from bovine mastitic milk in order to determine the resistance of dominant and 
rare  coagulase  genotypes  to  the  bactericidal  activities  of  bovine  blood 
neutrophils. A total of  453 isolates were collected from four countries: the Czech 
Republic, France, Korea and the United States. The isolates were subtyped into 
40 types by RFLP analysis of  the coagulase gene. 
The  present  study  on  the  coagulase  region  showed that  there  were  different 
genotypes among S.  aureus isolates from avian, human and animal sources. The 
86 avian S.  aureus isolates could be classified into four distinct groups based on 
their PCR-amplified coagulase gene products and eight distinct groups based on 202 
their unique Alul RFLP profiles (Tables 3.15 and 3.16). The latter method was 
therefore more discriminating than the former, e.g. for isolates 31178, 35, 36, 98, 
104,  595,  580,  597,  598, 496,  525, E and 32528 (Tables 3.15 and 3.16). Also, 
comparison of the coagulase gene RFLP with PFGE results  on the N.  Ireland 
isolates showed that avian S.  aureus isolates of type 24 and closely-related type 
24 isolates had identical band patterns. The possibly-related and unrelated strains 
could be  grouped  into  3  different  types  (Table  3.16  and  Figure 3.16).  The 
unrelated isolates 82, 83, 86,496, 525 and 562 had bands common to both avian 
and human strains (Table 3.16 and Figure 3.16). Thus this method has limited 
value in differentiating typical avian strains but human and animal isolates were 
readily distinguishable  from  typical  avian isolates  after restriction.  Coagulase 
gene typing gave the same discrimination as  PCR-ribotyping method 1 (Tables 
3.13 and 3.16). 
Shopsin  et  al.  (2000)  has  reported  recently  that  coagulase  gene  (eoa)  short 
sequence repeat region sequencing could be used to measure relatedness among 
a  collection  of  temporally  and  geographically  diverse  methicillin-resistant 
human S.  aureus isolates. Their results showed that eoa polymorphism is free of 
strong selective pressure and had a low index of variation that might be useful 
for  long-term  epidemiological  investigation.  Also  Chiou  et  al.  (2000)  has 
compared  PFGE  and  coagulase  gene  restriction  profile  (CRP)  analysis 
techniques  in  the  molecular  typing  of  human  S.  aureus  isolates.  These 
techniques  were  used to  analyse  71  isolates  recovered  from  nine  food-borne 
disease outbreaks. Twenty-two PFGE profiles and 11  CRPs were identified, with 
discrimination indices of  0.86 and 0.72, respectively. 
4.4.4 peR amplification and RFLP analysis of X-region of the protein A 
gene 
The key biological property of  protein A is its ability to bind to the Fc portion of 
IgG antibodies (Forsgren and Sjoquist, 1966). The expression of protein A (spa) 
is repressed by global regulatory loci sarA and agr. Although SarA may directly 203 
bind to  the spa promotor to  downregulate spa expression,  the mechanism by 
which agr represses  spa expression is  not clearly understood  (Cheung  et at., 
2001).  The spa  gene  is  composed of approximately  2150  bp  and harbours  a 
number of functionally distinct regions, an Fe-binding region, the so-called X-
region,  and,  at  the  C-terminus,  a  sequence required  for  cell  wall  attachment 
(Schneewind  et aI.,  1992).  The  portion of the  gene  encoding the Fe-binding 
region is composed of five 160 bp repeats. The X-region of the gene contains a 
varying number of 24 bp repeats (Guss et at.,  1984; Uhlen et at.,  1984). The X-
region  is  highly  polymorphic,  and  has  been  used  to  discriminate  between 
different human S.  aureus strains (Frenay et at.,  1994; Shopsin et at.,  1999; Tang 
et at.,  2000). For example, Shopsin et at.  (1999) studied 320 human S.  aureus 
isolates.  spa  typing identified 33  different strain types  and 24 distinct repeat 
types.  They  concluded  that  spa  typing  gave  no  further  discrimination  over 
PFGE,  but that spa  sequencing  is  a  rapid  typing  tool  for  S.  aureus  that has 
advantages  in  terms  of  speed,  ease  of  use,  ease  of  interpretation,  and 
standardisation among laboratories. 
In the present study, PCR amplification of the X-region of the protein A gene 
gave  a single band product, but the size of the band (0.3-0.6  kb) was able to 
identify and differentiate the avian, human and animal S.  aureus strains into five 
groups ('A'-'E') (Table 3.17). Restriction of the PCR product by RsaI (Tables 
3.17 and 3.18)  gave no  further  discrimination.  According to these results,  72 
(83 %) of  avian S.  aureus isolates had similar patterns. All of the N. Ireland avian 
S.  aureus isolates related to PFGE type 24, and those closely-related, possibly-
related and some of the unrelated strains were undistinguishable. Another group 
of unrelated strains however gave different profiles. Comparison of the protein 
A typing with other typing methods shows that the protein A typing does not 
have the discrimination power of PCR-ribotyping method  1,  REP-PCR or the 
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Isigidi  et al.  (1990)  suggested that the  absence  of protein A  differentiates  S. 
aureus  of the  poultry biotype  from  the  slaughterhouse  biotype.  On the  other 
hand,  Kusunoki  et  al.  (1990)  reported  that  strains  from  diseased  chickens 
produce extracellular low-molecular-mass protein A. In a study by Rodgers et al. 
(1999),  protein A was not present in some  strains isolated from broiler parent 
farm personnel but was in all strains isolated from hatchery personnel. 
The present study examined for  the  presence  of the  protein  A  gene  in  forty 
poultry and non-host specific biotype avian strains from N. Ireland (both typical 
and atypical) even though it was suggested that these did not express protein A, 
according to scheme of Isigidi et al.  (1990) (Tables 2.7 and 3.1). According to 
our PCR method,  all of them had at least the X-region of the protein A gene 
(Table 3.17 and Figure 3.17). It may be that avian S.  aureus isolates have the 
spa  gene but they are  not able  to  express  it  or only express  it under certain 
conditions. The present study suggests that expression of the protein A gene in 
avian strains should be investigated further. 
4.4.5 peR amplification and RFLP analysis of virulence-regulatory genes 
Two pleiotropically acting regulatory loci, agr and sar, have been identified that 
affect the temporal regulation of virulence  gene  expression in S.  aureus.  The 
product of  the sar gene, SarA, is a DNA-binding regulatory protein that activates 
expression of the two operons in the agr locus. One operon expressed from the 
P2 promotor encodes a quorum-sensing system that effects the switch for surface 
protein expression when the  population density is  high,  which occurs in later 
stages of infection or stationary phase laboratory cultures. The other operon in 
the agr locus is expressed from the P3 promotor. The most important product of 
its expression is  a regulatory RNA molecule (RNAIII) that directly upregulates 
the expression of many exoproteins such as a,  ~ and 8-haemolysins, toxic shock 
syndrome toxin-I, enterotoxins Band C,  fatty-acid-modifying  enzyme, lipase, 
serine  protease,  staphylokinase  and  serotype  5 capsular  polysaccharide.  Also 205 
RNAIII downregulates the  expression of some  exoproteins such as  protein A, 
fibronectin-binding proteins A and coagulase (Lee, 1998; Rechtin et al.,  1999). 
Although the agr locus is conserved throughout staphylococci, the autoinduction 
circuit,  consisting  of signal  receptor  AgrC,  the  auto inducing  peptide  (AlP) 
processed from AgrD, and the putative AlP processing-secretion protein AgrB, 
shows striking variation, which serves to define distinct specificity groups (Ji et 
at.,  1997).  Within  anyone group,  these  sequences  are  highly  conserved and 
mutual cross-activation is  observed.  Between groups, however, there is  mutual 
cross-inhibition of the agr signalling pathway (Ji et at.,  1997), giving rise to  a 
novel type of bacterial interference that may have a role in colonisation and/or 
infection. In an earlier study (Ji et at.,  1997), three distinct agr specificity groups 
(I,  II  and III) of S.  aureus strains were defined on the  basis of mutual cross-
inhibition of agr function,  and Jarraud et at.  (2000) demonstrated a fourth agr 
specificity  group  among  human  S.  aureus  strains  and  showed  that  most 
exfoliatin-producing strains belong to this group. A striking common feature of 
group IV strains is activation of the agr response early in exponential phase, at 
least 2 h earlier than in strains of the other groups. This finding by Jarraud et at. 
(2000) raises the question of the biological significance of the agr autoinduction 
threshold.  Also  Ji  et at.  (1997)  have  shown that most menstrual  toxic  shock 
human  strains  belong to  agr  specificity  group  III  but that  no  strong  clinical 
identity has been associated with strains of  the other two groups. 
Results from the present study are the first demonstration of  agr and sar in avian 
S.  aureus  strains.  It  may  be  concluded  that  many  of  virulence  factors 
characterised in this study in avian S.  aureus are likely to be regulated by the agr 
and sar loci  (agrP2,  agrBDC and sarA)  (Figures 3.17,  3.18,  3.19  and  3.25, 
Table  3.21).  The  results  of the  agrBDC  region  gene  RFLP  analysis  and 
sequencing of these regions in selected strains suggested that 80% of avian S. 
aureus  isolates  belonged  to  agr  specificity  group  II  (auto  inducing  peptide 
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24, closely-related, possibly-related, and some unrelated (typical avian) strains, 
as well as  Scottish, English and Sri Lankan isolates. On the other hand,  17% of 
the avian S.  aureus isolates belong to  agr specificity group  I.  Isolates in this 
group included some of the N.  Ireland atypical strains, unrelated PFGE type 24, 
and two of  the American isolates. 6% of the avian S.  aureus isolates were found 
to belong to agr specificity group III. Of the four human S.  aureus in which the 
agrBDC locus was restricted by MseI,  two isolates were included into each of 
specificity groups I and III. In conclusion, typical avian S.  aureus isolates were 
classified  into  specificity  group  II  and  atypical  avian S.  aureus  isolates  were 
classified into  specificity groups I  and  III  and this  may affect their ability to 
produce many of  the known virulence factors of  S.  aureus. However, there is no 
information  concerning  variations  of agr  and sar loci  in  avian  S.  aureus  so 
further work is required to investigate this suggestion. 
4.4.6  Development of a  multiplex peR for  enterotoxins  A-E,  exfoliative 
toxins A -B and toxic shock syndrome toxin-l (TSST-l) 
In this study, multiplex PCR was developed and shown to be effective for the 
detection of genes encoding enterotoxins A-E (sea to see), exfoliative toxin A-B 
(eta and etb) and toxic shock syndrome toxin-l (tst) genes. At the time this was 
done, there was no report of a multiplex PCR for all eight toxin genes. To give 
optimal resolution of each of the toxin genes, the concentration at which each 
primer was used was ten picomoles for sea, seb, sec,  see and tst, 20 picomoles 
for sed, 30 picomoles for etb and 50 picomoles for eta. 
PCR has been used for over a decade for the detection of these eight individual 
staphylococcal toxin genes (Neil et al.,  1990; Johnson et al.,  1991; Sakurai et al., 
1995; Jarraud et al.,  1999; Mehrota et al.,  2000; Sharma et al.,  2000). However, 
a  few  groups  have  recently  developed  multiplex  PCRs  for  the  simultaneous 
detection of some of the toxin genes (Becker et al.,  1998; Schmitz et al.,  1998; 
Jarraud et al.,  1999; Mehrotra et at.,  2000; Sharma et at.,  2000). For example, 
Schmitz et al.  (1998) used a multiplex PCR for the detection of seb,  sec and tst. 207 
The PCR conditions were different from those in the present study in that each 
step  had  a  shOlier  time  with  20  seconds  for  amplification,  20  seconds  for 
annealing and 50 seconds for  extension in contrast to  this study which allowed 
30  seconds  for  denaturation,  30  seconds  for  annealing  and  one  minute  for 
extension. The primers were also different and gave different sized products for 
both seb (231  base pairs) and tst (250 base pairs), compared to 163 base pairs for 
seb  and  445  base pairs  for  tst  in  this  study.  Becker et  al.  (1998)  developed 
separate multiplex PCRs which detected all eight toxins sea-see, tst,  eta and eab, 
with one  multiplex  detecting  five  genes  (sea,  seb,  sec,  sed,  see)  and  another 
multiplex screening for three genes (tst,  eta and etb).  Some of the primers used 
by Becker et al.  (1998) were different from those used in this study. For the PCR 
conditions, the same number of cycles was used as  in this study, as well as the 
temperatures of each stage.  The timing  of each stage,  however,  was  different 
from  the  present study  i.e.  with one  minute  for  denaturation,  one  minute  for 
annealing and two minutes for polymerisation. The advantage of having shorter 
timing  of each  segment  means  that  the  PCR  cycle  can  be  completed  more 
quickly, which is an impOliant factor in clinical diagnosis. Sharma et al.  (2000) 
reported  a  multiplex  PCR  assay  which  specifically  detects  genes  for  five 
staphylococcal  enterotoxins  (A  to  E)  in  strains  of toxigenic  S.  aureus  from 
various environmental sources. The PCR conditions were different from those in 
the present study, with 30s for denaturation at 94°C, 30s for annealing at 50°C 
and 30s for extension at 72°C. Jm"raud  et al.  (1999) and Mehrotra et al.  (2000) 
each developed two  separate  multiplex PCRs for  amplification of these  eight 
toxins, but again the conditions were different and the programmes were longer 
than the this study. In the present investigation all avian and some of the human 
and animal strains were screened for the eight toxin genes.  Only 5% (4/86) of 
the avian S.  aureus isolates but 53% (9/17) of the human S.  aureus were positive 
for  one  or  more  of these  genes.  These  findings  by  molecular methods  were 
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In  contrast,  a  number  of previous  studies  have  reported  that  a  fairly  high 
proportion  of S.  aureus  strains  isolated  from  birds  produce  enterotoxins  or 
contain enterotoxin genes.  For example,  Harvey et al.  (1982)  found  that 25% 
(35/139) of S.  aureus isolates from raw poultry carcasses were enterotoxigenic. 
The majority of these strains (32/35) produced enterotoxin D alone.  Only two 
isolates produced enterotoxin A and one isolate had enterotoxins C+D. Of those 
strains found to be enterotoxigenic, 91.4% were of  the intermediate biotype with 
the cultural characteristics of  human and animal types (Harvey et al.,  1982). 
From the results of  Simko  vic ova and Gilbert (1971), Wieneke (1974), Payne and 
Wood (1974),  and others,  many avian strains  of S.  aureus of different phage 
groups  or  non-typable  strains  are  reported  to  be  capable  of  producing 
enterotoxins, but the majority of strains isolated from foods  implicated in food 
poisoning incidents are human phage typable. This may be a result of either the 
ability of  strains of  these strains to produce higher levels of  enterotoxins in foods 
or to  have  a  higher  growth  rate  in  foods  than  other  strains,  or possibly the 
,  selective'  recontamination of processed  foods  with strains  from  human food 
handlers. Lukasova et al.  (1986) found that 45  strains of  S.  aureus isolated from 
slaughtered poultry were classified as biotype A (of human origin), according to 
the biochemical identification  scheme of Hajek and  Marsalek (1971),  and 20 
strains were biotype B (of poultry origin). Of the 20 biotype B strains, only one 
strain  produced  enterotoxin  B.  Of 22  biotype  A  strains,  12  (54.5%)  strains 
produced different enterotoxins. 
In another study,  Gibbs  et al.  (1978a)  showed the  results  of screening  55  S. 
aureus strains isolated from broiler and end-of-Iay hen processing plants for the 
production  of enterotoxins  A,  Band C.  Overall,  62%  of strains  produced 
enterotoxins,  enterotoxin A being by  far  the  most  common.  Genigeorgis  and 
Sadler (1966)  found  that  50%  of the  strains  they  isolated  from  the  livers  of 
commercially  slaughtered  poultry  were  enterotoxigenic.  Wieneke  (1974) 
reported  that  from  frozen  raw  chickens  26%  were  enterotoxigenic,  but none 209 
produced  enterotoxin  A.  From  cooked  chicken,  32%  of  strains  produced 
enterotoxins and 7.6% produced enterotoxin A, and these strains were thought to 
be of  human origin (Wieneke, 1974). 
Sharma  et  al.  (2000)  used  two  single-reaction  multiplex  PCR  assays  to 
determine the toxin types of randomly selected S.  aureus strains of ovine (67 
strains), bovine (11  strains), poultry (40 strains), and human (39 strains) origins. 
The poultry strains were from various sources within a poultry processing plant 
(both environmental and carcasses). In parallel, the strains were also tested by 
staphylococcal  enterotoxin  reversed  passive  latex  agglutination  (SET-RPLA) 
detection kit. The results showed that 31 % of human strains produced different 
enterotoxins and 9% of bovine strains produced enterotoxin C.  75% of ovine 
strains produced different enterotoxins and 50% of poultry strains were toxin 
positive  (enterotoxin  D).  The  toxin  serotype  results  agreed  with  the  PCR 
method, except that two ovine isolates were negative with PCR method, but they 
were positive with SET-RPLA. 
The  conclusion  from  this  published  work  is  that  some  strains  isolated  from 
poultry do  appear to  produce  enterotoxins  but most of these strains are  from 
processed birds and may therefore have been contaminants from the processing 
plant equipment or from human handlers.  This suggestion is  supported by the 
findings of biotyping studies where this has been done. Most of the enterotoxin-
producing isolates were non-poultry biotypes. 
The four avian S.  aureus strains in this study that were found to produce toxins 
were not typical avian strains in that they gave a positive reaction with PCR-
ribotyping method 2.  Isolate 32528 was shown to contain the tst, enterotoxin A 
and exofoliative toxin B genes. This strain was obtained from a Cockatoo. There 
has  been  no  previous  reports  that  avian  S.  aureus  strains  possess  tst  and 
exofoliative B genes and it may be this isolate was of  human origin. Three of  the 
four strains produced enterotoxin A.  Strains 496 and 525 were identified as the 210 
non-host specific biotype and strains 31178 and 32528 were not biotyped. All of 
these isolates according to  PCR-ribotyping method 2 and RFLP analysis of the 
agrBDC region had band patterns  similar to  human strains  (Table  3.19).  For 
these  reasons,  it  is  possible  that  these  strains  may be  of human  origin.  The 
present study concluded that 33.3% (4112) of  atypical avian S.  aureus strains, but 
none of the typical avian strains,  possessed one of more  of these  eight toxin 
genes. 
Results on the human S.  aureus strains in this study showed that 53% of strains 
produced one or more of the eight toxins.  Becker et al.  (1998) found that 42% 
of clinical isolates of MSSA were found to be toxin positive for one or more of 
these eight toxins by PCR.  Similarly, Neil et al.  (1990) found  59%  of clinical 
isolates  to  be  toxin  positive  for  one  or  more  of these  eight  toxins  by PCR. 
Adesiyum et al.  (1992) who used ELISA to detect sea, seb, and sec found 68% 
of isolates from human wounds and diarrhoea to  be toxigenic. Taken together 
these results show that human strains commonly produce these toxins. 
4.4.7 peR amplification of haemolysin genes and haemolysin production 
There  is  no  previous  report  describing  the  detection  of haemolysin  genes  in 
avian S.  aureus or other avian staphylococci species by molecular methods, nor 
is there any report of a multiplex PCR for  detection of a, y and o-haemolysin 
genes in avian, human or animal S.  aureus strains. 
The multiplex PCR results for haemolysin (a, y and 0) genes in the present study 
showed that all the 86 avian S.  aureus isolates had the a-haemolysin gene. The 
biological  results  for  a-toxin  production  agreed  largely  with  the  molecular 
method as  84  (97%) were a-haemolytic. Only two isolates, 82  and 83  (atypical 
avian isolates), did not show haemolysis on blood agar but were positive with 
the molecular method. These results are in agreement with previous reports. For 
example, Gibbs  et al.  (1978a) showed that  100% of S.  aureus strains isolated 
from  five  broiler processing plants  and  from  one  plant processing end-of-Iay 211 
hens produced a-haemolysin. Also, in the study by Gibbs et al.  (1978b), 83 % of 
S.  aureus strains isolated from processed poultry and processing plants produced 
a-haemolysin. Thompson et at.  (1980a) reported that 88% of S.  aureus strains 
isolated from  live-birds  produced a-haemolysin.  Harvey  et al.  (1982)  showed 
that 100% of S.  aureus strains isolated from raw poultry carcasses produced a-
haemolysin. 
Of thirteen  human  S.  aureus  isolates  examined  in  this  study  by  molecular 
methods  for  the  haemolysin  genes,  all  gave  a  positive  peR reaction  for  a-
haemolysin. Of the three avian coagulase-negative strains tested, none of them 
showed haemolysins genes. Of the four animal S.  aureus isolates examined, all 
isolates had the a-haemolysin gene. Christens  son and Hedstrom (1986) reported 
that,  in human isolates  of S.  aureus,  58%  of strains  produced  a-haemolysin. 
Coia  et  al.  (1992)  determined  haemolysin  produced  by  methicillin-resistant 
(MRS  A)  and  sensitive  (MSSA)  s.  aureus.  According  to  their  results,  the 
distribution  of a-haemolysin  production  was  81 %  and  65%  for  MRSA  and 
MSSA respectively. Aarestrup et al.  (1999) showed that 63% of human isolates 
of  S.  aureus and 37% of  bovine S.  aureus isolates were a-haemolytic. 
The multiplex PCR results showed that all the 86  avian S.  aureus isolates also 
had the o-haemolysin gene. Gibbs et al.  (1978a) showed that 100% of  S.  aureus 
strains isolated from five broiler processing plants and from one plant processing 
end-of-Iay  hens  produced  o-haemolysin.  In  another  study  by  Gibbs  et  al. 
(1978b),  98%  of  S.  aureus  strains  isolated  from  processed  poultry  and 
processing plants produced o-haemolysin. Thompson et al.  (1980a) reported that 
45%  of S.  aureus  strains  isolated  from  live-birds  from  different  countries 
produced o-haemolysin. The haemolysin results by the molecular method for 0-
haemolysin  in  the  present  study  on  avian  S.  aureus  strains  agreed  with  the 
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Of thirteen  human  S.  aureus  isolates  examined  in  this  study,  all  had  the  8-
haemolysin gene. According to the results of Coia et al.  (1992) 62% and 61 % of 
MRSA  and  MSSA respectively produced 8-haemolysin.  In  another report,  8-
haemolysin was produced by 97% of human S.  aureus isolates and also by 50-
70% of  coagulase-negative staphylococci (Bohach et al.,  1997). 
There  is  no  published  information  about  y-haemolysin  production  in  aVIan 
isolates of  S.  aureus. The multiplex PCR results in the present study showed that 
74  (86%)  the  86  avian  S.  aureus isolates  had the y-haemolysin  gene.  Of the 
twelve strains that did not appear to have the y-haemolysin gene, eight of these 
according to PCR-ribotyping method 2 and other molecular methods were in the 
atypical avian group. These isolates were 82, 83, 86,496,525,562,217 and 235 
(Table 3.20). Two of the four other strains did not have y-haemolysin were in 
another group of  atypical avian S.  aureus strains. These isolates were NFR (from 
bumbelfoot in a Gyr falcon) and 31039 (from skin scab lesions in a commercial 
flock)  (Table 3.21). Another two avian strains that did not have y-haemolysin 
were  PD458  from  Sri  Lanka  (typical  avian)  and  98  from  N.  Ireland  (typical 
avian) unrelated to type 24). 
Of thirteen  human  S.  aureus  isolates  examined  in  this  study,  61.5%  of the 
isolates  showed  a  y-haemolysin  band.  Christens  son  and  Hedstrom  (1986) 
reported  that,  in  human  isolates  of S.  aureus,  24%  of strains  produced  y-
haemolysin. Coia et al.  (1992) determined haemolysins produced by methicillin-
resistant (MRSA)  and sensitive (MSSA) s.  aureus. According to  their results, 
the distribution of y-haemolysin production was 69% and 57%  for  MRSA and 
MSSA  respectively.  Bohach  et  al.  (1997)  reported  that  nearly  all  human  S. 
aureus  strains  manufacture  y-haemolysin,  which  is  inactivated  by  agar  and 
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The PCR results for detection of  the  ~-toxin gene in this study showed that only 
four of the 86 avian S.  aureus isolates (5%) gave a positive reaction. According 
to PCR-rihotyping method 2 and other molecular methods, these strains were in 
the  atypical  avian  groups  (Tables  3.20,  3.21  and  3.23).  These  strains  were 
31178, 32528, 496 and 525. The biological assay for  ~-toxin in the present study 
agreed with the molecular method for  all  86  strains  except that two  avian S. 
aureus isolates, 31039 and 562 gave a positive result with the biological method 
but did not give a positive result with the molecular method. These two strains 
according to  other molecular methods were in an atypical avian group (Tables 
3.20,  3.21  and  3.23).  Sequence  variation  in  the  primer  regions  in  the  ~­
haemolysin encoding gene of isolates 31039 and 562 is suggested, and should be 
investigated further. 
Gibbs et at.  (1978a) showed that  18%  of S.  aureus  strains isolated from  five 
broiler processing plants and one plant processing end-of-Iay hens produced  ~­
haemolysin. In another study, Gibbs et at.  (1978b) showed that 24% of  S.  aureus 
strains  isolated  from  processed  poultry  and  processing  plants  produced  ~­
haemolysin.  On the  other hand,  Thompson  et  at.  (1980a)  reported  that  <1 % 
(1/108)  of S.  aureus  strain  isolated  from  live  birds  from  different  countries 
produced  ~-haemolysin. Harvey et at.  (1982)  showed that none of S.  aureus 
strains isolated from raw poultry carcasses produced  ~-haemolysin. Rodgers et 
at.  (1999) reported that none of the S.  aureus isolated from skeletal disease in 
broilers produced ~-haemolysin. Also, early work on staphylococci isolated from 
poultry has  shown wide  variations,  from  0-36%,  in  the  proportion of strains 
producing  ~-lysin (Genigeorgis and Sadler,  1966; Harry,  1967a, b;  Devriese et 
at.,  1972; Sato et at.,  1972). 
Of the two avian coagulase-negative strains examined for  ~-haemolysin, neither 
showed  any  band.  Of the  twelve  human  S.  aureus  isolated  tested  for  ~­
haemolysin, seven (58%) showed a  ~-haemolysin band. Coia et at.  (1992) had 
shown  ~-haemolysin was  produced by 23%  and  35%  of MRSA and  MSSA, 214 
respectively.  According to  other reports,  10-15% of S.  aureus human isolates 
and  75-100%  of bovine  isolates  were  ~-haemolytic (Elek  and  Levy,  1950; 
Poutrel  and Ducelliz,  1979).  Similarity  Aarestrup  et  at.  (1999)  found  the  ~­
haemolysin gene in 100% of bovine S.  aureus and in 56% of the human isolates 
examined.  Larsen et at.  (2002)  showed that 97%  of S.  aureus strains  isolated 
from bovine mastitis in Europe and USA were PCR-positive for and/or produced 
~-haemolysin on 5%  calf blood agar.  Except for three isolates, the Norwegian 
isolates were PCR-negative, but positive on 5% calf blood agar. 
Overall,  it  seems  that  ~-haemolysin production  is  common  in  human  and 
especially bovine strains of S.  aureus but uncommon in typical avian strains. It 
may be that the four atypical avian strains identified in this study as possessing 
the  ~-haemolysin gene  and  two  additional  strains  producing  ~-haemolysin on 
blood agar were originally from human or animal sources. 
4.5 SEQUENCE ANALYSIS 
DNA sequence  analysis  is  an  objective  genotyping  method and  the  resulting 
sequence is highly portable and easily stored and analysed in relevant databases. 
Recent advances  in  DNA sequencing  technology,  including rapid,  affordable, 
high-throughput systems, have made it possible for sequencing to be considered 
as  a  viable typing method.  Sequencing the  same  DNA targets  from  different 
isolates  and  then  cataloguing  the  allelic  patterns  is  called  comparative 
sequencing. Two different strategies have been used to provide genotyping data: 
multilocus  sequence  typing  (MLST),  which  compares  sequence  variation  in 
numerous housekeeping gene targets,  and  single-locus  sequence typing, which 
compares sequence variation of  a single target. 
In  the  present  study  sequence  analysis  of a  number  of selected  genes  was 
determined, for typical and atypical avian and some control S.  aureus strains. 215 
4.5.1 Sequence analysis of 16S rRNA gene 
Comparison  of  16S  rRNA  sequences  has  proved  extremely  useful  for 
determining  phylogenetic  relationships  among  eukaryotic  and  prokaryotic 
organisms (Woese et al.,  1985; Woese, 1987). Dewhirst et al.  (1992), using 16S 
rRNA sequence  comparisons,  demonstrated  that Pasteurella  haemolytica  and 
Pasteurella trehalosi belong to  different clusters in the family Pasteurellaceae 
and may,  in  fact,  belong to  different genera.  However, it should be noted that 
both P.  haemolytica and P.  trehalosi were excluded from the genus Pasteurella 
sensu  stricto  by  Mutters  et  al.  (1985),  and  P.  haemolytica  has  since  been 
reclassified  as  Mannheimia  haemolytica.  In  the  present  study  16S  rRNA 
sequences were examined for any differentiation between the S.  aureus isolates. 
Sequence analysis of 16S rRNA gene of  S.  aureus isolates including seven avian 
and one human strains showed that all were 100% identical and also identical to 
that  of another  human  S.  aureus  strain  ATCC  12600 published  in  GenBank 
(accession number L37597).  Thus there was  no evidence from  16S  sequences 
that avian strains form a group distinct from human strains. 
4.5.2 Sequence analysis of coagulase gene region 
The  present  study reports  the  sequence  of the  coagulase  gene  from  avian  S. 
aureus  strains.  As  described  in  section  3.9.2,  sequence  analysis  of the  repeat 
region of  the coagulase gene showed that typical avian S.  aureus isolates 24, 85, 
99,  2B,  31174,  PD27,  34  and  38  were  100%  identical,  and  they  were  97% 
(nucleotides)  and  100%  (amino  acids)  identical to  that of a human  S.  aureus 
isolate 213 in GenBank (accession number XI6457). The typical avian S.  aureus 
isolates 24,  85,  99,  2B,  31174, PD27,  34 and  38  were 95% (nucleotides)  and 
94%  (nucleotides)  identical  to  atypical  avian  S.  aureus  strains  82  and  496, 
respectively. These results indicate a relationship between RFLP analysis of the 
coagulase region and sequence analysis for typical avian S.  aureus (Table 3.15 
and Figures 3.15a and b and Appendix III-b).  Sequencing results of atypical 
avian isolates 82 and 496 also show that they were 94% and 95% identical with 
a human S.  aureus strain 213  in GenBank (accession number XI6457). Isolates 216 
82,  83,  86,  562,  217 and 235  were 98.5% (nucleotides) identical to strains 496 
and  525.  However,  the  sequence  of human  isolate  RN4220  was  only  94% 
(nucleotides) identical to that of  human isolate BB in the database. 
From sequence  analysis  of the  coagulase repeat  region  it  can  concluded that 
typical avian S.  aureus isolates  are  different from  atypical  avian or human S. 
aureus  isolates,  but more  isolates  would need to  be  compared before  a clear 
relationship could be discussed. 
4.5.3 Sequence analysis of agrBDC gene region 
Sequence analysis of the agrD gene within the agrBDC gene region was used to 
show variation in auto inducing peptide production in S.  aureus strains. Typical 
avian  strains  24,  85,  99,  2B,  31174,  PD27,  104,  595,  35,  98,  34  and 38  and 
atypical avian strains 82,  83, 86,  562, 217, 235, 496, 525, 31178 and 32528 had 
different sequences and the sequence of strains 82, 83, 86, 562,217 and 235 was 
different from  that of strains  496,  525,  31178  and  32528.  The  sequence  also 
revealed that the typical avian strains 24, 85,99, 2B, 31174, PD27, 104,595,35, 
98,  34 and 38  were in group II of the autoinducing peptides encoded by agrD 
(Jarraud et al.,  2000).  Strains  82,  83,  86,  562,  217,  235  and RN4220  (human 
strain) were in group I and strains 496, 525, 31178 and 32528 were in group III 
according to this classification scheme (Jarraud et al.,  2000). 
The biological role and significance of these AgrD  groupings is  not clear, but 
group-specific  differences  in  the  expression of subsets  of virulence  factors  or 
other extracellular proteins could be possibly related  to  differences  in  disease 
patterns. Atypical avian strains 31178, 32528, 496 and 525 were in group III and 
produced one  or more of enterotoxins A and  B,  exfoliative toxin B and toxic 
shock toxin-I. Ji et al.  (1997) have shown that most human S.  aureus strains that 
produced toxic shock toxin-1  were in agr specifity group III, but Jarraud et al. 
(2000)  showed  that most exfoliative toxin-producing  human S.  aureus  strains 217 
belong to group IV. However, the present study concluded that the sequence of 
agrD can be used to differentiate typical avian from some atypical avian isolates. 
4.6 EXTRACELLULAR PROTEINS 
4.6.1 Exoprotease activity in avian strains of  S. aureus 
At least four major extracellular proteases have been reported to be produced by 
strains  of S.  aureus  (Arvidson,  2000):  staphylococcal  serine  protease  (V8 
protease) (SspA), a metalloprotease named aureolysin (Aur), a cysteine protease 
(Scp) named staphopain (Hofmann et al.,  1993), and a second cysteine protease 
(SspB) encoded within the same operon as  SspA (McGavin et al.,  1997;  Chan 
and Foster, 1998). All four proteases appear to be synthesized as preproenzymes, 
which  are  proteolytically  cleaved  to  generate  the  mature  enzymes  (Drapeau, 
1978;  Rice et al.,  2001).  The synthesis of extracellular proteases is  positively 
regulated by agr and negatively regulated by SarA (Janzon et al.,  1986;  Chan 
and Foster, 1998). The gene for a second serine protease was identified in whole 
genome sequencing (Kuroda et al.,  2001) and this protease may have a function 
similar  to  V8  protease  (SspA).  Genes  encoding  metalloproteases  have  been 
cloned from S.  hyicus (Ayora and G6tz, 1994). Takeuchi et al.  (2000) reported a 
common metalloprotease in swine, avian and bovine isolates of  S.  hyicus and S. 
epidermidis  (Teufel  and  G6tz,  1993),  with  the  metalloprotease  from  S. 
epidermidis exhibiting elastase activity.  Recently in GenBank (January, 2001), 
Dubin reported the sequence of an extracellular cysteine proteinase in human S. 
epidermidis isolate 6746 (GenBank accession number AJ298299). 
At  the  start  of the  present  work  there  was  little  published  information  on 
protease activity in avian strains of  S.  aureus. Kuramasu et al.  (1967a) isolated 
strains of  S.  aureus which had strong proteolytic activity from chickens suffering 
from edematous and necrotic dermatitis. In addition, they conjectured that there 
might be a relationship between the protease and the dermatitis in the chickens, 218 
because dennatolysis was observed in young chickens and mice when they were 
inoculated subcutaneously with more than 10
7 cells of a protease-positive strain. 
More recently, Takeuchi et at.  (1999) characterised two proteases produced by 
an avian strain of  S.  aureus, from a chicken suffering from dennatitis. The two 
proteases, of  molecular weight 23.1 and 22.7 kDa, were purified from the culture 
supernate of this strain. Their isolelectic points were 5.85 and 5.55 respectively, 
they had antigenic similarity and their N-tenninal amino  acid  sequences were 
identical:  RAQYVNQLKNFKIRETQ. Their activity was strongly increased by 
reducing  agents  such  as  L-cysteine,  they  were  inhibited  by  thiol  (cysteine) 
protease inhibitors but not by metalloprotease or serine protease inhibitors and 
were thus presumed to be thiol (cysteine) proteases (Takeuchi et at.,  1999). 
One  of the  most striking  findings  in  the  present study was  the  presence of a 
single dominant protein band in the culture supernates of most avian S.  aureus 
strains.  The results from  SDS-PAGE gels  in this  study on  67  avian S.  aureus 
isolates showed that 60 (89.5%) of these isolates had a single dominant protein 
band  of 22  kDa  (Figure  3.5).  N-tenninal  sequence  analysis  of the  22  kDa 
protein  provided  the  first  11  amino  acids,  the  sequence  of  which, 
VRAQYVNQLKN, was almost identical to that reported for the thiol (cysteine) 
proteases studied by Takeuchi et at.  (1999). This finding suggested how the 22 
kDa protein could be further characterised. Screening on skim milk agar plates 
and  the  effect  of different  inhibitors  and  an  activator  on  protease  activity 
supported the conclusion that the 22  kDa band represented a cysteine protease. 
Amplification and sequencing of a 522 bp region from  avian S.  aureus isolates 
24 and 31179 and from  the human S.  epidermidis isolate  134  showed that the 
sequences  for  strains  24  and  31179  were  100%  identical  but  had  only  80% 
identity  to  that in  the  S.  epidermidis  strain  and  42%  identity to  the  cysteine 
protease  (staphopain)  gene  in  human  S.  aureus  isolates.  The  corresponding 
sequence of  the ecp gene of human S.  epidermidis isolate 134 used in the present 
study  showed  100%  identity  with  the  published  sequence  (Appendix  III-a). 
When  amino  acid  sequences  were  compared  the  avian  cysteine  protease  had 219 
81 % identity to the extracellular cysteine proteinase (ecp) in S.  epidermidis. 77% 
identity to the scp cysteine protese (staphopain) gene in human S.  aureus strains 
and  50%  identity  to  the  second  cysteine  protease  (sspB)  gene  in  human  S. 
aureus. 
Of the 67 avian strains examined, 60 strains had the 22 kDa band in the culture 
supernate  and  showed  protease  activity  on  skim  milk  agar.  It seems  likely 
therefore  that  all  of these  strains  produced  a  cysteine  protease.  All  of these 
strains  were  from  diseased  birds.  38  (65%)  isolates  were  from  broilers  with 
different  diseases  such  as  synovitis;  femoral  head  necrOSIS;  tibial 
dischondroplasia; rotated tibia; bumblefoot and proximal femoral degeneration 
and the site of isolation were joint, foot, and a case from skin. Eight (13.3%) of 
the 60 isolates were from chicks,  1-2 days old, with different diseases such as 
yolk sac infection and mushy chick disease and the sites of isolation were yolk 
sac and heart. For the other isolates, these was no record about disease history or 
site of isolation. The other seven isolates did not have a 22 kDa protease band in 
their culture supernates  and were negative  for  protease  activity on skim  milk 
agar (except isolate 31177 which was positive on skim milk agar). Four of these 
isolates, 31178, 32528, 82 and 496, showed bands with PCR-ribotyping method 
2,  and  thus  are  atypical  avian  isolates.  Two  other  isolates  that  did  not  give 
positive-protease  bands  were  31039  (from  skin  scab  lesions)  and  K  (from 
bumblefoot).  Again  these  strains  were  atypical  avian  S.  aureus  according  to 
different molecular  methods.  Strain  31177  was  typically  avian  by  molecular 
methods.  It  is  tempting  to  speculate  that  the  extracellular  cysteine  protease 
produced by disease-causing avian isolates might playa role in joint, foot and 
yolk sac diseases in birds. Further work is required to  confirm this suggestion. 
One way to do this would be to create "knock-out" mutants in the protease gene 
and to  compare the  virulence of the  wild-type and  mutant strains in different 
models of infection. For example, intravenous injection of staphylococci can be 
used to produce chronic synovitis in chicks (Forget et at.,  1974). 220 
This study also concluded that human S.  epidermidis isolates have the cysteine 
protease gene but they may not be  able to  express it under the in vitro growth 
conditions used here  (Figures 3.6 and 3.10). Protease activity on gelatin gels 
showed  slightly different  patterns  between  strains  of PFGE  type  24  (Figure 
3.11) and it may be possible to improve this method for discrimination between 
avian S.  aureus strains related to  PFGE type 24  according the  designation of 
McCullagh et al. (1998). 
4.7 GROWTH OF S.  aureus STRAINS AT HIGH TEMPERATURES 
These experiments need to be repeated with a wider selection of strains and with 
a more accurate temperature control over say 44-47 DC.  In this way, it may be 
possible to distinguish strains that are well adapted to growth in birds with their 
higher  body  temperatures  and  those  strains  that  have  been  acquired  more 
recently from other sources. 
4.8 SUMMARY OF TYPING OF AVIAN STRAINS 
One focus of  interest in the present study was to examine a collection of avian S. 
aureus  strains  that  had  been  biotyped  and  typed  by  PFGE  according  to  the 
scheme  of  McCullagh  et  ai.  (1998),  and  had  been  shown  to  be  either 
indistinguishable or related  or unrelated by  these  methods.  This  collection of 
strains that were "type  24",  "closely-related"  (CR),  "possibly-related"  (PR),  or 
"unrelated" (UR) to type strain 24 on the basis of their PFGE band patterns were 
kindly provided by Dr.  McCullagh (Veterinary Science Division of Agriculture 
for  Northern  Ireland,  Belfast).  These  strains  were  subjected  to  the  various 
molecular fingerprinting methods developed in this study and a summary of the 
results obtained with the genotyping methods is shown in Table 3.20. 
All  of the type 24  strains (i.e.  indistinguishable from  type strain 24 by PFGE) 
gave identical profiles by the panel of tests listed in the table and so these tests 221 
were no more discriminating than PFGE. Strain 77 was different from the other 
type  24  strains  by  plasmid profiles  (Table 3.4),  antibiotic  resistance  pattern 
(Table 3.9) and 22 kD protease band (Table 3.10). Strains 572 and 582 showed 
differences  by  antibiotic  resistance  pattern  (Table  3.9)  and  on  gelatin  gels 
(Figure 3.11).  Strain  100  was differentiated by its  antibiotic resistance pattern 
(Table 3.9).  Strains 85  and  123  were differentiated on the gelatin gels (Figure 
3.11). The majority of  the type 24 strains that had been biotyped belonged to the 
poultry group. Four type 24 strains (11, 31, 33,47) belonged to the NHS biotype 
i.e.  they differed from the poultry biotype in Table 3.1. None of the molecular 
methods listed in Table 3.20 or other tests were able to discriminate between 
these two biotypes. 
Four of the  strains examined had been designated as  CR by McCullagh et at. 
(personal  communication)  because  their  PFGE  profiles  showed  (1-3)  band 
differences  from  the  type  24  profile.  One  such  CR strain  (34)  had the  NHS 
biotype and two (38 and 564) had the poultry biotype but were indistinguishable 
by the methods listed in the Table.  Strain 564 was  different from the other CR 
strains by plasmid profiles (Table 3.4) and antibiotic resistance pattern (Table 
3.9).  One CR strain (595) and the only PR strain available (i.e.  differing from 
type 24 in (4-6) bands by PFGE), however, were distinguishable from all of the 
above strains in that they had distinct profiles by PCR ribotyping method 1 and 
after restriction of the  coagulase gene amplimer and also  by plasmid profiles 
(Table 3.4)  and antibiotic  resistance  pattern (Table 3.9).  In these properties, 
they resembled a group  of UR strains (see below)  but could be  distinguished 
from them by REP-PCR.  Thus the  genotyping methods  used in present study 
were able to distinguish one CR strain from three others. The CR strains differ 
from type 24 in their PFGE profiles but it is not known if they differ from each 
other by this method. Unfortunately, no records of  their individual profiles were 
available from  Dr McCullagh. It would be of interest,  therefore,  to  repeat the 
PFGE typing with these and other selected strains to compare this typing method 
with the methods developed in the present study. 222 
One group of strains listed in Table 3.20 (strains 35, 36, 98, 580, 597, 598) and 
designated as  DR (unrelated to  type 24  and differing by more than 6 bands in 
their  PFGE  profiles)  formed  a  distinct  group  that  were  identical  by  the 
genotyping methods used here but different from the above type 24 strains and 3 
of the  CR  strains  by  ribotyping  method  1,  REP-PCR  and  their  restricted 
coagulase  gene  PCR  amplimer.  According  to  McCullagh  (personal 
communication) these strains are also related to each other on the basis ofPFGE. 
Isolates  35,  580,  597,  598  were  indistinguishable  by  PFGE,  isolate  36  was 
closely-related  to  this  group  and  isolate  98  possibly-related  according  to  the 
PFGE patterns and the criteria used by McCullagh et at.  (1998). Thus there was 
good agreement between the PFGE method and the methods used in the present 
study  although the  former  was  more  discriminating.  Strains  98,  597  and  598 
could be differentiated among the DR strains by plasmid profiles (Table 3.4). 
An  interesting  group  of  strains  was  another group (82,  83,  86,  562, 496, 
525) of  DR strains that, unlike most of  the other avian strains, could be typed by 
ribotyping  method  2.  This  ribotyping  method  had  been  developed  for  the 
identification of bovine isolates of  S.  aureus (Forsman et aI.,  1997) but also gave 
amplimers  with all  14  of the  strains  from  human and  diverse  animal  sources 
obtained in the present study. Three strains had the poultry biotype, two had the 
NHS  biotype  and  one  had  the  slaughterhouse  biotype  (see  Table  3.1).  This 
atypical  group  of avian  isolates  also  differed  from  the  other  avian Northern 
Ireland  strains  in  their profiles  obtained  by  ribotyping  method  1,  REP-PCR, 
coagulase and protein A gene amplimers, after restriction of the agrBDC region 
and  by  their  lack of the  y-haemolysin gene.  Three  strains  (82,  83,  86)  were 
indistinguishable by these means.  Isolate 562  differed from  these three strains 
only in  the  band patterns  obtained  for  the  protein A  gene  region,  which was 
identical  to  those  for  the  more  typical  avian  strains  and  possibly  by  its 
production of ~-haemolysin (biological method).  The two NHS biotype strains 
496 and 525 were different but indistinguishable from each other. According to 
McCullagh (personal communication) strains 82  and  83  were isolates from  the 223 
same  broiler  farm  and  were  identical  to  each  other  by  PFGE.  They  were 
unrelated in their PFGE type to  isolate 86 but there was no  difference between 
these strains by the fingerprinting methods used in the present study. Strains 496 
and 525  had identical PFGE types and their genetic relatedness was confirmed 
by the methods used here,  including their toxin and haemolysin genes.  Isolate 
562 was from a pheasant and had a unique PFGE type and was also distinct by 
the fingerprinting methods used here. Again, there was good agreement between 
the PFGE method and the methods used in the present study although the former 
was more discriminating. It would be of interest to repeat the PFGE typing with 
these strains to compare this typing method with the methods developed in the 
present study. Strains 82, 83, 86 and 562 were differentiated among this group of 
the  UR strains  by plasmid profiles  (Table 3.4);  also  strains  86  and  562  had 
antibiotic resistance patterns different from  other strains of this  group  (Table 
3.9). 
The majority (24/35) of the other avian isolates used in the present study, from 
different  geographical  locations,  were  indistinguishable,  on  the  basis  of the 
genotyping methods  used  in  the  present  study,  from  the  type  strain 24  from 
Northern Ireland. Strains 3A,  6,  7  A,  7B  and PD458 were differentiated in  this 
group  of the  strains  by plasmid profiles  (Table 3.4).  Also,  except for  strains 
PD27, PD380, PD458 and PD486 that had similar antibiotic resistance patterns 
to  the type 24 strains,  other strains  had  different antibiotic resistance patterns 
from  type  24  (Table 3.9).  It appears,  therefore,  from  the collection of strains 
used  in  the  present study,  that the  majority  of avian  S.  aureus  isolates  from 
diseased birds form  a closely-related group,  irrespective of geographic origin. 
This  suggestion  could  be  investigated  by  thorough  taxonomic  studies,  for 
examples using MLEE and or MLST, as has been done for human isolates of  S. 
aureus (Enright et al., 2000). 
Only  11  of the  35  avian  strains  that  were  not  from  Northern  Ireland  gave 
atypical  profiles  by  the  genotyping  methods  used  here.  The  results  for  these 224 
strains  are  shown in  Table 3.21  and  they can be seen to  fall  into  two  broad 
groups depending on whether they  were typable by ribotyping method 2.  The 
strains that did not type by ribotyping method 2 were mostly very similar to the 
typical avian strains in that three of them differed in only one property i.e.  strain 
31036 differed only in the protein A gene region, 31039 differed by ribotyping 
method 1 and lack ofy-haemolysin gene (and possibly produce of p-haemolysin) 
and E differed only in the coagulase gene region. Strain K differed by ribotyping 
method  1 and  in  the  protein  A  gene  region  whereas  strain NFR differed  in 
several properties. 
The six strains  in this  group that typed by ribotyping method 2,  like those  in 
Table 3.20, were a heterogeneous group and also differed from typical strains by 
the  other  genotyping  methods  including  in  some  cases  their  toxin  and 
haemolysin gene profiles. Any future work on the above atypical isolates should 
also include PFGE typing according to the scheme of McCullagh et al.  (1998) 
and biotyping  according  to  the  scheme  of Devriese  (1984)  and  Isigidi  et  al. 
(1990) in order to  compare these methods with those developed in the present 
study. It could be predicted that they would be unrelated to type 24 and probably 
to each other by PFGE typing. Taxonomic studies by MLEE and MLST might 
reveal that the strains that type by ribotyping method 2 are only distantly related 
to the typical avian strains and might possibly be more closely related to human 
or  animal  strains.  This  last  possibility  is  reinforced  by  a  number  of the 
fingerprinting  methods used  in  the  present study where  these  atypical  strains 
have  profiles  which  contain  bands  in  common  with  some  of the  randomly 
collected human and animal strains used as  controls in Tables 3.13-3.19. Also, 
the only avian isolates found to produce staphylococcal enterotoxins (e.g. strains 
496,  525,  31178), TSST-l  and exfoliative toxin (strain 32528), were found  in 
this group. These particular strains may have been recently acquired from human 
or animal  sources  (e.g.  strain  32528,  isolated  from  a  cockatoo  and  therefore 
likely  to  be  in  contact  with  humans).  Other  strains  in  this  group  may  have 
evolved from  human or animal sources  but adapted to  the  avian environment. 225 
Some of  them, at least, were known to have the poultry biotype. Of these strains, 
only 31036 and E had the 22 kDa protein band. 
4.9 CONCLUSIONS 
Results of this investigation have shown that the majority of avian isolates of  S. 
aureus  appear to  be  clearly  distinct  from  S.  aureus  isolates  from  other  host 
species  and  from  avian  coagulase-negative  strains  of  staphylococci.  For 
example, a high proportion (95%) of avian S.  aureus isolates have one or more 
plasmids whereas only a low proportion of avian coagulase-negative and human 
S.  aureus isolates possess  one  or  more  plasmids.  In  addition,  the majority of 
avian isolates did not produce enterotoxins or p-haemolysin, yet they produced a 
large amount of the putative extracellular cysteine protease. By contrast, human 
isolates generally produced one or more enterotoxins and p-haemolysin, but not 
the exoprotease. 
The  clearest  difference  between  aVIan  S.  aureus  and  S.  aureus  from  other 
sources  was  provided by the  molecular  fingerprinting  methods.  The  majority 
(80%) of  the avian S.  aureus strains, even from different geographical locations, 
had similar "typical avian" profiles whereas 20% had atypical avian profiles but, 
overall, these latter strains were still distinct from human and animal isolates. 
Thus, from the avian S.  aureus strains collected in the present study, it appears 
that "typical" avian strains, like the type 24 strains described by McCullagh et 
al.  (1998) or those strains indistinguishable from type 24 by the fingerprinting 
methods  used  here,  are  responsible  for  the  majority  of cases  of disease  in 
chickens. However, many more isolates from different sources would need to be 
collected and typed before this hypothesis could be proved. Comparative studies 
in a suitable avian or animal model of infection would indicate whether these 
different properties were reflected in differences in the manner by which avian 
and other S.  aureus strains colonised and persisted in the host during infection. 226 
4.10 FUTURE WORK 
Many different lines of investigations are  suggested by the findings in this study, 
for example: 
1. The most important of  these would be to investigate the role that the extracellular 
cysteine protease in avian S.  aureus isolates might play in leg weakness Goint, foot) 
and yolk sac disease in birds. The aim would be to create "knock-out" mutants in 
the protease gene and to compare the virulence of the wild-type and mutant strains 
in different models  of infection.  Alternatively, the protease could be  purified or 
produced by recombinant means and made into a vaccine for testing as a protective 
antigen. 
2. Taxonomic studies by MLST and MLEE on a large number of  avian, animal and 
human isolates would be  interest.  For example this might reveal that the avian S. 
aureus strains that type by ribotyping method 2,  or  are  otherwise "atypical", are 
only  distantly  related  to  the  typical  avian  S.  aureus  strains  and  might be  more 
closely related to human or animal strains. 
3.  Other work could  be  to  determine  the  correlation,  if any,  between antibiotic 
resistance and the presence of some of the common plasmids in avian S.  aureus and 
avian coagUlase-negative, and if  these plasmids are transmissible between strains. 
4.  Expression  of the  protein  A  gene  in  aVIan  S.  aureus  strains  should  be 
investigated.  According to  the  biotyping  scheme  of Isigidi  et al.  (1990),  the 
avian biotype does not express protein A.  However, from the present work, the 
protein A gene is present in all avian strains. 5. APPENDICES Appendix I 
5.1 Media composition 
5.1.1 Luria Bertani broth (LB) 
1 Litre 
Tryptone 
Yeast extract 
Sodium chloride 
Add 1.2% agar for solid media 
5.2 Molecular biology solutions 
227 
109 
5g 
109 
5.2.1 Tris-borate-EDTA (TBE) buffer (5x stock solution) 
Tris 
Boric acid 
EDTA (0.5M stock) 
54g 
27.5g 
20ml 
5.2.2 DNA loading dye (6x stock solution) 
Tris 
EDTA 
Sucrose 
Bromophenol blue 
60mM 
6mM 
40% 
0.25% 5.3 Protein analysis solutions 
5.3.1 Protein sample buffer 
Glycerol 
20% SDS 
2-mercaptoethanol 
Tris (0.5ml, pH 6.8) 
Bromophenol blue 
5.3.2 Stacking gel (6%) 
Acrylamide/Bis solution 
dH20 
Tris-HCl (0.5M, pH 6.8) 
20% SDS 
TEMED 
228 
5ml 
2.5ml 
0.5ml 
2.5ml 
0.25% 
4ml 
1O.69ml 
5ml 
100/l1 
1O/l1 
10% Ammonium persulphate (APS)  200/ll 
5.3.3 Separating gel (12.5%, adjust volume of  AcrylamidelBis 
solution and dH20 \ to change percentage) 
Acrylamide/Bis solution 
dH20 
Tris-HCl (0.5M, pH 6.8) 
20% SDS 
TEMED 
10% Ammonium persulphate (APS) 
4ml 
12.6ml 
10ml 
400/l1 
30/l1 
300/l1 229 
5.3.4 PAGE running buffer (lOx) 
1 Litre 
Tris  30g 
Glycine  l44g  pH 8.3 
SDS  109 
5.3.5 Coomassie blue gel stain 
Coomassie blue  O.Sg 
Methanol  SOOml 
Acetic acid  lOOml 
dH20  400ml 
For destain solution the Coomassie blue was omitted. 230 
Appendix II Schematic representation of the amplification of different regions of 
the S. aureus genome. The approximate locations of the forward and reverse 
primers sites are shown. 
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Appendix III. Comparison of sequences of different genes. 
a) Comparison of sequences of cysteine protease genes 
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'31179 
b134 
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ATGAGAGCACAATATGTAAATCAATTAAAGAACTTTAAAATCAGAGAAACACAAGGTAAT  60 
ATGAGAGCACAATATGTAAATCAATTAAAGAACTTTAAAATCAGAGAAACACAAGGTAAT  60 
ATGTACGCAGAATATGTAAATCAATTAAAGAATTTCAGAATACGAGAAACACAAGGGTAT  60 
***  ***  **********************  **  *  ***  *************  ** 
AATGGTTGGTGTGCTGGATATACAATGTCAGCATTACTGAATGCAACTTATAATACAGAT  120 
AATGGTTGGTGTGCTGGATATACAATGTCAGCATTACTGAATGCAACTTATAATACAGAT  120 
AATAGTTGGTGTGCCGGCTATACCATGTCAGCACTACTCAATGCCACATATAATACAAAT  120 
***  **********  **  *****  *********  ****  *****  **  *********  ** 
CGTTATAATGCTGAGGCAGTAATGAGATATTTACATCCGAATTTACAAGGTGATGATTTC  180 
CGTTATAATGCTGAGGCAGTAATGAGATATTTACATCCGAATTTACAAGGTGATGATTTC  180 
CGATATAATGCAGAATCAGTAATGAGATATTTACATCCTAATTTAAGAGGTCACGACTTC  180 
**  ********  **  **********************  ******  ****  *  **  *** 
CAATTTACAGGTTTAACACCTCAAGAAATGATGAAGTATGGGAAATCACAGGGTAGAGAT  240 
CAATTTACAGGTTTAACACCTCAAGAAATGATGAAGTATGGGAAATCACAGGGTAGAGAT  240 
CAATTTACAGGACTAACATCTAACGAGATGCTTCGTTTTGGTAGATCACAAGGCAGAAAT  240 
***********  *****  **  *  **  ***  *  *  ***  *  ******  **  ***  ** 
ACTCAATATCTTAATAGAATGCCATCTTATAATGAAGTTGATAAATTGACTACTAATAAT  300 
ACTCAATATCTTAATAGAATGCCATCTTATAATGAAGTTGATAAATTGACTACTAATAAT  300 
ACTCAATATCTTAATAGAATGACTTCATATAATGAAGTAGACCAATTAACAACTAATAAT  300 
*********************  *  **  ***********  **  ****  **  ********* 
AAAGGCATTGCTATTTTAGGAAGTCGTGTAGAATCAACAGACGGTATTCATGCAGGACAT  360 
AAAGGCATTGCTATTTTAGGAAGTCGTGTAGAATCAACAGACGGTATTCATGCAGGACAT  360 
CAAGGTATAGCTGTATTAGGTAAGCGTGTTGAATCAAGCGATGGTATTCACGCTGGACAT  360 
****  **  ***  *  *****  *  *****  *******  **  ********  **  ****** 
GCTATGGCTGTAGTTGGTAATGCAGAATTAGAAGGTGGACAAGAAGTGATTATGATTTGG  420 
GCTATGGCTGTAGTTGGTAATGCAGAATTAGAAGGTGGACAAGAAGTGATTATGATTTGG  420 
GCCATGGCTGTGGCTGGTAATGCTAAAGTTAACAACGGACAAAAAGTCATTTTAATTTGG  420 
**  ********  *  *********  **  *  *  ******  ****  ***  *  ****** 
AACCCTTGGGACCGTGGTTTTATGACTCAAGATGCTGAAAGTAATATTATTCCAGTATCT  480 
AACCCTTGGGACCGTGGTTTTATGACTCAAGATGCTGAAAGTAATATTATTCCAGTATCT  480 
AACCCATGGGACAATGGTCTCATGACTCAAGATGCACATAGTAATATCATTCCAGTATCA  480 
*****  ******  ****  *  **************  *  ********  *********** 
AATGGAGATCACTATGAATGGTATGCATCAATTTATGGTTAT  522 
AATGGAGATCACTATGAATGGTATGCATCAATTTATGGTTAT  522 
AATGGCGATCACTATGAATGGTATGCATCAATTTATGGTTAT  522 
*****  ************************************ 
a. Typical avian S.  aureus isolates; b;  Human S.  epidermidis isolate. 234 
b) Comparison of sequences of the coagulase gene region 
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TAACGACAAATCAAGATGGCACAGTATCATACGGAGCTCGCCCAACACAAAACAAGCCAA  60 
TAACGACAAATCAAGATGGCACAGTATCATACGGAGCTCGCCCAACACAAAACAAGCCAA  60 
GTGAAACAAACGCATATAACGTAACAACACATGCAAATGGTCAAGTATCATACGGTGCTC  120 
GTGAAACAAACGCATATAACGTAACAACACATGCAAATGGTCAAGTATCATACGGTGCTC  120 
---------------ACAACGTAACAACACATGCAAATGGTCAAGTATCATATGGCGCTC  45 
---------------ATAACGTAACAACACATGCAAATGGTCAAGTATCATACGGAGCTC  45 
--------------TACAACGTAACGACAAATCAAGATGGCACAGTAACATATGGCGCTC  46 
*  ********  ***  **  *  ****  ****  ****  **  **** 
GCCCAACACAAAACAAGCCAAGCAAAACAAATGCATACAACGTAACAACACATGCAAATG  180 
GCCCAACACAAAACAAGCCAAGCAAAACAAATGCATACAACGTAACAACACATGCAAATG  180 
GCCCGACACAAAACAAGCCAAGCAAAACAAATGCATATAACGTAACAACACATGCAAATG  105 
GTCCGACATACAAGAAGCCAAGCGAAACGAATGCATACAATGTAACAACACATGCAAACG  105 
GCCCAACACAAAACAAACCAAGCAAAACAAATGCATACAACGTAACAACACATGCAAATG  106 
*  **  ***  *  **  **  ******  ****  ********  **  *****************  * 
GTCAAGTATCATATGGCGCTCGCCCGACACAAAAAAAGCCAAGCAAAACAAATGCATATA  240 
GTCAAGTATCATATGGCGCTCGCCCGACACAAAAAAAGCCAAGCAAAACAAATGCATATA  240 
GTCAAGTATCATACGGAGCTCGCCCGACATACAAGAAGCCAAGCGAAACAAATGCATACA  165 
GCCAAGTATCATACGGAGCTCGTCCGACACAAAACAAGCCAAGCAAAACAAACGCATATA  165 
GTCAAGTATCATATGGCGCTCGCCCGACACAAAACAAGCCAAGCAAAACAAATGCATATA  166 
*  ***********  **  *****  ******  *  **  *********  *******  *****  * 
ACGTAACAACACATGCAAATGGTCAAGTATCATACGGAGCTCGCCCGACATACAAGAAGC  300 
ACGTAACAACACATGCAAATGGTCAAGTATCATACGGAGCTCGCCCGACATACAAGAAGC  300 
ACGTAACAACACATGCAAATGGTCAAGTATCATATGGCGCTCGCCCGACACAAAACAAGC  225 
ACGTAACAACACATGGAAACGGCCAAGTATCATATGGCGCTCGCCCAACACAAAACAAGC  225 
ACGTAACAACACATGCAAATGGTCAAGTATCATACGGAGCTCGCCCGACACAAAACAAGC  226 
***************  ***  **  ***********  **  ********  ***  *  **  **** 
CAAGCGAAACAAATGCATACAACGTAACAACACATGCAAATGGTCAAGTATCATATGGCG  360 
CAAGCGAAACAAATGCATACAACGTAACAACACATGCAAATGGTCAAGTATCATATGGCG  360 
CAAGCGAAACAAACGCATATAACGTAACAACACATGCAAACGGTCAAGTATCATACGGCG  285 
CAAGCAAAACAAATGCATACAACGTAACAACACATGCAAACGGTCAAGTGTCATACGGAG  285 
CAAGCAAAACAAATGCATATAACGTAACAACACACGCAAACGGTCAAGTGTCATACGGAG  286 
*****  *******  *****  **************  *****  ********  *****  **  * 
CTCGCCCGACACAAAAAAAGCCAAGCGAAACAAACGCATATAACGTAACAACACATGCAG  420 
CTCGCCCGACACAAAAAAAGCCAAGCGAAACAAACGCATATAACGTAACAACACATGCAG  420 
CCCGCCCAACATACAAGAAGCCAAGCGAAACGAATGCATATAACGTAACAACACATGCAG  345 
CTCGCCCGACATACAAGAAGCCAAGTAAAACAAATGCATACAATGTAACAACACATGCAG  345 
CTCGCCCGACATACAAGAAGCCAAGTAAAACAAATGCATACAATGTAACAACACATGCAG  346 
*  *****  ***  *  **  ********  ****  **  *****  **  **************** 
ATGGTACTGCGACATATGGGCCTAGAGTAACAAAATAAATTTATAACTCTATCCAAAGAC  480 
ATGGTACTGCGACATATGGGCCTAGAGTAACAAAATAAATTTATAACTCTATCCAAAGAC  480 
ATGGTACTGCGACATATGGGCCTAGAGTAACAAAATAAGTTTGTAACTCTATCCAAAGAC  405 
ATGGTACTGCGACATATGGGCCTAGAGTAACAAAATAAGTTTGTAACTCTATCCAAAGAC  405 
ATGGTACTGCGACATATGGGCCTAGAGTAACAAAATAAGTTTGTAACTCTATCCAAAGAC  406 
**************************************  ***  ***************** 
ATACAGTCAATACAAAGAATTATGTATCTATACAACAGTAATCATGCATTCTATGATGCT  540 
ATACAGTCAATACAAAGAATTATGTATCTATACAACAGTAATCATGCATTCTATGATGCT  540 
ATACAGTCAATACAAAACATTACGTATCTTTACAACAGTAATCATGCATTCTATGATGCT  465 
ATACAGTCAATACAAAACATTACGTATCTTTACAACAGTAATCATGCATTCTATGATGCT  465 
ATACAGTCAATACAAAACATTACGTATCTTTACAACAGTAATCATGCATTCTATGATGCT  466 
****************  ****  ******  ****************************** 
TCTAACTGAATTAAAGCATCGAACAATCGGAAGCATATTTCTAAATTATTTATTCATTAT  600 
TCTAACTGAATTAAAGCATCGAACAATCGGAAGCATATTTCTAAATTATTTATTCATTAT  600 
TCTAACTGAATTAAAGCATCGAACAATCGGAAGCATATTTCTAAATTATTTATTCATTAT  525 
TCTAACTGAATTAAAGCATCGAACAATCGGAAGCATATTTCTAAATTATTTATTCATTAT  525 
TCTAACTGAATTAAAGCATCGAACAATCGGAAGCATATTTCTAAATTATTTATTCATTAT  526 
************************************************************ 
AGTCTTAAACATAACATGACCTAATATATTACTAACCTATTAAAATAAACCACGCACATC  660 
AGTCTTAAACATAACATGACCTAATATATTACTAACCTATTAAAATAAACCACGCACATC  660 
AGTCTTAAACATAACATGACCTAATATATTACTAACCTATTAAAATAAACCACGCACATC  585 
AGTCTTAAACATAACATGACCTAATATATTACTAACCTATTAAAATAAACCACGCACATC  585 
AGTCTTAAACATAACATGACCTAATATATTACTAACCTATTAAAATAAACCACGCACATC  586 
************************************************************ 
b) Continned ... b) Continued ... 
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TAAGTGATATACGACAATCACAGCAATAATAATTGCTTTAGAAAGTCGTACCGAACTGGA  720 
TAAGTGATATACGACAATCACAGCAATAATAATTGCTTTAGAAAGTCGTACCGAACTGGA  720 
TAAGTGATATACGACAATCACAGCAATAATAATTGTTTTAGAAAGTCGTACCGAACTGGA  645 
TAAGTGATATACGACAATCACAGCAATAATAATTGCTTTAGAAAGTCGTGCCGAACTGGA  645 
TAAGTGATATACGACAATCACAGCAATAATAATTGCTTTAGAAAGTCGTGCCGAACTGGA  646 
***********************************  *************  ********** 
ACTTACAAGTCTAGTTCGAACACACACTGATGTGAGTGG  759 
ACTTACAAGTCTAGTTCGAACACACACTGATGTGAGTGG  759 
ACTTACAAGTCTAGTTCGAACACACACTGATGTGAGTGG  684 
ACTTACAAGTCTAGTTCGAACACACACTGATGTGAGTGG  684 
ACTTACAAGTCTAGTTCGAACACACACTGATGTGAGTGG  685 
*************************************** 
a:  Typical avian S.  aureus isolates; b:  Atypical avian S.  aureus isolates; c:  Human 
S.  aureus isolate. 236 
c) Comparison of sequences of the agrBDC region 
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---------TATTAAACGAAAAAAATATTATGCGATTATTGTTAGTTTAACCCTTTTCAT  51 
--------TTATTAAACGAAAAAAATATTATGCGATTATTGTTAGTTTAACCCTTTTCAT  52 
AGCGAGGCTTGTAAAGCAAAAAAGATATTTTTCAATTATAATTAGTACAATTCTTTTCAT  60 
--TAAAATTAGTAAAACGTAAAAAGTATTTATCTATAATTATGTATTTATTAGTTTTGAT  58 
--TAAAATTAGTAAAACGTAAAAAGTATTTATCTATAATTATGTATTTATTAGTTTTGAT  58 
*  **  *  ****  ****  *  **  **  *  *  ****  ** 
TATCACACTTATCATCAAAGAGCCATTTGCCCAATTCATTCAATTAGGCATCATAATAGA  111 
TATCACACTTATCATCAAAGAGCCATTTGCCCAATTCATTCAATTAGGCATCATAATAGA  112 
TATCACACTTTTTGTAAAAGAACCATATACCCAATTTATTCAACTGGGTATTATTATACA  120 
TCTATCCTTAATAATACATCCATTTTATGCTCAATTTATGTTATTAGGAATTTTAGTAGA  118 
TCTATCCTTAATAATACATCCATTTTATGCTCAATTTATGTTATTAGGAATTTTAGTAGA  118 
*  *  *  *  *  *  *  *  *  *****  **  *  *  **  **  *  **  * 
AGCTATTACATTATTACCTATTTTCTTTATTAAGGAGGACTTAAA-ATGAATACATTATT  170 
AGCTATTACATTATTACCTATTTTCTTTATTAAGGAGGACTTAAA-ATGAATACATTATT  171 
AGCTATTACATTACTACCAATATACTATTCAAAGGAGGACTAAATTATGAAAAAATTACT  180 
ATCTATTACATTATTACCTATTTTTTTCCCTAAGGAGGA-TTAATCATGAATACACTTGT  177 
ATCTATTACATTATTACCTATTTTTTTCCCTAAGGAGGA-TTAATCATGAATACACTTGT  177 
*  ***********  ****  **  *  *  ********  *  **  *****  *  *  *  * 
TAACTTATTTTTTGATTTTATTACTGGGATTTTAAAAAACATTGGTAACATCGCAGCTTA  230 
TAACTTATTTTTTGATTTTATTACTGGGATTTTAAAAAACATTGGTAACATCGCAGCTTA  231 
CAACAAAGTTATTGAGCTTTTAGTTGACTTTTTCAACAGCATCGGTTACAGAGCCGCGTA  240 
TAATATGTTTTTTGATTTTATAATTAAATTAGCTAAAGCAATCGGAATTGTCGGTGGCGT  237 
TAATATGTTTTTTGATTTTATAATTAAATTAGCTAAAGCAATCGGAATTGTCGGTGGCGT  237 
**  **  ****  **  *  *  *  **  **  **  * 
TAGTACTTGTGACTTCATAATGGATGAAGTTGAAGTACCAAAAGAATTAACACAATTACA  290 
TAGTACTTGTGACTTCATAATGGATGAAGTTGAAGTACCAAAAGAATTAACACAATTACA  291 
TATAAATTGTGATTTTTTATTGGACGAAGCTGAAGTACCAAAAGAATTAACTCAATTACA  300 
AAACGCTTGCAGCAGTTTATTTGATGAACCTAAAGTACCCGCTGAATTAACGAATTTATA  297 
AAACGCTTGCAGCAGTTTATTTGATGAACCTAAAGTACCCGCTGAATTAACGAATTTATA  297 
*  ***  **  *  **  ***  *  *******  ********  *  ***  * 
CGAATAATTTAAATAGAGAGTGT-GATAGTAGGTGGAATTATTAAATAGTTA-TAATTTT  348 
CGAATAATTTAAATAGAGAGTGT-GATAGTAGGTGGAATTATTAAATAGTTA-TAATTTT  349 
CGAATAACTATAAGAGAAAGTGT-GATAGTAAGTGGAAGCATTAAATGATTA-TAATTAC  358 
CGACAAATAGTAAAAGTTATTTTAGAAAGTGTGTAGCATATGGAAACAATAAACAACTTA  357 
CGACAAATAGTAAAAGTTATTTTAGAAAGTGTGTAGCATATGGAAACAATAAACAACTTA  357 
***  **  **  **  *  *  *  **  ***  **  *  *  ***  *  *  **  * 
GTTTTATTCGTATTAACTCAAATGATATTAATGTTTACAATACCAGCTATAATTAGTGGT  408 
GTTTTATTCGTATTAACTCAAATGATATTAATGTTTACAATACCAGCTATAATTAGTGGT  409 
GTTTTATTTGTAATTGTTCAAGTTTCATTAATGTTCTTTATATCTGCATTTATTAGTGGA  418 
GCTATGGCCACTTT---TCAATTAGTAATACTTTTTACAGTAGCCAAATTCATTTCCTTT  414 
GCTATGGCCACTTT---TCAATTAGTAATACTTTTTACAGTAGCCAAATTCATTTCCTTT  414 
*  *  *  ****  *  *  **  *  **  **  *  *  *** 
ATTAAGTACAGTAAACTTGATTATTTTTTCATTATAGGAATTTCGACATTATCGTTATTT  468 
ATTAAGTACAGTAAACTTGATTATTTTTTCATCATAGTAATTTCGACATTATCGTTATTT  469 
ATAAGATACAAAAAATCAGATTATATATACATTATTGGAATAGTGTTATCTTCAGTATAT  478 
GTTAAATTTAATTTAAGGGATTATTTTATTATAGTTGGAATTATAATTCCAACCATGTTT  474 
GTTAAATTTAATTTAAGGGATTATTTTATTATAGTTGGAATTATAATTCCAACCATGTTT  474 
******  *  **  *  *  ***  *  *  *  * 
CTATTTAAAATGTTTGATAGCGCGTCCTTAATCATTTTAACTTCATTCATTATTATAATG  528 
CTATTTAAAATGTTTGATAGCGCGTCCTTAATCATATTAACTTCATTTATTATTATAATG  529 
TTCTTTGACAAAATCGGAAGTATTTCACTAGTTGTTATAACAATTTTTATAATAATTTTT  538 
TTGTATTACTTCTATGGAAGTAGAGCCGTATTGATTCCAACTTTTTCATCTATCATATTT  534 
TTGTATTACTTCTATGGAAGTAGAGCCGTATTGATTCCAACTTTTTCATCTATCATATTT  534 
*  *  *  *  *  **  *  **  *  *  ***  *  **  ** 
TATTTTGTCAAAATCAAATGGTATTCTATTTTGTTGATTATGACTTCACAGATTATTCTG  588 
TATTTTGTCAAAATCAAATGGTATTCTATTTTGTTGATTATGACTTCGCAGATTATTCTA  589 
CTCTATTTTAAAATTAGACTATATTCTGTATTTTTAGTAATGGTTACTCAAATCATTTTA  598 
TTATTCTTTAAATTAAAGTACTATGCAATAGTAACAATTTTAGTGACCATGATCATAATG  594 
TTATTCTTTAAATTAAAGTACTATGCAATAGTAACAATTTTAGTGACCATGATCATAATG  594 
*  *  ***  *  *  ***  *  *  *  *  **  ** 
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TACTGTGCTAACTACATGTATATTGTTATATATGCATATATCACCAAGATTTCTGATAGT  648 
TACTGTGCTAACTACATGTATATAGTTATATATGCATATATCACCAAAATTTCTGATAGT  649 
TATTGTGCAAATTTCGTTTATATCATTATTTTTTCATACATTATAACAATTTCACACAGC  658 
TATTTGAGTAATTTTGCAACAGTAGGTTTGTTTTTAACTTTAAGAAAATACACTACTGAT  654 
TATTTGAGTAATTTTGCAACAGTAGGTTTGTTTTTAACTTTAAGAAAATACACTACTGAT  654 
**  *  **  *  *  *  *  *  *  *  *  *  * 
ATATTTGTAATATTCCCTAGCTTTTTTGTAGTTTATGTGACTATTAGTATACTATTCT-C  707 
ATATTTGTAATATTCCCTAGCTTTTTTGTAGTTTATGTGACTATTAGTATACTATTCT-C  708 
GTGTTTATAGTTCTACCAATCTTTTTGGTAGTGTATGTATCAATTTCTTATGCACTTG-C  717 
CCTGCAATACTCTTACCATTATATATACTTTCTTTTTCATCAGTTTCATTATTAGCCGAC  714 
CCTGCAATACTCTTACCATTATATATACTTTCTTTTTCATCAGTTTCATTATTAGC-GAC  713 
**  *  *  **  *  *  *  *  *  *  *  **  *  * 
ATATATAATAAATAGAGTTCTCAAAAAAATTAGCACACCATATCTAATACTAAACAAAGG  767 
ATATATAATAAATAGAGTTCTCAAAAAAATTAGCACACCATATCTAATACTAAACAAAGG  768 
CTACATTTTAAATAGAATATTAAAAAGGATAAATGGTACATACCTTTCTCTTAATAAAAA  777 
ATATTTGGTAAGAATATCTCTAAAGAAATTTAAAAAATCATACTTATCTTTAAATAAAAC  774 
ATATTTGGTAAGAATATCTCTAAAGAAATTTAAAAAATCATACTTATCTTTAAATAAAAC  773 
**  ***  *  *  *  **  *  *  *  ****  *  **  *** 
ATTTTTAATAGTTATTTCGACTATCTTACTGCTCACTTTTTCATTATTTTTCTTTTATTC  827 
ATTTTTAATAGTTATTTCGACTATCTTACTGCTTACTTTTTCATTATTTTTCTTTTATTC  828 
ATTCCTTACTGTTATAACTATTGTTATAGTAATAACATTCTCTTTGTTATTTGCATATTC  837 
TTATATGATTATAATTTCATTCGTATTATTTGCAACATTTGCATTTTTTTATATTTATTC  834 
TTATATGATTATAATTTCATTCGTATTATTTGCAACATTTGCATTTTTTTATATTTATTC  833 
*  *  *  *  **  *  *  **  *  **  **  *  **  **  *  ***** 
-ACAAATA--AACTCGGATGAAGCTAAAGTAATAAGGCAGTATTCTTTTATTTTTATTGG  884 
-ACAAATA--AACTCGGATGAAGCTAAAGTAATAAGGCAGTATTCTTTTATTTTTATTGG  885 
-GCAAATT--GATGCGAGTGATGCATCAACAATCAAACAGTATTCGCTTTTATTCTTGGG  894 
TACAAATACAAGTTCAAACGGTGATAGCTTAATT---CCATATGCACTTGTATTTATAGG  891 
TACAAATACAAGTTCAAACGGTGATAGCTTAATT---CCATATGCACTTGTATTTATAGG  890 
*****  *  *  ***  *  ***  *  **  *  **  *  ** 
TATCACTATATTTTTAAGTATATTAACATTTGTTATTTCTCAATTTCTCCTTAAAGAGAT  944 
TATCACTATATTTTTAAGTATATTAACATTTGTTATTTCTCAATTTCTCCTTAAAGAGAT  945 
AATTATTATATTACTGAGTATCTTAATTTTTATTTATTCTCAATTTACTCTTAAAGAAAT  954 
ATTAATAATTTTTATCTCTGTTGTAATACTTATAATGTCGCTTTTCACCCTTAAAGAGAT  951 
ATTAATAATTTTTATCTCTGTTGTAATACTTATAATGTCGCTTTTCACCCTTAAAGAGAT  950 
*  *  **  **  *  *  ***  **  *  **  *  **  ********  ** 
GAAATATAAACGTAATCAAGAAGAAATTGAAACCTATTA--------------- 983 
GAAATATAAACGTAATCAAGAAGAAATTGAAACCTATTA-GAATATAC------ 992 
GAAATATAAACGTAATCAAGAAGAAATTGAAACCTATTATGAATACACATTAAA  1008 
GAAATACAAACGAAATCAAGAAGAAATTGAGACCTATTACGAATACACATTAAA  1005 
GAAATACAAACGAAATCAAGAAGAAATTGAGACCTATTACGAATACACATTAAA  1004 
******  *****  *****************  ******** 
a:  Atypical avian S.  aureus isolates; b:Human S.  aureus isolate; c:  Typical avian 
S.  aureus isolates. 238 
d) Comparison of sequences of the agrD gene 
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'85 
b82 
CRN422 0 
d496 
24 
85 
82 
RN4220 
496 
24 
85 
82 
RN4220 
496 
ATGAATACACTTGTTAATATGTTTTTTGATTTTATAATTAAATTAGCTAAAGCAATCGGA  60 
ATGAATACACTTGTTAATATGTTTTTTGATTTTATAATTAAATTAGCTAAAGCAATCGGA  60 
ATGAATACATTATTTAACTTATTTTTTGATTTTATTACTGGGATTTTAAAAAACATTGGT  60 
ATGAATACATTATTTAACTTATTTTTTGATTTTATTACTGGGATTTTAAAAAACATTGGT  60 
ATGAAAAAATTACTCAACAAAGTTATTGAGCTTTTAGTTGACTTTTTCAACAGCATCGGT  60 
*****  *  *  *  *  **  **  ****  **  *  *  *  **  ** 
ATTGTCGGTGGCGTAAAC-GCTTGCAGCAGTTTATTTGATGAACCTAAAGTACCCGCTGA  119 
ATTGTCGGTGGCGTAAAC-GCTTGCAGCAGTTTATTTGATGAACCTAAAGTACCCGCTGA  119 
AACAT-CGCAGCTTATAGTACTTGTGACTTCATAATGGATGAAGTTGAAGTACCAAAAGA  119 
AACAT-CGCAGCTTATAGTACTTGTGACTTCATAATGGATGAAGTTGAAGTACCAAAAGA  119 
TACAG-AGCCGCGTATATAAATTGTGATTTTTTATTGGACGAAGCTGAAGTACCAAAAGA  119 
*  **  **  *  *** 
ATTAACGAATTTATACGACAAATAG  144 
ATTAACGAATTTATACGACAAATAG  144 
ATTAACACAATTACACGAATAA--- 141 
ATTAACACAATTACACGAATAA--- 141 
ATTAACTCAATTACACGAATAA--- 141 
******  *  ***  ****  ** 
**  *  **  ***  *  *******  ** 
a:  Typical avian S.  aureus isolates (group II of the autoinducing peptides); 
b:  Atypical avian S.  aureus isolate (group I of the autoinducing peptides); 
c:Human S.  aureus isolate (group I of the autoinducing peptides); 
d:  Atypical avian S.  aureus isolate (group III of the autoinducing peptides). 6. REFERENCES 239 
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